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Abstract
This research characterized the cells used in the formation and growth of substitute 
arteries for use in treatments such as bypass surgery. Two cell types including 
immortalized rat smooth muscle cells (rSMCs) and adult human mesenchymal stem 
cells (hMSCs) were used to study this tissue engineered blood vessel system. Sodium 
alginate was used as the natural polymer to construct the tubular three-dimensional 
construct. Normally biologically inert, the alginate was modified to incorporate 
GRGDY peptides using carbodiiamide chemistry to provide cell adhesion sites for the 
cells.
The growth characteristics of the rSMCs and hMSCs in tissue flasks were established. 
Each cell source was assessed according to the viability post-thaw and at each 
passage, the cell yield and the glucose concentration in the spent medium. Following 
these measurements, the population doubling per day, the specific growth rate and the 
glucose consumption rate of the cells were calculated. Concurrently, the alginate was 
formed into sheets, beads or hollow tubes and the interaction of the cells with the 
alginate was studied. The biological activity of the alginate matrices was assessed by 
observing the cells’ interaction with the matrices. Measurements such as viability of 
the cells post-immobilization into the alginate, cell growth and glucose consumption 
were made and compare to data for cell growth in tissue flasks. The survival and 
metabolic activity of the cells within the alginate matrices were also measured using 
the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. 
Modifications were made to dissolve the cell/alginate matrix and incorporate a frozen 
storage step for analysis of time course samples.
Both the rSMCs and hMSCs readily attached and elongated when seeded onto the 
surface of alginate-GRGDY hydrogel sheets. However, only the hMSCs attached and 
elongation when immobilized within the alginate-GRGDY tubes and beads. 
Differentiation studies were conducted on the hMSCs immobilized within alginate- 
GRGDY beads using conditioned-medium (microfiltrate) from rSMC co-cultures. 
Expression of the hMSC surface markers SH2 and SH4 were lost after 6 days in co­
culture. Immunohistological preparations of the beads confirmed the hMSCs 
expressed a-smooth muscle actin (ASMA). Control cultures of hMSCs in alginate-
GRGDY beads placed in unconditioned medium retained their expression of SH2 and 
SH4 and did not express ASMA. Using the MTT assay, the hMSCs were shown not 
to proliferate in unmodified alginate and alginate-GRGDY beads over the 2 week 
period examined.
Note to reviewers
This thesis is written in American English.
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1. Introduction
In this age of biomedical discovery, it has become more of a potential reality that 
damaged or failing organs or tissue can be restored using replacements that are 
natural, synthetic or a combination of both. Although still in its infancy, tissue 
engineering has become a promising field (section 1.1). Advances in biomaterial 
science and successful delivery of bioactive substances, such as growth factors to 
develop tissue, have paved the way for viable prospects for tissue engineered 
matrices. Several companies have approved tissue engineered products in the 
marketplace, mostly serving as structural tissue substitutes including skin, cartilage 
and bone (section 1.2). However, more recently there has been a resurgence of 
companies focused in the cellular and metabolic sectors.
This research project was focused on vascular tissue engineering. The medical 
requirement for small diameter (<5-6mm) vascular grafts represents an unmet need in 
coronary and peripheral bypass surgeries. Currently surgeons must harvest vein or 
artery from other locations in the patient’s body to replumb blocked arteries. The 
pathology of coronary heart disease and the corrective procedure for bypass surgery 
are described (section 1.3.1) with emphasis placed on the patency of the autografts 
currently being used. In addition the cellular composition and physical properties of 
native blood vessels are detailed (section 1.3.2). Although synthetic grafts have been 
developed and are in surgical use for larger diameter vessels with high flow; these 
materials are not suitable for low flow or small diameter sites (Teebken and Haverich,
2002). The synthetic and natural materials being investigated for use in tissue 
engineered vascular grafts and the approaches of different research groups are 
discussed (section 1.4). Cell-seeded vascular grafts that better mimic native vessels 
have met with some preliminary success (Mitchell and Niklason, 2003). The types of 
cells available for use in a tissue engineered blood vessel (TEBV) are discussed 
(section 1.5). In addition, bioactive substances such as adhesion molecules or growth 
factors that can be incorporated into the TEBV are reviewed (section 1.6). Finally in 
the context of this overview, the research plans for this doctoral thesis are described 
and include the materials, bioactive substances and cells selected for investigation 
(section 1.7).
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1.1 The nature of tissue engineering 
Historically, medical treatments for damaged or failing organs or tissue have included 
transplantation, surgical repair, artificial prostheses, mechanical devices or drug 
therapy (Persidis, 1999). However, many limitations exist in these options due to the 
lack of availability of donor organs, advanced progression of the disease state, and 
lack of compliance of artificial prostheses to allow growth. Tissue engineering has 
become a promising solution as a component of regenerative medicine; that is, using 
living cell substitutes to restore or improve lost tissue function or structure (Ross, 
1998; Niklason and Langer, 2001).
One approach to tissue engineering is simple in that it just includes injecting a 
bioactive substance, such as a growth factor, into the damaged tissue or organ. That 
substance recruits the patient’s own cells to migrate into the desired area, and 
encourages proliferation or differentiation to reform new healthy tissue. Delivery of 
the substance can be time-released. A slightly more complex approach is delivery of 
live cells that produce the desired bioactive product. In this cell therapy approach, the 
cells could remain isolated from the patient if there is incompatibility issues; or they 
could repopulate the diseased tissue or failing organ if there is not. The most 
complex and challenging approach involves the patient receiving a three-dimensional 
structure that may contain a combination of cells, scaffold or support material, and 
bioactive substances. The cells can be obtained from the patient’s own cells 
(autologous) or from a donor source (allogeneic). The scaffold can be composed of 
natural or artificial materials, and be biodegradable or non-biodegradable. The 
bioactive substances can be growth factors, hormones, peptide sequences or protein 
coatings to promote cell attachment, migration and/or proliferation. Then the entire 
3-D structure is transplanted into the damaged site where the cells proliferate and/or 
the patient’s cells are recruited and organized into new tissue. As the tissue matures, 
the scaffold material can degrade, leaving only tissue (Persidis, 1999; Vacanti and 
Langer 1999; Niklason and Langer, 2001; Griffith and Naughton, 2002).
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1.2 The current status of tissue engineering/cell therapies
Tissue engineering applications already exist for angiogenesis stimulating molecules 
for production of blood vessels from existing cells (Laham, 1999; Francis, 2001; 
Rasmussen, 2002), and for creation of structural tissue such as skin, bone and 
cartilage (Brittberg, 1994; Wilkins, 1994; Howell, 1995). Success in these areas has 
stemmed from advances in biomaterials and development of tissue via delivery of 
bioactive substances such as growth factors. A variety of methods can be used for 
delivery of the bioactive substances to the target tissue. One method is using 
controlled delivery using transdermal patches or injectable, biodegradable hydrogels 
or polymers with distinct release kinetics (Laham, 1999; Richardson, 2001; Perets, 
2003). An alternative method of delivery is introducing genes coded for these 
substances in the form of plasmid DNA or using viral vectors (Wright, 2001; 
Rasmussen, 2002). Both delivery methods result in transient expression of the 
substance; however the gene delivery approach may result in longer term expression. 
These substances can also be incorporated within the pre-formed scaffold material 
which will help promote tissue growth at the same time as the scaffold material 
degrades (Simmons, 2004). In late 2002, Curis (previously Creative Biomolecules, 
Cambridge, MA) partnered with J&J Ortho Biotech to conduct human clinical studies 
on their bone morphogenic protein (BMP-7) product (www.curis.com). A number of 
proof-of-concept studies using virus-based or plasmid-based gene delivery of vascular 
endothelial growth factor (VEGF) or fibroblast growth factor (FGF) have been 
successfully conducted for treatment of coronary artery disease (CAD) or peripheral 
vascular disease (PVD) (Laham, 1999; Rasmussen, 2002).
Initially most regenerative scaffolds were produced from components of the natural 
extracellular matrix (ECM) or from a synthetic polymer material and have focused on 
the structural area of the market in skin-equivalents (Mooney and Mikos, 1997; 
Persidis, 1999; Vacanti and Langer, 1999). Decellularized allogeneic (same species) 
and xenogeneic (different species) tissues as well as purified matrix proteins, such as 
collagen and glycosaminoglycans, have been used. Some successful approaches use 
decellularized tissue including LifeCell (The Woodlands, Texas, USA) with their 
product, AlloDerm®, which is a decellularized human dermal tissue for skin 
replacement (www.lifecell.com). Medtronics (Minneapolis, Minnestota, USA) and
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Edwards Lifesciences LLC (Irvine, California, USA) have FDA approval for 
decellularized porcine heart valves (www.medtronic.com;
www.edwardslifesciences.com; Persidis, 1999). More recently OsteoBiologics, Inc. 
(San Antonio, Texas, USA) obtained 510(k) clearance from the FDA in July, 2003 to 
license PolyGraft BGS, a porous scaffold as a bone graft substitute. It consists of a 
patented blend of polylactide-co-glycolide, calcium sulfate and polyglycolide fibers, 
making it the first polymeric bone void filler to be cleared by the FDA 
(www.obi.com).
Greater success in promoting structural tissue development was achieved by seeding 
scaffold material (usually synthetic polymers or collagen) with cultured cells. In May 
1998, Apligraf™ (Organogenesis, Canton, Massachusetts, USA) was the first ‘living’ 
tissue engineered product to obtain FDA approval for treatment of venous leg ulcers. 
Human allogeneic dermal cells (fibroblasts) and epidermal cells (keratinocytes) were 
seeded onto a bovine collagen (Type 1) matrix which developed in 20 days into a 
viable skin construct (Wilkins, 1994; www.apligraf.com). Similarly Dermagraft® was 
Advanced Tissue Sciences’ (La Jolla, California, USA) skin replacement consisting of 
living human dermal fibroblasts on a bioabsorbable scaffold for skin ulcers. 
Dermagraft® was an improvement over their first product, TransCyte®, which was 
the first human based temporary skin substitute for treatment of bums to be approved 
by the FDA in 1997 which consisted of a human dermal with synthetic epidermal 
layer as an alternative to cadaver skin (www.dermagraft.com; http://wound.smith- 
nephew.com; Persidis, 1999).
For other structural tissue, Genzyme Biosurgery (Cambridge, Massachusetts, USA) 
received FDA approval for Carticel®, which was the first product which used 
patient’s own (autologous) chondrocytes to replace cartilage in traumatic knee- 
cartilage damage (www.carticel.com; Mooney and Mikos, 1997; Persidis, 1999). 
Biotissue Technologies GmbH (Freiburg, Germany) have obtained a German 
commercial license for 5 products consisting of three-dimensional grafts seeded with 
cultured autologous cells. BioSeed®-Oral Bone, approved in 2001, utilizes 
autologous periosteum cells removed from the patient’s jaw, which are cultivated in 
vitro in autologous blood serum for ca. 7 XA weeks and seeded onto a 3-D matrix for
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strengthening and replacing missing jawbone material. They have similar autologous 
products for chondrocytes cultured 3-6 weeks in autologous blood serum, seeded onto 
a resorbable ‘fleece’ and placed into the cartilage defect site which was approved in 
2001. Finally their product for skin cells (keratinocytes) cultured 2-3 weeks in vitro, 
mixed within a fibrin adhesive gel and applied to leg ulcers, was approved in 1999 
(www.biotissue-tec.com).
The field of dentistry also has effectively integrated the advancements in biomaterials, 
gene therapy, and tissue engineering. Growth factors (GF) have promoted periodontal 
tissue regeneration and alveolar bone repair in the oral cavity in varying degrees 
(Giannobile, 1996). Future studies require longer term GF release by refining the 
methods of delivery. Rutherford (2002) demonstrated formation of bone in vivo using 
porous biodegradable scaffolds (Matrigel and rat-tail collagen) implanted with dermal 
fibroblasts transduced with bone morphogenesis protein (BMP)-7 ex vivo using a 
recombinant adenovirus (AdCMVBMP). Rutherford is now CSO of Dentigenix Inc. 
(Seattle, Washington, USA) which has projects in development that treat and repair 
progressive destruction of tooth enamel and dentin by encouraging remineralization 
(www.dentigenix.com).
In 2000, the first phase I human trial using autologous skeletal myoblasts 
transplantation into ischemic myocardium (heart muscle with decreased blood flow) 
was conducted. Although the trial was only 10 patients and had no control group, 60% 
of the cell-implanted scar areas showed systolic thickening (increase in apparent 
tracer activity during systolic contraction) (Menasche, 2003). Other similar clinical 
trials are underway.
The cellular sector of tissue engineering has progressed significantly due to stem cell 
technologies and therapeutic cloning advances. There are a number of small biotech 
companies in clinical development. Osiris Therapeutics (Baltimore, Maryland, USA) 
has entered clinical trials with several products using adult human mesenchymal stem 
cells (hMSCs). They are in Phase II development of allogeneic bone marrow or blood 
stem cell transplants to improve engraftment of blood cells after transplantation.
They have completed a Phase I study for delivery of autologous hMSCs on a 
hydroxyapatite matrix into the jaw to promote new bone formation in preparation for
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dental implants. They have also conducted large animal studies for delivery of 
hMSCs into damaged myocardium and for hMSCs suspended in hyaluronan into 
damaged meniscus of the knee (www.osiristx.com). StemCells Inc. (Palto Alto, 
California, USA) have succeeded in identifying and sorting neural stem cells using 
surface markers (Uchida, 2000), and are in preclinical development of neural stem 
cell transplantation into the brain to treat neurological disorders such as Parkinson’s 
and Alzheimer’s disease (www.stemcellsinc.com).
Advances in the tissue engineering field also have offered great potential for drug 
screening and toxicity testing for consumer health products and pharmaceutical 
products. MatTek Corporation (Ashland, Massachusetts, USA) has three product 
lines for in vitro means of assessing dermal irritancy and corrosivity. EpiDerm™, is a 
skin model which is derived from normal, human derived epidermal keratinocytes 
which have been cultured to form a multi-layered, highly differentiated model of the 
human epidermis. Similarly, EpiOcular™ is a model for the cornea and EpiAirway™ 
uses tracheal/bronchial epithelial cells for a model for epithelial tissue of the 
respiratory tract (www.mattek.com). These products offer a promising alternative to 
animal testing (Persidis, 1999). Biopredic International (Rennes, France) has 
developed Liverbeads™, hepatocytes entrapped within an alginate matrix, which have 
shown suitability as a tool for toxicology testing (Vian, 2002).
At the end of 2002, 10 tissue-engineering products were in various stages of clinical 
trials; however 6 products had either failed or were abandoned. Two products, 
CytoTherapeutics’ acute hepatic assist device and Circe’s encapsulated cells for 
chronic pain, failed at Phase III efficacy because the trials were not powered to 
produce statistically significant end points (Lysaght and Hazlehurst, 2004). Financial 
challenges of development, manufacture, testing, distribution and poor market 
acceptance caused the industry leaders, Organogenesis and Advanced Tissue 
Sciences, to file for Chapter 11 and reorganize under new organizations (Novartis and 
Smith and Nephew, respectively) in late 2002. These tissue engineering companies 
held a large number of patents; however in order to convert these into revenue and 
profit streams, they needed to form alliances, such as marketing and distribution 
agreements, to enable them to realize the potential of their inventions (Pangarkar and
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Hutmacher, 2003). Both companies suffered pressures created by slow regulatory 
approval, reduction in product pricing for coverage under US national insurance 
policies, competitors entering the market, and highly laborious and expensive 
manufacturing process prone to introduction of microbial contaminations (Stone,
2003). In order to be successful, new tissue engineering applications need to be 
designed to be highly automated and streamlined from platform technologies when 
feasible such that new applications can be addressed within the company’s existing 
equipment and GMP facilities to decrease time to market (Mason, 2003a & 2003b; 
Naughton, 2002). Finally due to the failure of these companies in the structural 
sector of tissue engineering and the rapid emergence of stem cell technology and 
therapeutic cloning, there has been a dramatic shift in the specialization area of tissue 
engineering firms between 2000 and 2002. Growth in the cellular sector increased by 
37%; whereas growth in the structural area decreased by 50%, and the metabolic area 
decreased by 33% (Lysaght and Hazlehurst, 2004).
1.3 Vascular tissue engineering
There are two main fields of research in vascular tissue engineering: one based upon 
cell seeding of synthetic polymers and the other based upon creating a completely 
biological scaffold. For either, the vascular graft must be biocompatible and have 
adequate mechanical strength, durability and compliance comparable to the existing 
vessel (Nerem, 2000; Teebken and Haverich, 2002). In addition the construct must 
have versatility, ease of use in terms of suturability and availability, and also have 
suitability of cost for health care management (Niklason and Langer, 2001; Mason, 
2003b). Before discussing the current prospects for a tissue engineered blood vessel, 
a brief background is provided consisting of an introduction to coronary heart disease, 
an overview of the existing vascular autografts used for bypass surgery, and 
information relevant to blood vessel composition and important properties.
1.3.1 Coronary heart disease and bypass surgery 
Advanced progression of arteriosclerosis leads to narrowing of the coronary arteries 
and weakening of the wall of the heart, the myocardium. A heart attack, or 
myocardial infraction, will eventually occur unless surgery is performed to bypass the 
blocked arteries. The surgeon uses existing vessels in the patient’s body (autografts, 
e.g. the mammary arteries in the chest or the saphenous veins in the legs); however,
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these vessels must be disease free and accessible (not removed from a previous 
surgery). The removal of the vessel adds additional complications to the surgery.
The side branches of the vessel must be removed and stitched closed. Figure 1 shows 
the placement of the graft on the heart. Since over a half million coronary artery 
bypass graft (CABG) surgeries are performed in the United States alone, the potential 
benefit of an alternative vessel is enormous (Nerem and Seliktar, 2001). The 
saphenous vein (SV) remains the most commonly used conduit for CABG; however, 
the long term outcome of SV grafts shows limitations due to stenosis (narrowing of 
the graft) and subsequent occlusion (obstruction or closure) of the grafts (Davies and 
Hagen, 1995). After CABG surgery the SV is exposed to increased blood flow and 
pressure which is not the usual milieu of the veinous system. These changes trigger 
the SV grafts to remodel improperly following exposure to the arterial hemodynamic 
environment. In ex vivo studies mimicking this change, the production of matrix 
metalloproteinase decreased by 50% and cell proliferation was stimulated 220% to 
750% - both conditions are undesirable consequences (Mavromatis, 2000). In 
addition, progression of atherosclerosis in SV grafts is the predominant cause of late 
graft closure after CABG. Only 60% of SV grafts are patent (i.e. unblocked) between 
10-12 years after surgery. Of patent grafts, 45% show evidence of atherosclerosis 
with 70% of the vessels’ lumen blocked 50% or greater (Bourassa, 1984). Internal 
mammary artery (IMA) grafts have been shown to be significantly better than SV 
grafts (Loop, 1986). At 10 years, 84% of IMA grafts were patent versus 53% of SV 
grafts (Grondin, 1984). However these IMAs have limited length and can only be 
used to bypass near the beginning (proximal end) of the coronary arteries. Surgery 
time is also longer due to the extra time needed remove them from the chest wall; 
therefore they cannot be used during emergency CABG. The radial artery has also 
been used with success, but their patency rates compared to SV grafts remain disputed 
(Khot, 2004; Zacharias, 2004).
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Figure 1. Schematic o f the coronary artery bypass graft. Cholesterol buildup in the 
native coronary arteries eventually blocks the flow o f blood causing the heart muscle 
to die. The bypass graft, usually saphenous vein from the leg, is sewn between the 
aorta and the coronary arteries beyond the blockage; or the internal mammary artery 
is joined to the coronary artery (from www.mercksource.com).
Blood vessels are composed of concentric layers of three cell types: endothelial, 
smooth muscle and fibroblast that are schematically depicted in Figure 2. The 
innermost layer (intima) surrounding the central lumen, through which blood flows, is 
lined with endothelial cells (ECs) which are one cell layer thick. The center core o f 
the vessel wall (media) consists of several layers of smooth muscle cells (SMCs), ca. 
200pm thick, which provides the mechanical strength of the structure and the 
capability of the vessel to dilate or contract. The outer surface (adventitia) o f the 
SMCs is covered by a layer of fibroblast cells that provide the connective tissue where 
nerve cells are also located (Nerem and Seliktar, 2001; Junqueira, 1998).
The extracellular matrix (ECM) that surrounds these cells consists of a complex 
network of proteins and glycoaminoglycans. The ECM organizes the cells in space, 
regulates the cells by providing environmental signals, and maintains the separate 
tissue space. The physical and chemical interactions between the cells and ECM are
1.3 .2 The nature of blood vessels
1.3.2.1 Cellular composition
- 2 7 -
bidirectional and constantly changing. The feedback is cyclical -  the cells receive 
environmental cues from the ECM and then the cells remodel their ECM in response 
to the cues (Ross, 1998; Hubbell, 2000). The ECM controls cell behavior by 
providing adhesion signals, growth factor binding sites and degradation sites as cells 
migrate (Roskelley, 1995). Interactions between the cells and ECM are mediated by 
cell surface glycoprotein and proteoglycan receptors interacting with proteins which 
include cadherins, selectins, and immunoglobins denoted as cell adhesion molecules 
(CAMs), and integrins. Integrins are involved in both cell-cell and cell-ECM binding. 
The other three receptor proteins are involved primarily in cell-cell binding. Collagen 
is the primary structural protein and interacts directly with integrins. Fibronectin, 
vitronectin and laminin are other major adhesion proteins in the ECM (Hubbell,
2000). Elastin acts as a recoil protein that maintains the compliance of the vessel 
allowing it to stretch and then return to its original size with changes in pressure 
(Mitchell and Niklason, 2003).
1.3.2.2 Physical properties 
Arterial pressure ranges up to 200mmHg; and native arteries have been shown to 
withstand a high rupture or burst pressure >2000mmHg (Nerem, 2000). Blood vessel 
cells are exposed to cyclical strain due to the fluctuation of blood pressure from the 
heart pumping blood through the body. In addition, the endothelial cells are exposed 
to shear stress due to the blood flow through the central lumen and must be non- 
thrombogenic (non-clotting) (Gooch, 1998). The ECs respond to increased or 
decreased blood flow by releasing factors (e.g. endostatin) which in turn cause the 
SMCs to contract or dilate. ECs also respond to flow by elongating and aligning 
parallel to the flow (Sato and Ohshima, 1994; Thoumine, 1995). The cells must be 
able to repair and replenish as needed (Nerem and Seliktar, 2001). In contrast, veins 
carry de-oxygenated blood back to the heart and as a result are from a 
correspondingly lower pressure system. Their cellular composition is the same as 
arteries, but the layers are thinner (Junqueira, 1998).
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Figure 2. Composition of a blood vessel. The intima (inner layer) is composed of 
ECs, the media (center) is composed of SMCs, and the adventitia (outer layer) is 
composed of fibroblasts (adapted from Nerem and Seliktar, 2001).
Current CABG surgery has a reasonable success rate using autografts (e.g. SV and 
IMA), although long term patency (state o f remaining unblocked) remains an issue.
A suitable tissue engineered blood vessel (TEBV) would have to be proven to be a 
considerable improvement over the current option of autografts from vein and artery. 
It would have to be nearly 100% compliant to all of the physical and mechanical 
properties (e.g. strength, elasticity) o f native vessel. It should be easy to prepare and 
suture by the surgeon and be o f adequate length (ca. 6-12in/bypass). In addition, most 
CABG surgeries involve 2-4 arteries being bypassed. The replacement vessels must 
be free from contaminating microorganisms and must not be immunogenic since 
either would lead to thrombosis and/or inflammation which results in rejection 
(Mitchell and Niklason, 2003). The cells, in particular the endothelial cells (ECs), at 
minimum would need to be human leukocyte antigen (HLA) matched as is currently 
required for hematopoietic stem cell transplantation (HSCT) (Storb, 2003). HLA 
molecules are the alloantigens that trigger immune recognition and graft rejection in 
unmatched recipients (Parham, 1999). The ECs must be assembled in a confluent 
monolayer in order to prevent thrombosis. The cells must be viable and functional.
In addition, the orientation of the cells and creation of ECM are critical for
mechanical strength and vasoactivity of the construct. The smooth muscle cells and 
structural fibers (e.g. collagen and elastin) must be orientated around the 
circumference of the vessel (Nerem and Seliktar, 2001).
1.4 Materials for bioengineered blood vessels 
In order to be used for transplantation, matrix components of a tissue engineered 
product must be non-toxic, biocompatible, non-immunogenic and pyrogen free -  that 
is clear of components such as proteins, complex carbohydrates and nucleotides from 
microorganisms (Skjak-Braek, 1989). Synthetic substrates should mimic natural 
extracellular matrices such that the architecture and surface biochemistry of the target 
tissue (e.g. collagen and fibronectin) enhances the development of functional 
replacement organs (Niklason and Langer, 2001).
Initial research to develop replacement vessels centered on synthetic materials such as 
Dacron™ or expanded polytetrafluoroethylene (ePTFE). These artificial materials 
have had success in humans when autologous vessels were not available for 
peripheral bypasses in large diameter (6- 10mm) vessels and higher flow areas (above 
knee) (Tiwari, 2002b; Klinkert, 2004). However, when applied to low flow (below 
knee) or smaller diameter (3-4mm) vessels, thrombosis set in and closed the vessels 
off. Efforts were then focused to reduce these thrombotic effects by improving the 
surfaces of the synthetic polymers to permit seeding of autologous endothelial cells 
(ECs) (Deutsch, 1999). Despite these improvements, the EC-seeded synthetic grafts 
prohibit long-term adaption of a normal vascular system that permits a response to 
remodeling of cells and ECM (described in section 1.3.2.1). Therefore alternative 
approaches include the use of natural material such as collagen or biodegradable 
synthetic polymers such as PGA that permit the cells to remodel collagen and elastin 
as the original construct gradually decomposes (Nerem and Seliktar, 2001).
Most tissue-derived cells are anchorage dependent and require attachment to a surface 
for viability and growth. Therefore, the surface must promote cell adhesion, 
spreading, migration, and differentiated cell function (Saltzman, 2000). The surface 
chemistry of many polymers has been altered to improve these cellular functions.
1.4.1 Synthetic matrix materials 
Polymers are made more suitable for cell attachment and growth by surface 
modification. Polystyrene (PS), which is commonly used for tissue flasks and 
microwells, can be modified to increase the number of charged groups at the surface. 
This is commonly done through treatment by radiofrequency plasma deposition or 
exposure to sulfuric acid (Ertel, 1990). The optimal surface for cell adhesion has an 
intermediate wettability and high surface free energy which allows cell adhesion 
proteins to adsorb to the surface. Alternatively, polymer surfaces are treated with 
purified protein solutions (such as fibronectin, collagen and other extracellular matrix 
(ECM) proteins) that permit cell adhesion (Ross, 1998). The more sophisticated 
polymer studies now incorporate smaller biologically active functional groups of the 
ECM that produce surfaces that are simpler and easier to characterize (Saltzman,
2000). The major cell binding peptide is arginine, glycine, and aspartic acid (RGD) 
which is the base amino acid sequence found in fibronectin, vitronectin, collagen and 
thrombospondin which only differ by a flanking residue. Another cell binding 
domain sequence is the laminin pentapeptide -  tyrosine, isoleucine, glycine, serine, 
arginine (YIGSR) (Hubbell, 2000).
A variety of approaches are currently being used to develop compliant grafts for a 
tissue engineered blood vessel (TEBV). Many of these involve the fabrication of a 
tube using 1) non-degradable polymers such as polyethylene tetraphthlate (Dacron™), 
expanded polytetrafluoroethylene (ePTFE) (Nerem and Seliktar, 2001), MyoLink™ 
which is composed of poly(carbonate-urea)urethane (Tai, 2000 and Tiwari, 2002b);
2) biodegradable polymers including polyglycolic acid (PGA) (Niklason, 1999), 
poly(L-lactic acid) (PLA), poly(lactide-coglycolide) (PLGA), and a copolymer of 
lactic acid and e-carprolactone [P(CL/LA)J (Shin’oka, 2001); and
3) photopolymerized hydrogels consisting of poly(ethylene oxide) PEG (Mann,
2001) and polyvinyl alcohol (PVA) (Schmedlen, 2002). Some of these polymers 
(PLA, PGA, PLGA) have been used as suture material for several decades since they 
are biodegradable (Saltzman, 2000). Many of these polymer constructs include 
surface treatments to improve hydrophilicity, porosity, and protein adsorption by 
addition of coatings (such as plasma or fibronectin) or adhesion factors (such as
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RGD-containing peptides) to improve vascular cell attachment onto the surface of 
these scaffolds (Deutsch, 1999; Salacinski, 2000).
Dacron and PTFE are the most widely used synthetic polymers for peripheral bypass 
when acceptable autologous saphenous vein (SV) is not available because the patency 
of SV is still greater than PTFE. One survey of surgical cases showed SV was 81% 
patent at 2 years versus 69% for PTFE. At 5 years, patency was 69% versus 49%, 
respectively (Klinkert, 2004). Long term patency of the ePTFE femoropopliteal 
bypass graft (vessel located above or below the knee) was improved by clinical in 
vitro endothelialization. The 9-year patency rate was 65% for the 6mm 
endothelialized graft versus 16% for the control (non-treated) graft (Deutsch, 1999).
Despite markedly improved studies using endothelialized grafts, these synthetic 
materials are rigid and have been shown to have poorer compliance when used in low 
flow states such as below knee bypass and in vessels with <6mm in diameter (Tiwari, 
2002b). MyoLink™ which is composed of poly(carbonate-urea)urethane (CPU) has 
demonstrated success in larger diameter vessels. It is being used worldwide as a 
peripheral arteriovenous fistula graft (abnormal channel between an artery and vein 
which bypasses the capillaries) and has shown patency for over 36 months in a dog 
aorta model. Its compliance was shown to be comparable to native artery; whereas 
Dacron and ePTFE have lower compliance and stiffness values differing significantly 
from artery (Tai, 2000). More recently, RGD and heparin were covalently 
immobilized onto the surface of MyoLink™ to help improve human umbilical vein 
endothelial cell (HUVEC) attachment and retention and to enhance anticoagulant 
properties of the graft under pulsatile flow as shown in in vitro studies (Tiwari, 
2002a). In addition, sodium alginate was coated onto the surface of Dacron grafts to 
increase the imperviousness of the grafts and found to be equivalent to other sealants 
used including collagen, gelatin and albumin in a canine model (Lee, 1997). Prior to 
bankruptcy, Advance Tissue Sciences was developing a TEBV consisting of a 
polyurethane scaffold seeded with both SMCs and ECs because polyurethanes have 
the appropriate elastic properties and have been used in vascular applications 
(Ratcliffe, 2000). Finally a degradable, biocompatible, porous polyesterurethane
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polymer, DegraPol®, has been tested for cartilage and bone (Yang, 2003) as well as 
in a porcine stent with good function over 3 months (Schob, 1997).
Niklason (1999) has developed a biodegradable PGA scaffold chemically modified 
with sodium hydroxide which caused increased hydrophilicity, absorption of serum 
proteins and SMC attachment. After seeding and 8 weeks of culture under pulsatile 
flow, the gross appearance of the vessels was similar to native arteries. The pulsatile 
flow was shown to increase collagen deposition by the SMCs. The grafts were shown 
to be patent in a swine model using autologous SMCs and ECs cultured under 
pulsatile flow in vitro and then implanted and monitored out to 4 weeks (Niklason, 
1999).
Shin’oka (2001) successfully implanted a TEBV into a 4 year old Japanese girl with a 
totally occluded right intermediate pulmonary artery in 1999. Cells were obtained 
from a peripheral vein biopsy and expanded in vitro for eight weeks prior to seeding 
onto a copolymer of e-caprolactone and lactic acid [P(CL/LA)] reinforced with woven 
polyglycolic acid (PGA). Ten days after seeding the graft was transplanted, and no 
postoperative complications occurred. Since this landmark operation, this procedure 
was successfully repeated on 22 patients using cells obtained from autologous bone 
marrow cells (BMCs) which were seeded onto the scaffold on the day of surgery -  
with no maturation in vitro (Matsumura, 2003a). This modified procedure was 
performed using a woven fabric reinforcement of polylactide acid (PLA) instead of 
PGA. Separate large animal studies using BMCs labeled with green fluorescence 
indicated that the BMCs enable the establishment of this graft as indicated by the 
expression of endothelial cell and smooth muscle cell markers, and the production of 
vascular endothelial growth factor (VEGF) and angiopoietin-1 by the cells 
(Matsumura, 2003b). Shin’oka and Matsumura’s work represents the only human 
studies successfully performed with cell-seeded, biodegradable TEBVs.
Due to the harsh manufacturing conditions, these aforementioned polymer grafts are 
fabricated first, and then in a second step the cells are seeded onto the graft. Other 
polymers have been developed that form hydrogels that are “castable” during seeding 
such as the photodimerizable hydrophilic copolymer acryloyl-poly(ethylene glycol) 
PEG that has also incorporated a cell adhesive ligand KQAGDV (Lys, Gin, Ala, Gly,
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Asp, Val). This hydrogel polymer was shown to support rat SMC growth (Mann,
2001). Some other synthetic hydrogels include: photopolymerized poly (ethylene 
glycol) di-[ethyl phosphatidyl (ethylene glycol) methacrylate] “PhosPEG-dMa” 
(Wang, D., 2003), photopolymerized polyvinyl alcohol (PVA) with peptide RGDS 
(Schmedlen, 2002), and photopolymerized N, N-dimethylacrylamide-acryloxy 
succinimide with peptide GGGRGDSP (Moghaddam and Matsuda, 1991). These 
synthetic hydrogels and natural hydrogels, such as chitosans (Chung, 2002) and 
sodium alginate (Rowley, 1999), have been shown to be compatible for cell 
association and growth; however they have not yet been studied for their capability to 
form a compliant TEBV.
Synthetic materials can be well-characterized and the manufacturing process can be 
tightly controlled; therefore the regulatory issues surrounding use and fabrication of 
synthetic materials are less troublesome than natural materials. Many polymers are 
already used in biomedical devices. Some synthetic materials do not break down nor 
have the ability to remodel, so determination of the long term patency of a tissue 
engineered product will be critical to determine if the application is suitable for 
human use. The degradation rate and the local effect of the by-products of 
biodegradable polymers must be well understood. Although deemed an early 
successful model for a TEBV candidate, the by-products of PGA have recently been 
reported to have undesirable effects on the SMCs during decomposition in vitro.
Local areas containing residual polymer were found to contain SMCs with increased 
proliferation rate and dedifferentiated phenotype (Higgins, 2003).
1.4.2 Natural matrix materials 
The use of a natural, biological material for developing a blood vessel has an 
advantage over use of an artificial matrix since the body can remodel the system. 
However, natural materials may be prone to immunological response if they are 
derived from animal proteins. In addition, there are substantial regulatory issues that 
need to be overcome surrounding the likelihood of transmission of adventitious agents 
from the material. Recombinantly produced or non-animal derived natural materials 
would be less contentious. Fibronectin-fibrinogen, collagen and sodium alginate are 
described in this section as possible TEBV materials. Finally the production of a
blood vessel from a cell-generated ECM matrix consisting of over confluent 
monolayers of SMCs and fibroblast cultures is described.
1.4.2.1 F ibronectin-fibrinogen
Fibronectin is a well-characterized cell adhesion protein. It is a natural extracellular 
matrix (ECM) molecule that has the ability to bind fibrin, gelatin and collagen, and is 
used to coat synthetic polymers to improve cell attachment. It is commercially 
available as a cryoprecipitated fraction of blood plasma. Fibronectin cable was 
produced at University College London and was previously investigated for use as a 
tissue repair aid. The cable was constructed from a solution of both fibronectin and 
fibrinogen (2:1 molar ratio). The solution was extruded into an acid bath (0.25M 
HC1, 2% CaCb) at room temperature to form cables. The cables were then washed 
with buffer and water and allowed to air dry. The basic material properties of the 
fibronectin/fibrinogen cable were extensively characterized by evaluating solubility 
curves, composition analysis using enzyme linked immunosorbent assay (ELISA), 
tensile strength, moisture absorption, stability in water, and solution viscosity. The 
cable was dried to promote cross-linking of the proteins to maintain stability. Further 
cross-linking and increased stability was achieved by gamma irradiation (Underwood,
1999).
The human plasma-derived fibronectin-fibrinogen cables were wet extruded with and 
without sodium alginate. Cables were prepared with solutions containing 140mg/mL 
total protein with 12.9mg/mL alginate (high protein) and 46mg/mL total protein with 
47.6mg/mL alginate (high alginate) in a coagulation bath containing 0.25 M HC1, 2% 
CaCL at a pH of <0.9. The cables had a suitable mechanical strength of 30kPa 
(225mmHg) needed for wound repair and nerve regeneration (Underwood, 2001). In 
addition, these multi-fiber cables had the ability to align human fibroblast cells which 
is important for restoration of normal connective tissue that is stronger and more 
flexible for wound repair (Harding, 2000). These cables had the ability to be wet 
spun at larger scale into hollow tubes for potential application for nerve guidance and 
vascular substitute. However the tubes made of wound fibers as on a bobbin of cotton 
came apart. Instead greater success was obtained when the tubes were extruded 
(Harding, 2002). However, because the fibronectin-fibrinogen was derived from
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blood plasma, it is unlikely to be a viable matrix for a TEBV unless it can be 
produced recombinantly or derived from the patients own plasma (Bak, 2002).
1.4.2.2 Collagen
Another suitable natural approach to produce a TEBV utilizes collagen as the primary 
scaffold material. Collagen is one of the main ECM components of the native blood 
vessel. This “tissue-equivalent” approach refers to cells cultured within a collagen 
gel. The collagen is obtained from either acid-extracted or pepsin-digested type I 
collagen. The molecules self-assemble into a gel when physiological pH and 
temperature are restored (Tranquillo, 1999). Weinberg and Bell (1986) were the first 
to produce a totally biological TEBV. They constructed the vessel by combining 
individual collagen gel layers seeded with fibroblast, smooth muscle and endothelial 
cells. These constructs were structurally weak and could only withstand a burst 
pressure of less than lOmmHg without the use of a Dacron™ support sleeve to 
withstand physiological pressures (Weinberg and Bell, 1986). The rupture pressure of 
these vessels was increased from 50 to lOOmmHg by increasing the concentration of 
collagen ffom 0.625mg of collagen per mL of solution to 1.25 or 2.5mg of collagen 
per mL of solution (Hirai, 1994). The collagen gel contructs were also strengthened 
by adding elevated levels of glucose or 30mM ribose to the growth medium. These 
agents cause glycation of the collagen matrix and increased the circumferential tensile 
modulus ffom 63 to 1025 kPa (473 to 7688 mmHg) (Girton, 2000). Finally, the 
strength of the collagen constructs was also improved by using dynamic mechanical 
stimulation (cyclic strain) to induce cell-mediated remodeling of the collagen gel 
scaffold. After eight days of exposure to dynamic stimulation (cyclic strain at 1 
hertz), collagen constructs containing SMCs exhibited a modulus increase ffom 68 to 
142 kPa (510 to 1065 mmHg) (Seliktar, 2000).
Another method utilizing collagen as the scaffold material begins with actual human 
or animal (e.g. porcine) vascular grafts. These grafts are decellularized and 
deproteinized without disrupting the native architecture of the collagen/elastin 
extracellular matrix. Since this material is devoid of foreign cells, proteins, lipids and 
nucleic acids, the construct is believed to be non-immunogenic. These acellular grafts 
rely on recruitment of autologous endothelial cells to seed the intimal (inner) surface 
after implantation and have shown some success in animal models (Nerem and
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Seliktar, 2001). Dahl improved the decellularization method for native and 
engineered arteries that maximized cellular elimination, without greatly 
compromising mechanical integrity (Dahl, 2003). Rolled human acellular dermal 
matrix was also investigated as a small-diameter vascular graft; however, these grafts 
experienced false aneurysms (sac-like widening) along the longitudinal suture line 
made to join the seam of the rolled dermal matrix (Inoue, 1996). Another acellular 
collagen graft approach utilized rolled small intestinal submucosa (SIS). The SIS is a 
cell-free 100pm thick collagen layer derived from the small intestine. The burst 
pressure of 5.5mm diameter SIS averaged 3517mmHg (Hiles, 1995; Roeder, 1999). 
Another group used an alternative approach by wrapping porcine SIS around a 
mandrel to create a two-layer tube. Bovine type I collagen was deposited on the 
luminal (inner) surface and the entire graft was crosslinked; however a burst pressure 
of only 931+/-284mmHg was achieved (Huynh, 1999).
Materials such as collagen and fibronectin are animal proteins/materials usually 
derived from human, porcine or bovine sources. The largest risk involved in using 
animal-derived materials is the transmission of infectious agents to the recipient. 
Many infectious agents including bacteria and viruses are detectible and can be 
removed or inactivated. However, transmissible spongiform encephalopathies (TSE) 
are fatal human and animal neurological diseases that to-date have no early detection 
tests (Dormont, 2002). TSE agents are spread through bone and meat meal from 
infected animals. Bovine spongiform encephalopathy (BSE), also known as mad cow 
disease, is spread in cattle and is believed to have crossed species and infected 
humans who develop new variant Creutzfeldt-Jakob disease. Infected individuals 
and cattle have a long incubation period during which no detectable symptoms appear 
(Stecklow, 2001). Due to this predicament, and the fact that infection and 
pathogenicity is still not completely understood, animal-derived materials are 
significantly less desirable for a matrix material.
1.4.2.3 Sodium alginate
Sodium alginate is a natural water soluble copolymer of 1, 4-linked p-D-mannuronic 
(M) and a-L-guluronic (G) acids derived from kelp (brown seaweed). The ratio of 
the M and G polysaccharides and their sequential arrangement (e.g. in series of M or
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G units or alternating MG) depends upon the source of the alginate which is harvested 
from different geographical locations and ffom whole plants or ffom individual 
sections -  the stipe, blades, or leaves. Adjacent blocks of G subunits can be cross 
linked to form a 3-D hydrogel using divalent cations. A solution of calcium chloride 
is most commonly used to donate the calcium ions which compete for the sodium ion 
position on the carboxylic acid groups of adjacent blocks of G subunits. The gel 
formation can be reversed by the addition of excess sodium ions (Martinsen, 1989) or 
chelators of divalent cations such as citrate or EDTA. Figure 3 shows the molecular 
structure of these subunits and the formation of a hydrogel ffom an alginate solution 
using calcium ions. The ratio of M and G residues determines the alginate hydrogel 
strength. High G alginates produce gels with a strong, rigid structure due to the 
tightly nested molecular formation as shown in Figure 3.B; whereas high M alginates 
produce gels with less rigid gel structure (Constantinidis, 1999).
The mechanical and swelling properties of sodium alginate gels depend upon the 
monomeric composition, block-structure, molecular size and concentration of 
polymer and calcium ions. Nuclear Magnetic Resonance (NMR) spectroscopy can be 
used to determine the length of the G-blocks (repeating guluronic residues). Gel 
strength increases with increasing alginate concentration (e.g. 0.5 to 4% w/v) and with 
increasing proportion of G-blocks (Martinsen, 1989).
Upon cross linking, alginate gels shrink which causes an increased concentration of 
alginate in the gel due to loss of water relative to the concentration in the original 
alginate solution. Volume reduction and strength are dependent upon the type of 
alginate, but gel strength and volume reduction are independent of CaCh 
concentration above a concentration of 0.02M (Smidsrod and Haug, 1972).
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Figure 3. Molecular structure of alginate. (A) Repeat units of guluronic acid (G) and 
mannuronic acid (M). Sodium alginate would have sodium ions (Na+) associated 
with the carboxylic acid groups (COO-). (B) Polymerization of alginate. The poly- 
G chains initially in solution form nested structures in the presence of divalent ions 
such as calcium to form the hydrogel structure.
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Gel strength is also dependent upon the molecular weight of the alginate. The 
molecular weight of alginate is determined from the viscosity of the alginate using the 
Mark Houwink Equation: [r\] = K * Ma where a = 1 and K = 2x1 O'5 (Smidsrod
and Haug, 1972). Gels with low molecular weight (low viscosity) do not form gels. 
Gels with a molecular weight below 2.4x105Da, exhibit an increase in strength with 
increasing molecular weight. However, gel strength is independent of molecular 
weight for alginates with molecular weights above 2.4x105Da. This characteristic is 
independent of the alginate concentration (Martinsen, 1989).
Heavy metals and polyphenols are present in alginate in various amounts according to 
the alginate source and species. The phenolic compounds can be detected using 
florescence spectroscopy. These contaminants can be reduced by selection of alginate 
material with low initial polyphenols or by their removal from the alginate by various 
purification methods. Some of these purification steps include treatment with H2 O2  or 
another bleaching process such as sodium chlorite (NaClCh); followed by dialysis to 
remove low molecular weight constituents; extraction with organic solvents, such as 
acetone or ethanol; adsorption chromatography through polyamide beads or 
granulated activated carbon; and filtration through a 0.45 pm membrane filter (Skjak- 
Braek, 1989).
The decomposition of sodium alginate has been studied in several animal models, but 
the degradation has varied based upon size, composition, method of matrix formation 
and application. Iannuccelli (1996) studied the release of an antibiotic during 
degradation of sodium alginate spheres cross linked with calcium and implanted in 
rats. In the first 12 hours the beads swelled approximately 2.5 fold, some cross 
linking bonds were cleaved at the surface and -10% mass was lost. From 12 hours to 
3 days, the mass reduced by 40% due to further hydrogel dissolution due to calcium 
ion displacement. The hydrogel was completely dissolved by 8-10 days (Iannuccelli,
1996). Matthews (1995) found the alginate dressing Kaltostat® created a foreign 
body reaction (i.e. inflammation, macrophage infiltration and fibrous tissue 
formation) when implanted between the bone and periosteum in the jaw of a dog and 
persisted out to 24 weeks after implantation (Matthew, 1995). The lack of 
biocompatibility in this last example likely elicited the dog’s body to breakdown the
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alginate. Mammals do not have indigenous enzymes to breakdown alginate in vivo. 
Enzymatic degradation of uronic acid subunits by p-elimination was demonstrated to 
be slow at physiological pH (Haug, 1963). In other in vitro studies, activated 
phagocytic cells were unable to degrade alginate that was derived from both seaweed 
and Pseudomonas aeruginosa bacteria (Simpson, 1993).
Alginate clearance from the body is another issue. Low molecular weight alginate 
(below 48,000Dalton) was demonstrated to be cleared by the kidneys and excreted in 
the urine using radioiodination labeling (Al-Shamkhani and Duncan, 1995). The high 
molecular weight components of alginate can be reduced by sterilization methods 
such as membrane filtration (Schneider, 2003), heat (Vandenbossche and Remon, 
1993) and gamma irradiation (Alsberg, 2003). Gamma irradiation of alginate to 
create molecular weight components below 50kD has been demonstrated (Eiselt,
2000) and shown to have significant increase in alginate degradation rate in mice 
studies as compared to non-irradiated (higher molecular weight) alginate (Alsberg, 
2003).
The biocompatibility of alginate has been widely studied in animal models. The 
reasons for immunogenicity of alginate implants have been widely disputed. 
Purification of commercial alginates reduces the total amount of impurities (e.g. 
polyphenols, endotoxins and protein) and has the greatest impact on whether the 
implants invoke an immune response (Klock, 1994; Zimmerman, 2000; Orive, 2002). 
From more recent studies, it is less clear whether chemical composition (e.g. high G, 
high M or molecular weight) has an impact (Orive, 2002; Schneider, 2003; 
vanHoogmoed, 2003). There are some studies demonstrating that low molecular 
weight alginate elicited a much stronger fibrotic response compared to higher 
molecular weight (Schneider, 2003). An ultra-pure alginate, Pronova™ MV (Pronova 
Biomedical, Oslo, Norway), was shown to support tissue and vascular ingrowth with 
minimal inflammatory response and capsule formation surrounding the implants when 
injected in the subcutaneous space of adult sheep (Halberstadt, 2002).
The easiest method of hydrogel formation using alginate is to add drop wise into a 
solution of CaCh (l-2%v/v) forming spherical beads. A solution of BaCh can also be
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used (Zheng, 2003). The outside shell of the bead gels instantaneously, but the 
remainder takes several minutes. Others have made hydrogels by adding calcium 
sulfate (CaS0 4 ) to the alginate solution and pouring into molds (Rowley, 1999; Kong, 
2003) which gel in 30-45 minutes. These techniques form a hydrogel with a closed 
pore structure which has been used extensively in cell therapy applications (DeVos, 
1997; Constantinidis, 1999; Read, 2001). Often the alginate beads are coated with 
poly L-lysine (PLL) to further increase the stability of the bead (Joki, 2001). Several 
groups have modified the alginate hydrogel formation to produce larger, open pore 
matrix. Mooney’s group, then at the University of Michigan now at Harvard, include 
sodium bicarbonate in the alginate mixture to create a foam, then form beads in CaC^ 
solution with acetic acid. Finally the beads are exposed to vacuum to open the pores 
(Eiselt, 2000). Cohen’s group at the Ben-Gurion University produces porous 
scaffolds by freeze drying (Dar, 2002; Zmora, 2002) to create an open pore structure 
which also allows inclusion of drugs or proteins in the matrix (Perets, 2003). Cells 
are then seeded onto the surface of these alginate matrices.
Alginate hydrogels have been used successfully to encapsulate enzymes, secretory 
(e.g. pancreatic islet) cells (DeVos, 1997; Mullen, 2000), and transformed producer- 
cell lines such as transformed P-cells for secretion of insulin for treatment of diabetes 
(Constantinidis, 1999), delivery of recombinant proteins for cancer therapy such as 
tumour inhibitors (Joki, 2001; Read, 2001; Zheng, 2003) and for neuron regeneration 
(Tobias, 2001; Wu, 2002). In applications that require anchorage-dependent cell 
cultures, hydrogels have been chemically modified to covalently attach cell adhesion 
molecules. Some examples of cells cultured with peptide-modified alginate hydrogels 
have included osteoblasts on alginate-GGGGRGDY ((Gly)4 -Arg-Gly-Asp-Tyr)
(Kong, 2003), mouse skeletal myoblasts on alginate-GRGDY (Gly-Arg-Gly-Asp-Tyr) 
(Rowley, 1999) and alginate-G4 RGDY (Rowley, 2002). However, others have found 
that alginate hydrogels without peptide motifs were suitable constructs for 
chondrocytes (Atala, 1994; Wong, 2001), myocytes (Dar, 2002) and rat bone marrow 
cells (Wang, L. 2003).
Data for retention of cell function and differentiation have been reported using 
alginate as a matrix. Chondrocytes have been shown to maintain a stable
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differentiated phenotype when cultured in alginate as compared to 2-D cultures 
(Hauselmann, 1994; Lee, 2003); and liver cells in alginate secreted as much protein 
(e.g. albumin, fibrinogen, prothrombin) as in whole liver (Selden, 1998). Primary 
bovine chondrocytes entrapped in alginate were shown to synthesize extracellular 
matrix proteins (Wong, M., 2001). Bone marrow cells have been shown to proliferate 
on the surface of unmodified alginate and express osteoblast associated markers 
(Wang, L., 2003). However, rat neonatal cardiac cells were shown not to proliferate 
entrapped in unmodified alginate scaffolds despite retaining some spontaneous 
contraction for 2 weeks (Dar, 2002). Similar lack of growth was shown for entrapped 
human MSCs in alginate despite expression of differentiation markers for 
chondrocytes (Ma, 2003).
Although showing promise for structural tissues such as soft tissue, cartilage, 
myocardium, bone and liver; as of yet, no one has demonstrated that alginate has 
properties suitable for a TEBV. Natural, non-animal derived matrices are more 
desirable ffom a regulatory standpoint. Plant derived materials, such as alginate, are 
promising because they do not harbor human pathogens. However they still have 
natural mitogenic and cytotoxic impurities, as well as bacterial compounds of animal 
and human origin that need to be removed (Zimmermann, 2001).
1.4.3 C ell‘self-generated’ matrix 
An unconventional technique to develop a TEBV was developed by L’Heureux 
(1998) and requires no starting matrix material at all. Using this approach, human 
smooth muscle cells (SMCs) and fibroblast cells were grown independently to over 
confluence in culture vessels to form multilayers of cells and ECM. A tubular 
construct was fabricated by first placing a tubular acellular inner membrane (IM) 
produced by fibroblast cells over a perforated tubular mandrel, then rolling a sheet of 
SMCs over the IM and allowing the SMCs to mature for 1 week. Thereafter a sheet 
of fibroblast cells was rolled over top of the SMCs and allowed to mature for 7 weeks 
during which the cells (particularly the fibroblast cells) reorganize their ECM to 
orientate around the circumference of the tube. These constructs exhibited a burst 
pressure over 2000mmHg. Finally, endothelial cells were seeded onto the luminal 
surface of the vessel to form a confluent monolayer (L’Heureux, 1998). The entire 
maturation took over 3 months plus an additional month for the initial cell isolation
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and expansion. Un-endothelialized human TEBVs created by this method were 
implanted into a canine femur model with 50% patency (L’Heureux, 1998). 
Subsequently, these TEBVs were characterized to have contractile and relaxation 
responses, cyclic nucleotide sensitivity and calcium ion handling mechanisms 
(stimulated by antagonists) comparable to normal vessel (L’Heureux, 2001).
Although the fabrication process appears to be cumbersome; this method has definite 
potential as a TEBV. Cytograft Tissue Engineering, Inc. (Novato, CA, USA) was 
established to develop this approach and to bring forward this TEBV into clinical 
trials (www.cytograft.com).
1.4.4 Modification of materials for biocompatibility 
A large number of ECM proteins (fibronectin, collagen, vitronectin, thrombospondin, 
tenascin, laminin and entactin) contain the RGD sequence (Saltzman, 2000). In order 
to simplify and improve cell binding to synthetic polymers, RGD peptides have been 
immobilized onto synthetic polymers including ePTFE, poly(carbonate-urea) urethane 
(Tai, 2000; Tiwari, 2002b), PEG (Mann, 2001), PVA (Schmedlen, 2002), PLA/PLGA 
(Eid, 2001; Yang, X., 2001) as described in section 1.4.1.
Alginate constructs have successfully incorporated cell adhesive ligand polypeptides 
(e.g. RGD) and have been used to grow adherent cells including pre-adipocytes for 
reconstruction of soft tissue defects caused by trauma or cancer (Halberstadt, 2002) 
and myoblasts which are precursors to skeletal muscle (Rowley, 1999 and 2002) as 
previously described in section 1.4.2.3.
In addition to surface chemistry, the overall micro-architecture of the matrix is 
critical. For building a solid organ, enhancing vascularization consisting of capillary 
networks will be essential for adequate mass transfer characteristics. Some 
approaches that have been utilized include altering pore size and microstructure or 
inclusion of growth factors (Nikalson and Langer, 2001; Leor, 2000; Perets, 2003).
Finally for long term biocompatibility, the degradation of the matrix needs to be 
considered. The rate of degradation will need to be established, what the degradation 
products are and where they end up (i.e. remain at implantation site, circulate into the 
blood stream or passed through the kidneys). For example large molecular weight
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alginate (>48kD) is known not to be cleared by the kidneys (Al-Shamkhani and 
Duncan, 1995). Another more recent study found that degradation of synthetic PGA 
polymer graft in vitro resulted in localized areas of high acidity which caused 
undesirable de-differentiation of the SMCs (Higgens, 2003).
1.5 Cell selection for a tissue engineered blood vessel (TEBV)
The source of the cells used for implantation will be determined by whether the 
clinical procedure is elective or emergency. The urgency or lack of urgency will 
determine how the cells are obtained, cultivated, and manipulated (i.e. whether a 
saphenous vein or internal mammary artery would have to be used or a TEBV could 
be grown). For example, nerve repair must occur within several hours/days ffom the 
initial damage in order to be successful. Therefore stem cells or pre-cultured cells 
must be utilized. The type of cell selected for repair must address the proliferation 
requirements (and possible limitations) for expansion of large numbers in culture. 
Currently, a few cell types such as keratinocytes, fibroblasts, chondrocytes, and 
myoblasts can be expanded in sufficient quantity in culture (Young, 1997; Terskikh 
and Vasiliev, 1999). Embryonic and most adult stems cells are also capable of being 
expanded to sufficient number in vitro (Devine 2001; Zandstra and Nagy, 2001; 
Gepstein, 2002).
1.5.1 Autologous, allogeneic and xenogeneic cells 
Autologous (recipient’s own) cells are harvested ffom a tissue biopsy or blood 
sample, grown in culture and then reintroduced into the original donor. The use of 
autologous cells obviates the problem of host’s immune rejection. Cultured 
autologous cells were the first clinical application of cellular tissue engineering. 
Autologous keratinocytes were grown in culture and grafted onto bum victims 
(Gallico, 1984). Autologous cultured chondrocyte transplantation was introduced in 
1987 and has resulted in good to excellent long term (2-9 years) clinical results 
(Peterson, 2000). As mentioned above, autologous cells could be used for implants 
prepared in advance of the procedure. However, the time required to harvest the cells, 
expand the cells in culture, construct the implant, and release the final product back to 
the patient could limit the feasibility of using ex vivo cell therapies unless a validated 
quality assurance program is in place (Mayhew, 1998). Most fully differentiated cell 
types have a limited number of expansions in culture and may never grow to
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sufficient quantity to seed a tissue engineered matrix (Seruya, 2004). Reagents and 
methods used in the culture of cells for cell/tissue therapies need to be screened and 
validated so that the cell population is not altered and adventitious agents are not 
introduced (Louet, 2004).
Autologous replacement of tissue function can also be achieved by providing an 
appropriate scaffold that fosters cell migration and proliferation. Once the scaffold is 
implanted, cells are recruited onto the surface and ultimately replace the implanted 
matrix components with new, host-derived, extracellular matrix. This approach has 
been taken for nerve regeneration because autologous cells are limited (Yu and 
Bellamkonda, 2003). The scaffolds can contain bioactive factors that can stimulate 
chemotaxis and cell differentiation (Young, 1997).
Autologous cells required for blood vessel repair could be isolated from the patient’s 
own body, if the cell isolation and cultivation procedure is performed in advance as is 
currently done for autologous chondrocyte transplantation (Brittberg, 1994).
Shin’oka (2001) successfully implanted an autologous TEBV into a 4 year old 
Japanese girl. The cells had been expanded in vitro for eight weeks prior to seeding 
onto the polymer matrix and then matured for a further ten days before 
transplantation. More recently autologous bone marrow cells (BMCs) were seeded 
onto a TEBV scaffold on the day of surgery in 22 human patients- with no maturation 
in vitro (Matsumura, 2003a).
Tissue availability, inherent variability and limitations on expansion in culture are the 
major drawbacks to the use of autologous cells. The use of allogeneic cells (cells 
derived from a different source within same animal species) permits the cells to be 
cultured and cryopreserved in sufficient quantity ready for immediate use. Allogeneic 
cells can be well characterized and allow development of a reproducible and 
consistent product. In addition, if cell lines are created, the cells can be screened for 
adventitious agents, abnormal karyotype, tumorigenicity, and phenotypic changes 
well beyond their use level (Wilkins, 1994).
One disadvantage of allogeneic cells is that they may be immunogenic to the host in 
which they are implanted. Allograft rejection is primarily a T cell mediated immune
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response. Leukocytes and endothelial cells are strongly allostimulatory; whereas, 
keratinocytes, smooth muscle cells, and fibroblasts do not stimulate naive T cells and 
are less allostimulatory (Young, 1997). There have been successful approaches to 
using allogeneic cells in tissue engineering. Allogeneic cells (e.g. keratinocytes and 
fibroblasts) have been used for skin replacement and wound healing in FDA approved 
skin substitutes such as Apligraf and Dermagraft. Bone marrow transplantations 
using allogeneic bone marrow cells have been successful since the 1970s and have 
advanced considerably in the 1990s due to several developments including 
improvement in histocompatibility typing technology (Storb, 2003). However the 
recipients (usually cancer patients) have undergone extensive chemotherapy and 
radiation treatment prior to transplantation and also have to be on anti­
rejection/immunosuppression therapy since as many as 50% acutely suffer ffom Graft 
vs. Host Disease (GVHD) (Storb, 2003; www.osiristx.com). The major 
histocompatibility complex (MHC) proteins on the cells’ surface play a major role in 
immune response. Resting T-cells are activated by the expression of antigens on the 
surface of antigen-presenting cells (Geppert and Lipsky, 1985). Techniques are 
currently being tested to both knock out expression of these proteins on the cells’ 
surface (Hunt, 1998) and transfer the donor’s MHC antigens to the transplant 
recipient using gene therapy (Wong and Wood, 2004).
Xenogeneic cells (cells derived ffom a different animal species, such as porcine) have 
been used to generate tissue. New technology including cell encapsulation, immune 
protection, extracorporeal systems, and genetic manipulation is being developed to 
enable the use of xenogeneic tissue. The use of xenogeneic cells requires additional 
safety assessment so that pathogenic viruses and prions are not introduced into the 
human population (Young, 1997; Dormont, 2002). Alginate beads containing 
xenogeneic (porcine) pancreatic islets and cross linked with barium ions have shown 
success in long-term immunoisolated transplantation studies in animal and human 
hypoparathyroidism (Zimmermann, 2000). However, it is extremely unlikely that 
xenogeneic cells would be used for a TEBV since the cells could not remain isolated.
1.5.2 Stem cells
Embryonic stem cells are pluripotent and can mature into virtually any cell type in the 
body. If the differentiation of human embryonic stem cells in culture could be well-
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controlled and characterized, the resulting cells could be used to help repair human 
tissue. Human embryonic stem cells can be cultured by isolating a blastocyst, 
removing the outer cell wall, placing into culture with a layer of mouse feeder cells, 
and adding selected differentiation factors after colonies of embryonic stem cells have 
been formed (Pederson, 1997). This field is just beginning to be understood and 
obviously has many scientific challenges and ethical issues that need to be addressed 
prior to the feasibility of use for a repair aid. Researchers have already identified 
precursor cells that will preferentially differentiate into vascular endothelial or 
vascular SMCs (Carmeliet, 2000).
1.5.2.1 Adult stem cells 
Adult stem cells are responsible for maintaining homeostasis of body tissue by 
continually replacing cells during normal physiological turnover. Many tissue- 
specific stem cells have been identified in skin (basal cells), muscle, liver, 
gastrointestinal tissue (intestinal crypt cells), bone marrow/whole blood and the brain 
(central nervous system stem cells). Initially adult stem cells were thought to have 
restricted capacity to differentiate, so-called ‘committed-progenitors’. However, 
recently many more primitive progenitor stem cells have been acknowledged with 
long-term proliferation capacity and greater differentiation (multi-lineage) potential 
(Piscaglia, 2003).
Muscle-derived stem cells (satellite cells) have a great potential for autologous cell- 
mediated therapy. A muscle biopsy can be easily obtained ffom the patient without 
compromising the patient’s health. The cells have capacity for ex vivo manipulation 
and expansion in culture, and can be used as a vehicle for gene therapy (Deasy, 2001; 
Wright, 2001). Human clinical trials have been successfully conducted using skeletal 
muscle satellite cells that were transplanted into cardiac muscle (Menasche, 2003); 
however, some groups have shown that these studies have not rigorously established 
expression of cardiac markers in cells originated ffom skeletal muscle (Reinecke,
2002). More recently adult stem cells from muscle have been shown to differentiate 
into SMCs (Seruya, 2004).
Human bone marrow is one of the most widely used sources of adult stem cells. 
Peripheral blood constantly regenerates from stem cells derived in bone marrow.
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Bone marrow cells give rise to many cell types including hemopoietic and non- 
hemopoietic cell types. Mesenchymal stem cells (MSCs) derived from human adult 
bone marrow may provide a suitable source of autologous cells for cell and gene 
therapy (Prockop, 1997) and regeneration of tissue (Caplan and Bruder, 2001). MSCs 
are present in the bone marrow at about 1 in 100,000 cells (Galotto, 1999). Others 
have estimated from 1 in 10,000 to 1 in 100,000 (Deans and Moseley, 2000), or 
between 2-5 MSCs per 106 mononuclear cells (Koc and Lazarus, 2001). MSCs are 
selected in culture by adherence to tissue culture plastic (TCP) (Koc and Lazarus, 
2001).
MSCs have been shown to differentiate in vitro into adipocytes, chondrocytes and 
osteoblasts (Pittenger, 1999), as well as myoblasts and myotubes (Wakitani, 1995). 
Recent studies have demonstrated the increased breadth of pluripotency of MSCs. By 
adding appropriate levels of growth factors in vitro, rat and mouse multipotent adult 
progenitor cell (MAPC) have been shown to differentiate into endothelium 
(mesoderm), neurons (ectoderm) and hepatocytes (endoderm) (Jiang, 2002). MAPCs 
have also been identified in human bone marrow cells which differentiate in vitro into 
myocytes (mesoderm), endothelium (visceral mesoderm), neurons (ectoderm) and 
hepatocytes (endoderm) (Reyes, 2001; Schwartz, 2002; Muguruma, 2003). Toma 
(2002) showed hMSCs differentiated into a cardiomyocyte phenotype in the adult 
murine heart. Although cell fusion could not be out-ruled as a contributing factor in 
this murine in vivo study, since bone marrow cells have recently been shown to adopt 
the phenotype of somatic cells by spontaneous cell fusion (Terada, 2002; Wang, X.,
2003). Since these studies others have reported differentiation of hMSCs into 
cardiomyocyte phenotype in vitro (Xu, 2004).
Adult stem cells derived from human blood have also been shown to differentiate into 
SMCs (Simper, 2002). Circulating skeletal stem cells have been identified that are 
distinguishable from MSCs or stromal stem cells which have osteogenic and 
adipogenic potential (Kuznetsov, 2001).
The use of MSCs in tissue engineering and cell therapy applications has exploded in 
the last couple years, especially in the areas of bone and cartilage. Osiris 
Therapeutics is in Phase I clinical studies with their dental implants seeded with
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MSCs, and were the first company with fast tract designation by the FDA for 
Prochymal, their adult stem cells for treatment of GVHD, after completion of Phase I 
studies in January 2005 (www.osiristx.com). As previously mentioned in section
1.4.1, BMCs have also been successful seeded onto vascular scaffolds of human 
patients (Matsumura, 2003a).
1.6 Selection of bioactive agents for a TEBV 
The matrix and/or growth medium can be filled with cue materials to promote tissue 
regeneration. The cue materials can include support matrices (e.g. fibrin precursors, 
hyaluronic acid); bioactive agents such as simple molecules (e.g. ascorbic acid); 
insoluble ECM molecules such as laminin, fibronectin, or collagen (Hubbell, 2000; 
Saltzman, 2000); and soluble factors such as growth factors or hormones (Gooch, 
1998). Chemicals can also be used to induce differentiation as has been shown using 
dexamethasone for triggering MSCs down an osteogenic pathway (Pittenger, 1999) 
and 5-azacytidine for differentiating MSCs into myocytes (Wakitani, 1995).
1.6.1 Adhesion molecules 
Some polymers can be improved by just by coating the surface with ECM molecules 
(e.g. collagen, fibronectin). For example many tissue culture plates are treated with 
these molecules to improve cell binding. Bioactive polymers, polymer material 
enhanced through the incorporation of specific bioactive sequences, have been used 
for wound healing scaffolds. Short peptide sequences derived from cell binding 
regions of extracellular matrix proteins can be utilized to achieve biospecific adhesion 
of cells to biomaterials via integrins (a family of cell surface proteins that are involved 
in binding to extracellular matrix components) (Gooch, 1998). Some of these 
sequences include (see glossary for amino acid abbreviations):
a) RGD -  fibronectin, collagen, fibrogen, laminin
b) YIGSR, IKVAV, LRE -  laminin
c) REDV -  fibronectin
d) DGEA -  collagen
e) VTXG -  thrombospondin
f) VGVAPG-elastin
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Other bioactive substances have been used to achieve biospecific cell adhesion 
through immobilization of carbohydrate moieties such as N-acetylglucosamine and 
lactose, likewise immobilization of growth factors (EGF) and insulin. Several short 
peptide sequences derived from growth factors have been identified that can bind to 
the appropriate receptors. These have been used and may be advantageous over the 
intact proteins due to the denaturation and degradation that can occur with proteins 
(Sawhney, 1998).
1.6.2 Growth hormones and growth factors 
Microencapsulated recombinant human growth hormone (rhGH) in PLGA was 
injected into rhesus monkeys and resulted in elevated serum levels of rhGH for more 
than one month. These data suggest that, in principle, any protein could be stabilized 
by forming a complex with zinc, atomizing, freezing and lyophilizing into a powder 
and encapsulating with a polymer in a methylene chloride solution since there is no 
water present during the encapsulation process that would promote chemical 
modification, denaturation and/or aggregation (Johnson, 1996).
Growth factors can stimulate or inhibit cell division, differentiation, and migration. 
They up- or down-regulate cellular processes such as gene expression, DNA and 
protein synthesis, and autocrine and paracrine factor release. Growth factors can 
interact with one another in an additive, cooperative, synergistic, or antagonistic 
manner. They can be added to the cell culture media in vitro to enhance cell 
proliferation. Alternatively, growth factors can be added either during manufacture of 
the scaffold or bound onto the scaffold after manufacture. Controlled delivery of 
growth factors can be examined using devices made from biodegradable polymers or 
gels incorporated with the desired growth factor (Johnson, 1996; Laham 1999; 
Richardson, 2001; Perets, 2003; Simmons, 2004). The growth factor can be 
strategically located on the scaffold, thereby creating a gradient to preferentially 
enhance cell attachment and/or direct cell migration (Gooch, 1998).
Potent mitogens (agents that induce cell division) for the two major cell types of large 
blood vessels, endothelial cells and smooth muscle cells, have been well 
characterized, they include:
a) basic fibroblast growth factor (bFGF) -  both endothelial and smooth muscle
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b) vascular endothelial cell growth factor (VEGF) -  endothelial cells
c) platelet-derived growth factor (PDGF) -  smooth muscle cells
d) epidermal growth factor (EGF) -  smooth muscle cells
i) heparin-binding EGF-like growth factor (HB-EGF)
ii) betacellulin
e) endothelin-1 (ET-1) -  smooth muscle cells
Each of these growth factors may up or down-regulate the production of others, and 
thus must first be studied individually. For tissue engineering, whether the cells are 
quiescent or activated, and whether they are in a two or three-dimensional culture will 
influence endogenous growth factor production and thus also the response to 
exogenously applied bioactive molecules. Endothelial and smooth muscle cells 
cultured together will respond differently to exogenous growth factors than will 
cultures of each cell type alone (Gooch, 1998).
A variety of these growth factors have been reported in the literature that directly 
affect differentiation of stem cells into SMCs. Yamashita (2000) found mouse 
embryonic precursors that gave rise to either endothelial cells using VEGF or to 
SMCs using PDGF-BB. However no evidence for such a growth factor driven 
differentiation events existed for adult humans until Simper (2002) demonstrated that 
smooth muscle progenitor cells exist in human blood. They isolated smooth muscle 
progenitor cells from peripheral blood samples and either maintained an endothelial 
cell phenotype using medium containing VEGF (lOpg/mL) or differentiated the cells 
into SMCs by supplementing with PDGF-BB (50ng/mL). Subsequent to this 
research, Seruya (2004) used TGF-pl (9pg/mL) to differentiate adult rat MSCs 
derived ffom leg muscle into smooth muscle cells (cells expressing a-smooth muscle 
actin (ASMA) and calponin).
1.6.3 Conditioned medium and co-cultures 
In the absence of a definitive medium for differentiation of MSCs into SMCs, a 
feasible approach to perform differentiation studies was using conditioned medium. 
Potent mitogens and other non-mitogenic growth factors have been identified in 
vascular rSMC conditioned medium (Molloy, 1996; Pawlowski, 1997; Taylor, 1999). 
Therefore conditioned medium from fully differentiated rSMC cultures could
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theoretically provide the necessary growth factors and biochemical cues to 
differentiate hMSCs into SMCs provided these molecules are conserved between 
species. Conditioned medium has been shown to be effective in cloning studies when 
cultures are below critical density (Takahashi and Okada, 1970). Researchers have 
studied the effect of soluble factors in conditioned (astrocyte) medium and co-cultures 
on the differentiation of neurons (Kilpatrick, 1993). Likewise many conflicting 
studies on EC-SMC interactions have been reported using co-cultures to investigate 
underlying pathology of arthrosclerosis which have reported that EC conditioned 
medium stimulated SMC growth (Schwartz, 1981; Vernon, 1997); while others have 
reported that EC conditioned medium or confluent co-cultures of ECs inhibited 
growth and delayed de-differentiation of SMCs in culture (Campbell and Campbell, 
1986).
The use of feeder cells or co-cultures has been a common method for maintaining cell 
cultures. Undifferentiated human embryonic stem cells have been maintained on 
mouse embryonic fibroblast feeders (Thomson, 1998); although feeder-free growth is 
now possible (Xu, 2001). More recently, researchers have tested conditioned 
medium and co-cultures (in direct physical contact) to direct differentiation of MSCs 
(Rangappa, 2003). However cell fusion cannot be ruled out in these types of studies 
if co-cultures are in physical contact with the stem cells (Terada, 2002).
1.7 Planned research 
The University College London Department of Biochemical Engineering group is 
interested in the formation of substitute arteries for use in treatments such as by-pass 
surgery. Sodium alginate was chosen as the polymer matrix since it is a natural, 
biodegradable polymer that sets rapidly within a solution of divalent ions. There is 
wide spread interest in alginate’s use in tissue engineering (Atala, 1994; Hauselmann, 
1994; Lee, 1997; Rowley, 1999; Eiselt, 2000; Alsberg, 2001; Dar, 2002; Halberstadt, 
2002; Wu, 2002; Dvir-Ginzberg, 2003; Lee, 2003; Ma, 2003; Perets, 2003; 
Zimmerman and Eschenhagen, 2003; Wang, L., 2003; Kamil, 2004) and initial 
clinical studies have shown it to be safe (Hasse, 1997; Caldamone and Diamond,
2001). It was desirable to develop an engineering system to fabricate a tubular 
scaffold which provided initial 3-D form, encouraged cell attachment and 
proliferation using a process that achieved high initial cell viability after formation of
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scaffold, provided the necessary bioactive molecules to encourage cell growth similar 
to in vivo conditions, and easily translated into a bioreactor system for automation.
In this project, in order to simplify the complexity of multiple cell types in a native 
blood vessel, only one cell type was investigated with the alginate scaffold. Either rat 
smooth muscle cells (rSMCs) or human mesenchymal stem cells (hMSCs) were 
homogeneously mixed with sodium alginate in normal-saline (n-saline, 0.9% w/v 
NaCl in distilled water, pH 7-7.4) and bioactive molecules (collagen or RGD 
containing peptides) prior to formation of the 3-D scaffold (bead, sheet or tube). A 
solution of divalent cations (e.g. CaCh) was used to cross link the alginate molecules 
to form a hydrogel containing the cells.
Tubes were fabricated using an extrusion process which allowed the cells to be 
immobilized within the scaffold. This technique allowed rapid formation of a tube 
with a 100-250pm cell/alginate wall thickness without necessitating a two step 
process involving tube formation and then cell seeding. The extrusion method was a 
type of reverse coating by which the cell/alginate hydrogel tube was formed on the 
inside surface of a hollow glass tube. The cells were mixed within the alginate prior 
to formation. After cross linking was completed using a solution of divalent cations, 
the tube was washed with culture medium to reduce the residual divalent cation 
concentration. The alginate/cell tube was matured within the hollow glass tube.
Because the availability of cells was severely limited (at the high concentrations being 
studied), beads were examined as a proxy for tubular artery constructs to produce 
significant amount of material on which to test multiple conditions. For example, 
0.4mL of cell/alginate material could be used to form one tube or produce ca. 30 
beads. Hydrogel sheets were initially studied because they permitted uncoupling of 
the cell seeding and hydrogel formation steps in order to study cell attachment and 
elongation without the cells immobilized within the alginate.
The sodium alginate from various commercial suppliers was chemically modified 
using carbodiiamide chemistry to incorporate GRGDY peptides onto the carboxylate 
moieties of the alginate’s poly-guluronic acid backbone to provide cell adhesion sites. 
This modified alginate (alginate-GRGDY) was studied with cells comparatively
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against the unmodified alginate. The method of derivatization of the alginate 
continuously evolved during the course of the research.
The general project goals of this research were to:
• determine conditions in which rSMCs and hMSCs were viable and proliferated in 
a natural matrix (e.g. alginate, collagen)
• characterize the growth of rSMCs and hMSCs incorporated into a 3-D scaffold 
and compare to 2-D growth in tissue flasks
• study the effect of biological cues (e.g. RGD peptide) on attachment, elongation 
and growth of the cells on the alginate scaffold
• examine differentiation of the hMSCs into SMCs using conditioned rSMC 
medium.
1.7.1 Characterization studies with alginate and rSMCs 
So that numerous experiments could be performed with safe and consistent starting 
material, a cell line of rSMCs was established at UCL. A well characterized rat aortic 
smooth muscle cell line (ATCC cell line A7r5) (Kimes and Brandt, 1976) was used to 
complete the initial conceptualization and research. This immortalized clonal cell line 
was shown to maintain the biochemical, physiological and phenotypic characteristics 
of rSMCs in vitro (Kimes and Brandt, 1976) and provided a reliable supply for these 
studies. Cell culturing using this immortalized rSMC cell line was feasible for many 
passages; whereas, primary cell cultures derived from explants and other sources are 
usually limited (Hayflick, 1965). Hayflick showed fibroblasts (diploid cells) from 
fetal lung were capable of -48 (35-63) doublings whereas fibroblasts from adult lung 
were only capable of -20 (14-29) doublings (Hayflick, 1965). It was recognized that 
these immortalized cells would differ somewhat from primary sources; therefore later 
in the project, adult hMSCs derived from bone marrow cells were studied for this 
reason. This work is summarized in section 1.7.2 and 1.7.3.
The rSMCs were combined with sodium alginate in n-saline and then immediately 
formed into a hydrogel by cross linking the alginate molecules using a divalent cation 
solution such as CaCh. Three hydrogel forms were made -  sheets, beads or tubes. 
Both unmodified sodium alginate and alginate-GRGDY were studied using rSMCs. 
Varying concentrations (e.g. 1X-50X) of the carbodiimide reagents were used to
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determine the optimal concentration to allow cell attachment, elongation and 
networking within the alginate hydrogel while maintaining hydrogel integrity. 
Collagen containing matrices were also tested initially to study the effect of the cross 
linking solution concentration on the rSMCs. Characterization of these 
rSMC/alginate constructs included phase contrast microscopy, cell viability, 
proliferation and glucose metabolism studies.
1.7.2 Characterization studies with alginate and hMSCs
MSCs derived from human adult bone marrow provided a suitable source of primary 
cells for testing this cell/alginate system. HMSCs were isolated from bone marrow 
cells using a Ficoll gradient with prior approval from University College London 
Hospital ethics of human research committee. HMSCs were selected by their 
adherence to tissue culture flasks (Koc and Lazarus, 2001) and the cell population was 
confirmed using cell surface markers specific for MSCs (e.g. SH2+, SH4+ and CD34- 
) (Haynesworth, 1992). Frozen banks were produced to establish a consistent supply.
HMSCs were studied with both unmodified alginate and alginate-GRGDY hydrogels. 
Additional characterization was performed on these hMSC/alginate constructs 
including cytology and histology to examine overall cell morphology. A Live/Dead 
fluorescence assay was used to observe the hMSCs in situ in the beads. In addition, a 
modified MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay 
was developed to examine cell proliferation/metabolism (Mosmann, 1983).
1.7.3 Differentiation experiments with hMSCs
MSCs have been shown to readily differentiate in vitro into adipocytes, chondrocytes 
and osteoblasts (Pittenger, 1999), as well as myoblasts and myotubes (Wakitani,
1995). Numerous in vivo studies have shown MSCs differentiate into cardiomyocytes 
(Toma, 2002), although cell fusion could not be ruled out for causing this (Terada,
2002). Therefore the first step toward production of an autologous tissue engineered 
blood vessel (TEBV) in vitro would be to differentiate the MSCs into SMCs. It was 
anticipated that conversion of MSCs to SMCs would be enhanced in a three- 
dimensional gel as was found with differentiation of MSCs to chondrocytes (Ma, 
2003; Steinert, 2003). Chondrocytes have been shown to maintain a stable 
differentiated phenotype when cultured in alginate as compared to 2-D cultures
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(Hauselmann, 1994; Lee, 2003). At the time of this research, a suitable differentiation 
medium was not published. Therefore, preliminary studies were conducted to 
examine differentiation of MSCs within alginate-GRGDY beads using conditioned 
rSMC medium and rSMC co-cultures.
Charbord (2000) and Remy-Martin (1999) proposed a sequential model of 
differentiation of MSCs to vascular-smooth muscle-like stromal cells from 
cytoskeletal and extracellular matrix protein expression in both mice and humans.
The markers that appear sequentially in long term cultures of hMSCs were identified 
(Charbord, 2000) and are listed in Table 1. Remy-Martin and Charbord’s model of 
stromal cell differentiation collaborates with Owens (1995) developmental studies 
performed on vascular SMCs.
Stage of Differentiation Protein Marker Expressed
Early Vimentin, laminin 01, fibronectin
Early-mid EDa+ fibronectin, thrombospondin-1, ASMA
Mid h-1 calponin, SM22a
Mid-late h-caldesmon, metavinculin
Late SM myosin heavy chain SMI
Table 1. Sequential expression of proteins in long term cultures of hMSCs 
(Charbord, 2000).
Immunohistochemistry was used to identify the presence of these cell-specific 
proteins (such as ASMA) in the cultures of MSC/alginate beads that were exposed to 
SMC conditioned medium as compared to control cultures. Additional 
characterization using fluorescence activated cell sorting (FACS) was used to monitor 
the change in MSC surface markers (e.g. SH2, SH4) during differentiation.
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2. Materials and Methods
2.1. Methods of rat smooth muscle cell (rSMC) culture
Rat smooth muscle cells (rSMCs) were cultured in sterile, polystyrene tissue culture 
flasks (Coming Life Sciences, Coming, New York) which were treated to encourage 
cell attachment using a plasma charge which introduces a hydrophobic, negatively 
charged surface. The cell growth medium was Dulbecco’s Modified Eagles Medium 
(DMEM) supplemented with 10% Fetal Bovine Serum (FBS), 2mM 1-glutamine,
100U penicillin/mL and lOOpL streptomycin/mL (all obtained from BioWhittaker 
Inc., Walkersville, Maryland, USA) and was used at 30mL/T150 flask or 0.2mL/cm2. 
This supplemented cell growth medium will be referred to as “complete DMEM” for 
the remainder of this thesis.
2.1.1. Cell culture
2.1.1.1. Creation of frozen working cell bank
A cell bank of rSMCs was created at UCL to supply experimental material for this 
research. One vial of A7r5 rSMCs (American Type Culture Collection, Manassas, 
Virginia; product code CRL-1444; Kimes and Brandt, 1976) was obtained from
"jATCC and was planted into a vented 75cm tissue flask (T75) containing 0.2mL/cm 
growth medium. The culture was incubated at 37°C in a 10% CO2 humidified 
incubator (Galaxy S, RS Biotech Laboratory Equipment Ltd., Irvine, Scotland). Two 
days after seeding, the spent medium was removed and fresh complete DMEM was 
added two days after seeding. Then on day 3, cells were trypsinized as per next 
section 2.1.1.2 and passaged into new flasks at a 1:2 to 1:3 split ratio (1 vessel into 2 
or 3 new vessels). After 5 passages (6.7 population doublings) using this same 
procedure, the cells were trypsinized, counted using a hemacytometer, centrifuged at 
lOOg for 10 minutes (Universal 32, Hettich-Zentrifugen, Tuttlingen, Germany) and 
resuspended to 2xl06cells/mL in cry ©preservation medium. The cry ©preservation 
medium was DMEM containing 5% DMSO (Sigma Chemical Co., St. Louis, 
Missouri, USA), 29% FBS, 1.5mM 1-glutamine, 73U penicillin/mL and 73pL 
streptomycin/mL. (Unless noted, all obtained from BioWhittaker.) Approximately 
lmL of cell suspension was aliquoted into cryovials (Nalgene, Nalge Nunc 
International, Rochester, New York, USA) which then were frozen slowly in a 
insulated Styrofoam box in a -70°C freezer overnight. Then the cells were transferred 
to liquid nitrogen (< -150°C) for long term storage.
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2.1.1.2. Cell passaging protocol in tissue flasks
A7r5 rSMCs derived from the UCL cell bank were thawed and seeded into 150cm 
tissue flasks (T150) and passaged every 3-5 days at a split ratio of 1:3 (1 vessel into 3 
new vessels). The cells were observed macro and microscopically for cell confluency 
(density), evidence of mitotic cells, pH/color of medium, amount of cell debris in 
medium, and other characteristics of the cells morphology (e.g. cells in stationary 
culture were more grainy in appearance due to increased ribosomes on the ER.).
During a typical passage, the spent medium was removed from the flask using a pipet. 
The spent medium from individual flasks was pooled together; samples were removed 
and frozen for later analysis for glucose and lactate concentration (section 2.3.6).
Then the flask’s cell growth surface was rinsed with 30mL (0.2mL/cm ) of phosphate 
buffered saline, PBS, (BioWhittaker) to remove residual FBS proteins that will reduce 
trypsin activity. Next, 6mL (0.04mL/cm2) of 0.25% trypsin/0.02% EDTA (Sigma) 
was added to each flask and spread evenly over the growth surface. After 5-7 
minutes, the rSMCs were detached from the growth surface by tapping the flask 
against the palm of the hand. After completely dislodging the cells, 18mL 
(0.12mL/cm ) of complete DMEM was immediately added to quench remaining 
trypsin activity. The cells were not exposed to trypsin longer than 15 minutes since 
trypsin is a nonspecific protease which will eventually permeate the cell membrane. 
The cell suspension from all individual flasks was pooled together and a sample was 
taken to determine cell density by counting the cells using a hemacytometer (section
2.5.2). Viability was assessed using trypan blue dye exclusion assay (section 2.5.3). 
To plant the next passage flasks, 8mL of the cell suspension were added to 22mL of 
fresh complete DMEM into each new T150 flask. Samples of the diluted cell 
suspension were removed for determination of initial glucose concentration and 
frozen for later analysis. Finally, the flasks were incubated at 37°C in a 10% CO2  
humidified incubator. Typical culture seeding densities were 5-9x10 cells/cm and 
final cell densities ranged from l-1.7xl05cells/mL or 1.5-3.Ox 104cells/cm2 (1.3-2.0 
population doublings per passage).
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2.2. Methods of human mesenchymal stem cell (hMSC) culture
Adult human mesenchymal stem cells (hMSCs) were cultured in sterile, polystyrene 
tissue culture flasks (Coming) which were treated by the manufacturer for cell 
attachment using a plasma charge which creates a hydrophobic, negatively charged 
surface. The hMSC growth medium was MesenCult (Stem Cell Technologies, Inc., 
Vancouver, British Columbia, Canada) combined with Mesenchymal Stem Cell 
Stimulatory Supplements (Stem Cell Technologies), 100U penicillin/mL and lOOpL 
streptomycin/mL (BioWhittaker) and Ing/mL recombinant human fibroblast growth 
factor (rhFGF) (R&D Systems, Minneapolis, Minnesota, USA). This supplemented 
hMSC medium was used at 20mL/T150 flask or 0.13mL/cm and will be referred to 
as “MSCCM” for the remainder of this thesis.
2.2.1. Isolation of hMSCs from bone marrow sample
Human MSCs were received from Dr. Chris Boshoff s lab at the Wolfson Institute of 
Biomedical Research, University College London. The use of human clinical samples 
had been approved by the joint UCL/University College London Hospital Ethics 
Committee of Human Research. The isolation procedure involved taking freshly 
harvested adult bone marrow and isolating the mononuclear cells in a Ficoll gradient. 
This procedure will be described using 7.5mL of sample, typically 5-10mL was used 
and the corresponding volumes adjusted for the specific volume used. First of all, the 
7.5mL of bone marrow sample was filtered through a 40pm nylon cell strainer 
(Falcon, Bibby Sterilin, Stone, UK) and then rinsed with an equal volume (7.5mL) of 
Dulbecco’s phosphate buffered saline without calcium and magnesium (DPBS, 
Biowhittaker). A 15mL aliquot of Ficoll (density 1.077g/mL, Histopaque-1077, 
Sigma) was added to a 50mL centrifuge tube (Coming) and the tube was held at a 
sharp, slanted angle to create a large surface area on the top of the liquid. Using a 
pipet, the DPBS/bone marrow sample was very carefully added to the edge of the 
50mL tube such that the sample remained above the Ficoll surface. A counter-weight 
centrifuge tube was made with the same relative volumes of Ficoll and DPBS 
substituted for the bone marrow volume. The tubes were centrifuged (581 OR 
Centrifuge, Eppendorf AG, Hamburg, Germany) at 652g for 30 minutes at room 
temperature (20°C) with no brake applied. This procedure fractionated most of the 
red blood cells to the bottom of the tube; whereas, the mononuclear cells remained at
- 6 0 -
the interface of the Ficoll liquid. Using a sterile plastic Pasteur pipet bulb (Fisher 
Scientific, Loughborough, UK), the mononuclear cells were carefully removed while 
trying not to disturb the Ficoll interface. Approximately 5-6mL was collected 
(maximum of lOmL) and placed into a 50mL centrifuge tube. The cells were rinsed 
with ca. 40mL of DPBS and then the tube was centrifuged at 290g for 8-10 minutes at 
room temperature with low brake setting. The supernatant was discarded and the cell 
pellet was gently resuspended with 5mL of MSCCM and added to a vented T75 flask 
(Coming, 75cm2) or 10cm petri-dish (Coming, 55cm2) containing 5mL MSCCM 
(total volume ca. lOmL). The flask or petri-dish was incubated at 37°C in a 5% CO2  
humidified incubator (HeraCelll50, Kendro Laboratory Products GmbH, 
Langenselbold, Germany or Galaxy S, RS Biotech Laboratory Equipment Ltd., Irvine, 
Scotland) to allow the hMSCs to attach. After 2 days, the spent medium containing 
non-adherent cells was removed and fresh MSCCM was added. The hMSCs become 
visible within one week and within 2-3 weeks were ready for passaging. During this 
time, fresh MSCCM was added every 2-3 days. When the hMSCs were ca. 70-80% 
confluent, the cells were split into four new 10cm dishes or vented T75 flasks and 
labeled as passage 2 (P2). After 4-7 days, when the cells were 70-80% confluent; the 
cells were either frozen or passaged.
2.2.2. Cell culture
2.2.2.1. Creation of frozen working cell bank
A working cell bank of passage 4 (P4) hMSCs was created to supply experimental 
material for this research. P2 hMSCs were received from the Wolfson Institute in a 
vented 75cm2 tissue flask containing MSCCM. This culture was about 50% 
confluent, so the spent medium was removed and lOmL of fresh MSCCM was added; 
then it was incubated at 37°C in a 5% CO2 humidified incubator. The next day (day 6 
in culture), the cells were passaged. The spent medium was removed and lOmL 
(0.13mL/cm2) of DPBS was added to remove the residual proteins from the cell 
growth surface of the flask. The DPBS was discarded and 3mL of 0.25% 
trypsin/0.02% EDTA (Sigma) was added and rocked gently over the cell growth 
surface. The cells were allowed to detach and MSCCM was added after 6 minutes to 
quench the trypsin activity. A 0.5mL sample was removed for cell density 
determination (section 2.5.2) and then the remaining cell suspension was centrifuged 
at 160g for 5 minutes to remove the residual trypsin/EDTA. The supernatant was
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discarded and the cell pellet was resuspended with 2mL of MSCCM. Then lmL of 
cells was added to each of two new 150cm2 tissue flasks (T150, Coming) containing 
20mL of MSCCM; then the P3 cells were placed at 37°C in a 5% CO2 humidified 
incubator.
The cells were refed with 20 mL MSCCM on day 2. On day 5 the cells were 
passaged. The spent medium was removed and 20mL of DPBS was added to rinse 
the flask. Then the DPBS was discarded and 6mL of trypsin/EDTA was added, the 
cells were allowed to detach and MSCCM was added after 5 minutes to quench the 
trypsin activity. A sample was removed for a cell count and then the cell suspension 
was centrifuged at 160g for 5 minutes. The supernatant was discarded and the cell 
pellet was resuspended with 9mL of MSCCM. Then lmL of cells was added to each 
of nine new T150 flasks with 20mL of MSCCM; then the P4 cells were placed in at 
37°C in a 5% CO2 humidified incubator. The cells were refed with 20mL MSCCM on 
day 3 and then harvested on day 5. Seven flasks were used to make a P4 cell bank. 
The flasks were trypsinized identically to the previous passage and counted using a 
hemacytometer. After centrifuging the cells, the cell pellets were combined and 
resuspended in a total of 12.6mL in MSCCM. Then 3.2mL of freezing medium 
consisting of 75% fetal bovine serum (FBS, Biowhittaker) and 25% DMSO (Sigma) 
were added drop-wise to the cells such that the final cell concentration was 
2.5x106cells/mL. The final concentrations in the freezing medium were 5% v/v 
DMSO and 15% v/v FBS. One mL aliquots of cell suspension were transferred into 
16 cryo vials (Nalgene); and then the vials were placed into a styrofoam box in a - 
70°C freezer and allowed to freeze overnight. The next day the 16 vials were 
transferred to liquid nitrogen for long term storage at < -150°C.
Additional working banks of hMSCs were produced during this research project. The 
same procedures were used as described above. Some modifications included using a 
reduced centrifugation speed of lOOg. A working bank of 17 vials of P8 cells was 
produced; and a bank of 25 vials of P7 cells was produced from frozen P4 cells from 
Steve Elliman, at the Wolfson Institute of Biomedical Research, University College 
London.
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2.2.2.2. Cell passaging protocol in tissue flasks
Human MSCs derived from a UCL working cell bank were thawed and seeded ino 
150 cm2 tissue flasks (T150) and passaged every 3-5 days at a split ratio of 1:3 to 1:4 
(1 flask into 3 or 4 new flasks). The cells were observed macro and microscopically 
for cell confluency (density), evidence of mitotic cells, pH/color of medium, amount 
of cell debris in medium, and other characteristics of the cells morphology.
During a typical tissue flask passage, the spent medium was removed from the flask 
using a pipet, samples were removed and frozen for analysis for glucose and lactate 
concentration using a YSI 2700 Select Biochemistry Analyzer (YSI (UK) Ltd, 
Analytical Technologies, Famborough, UK; section 2.5.6). Then the flask’s cell 
growth surface was rinsed with 20mL (0.13 mL/cm2) of DPBS to remove residual 
FBS proteins that reduce trypsin activity. Next, 6mL (0.04 mL/cm ) of 0.25% 
trypsin/0.02% EDTA was added to each flask and spread evenly over the growth 
surface. After 5-7 minutes, the hMSCs were detached from the growth surface by 
tapping the flask against the palm of the hand. After completely dislodging the cells, 
12mL (0.08 mL/cm2) of MSCCM was immediately added to quench remaining 
trypsin activity. The cells were not exposed to trypsin longer than 15 minutes since 
trypsin is a nonspecific protease which will eventually permeate the cell membrane. 
The cell suspension from all individual flasks was pooled together and a sample was 
taken to determine cell density by counting the cells using a hemacytometer (section
2.5.2). Viability was assessed using the trypan blue dye assay (section 2.5.3). To 
plant the next passage flasks, the cell suspension was transferred into 50mL centrifuge 
tubes and centrifuged at lOOg for 5 minutes. The supernatant was discarded and the 
cell pellet was resuspended with lmL of MSCCM for each T150 flask planted. The 
lmL of the cell suspension was added to 20mL of fresh MSCCM medium into each 
new T150 flask. Samples of the diluted cell suspension were removed for 
determination of initial glucose and lactate concentration and frozen for later analysis. 
Finally, the flasks were incubated at 37°C in a 5% CO2  humidified incubator. The 
hMSC cultures were also refed with fresh MSCCM after 2-3 days to prevent buildup 
of metabolic intermediates and waste products, and depletion of nutrients and growth 
factors in the medium.
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The initial cell seeding density of the P4 frozen cells in tissue flasks was higher at P5 
(l.l+/-0.2xl04cells/cm2) due to the concentration of the cells in the vial (ca. 
2xl06cell/vial); however subsequent passages averaged a seeding density of 6.6+/- 
2.3x10 cells/cm . The remaining growth characteristics of the hMSCs are discussed in 
section 3.4.1.
2.2.2.3. Sterility of cultured hMSCs
During the project it was necessary to examine each component of the cell-matrix 
system to determine whether microorganisms/contaminants were being inadvertently 
introduced because cultures were maintained for several months. Most typical human 
(e.g. skin) and environmental microbes immediately overgrow the cultures and 
become visible either through a pH or turbidity change in the culture medium. 
However, low level or slow growing contaminants do not overwhelm the culture until 
several passages later, if ever. In addition, the growth medium is changed frequently 
in hMSCs cultures, every 2-4 days which also dilutes the microbes. Therefore, the 
spent medium was removed from ongoing cultures of hMSCs and placed into 
microwell plates to observe microscopically without the visual interference of cells on 
the surface of the plate. This allowed the presence of microbes to become visible 
microscopically at 400X magnification that would not be apparent in the regular 
cultures. As a negative control the MSCCM was also incubated with the spent 
medium. As a precautionary measure, the formulated MSCCM was also filtered 
through a 0.2pm cellulose acetate Nalgene filter flask to ensure sterility.
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2.3. Preparation of matrix solutions
Initially matrix research focused on sodium alginate solutions based upon the widely 
established literature using alginate constructs in the cell therapy field (Constantinidis, 
1999; Read, 1999; Mullen, 2000; Tobias, 2001) of which cells were of a secretory 
type (e.g. islet cells) or transformed producer-cell lines. These cells are capable of 
expansion in suspension cultures. Since this project was based upon attachment 
dependent cells (e.g. rSMCs and later hMSCs), work gradually progressed toward 
derivatization of alginate using the pentapeptide glycine-arginine-glycine-aspartic 
acid-tyrosine (GRGDY) based upon recent literature which showed improved cellular 
interaction with hydrogels that had been chemically modified to covalently attach cell 
adhesion molecules i.e. RGD-containing peptides (Rowley, 1999; Schmedlen, 2002; 
Chung, 2002). Concurrent to the preparation of derivatized alginate, some work was 
also performed using collagen matrices and combined collagen/alginate matrices 
using rSMCs to observe the effects of cross linking solutions. This section describes 
the preparation of sodium alginate, collagen and alginate-GRGDY matrices. The 
incorporation of cells within these matrices is described in section 2.4.
2.3.1. Sodium alginate matrix
Table 2 provides the list of sodium alginate manufacturers used in this research which 
included Fluka, ISP Alginates (Manugel), NovaMatrix (Pronova) and Sigma. The 
defining characteristics of the alginate such as the uronic acid content and molecular 
weight as measured by viscosity were provided by the manufacturer. Also included in 
the table are the studies in which the alginate was used. A variety of alginate types 
were selected to be evaluated due to the significant differences in hydrogel properties 
(e.g. porosity, strength) depending upon the monomeric composition, guluronic acid 
and mannuronic acid ratios and molecular weight (Martinsen, 1989 and 1992).
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Manufacturer 
and location
Uronic
acid
content
Molecular
weight
(viscosity)*
Cell studies in 
which used
Fluka
(prod. 71238)
Fluka Chemie 
GmbH, Buchs, 
Switzerland
65-75% G MW: 100-200 
kg/mol;
1%: 100-200 
mPas
rSMCs
rSMCs+colla-
gen
hMSCs
Manugel© DMB 
(prod. 1131073)
ISP Alginates 
(UK) Ltd., 
Tadworth, UK 
and Koln, 
Germany
high G ‘high’
1%: 200-400 
mPas
rSMCs 
hMSCs 
MTT assays
Pronova™ MVG Pronova 
Biomedical, 
Oslo, Norway 
(NovaMatrix)
73% G MW: 231 
kg/mol,
1%: 287 mPas
rSMCs
Pronova 
SLG 100 
(prod. 
28023206)
NovaMatrix
FMC
BioPolymer 
AS, Drammen, 
Norway
>60% G 
(67% G)
1%: >100 
mPas
(148 mPa s)
rSMCs 
hMSCs 
MTT assays
Sigma (A-2033) Sigma, St. 
Louis, Missouri
‘primarily
M’
‘medium’
2%:
3500 mPas
rSMCs not 
derivatized
Sigma (A-2158) Sigma, St. 
Louis, Missouri
‘primarily
M’
‘low’
2%: 250 mPas
rSMCs
* Molecular weight/viscosity specifications provic 
specific certificate of analysis (when available).
ed from vendor literature or
Table 2. Types of sodium alginate investigated. Details were obtained from the 
manufacturer including the uronic acid content (G=guluronic acid, M=mannuronic 
acid), molecular weight as defined by apparent viscosity and the cell experiments) in 
which used.
To prepare a solution, the powdered alginate was weighed and added to water or 
saline solutions to concentrations ranging from 0.5-6% w/v alginate. Initially, cell 
culture grade water (BioWhittaker) was used to mix with the alginate. Then 
phosphate buffered saline (e.g. DPBS and PBS, BioWhittaker) and normal saline 
solution (n-saline, 0.9% w/v NaCl (Sigma) in cell culture grade water) were tested. 
The n-saline solution was adjusted to pH 7-7.4 using 0.1N NaOH using a 10-fold 
dilution of IN NaOH (Sigma).
Since sodium alginate is water soluble, solutions with a concentration less than 2% 
w/v were homogeneous after mixing overnight on a platform roller (Roller Mixer
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SRT2, Bibby Stuart Scientific, Stone, UK). Alternatively, the sodium alginate 
solutions were dissolved by autoclaving for ca. 22 minutes at 121 °C (Omega Media, 
Prestige Medical, Blackburn, UK). Higher concentrations (2-6% w/v) had to be 
autoclaved to ensure a homogeneous mixture. This heat treatment not only served to 
completely dissolve the alginate, but also was intended to sterilize the solution.
An alternative method for sterilization of the alginate solution using filtration through 
a 0.22 or 0.1 micron membrane was also tried. Due to the high viscosity of the 
alginate solution, at least a 10-fold dilution of a 1% w/v alginate solution (to 0.1%) 
was required to effectively filter the solution. In addition, a slow flow rate (3mL/min) 
and large filtration surface area was required with a step-down series of filters ending 
in a sterilizing 0.22 or 0.1 micron membrane. Approximately 500mL of a 0.1% 
alginate solution (Manugel DMB, ISP Alginates) in water (pH 5.6) was filtered 
through a series of filters (CUNO Inc., Meriden, Connecticut) including a carbon zeta 
plus (catalog BC0030AR53SP, 27cm2 disc capsule composed of cellulose fibers, 
activated charcoal and resin for binding), a zeta plus (BC0030A90SP, 27cm2 disc 
capsule composed of cellulose fibers, diatomaceous earth and resin for binding), and 
then only ca. 250mL were filtered either through a 0.2pm filter (PSA020, 14cm2 disc 
capsule with 0.65pm prefilter) or 0.1pm filter (PSA010, 14cm2 disc capsule with 
0.45pm prefilter). The filtrate was lyophilized and then reconstituted to 1/10* of its 
original volume to obtain 1% alginate.
The sterilization of the alginate by autoclaving for ca. 22 minutes at 121 °C was one 
method used to sterilize the alginate prior to the discovery of thermophilic spores in 
the alginate which will be discussed in section 3.1.2. This problem led to the required 
sourcing of sterile alginate, Pronova SLG100 (NovaMatrix). Vials of sterile alginate 
were reconstituted as required with sterile filtered n-saline or buffer for derivatization 
of alginate-GRGDY as described in section 2.3.3.
2.3.1.1. Cross linking solution
Several formulations were examined for the cross linking solution. Calcium chloride 
(Sigma) was weighed and solutions between 0.1 to 2% w/v were prepared in distilled 
water, buffered saline (such as PBS and DPBS) and in n-saline to examine the best
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solution for cross linking the alginate matrices. The pH of the Ca.Ch in n-saline 
solution was adjusted to 7-7.4 using 0.1N NaOH. All of the CaCh formulations were 
sterile-filtered through a 0.22pm cellulose acetate membrane (Nalgene) or sterilized 
by autoclaving for ca. 22 minutes at 121 °C. In addition, barium chloride (Riedel-de 
Haen AG, Seelze, Germany) was tested as a cross linking solution.
2.3.2. Collagen matrix
Rat SMCs are attachment dependent cells. In order to proliferate they need to 
physically attach to a binding site. Rat SMCs cultured in tissue flasks attach readily 
to the treated polystyrene surface; however, alginate has no attachment sites for cells. 
Collagen is the primary protein of tissue and is a component of the extracellular 
matrix that rSMCs naturally produce. Collagen has the role of organizing cells 
through association with other proteins. It also interacts directly with cell integrins 
(Hubbell, 2000); therefore, it should encourage cell attachment and/or proliferation.
A series of experiments were conducted to characterize rSMC growth in a 3-D 
collagen matrix.
Rat tail collagen type 1 (First Link (UK) Ltd., Brierley Hill, UK; product no. 60-30- 
810) was supplied in a 0.6% acetic acid solution. The collagen was set by increasing 
the pH to ca. 7 using IN NaOH. Therefore collagen scaffolds were fabricated without 
the requirement of a cross linking solution that alginate required. It was not known 
prior to these studies if the alginate or the high molar concentration of cross linking 
solution was detrimental to cell viability and proliferation. The collagen matrix was 
prepared by combining 400pL of collagen with 50pL of 10X Eagles Minimum 
Essential Medium (10X EMEM, BioWhittaker). The concentrated 10X EMEM was 
required to provide a suitable physiological environment for the cells and to indicate 
the pH of the collagen matrix (from the phenol red component). Due to the presence 
of phenol red in the 10X EMEM, the collagen matrix turned from yellow (acidic) to 
bright pink (alkaline) upon increasing the pH using NaOH. In order to determine the 
amount of base required to set the collagen, aliquots of IN NaOH were placed into 
microwells ranging from 37.5pL to 50pL per well. Then 450pL of the collagen and 
EMEM were added to each well and mixed thoroughly. Cells were added as per 
section 2.4.2.2. In addition, alginate was added to the collagen matrix to determine
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the effects of cross linking solution on cell viability and proliferation as described in 
section 2A.2.3.
2.3.3. Denvatized alginate-GRGDY
Alginate hydrogels do not permit cell adhesion due to their hydrophilic properties. 
Mooney’s lab at University of Michigan successfully incorporated the pentapeptide, 
GRGDY, onto the alginate polysaccharide backbone and reported improved cell 
attachment and proliferation for myoblasts, precursors to skeletal muscle cells 
(Rowley, 1999). In this research, sodium alginate was chemically modified in a 
similar manner using carbodiimide chemistry to incorporate GRGDY peptides that 
will be referred to in this thesis as alginate-GRGDY. A schematic is provided in 
Figure 4 of the methods used to prepare alginate-GRGDY during the course of this 
research. Three generalized processes (initial, intermediate and sterile) were used as 
research progressed. Detailed descriptions of each of these methods follow the figure.
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0.2 pm filtered
Sulfo-NHS
EDC
GRGDY peptide
1% alginate
(autoclaved) 
(Pronova SLG100)
Initial P rocess  
In term ed iate  P rocess
Sterile  P rocess
Mix 20 hrs.
Add to dialysis 
cassette
(3-irradiated)
To
vacuum
Add activated 
charcoal and filter 
through Celite
Dialysis in water 
for 2-6 days
(Sterile 
equipment and 
0.2 pm filtered 
water in LFH)
No concentration or 
lyophili/ation
PEG concentration 
(here depicted in blue, 
but actually clear) Aliquot into sterile 
vials and lyophilize
Figure 4. Schematic of alginate-GRGDY derivatization methods. Three generalized 
processes were utilized: initial, intermediate and sterile. Steps specific to the initial 
process in red text, intermediate process in blue text and sterile process in purple text.
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The pentapeptide was incorporated onto the alginate’s carboxylic acid groups on the 
uronic acid polysaccharide chains. The GRGDY pentapeptide was either synthesized 
in a peptide synthesizer (model 9050, Millipore, Billerica, Massachusetts, USA) or 
purchased from commercial suppliers (Neosystem Groupe SNPE, Strasbourg, France; 
or Albachem, East Lothian, UK). A reaction vessel (50 mL tube, Bibby Sterilin Ltd., 
Stone, UK) was set up containing 1% w/v alginate in 0.1 M 2-(N- 
Morpholino)ethanesulfonic acid (MES) buffer (Lancaster, Morecombe, England) with 
0.3 M NaCl, pH 6.5 containing l-ethyl-(dimethylaminpropyl) carbodiimide (EDC, 
Sigma-Aldrich Co., Ltd., Gillingham, Dorset, UK), which linked amino containing 
molecules to carboxylic acid sites on the polysaccharide. The co-reactant N- 
hydroxysulfosuccinimide (sulfo-NHS, Sigma-Aldrich) was added to the reaction to 
stabilize the intermediate product which was prone to hydrolysis. This reaction is 
shown in Figure 5. The reagents were added to the alginate in the following order: 
sulfo-NHS mixed for 5 minutes, EDC mixed for 30 minutes and finally the 
pentapeptide. Then the tube was covered with aluminium foil and mixed for ca. 20 
hours.
GRGDY
HjN-GRGDY
NaOjCT
I % sodium alginate solution O-acylisourw intermediate
Figure 5. Schematic for incorporating the pentapeptide, GRGDY, onto the carboxylic 
acid moiety on the uronic acid molecule (Rowley, 1999).
All mixing steps occurred on a platform roller (Roller Mixer SRT2, Bibby Stuart 
Scientific, Stone, UK) at room temperature (ca. 20-26°C) during which it was 
protected from light by wrapping in foil.
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2.3.3.1. Alginate treatment prior to reaction
For the ‘initial process’, the 1% w/v alginate was reconstituted with the MES/NaCl 
buffer, mixed overnight, then the sulfo-NHS, EDC and peptide reactants were added 
as previously described. During the ‘intermediate process’, the alginate in MES/NaCl 
buffer was autoclaved at 121 °C for ca. 22 minutes in order to sterilize the contents 
prior to the reaction. This step reduced the molecular weight of the alginate since the 
high temperature tended to cleave the covalent C-O bonds (Leo, 1990;
Vandenbossche and Remon, 1993; Wong, M. 2001). The ‘sterile process’ used only 
Pronova SLG100 alginate which was supplied as a sterile product. This alginate was 
reconstituted with sterile filtered MES/ NaCl buffer and mixed until visibly 
homogeneous; then the sterile filtered reactants were added as described in the next 
section.
2.3.3.2. Concentration of reactants
Rowley (1999) determined the concentration of reactants based upon the efficiency of 
peptide incorporation onto the uronic acid units of the alginate, which they estimated 
for lmg of alginate to be 38pg of sulfo-NHS, 67pg of EDC and lpg of peptide. 
Unfortunately, Rowley did not provide the number of uronic acid units per mg of their 
alginate; and they used a radioactive label to measure the amount of peptide 
incorporated into the alginate, which was not feasible to implement for this project.
In addition, alginate manufacturers do not report the number of uronic acid units per 
mg of alginate which would be expected to be different according to the type of 
alginate and the processes used to manufacture and purify the alginate. Therefore, 
range finding experiments were necessary for this research to determine the 
concentration of reactants needed for this system.
The ‘initial method’ for alginate-GRGDY derivatization utilized large increments 
(e.g. IX, 10X and 50X) for Rowley’s reactant concentrations, where IX was lmg of 
alginate containing 38pg of sulfo-NHS, 67pg of EDC and lpg of peptide; 10X was 
ten times the reactants for lmg of alginate or 380pg of sulfo-NHS, 670pg of EDC and 
lOpg of peptide; and 50X was fifty times the reactants for lmg of alginate or 1.9mg of 
sulfo-NHS, 3.35mg of EDC and 50jig of peptide. Since the viscosity of the alginate 
used in the ‘intermediate method’ was reduced due to autoclaving, lower 
concentrations of reactants were used for range finding (e.g. IX, 3X, 9X and 27X).
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Likewise the ‘sterile method’ utilized low viscosity, highly purified alginate such that 
the reactant concentrations tested were similar (e.g. IX, 3X, 6X, 9X, 12X and 27X).
For range finding experiments, each reactant (sulfo-NHS, EDC and peptide) was 
weighed and dissolved in a small volume (ca. 0.5-1.OmL) of WFI (Biowhittaker).
Then the desired concentration of reactant was added to the 1% w/v alginate (typical 
alginate volumes were 3-12mL) in the 50mL reaction vessel as described previously. 
The reactants for the ‘sterile process’ were filtered through 13mm syringe filters 
(0.2pm pore size) prior to addition to the reaction vessel. A low binding PVDF 
membrane (Durapore, Millex®-GV, Millipore Corp., Bedford, Massachusetts, USA) 
was used for the peptide and a PTFE membrane (Millex®-LG, Millipore) was used 
for the sulfo-NHS and EDC.
2.3.3.3. Dialysis
After the 20 hour reaction, the alginate-GRGDY was dialyzed for 2-6 days using 
dialysis cassettes (Slide-A-Lyzer®, Pierce, Rockford, Illinois) with a molecular 
weight cutoff (MWCO) of 3.5 or 10 kDaltons. The alginate was carefully injected 
into the pre-wetted dialysis cassettes using a 20mL leur-lock syringe with a 21 gauge 
needle (Becton Dickinson UK Ltd., Cowley, UK). Dialysis occurred in 5 liter beakers 
(Azlon, Bibby Sterilin Ltd., Stone, UK) with slow mixing (ca. 80-120 rpm) in a cold 
room (ca. 8-12°C) using ca. 4-5 liters of purified, autoclaved water that was changed 
twice per day at approximately 12 hour intervals. The beakers were covered with 
aluminum foil and lighting was kept to a minimum. For the ‘sterile process’, all 
aseptic operations were conducted inside a laminar floor hood (LFH) using sterilized 
equipment. Gamma-irradiated dialysis cassettes (Pierce) were used and the water for 
dialysis was filtered through a 0.2pm filter (Acropak 500 capsule, Pall, Ann Arbor, 
Michigan) immediately prior to use every 12 hours. Due to processing inside the 
LFH, the temperature during dialysis was considerably warmer (ca. 26-31°C).
2.3.3.4. Post-dialysis treatment
After dialysis for the ‘initial process’ only, the alginate-GRGDY was mixed with 0.5 
g of activated charcoal (Sigma, C-9157) per gram of alginate to remove impurities on 
a platform roller for 5-30 minutes. Then the alginate/charcoal mixture was filtered
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through a vacuum flask containing Celite® diatomaceous earth (Celite Corp, Lompoc, 
California) to remove the charcoal.
2.3.3.S. Concentration of alginate
During dialysis the alginate-GRGDY volume increased due to the influx of water into 
the dialysis cassette. Due to the increased water content, the resulting alginate 
concentration was much lower than the desired concentration of 1% to allow addition 
of the cell suspension. One solution to this problem was that the cells were 
resuspended in a very small volume of culture medium (e.g. lOOpL) and then added 
to the alginate-GRGDY in order to make into hydrogels. This allowed the alginate- 
GRGDY to be used without having to lyophilize or concentrate. However the 
resulting hydrogels still had low strength and amorphous shape.
During the ‘initial process’ the alginate-GRGDY was snap frozen in liquid nitrogen in 
a glass flask and then lyophilized by attaching to a freeze drier chamber (Edwards 
Freeze Dryer Modulyo, Edwards High Vacuum, Crawley, UK) in order to increase 
the concentration of the alginate. However this technique was associated with 
decreased biological activity that was characterized by decreased cell binding or the 
cells’ capacity to elongate. In addition, the biological activity seemed to decrease 
over storage in the liquid form.
During the ‘intermediate method’, polyethylene glycol (PEG) was used to concentrate 
the alginate-GRGDY after dialysis while it was still inside the dialysis cassette. 
Initially, solid PEG crystals were tried 8k MW (Sigma, P-2139) for 3.5kDa MWCO 
dialysis cassettes and 35k MW (Fluka Chemie, no. 94646) for lOkDa MWCO 
cassettes. The PEG absorbed water through the dialysis membrane over about 2-12 
hours. During this concentration step, the weight of the alginate and dialysis cassette 
was monitored to target a final 1% alginate concentration at the completion of the 
step. Sterile Slide-A-Lyzer® concentrating solution (Pierce, identity of which was 
proprietary) was also used to concentrate the alginate in the dialysis cassette.
Although supplied sterile, it was still difficult to use because it required excessive 
handling and non-aseptic manipulations as weighing was still required to target the 
final alginate concentration.
Due to the cumbersome PEG concentration step, lyophilization was revisited during 
preparation of the ‘sterile process’ as the method to concentrate the alginate-GRGDY. 
It had a great advantage for sterile processing due to decreased aseptic manipulations; 
however, the process was longer (2 days) and was previously associated with loss in 
biological activity. After dialysis the alginate-GRGDY was carefully removed from 
the swollen dialysis cassette using a 50 mL Luer-Lok syringe with a 21 gauge needle 
(Becton Dickinson). Air was injected into the cassette as the alginate was removed to 
prevent damage to the membrane. The alginate-GRGDY was subdivided into 
75x25mm sterilized soda glass vials (Samco, LIG Supplies Ltd., March, UK). The 
vials were loaded onto a tube rack, loosely covered with sterilized aluminium foil, and 
then plunged into liquid nitrogen for 10 minutes. The rack was only submerged 1/3 of 
the way up the vial so nitrogen did not enter the vials. After the alginate was 
completely frozen, the rack and vials were placed onto the shelf of the pre-cooled (- 
60°C) freeze drier chamber (Edwards Freeze Dryer Modulyo), the foil was removed, 
and the cover containing a thin film of vacuum sealant (Dow Coming high vacuum 
grease, Dow Coming Corp, Midland, Michigan, USA) was placed over the chamber. 
The vacuum pump for the chamber was immediately turned on to prevent a 
temperature transition in the vials above -60°C. The alginate-GRGDY was allowed to 
freeze dry for ca. 2 days. The initial vacuum was ca. 0.2-0.4mbar, and after two days 
the vacuum pressure decreased to 0.6-0.8mbar which indicated the contents were dry. 
The alginate plug also appeared to be dry and slightly pulled away from the sides of 
the vial. The vacuum was shut off and the chamber was slowly vented through a 
0.2pm PTFE filter (Midisart®2000, Sartorious AG, Goettingen, Germany). The 
cover of the chamber was removed and the vials were covered with sterilized foil and 
transferred to the LFH where they were covered with sterilized caps.
2.3.3.6. Alginate storage conditions
Liquid alginate-GRGDY or reconstituted alginate was stored in a refrigerator at ca. 6- 
12°C. The lyophilized alginate-GRGDY was stored in a freezer at ca. -10 to -15°C.
2.3.3.7. Sterility testing
During the ‘initial’ and ‘intermediate’ process, the alginate-GRGDY was produced 
using methods that were not designed to produce microbe-free product; for example, 
the charcoal adsorption and Celite filtration steps were not sterile steps. However, 
effort was made to progress to a process that would be free of microbial 
contamination when tested. During the ‘sterile process’, the alginate and all of the 
reactants were tested for sterility at each stage of the process so that every component 
and every process step could be tested to see if contamination was introduced. The 
samples tested included: MES/NaCl buffer, reconstituted Pronova SLG100 alginate 
in MES/NaCl buffer, filtered sulfo-NHS, filtered EDC and filtered peptide. Then the 
alginate-GRGDY was tested after the 20 hour reaction, after completion of dialysis 
and after lyophilization (post-reconstitution with n-saline). A sample aliquot (ca. 50- 
lOOpl) was added to lmL of terrific broth (Sigma, T-0918) in a microplate (24 well) 
which was placed in a humidified incubator at 37°C. For each test, a control well of 
lmL terrific broth was always included as a negative control. Terrific broth was 
made by combining 47.6g of powdered terrific broth with 8mL of glycerol (Sigma, G- 
5150) in 1 liter of water. After the solution was thoroughly mixed, the terrific broth 
was aliquoted into lOOmL aliquots in glass bottles (Schott bottle, Fisher Scientific, 
Loughborough, UK) and autoclaved with loose caps at 121°C for 22 minutes. After 
removal from the autoclave, the caps were tightened and the terrific broth was stored 
at room temperature. The sterility samples were observed under a microscope for 
presence of microbes. Because the terrific broth contained lint/particulates, it was 
also filtered through a 33mm Millex®-GV syringe filter (0.2pm pore size) to clear 
particulates out of the samples for improved clarity of microscopic observation. The 
samples were observed microscopically every 2-4 days for at least 9-14 days.
2.4. General methods of cell-matrix construction
The creation of the cell-matrix three dimensional complexes are described in this 
section. For ease of explanation, general methods are provided. In preparation of the 
constructs, sodium alginate (various suppliers), derivatized alginate-GRGDY (various 
reactant levels) or collagen was used. The cells (rSMCs or hMSCs) were prepared for 
mixing with the matrix solution as described in section 2.4.1. The presence of cells, 
or even cell type, did not affect the basic methods of formation of the construct unless 
specifically noted. Three types of cell-matrix constructs were made during this 
research including sheets, tubes and beads. Figure 6 shows a schematic of these 
processes. The method of formation of each individual construct is described in each 
of the following sections: sheets (section 2.4.2), tubes (section 2.4.3) and beads 
(section 2.4.4). Specific experiments are also described which were used to evaluate 
hydrogel tubes by cutting into discs (section 2.4.3.1), to evaluate the effect of matrix 
components and cross linking solution (section 2.4.3.2) and to evaluate hydrogel tubes 
in situ (section 2.4.3.3).
2.4.1. Preparation of cells for mixing with matrix solution
Cells (either rSMCs or hMSCs) were harvested from tissue flask cultures using the 
same trypsinization protocol as used for cell passaging. After the trypsinized cell 
suspension was pooled together, a sample was removed for cell density determination 
using a hemacytometer. Then the cells were centrifuged in 50mL centrifuge tubes at 
100-160g for 5-10 minutes. The supernatant was removed and discarded, and the cell 
pellet was resuspended using the selected culture medium (e.g. complete DMEM or 
MSCCM) to the desired concentration. The residual trypsin/EDTA present in the 
trypsinized cell suspension needed to be removed from the cell suspension because 
EDTA chelates divalent ions such as calcium, so it would dissolve the alginate 
hydrogel if it was added as part of the cell suspension. In cases of very small working 
volumes (e.g. 100-500fiL) and/or high cell concentrations (>107cells/ml), the cells 
were often centrifuged twice to allow an intermediate resuspension of the cells in a 
larger volume (e.g. 5-7mL) of culture medium prior to being resuspended in a small 
volume and mixed homogeneously into the matrix solution. This was performed to 
further dilute the trypsin/EDTA residuals because the cell pellet comprised of the 
majority of the resuspended volume.
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Figure 6. Schematic of cell-matrix construction. Cells were combined with alginate and formed into tubes, beads or sheets. The methods are 
described in each section (designated in parentheses). Color coding includes red (culture medium), grey (alginate), black dots (cells) and light 
blue (cross linking solution).
Initially when working with non-derivatized alginate, the cell pellet was resuspended 
in culture medium and added to an equal volume of matrix solution (e.g. 50% v/v 
composition). Later when using collagen and derivatized alginate, the resuspended 
cell pellet comprised of a smaller amount (e.g. 15-25% v/v) and the matrix solution a 
larger amount (e.g. 75-85% v/v) to achieve stronger gels and higher matrix 
composition. Typical combined cell/matrix working volumes were 0.2-1.2mL.
An alternative culture medium to complete DMEM was tested with rSMCs 
immobilized in collagen and non-derivatized alginate matrices. Minimum Essential 
Medium (MEM) alpha Medium (aMEM) (Gibco™, Invitrogen™ Life Technologies, 
Carlsbad, California, USA) was used as the basal medium. The aMEM medium had 
the same inorganic salts and vitamins, but higher concentrations of amino acids than 
DMEM contained plus the addition of non-essential amino acids and their derivatives 
(1-alanine, 1-asparagine, 1-aspartic acid), lipoic acid, sodium pyruvate, 1-ascorbic acid, 
biotin, vitamin B 12, ribonucleosides and deoxyribonucleosides. The aMEM medium 
was supplemented with 10% FBS, 100U penicillin/mL, lOOpL streptomycin/mL and 
additional D-glucose (Sigma) to achieve ca. 3.5g/L.
2.4.2. Formation of sheets
Despite the project’s aim to immobilize cells within the alginate hydrogel in a one- 
step process, alginate sheets were initially fabricated to de-couple the cell seeding step 
from the alginate scaffold formation in order to investigate the possible detrimental 
effects of the high molar concentration of the cross linking solution when the cells 
were immobilized directly within the alginate. For example, a 1% CaCL solution 
used to cross link the alginate was hypertonic at 90mM; whereas the physiological 
CaCL concentration for cell maintenance and growth, i.e. level in DMEM medium, 
was merely 1.8mM (Biowhittaker Product Catalog, 2001). In addition at the start of 
research, attachment dependent cells had not yet been reported in the literature as 
‘successfully’ immobilized within alginate, only suspension adapted cells for cell 
therapy applications. Even Mooney’s group’s work had been performed by 
constructing alginate sheets and then seeding on the surface with cells (Rowley,
1999). Collagen sheets were also made to further de-couple the alginate and cell 
seeding steps to determine the effects of the cross linking solution.
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2.4.2.1. Alginate sheets
Alginate sheets were fabricated by spraying a fine mist of 40-50% w/v CaCh solution 
onto 22mm diameter glass coverslips (BDH, VWR International Ltd., Poole, UK). 
The glass coverslips were first heated through an aluminum heat block using a 
propane blow torch. Then the coverslips were sprayed with a fine mist of CaCI2  
solution which immediately evaporated the solution into a powder on the surface of 
the coverslip. The coated coverslips were immediately placed inside a 12 well 
(3.8cm2) microplate (Costar, Coming Life Sciences, Coming, New York); then 0.4- 
0.6mL of alginate solution (usually derivatized with GRGDY peptide) was added to 
each well. The calcium ions diffused into the alginate and formed a hydrogel sheet. 
After washing the hydrogel sheet extensively with sterile WFI (to reduce residual 
CaCh), culture medium (either complete DMEM or MSCCM) was added as a final 
rinse. The cell suspension (either rSMCs or hMSCs) was prepared by trypsinizing 
flasks, then centrifuging and resuspending the cells in culture medium to remove 
residual trypsin and EDTA present in the trypsinized cell suspension. Then the cell 
suspension was seeded into the microwells at 1.2xl05 to 3xl05cells/well (3x104 to 
8xl04cells/cm2) containing the alginate hydrogels with 2mL of medium/well (0.5 
mL/cm ). Then the plate was placed at 37°C in a humidified incubator containing 5- 
10%CC>2 depending upon the culture media selection. The cells were observed 
microscopically over several days to see if the cells attached and elongated on the 
surface of the hydrogel. Experiments were also performed where cells were mixed 
directly within the alginate as described in section 2.4.1. In this case, after formation 
of the sheet the cell/alginate hydrogels were rinsed with culture medium (either 
complete DMEM or MSCCM) instead of WFI to maintain balanced physiological 
conditions (osmolarity/pH) for the cells.
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2.4.2.2. Collagen sheets
Several formulations of rat tail collagen were prepared by adding 10X EMEM and 
graduated amounts (37.5-50pL) of IN NaOH to the collagen as per methods 
described in section 2.3.2. Each formulation was made in the well of a microplate (24 
well, Coming). Rat SMCs were trypsinized, centrifuged and resuspended by gentle 
pipetting in complete aMEM medium. Then 50|iL aliquots of rSMCs were added to 
each well. The cells were mixed throughout the collagen matrix in each microwell 
and then the collagen was allowed to set at 37°C for 10 minutes. Then lmL of 
complete aMEM medium was added to each well. All of the microwells were 
incubated at 37°C/10% CO2 . The final concentrations in the matrices were: 73-74% 
v/v rat-tail collagen type 1 (final concentration ca.l.6mg/mL), 9% v/v 10X EMEM, 7- 
9% v/v IN NaOH, and 9% v/v rSMCs resuspended in complete aMEM medium.
In this experiment the aMEM medium was supplemented with 10% FBS, 60U 
penicillin/mL, 60pL streptomycin/mL (all obtained from Biowhittaker) and additional 
glucose to a final concentration of 3.3g/L. The final SMC concentration in the 
collagen matrix was lx l06cells/mL with 0.5 mL in each microwell or 5xl05cells/well.
Control cells were seeded directly into microwells (24 well, 1.9cm2) with no matrix at 
9.6x103cells/well (5xl03cells/cm2). The amount of complete aMEM medium used in 
each microwell was lmL (0.5mL/cm2).
At each time interval, the matrix was observed macroscopically to determine the 
extent of matrix shrinkage, and microscopically to determine if the cells were 
associated with the matrix. The spent medium was removed from one well and 
measured to determine losses due to evaporation. At the conclusion of the 
experiment, the glucose concentration in the spent medium was determined using the 
YSI bioanalyzer.
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2.4.2.3. Collagen and alginate sheets
Once cell growth was observed in the collagen matrix, the next step was to examine 
the effect of cell proliferation in collagen and alginate matrices when cross linking 
solutions were introduced. A scaffold containing both collagen (1.25 mg/mL) and 1% 
alginate was constructed and different cross linking solutions (CaCh or BaCh) at 
concentrations between 0.1 to 1% were tested. 1% cross linking solutions were 
prepared by combining 0.5g of CaCh or BaCh with 50mL of n-saline solution. Then 
0.5% and 0.1% solutions were prepared by combining lOmL of 1% solution with 
lOmL of n-saline, and 2mL of 1% solution with 18mL of n-saline, respectively. The 
pH of the solutions was adjusted between 7.0 to 7.4 using 0.1N NaOH. The final 
molar concentrations were calculated as 48, 24 and 4.8mM BaCk and 90,45 and 
9mM CaCh for the 1.0, 0.5 and 0.1% solutions respectively. In addition, both 
complete medium and n-saline solution were used as control conditions to the cross 
linking solutions. These media contain 1.6mM and OmM CaCb, respectively.
The collagen/alginate matrix was prepared by combining in sequential order: 58% 
v/v rat-tail collagen (final concentration 1.25mg/mL), 7.2% v/v 10X EMEM, 24.2% 
v/v of 4% alginate (final concentration 1%), 6.4% v/v IN NaOH, and 4.2% v/v SMCs 
resuspended in complete medium. Rat SMCs were trypsinized, centrifuged, 
resuspended with complete DMEM medium according to section 2.4.1, and added to 
this homogeneous mixture. Then 0.3mL of cells/matrix solution was aliquoted into 
each microwell. The final rSMC concentration in the matrix was 4.2x105cell/mL with 
0.3mL aliquoted into each microwell or 1.26xl05cells/well.
The collagen in each microwell was allowed to set at 37°C for 10 minutes then lmL 
of cross linking solution (0 to 1%) was added to each individual microwell for ca. 10 
minutes. After the cross linking solution was carefully removed, lmL of complete 
medium was added for ca. 10 minutes, removed and replaced with lmL of complete 
medium. Control matrices were set up using the identical conditions using n-saline or 
complete DMEM medium instead of the cross linking solution. In addition, control 
cells with no matrix were seeded directly into microwells at 1.26xl05cells/well 
(6.63x104cells/cm2). Collagen/alginate matrices with no cells were also set up to 
measure the decrease in glucose due to degradation at 37°C. All of the microwells
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were incubated at 37°C/10% CO2 and removed after 1, 3, 5, 7,10 and 13 days. The 
matrix was observed macroscopically to determine the extent of matrix shrinkage and 
microscopically to determine if the cells elongated within the matrix. At each time 
interval, the spent medium was removed from one well and measured to determine 
losses due to evaporation. At the conclusion of the experiment, the glucose 
concentrations in the spent medium were determined using the YSI bioanalyzer.
2.4.3. Extrusion of alginate tubes
Alginate tubes were fabricated using a single step extrusion/cell immobilization 
process which allowed rapid formation of a tube under ‘ cell-friendly ’ process 
conditions thereby eliminating the traditional two step tube formation and cell seeding 
process that were required for many synthetic polymers such as PTFE, PGA or 
PLGA.
The extrusion method was developed by Mason and Town (2002) and was a type of 
reverse coating by which a hydrogel tube was formed on the inside surface of a glass 
tube. As shown in Figure 7, the device consisted of a dual injection chamber -  one 
for the cell and alginate mixture and one for the CaCL solution. First, the cells were 
trypsinized and centrifuged according to section 2.4.1. The cell pellet was 
resuspended to the desired cell concentration and combined with the alginate solution, 
mixed and injected into the bottom of a hollow glass tube using a lmL syringe 
(Becton Dickinson). The cell/alginate mixture (ca. 0.3-0.4mL -  minus volume held 
up in the syringe and device port) filled the space surrounding a small float that was 
positioned inside the glass tube directly above the inlet port in which 0.5 - 2% CaCh 
solution was injected. Then as the CaCh was rapidly injected (lOOmL/min) into the 
tube device using a 50mL glass syringe (Samco) and syringe driver (Harvard 
Apparatus PHD2000, Holliston, Massachusetts, USA), the displacement of the CaCL 
fluid propelled the float upward through the alginate, leaving a thin coating of alginate 
and cells (100-200|im) on the inner surface of the glass tube which immediately cross 
linked the alginate molecules forming a hydrogel tube of alginate and cells. A time 
lapse schematic of the tube formation is shown in Figure 8.
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Figure 7. Hydrogel tube extrusion device. The alginate and cell mixture (grey) was 
injected into the hollow glass tube through the side port and CaCb (light purple) was 
used to propel the float upward through the center port using a syringe driver (Mason, 
2005).
After cross linking was completed (ca. 5-15 minutes), culture medium was injected 
into the tube to reduce the residual CaCh concentration. The cell/alginate tube was 
either matured within the glass tube in a 37°C incubator containing 5-10% CO2 as 
described in section 2.4.3.3 or the cell/alginate tube was dissolved using trisodium 
citrate for further analysis as described in section 2.4.3.2. The tubes fabricated using 
this technique were approximately 4mm in diameter, 100-200(im in wall thickness 
and typically 6-12cm in length. The tube wall thickness was varied by changing the 
size (diameter) of the float from 3.6-3.8mm. Smaller diameter floats produced thicker 
wall tubes. In addition the shape of the float was changed from bullet-shaped to 
spherical which provided better stability of movement as the cross linking solution 
was injected.
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Figure 8. Time lapse of hydrogel tube formation. Alginate and cells (grey) coated the 
wall of the glass tube as the CaCh solution (light purple) filled the space cleared by 
the float as the solution was driven upward into the glass tube through the center port 
(Mason, 2005).
Originally an alternative technique (pneumatic, piston driven tube-forming device) 
was used to fabricate 9mm diameter x 14cm length tubes during initial alginate 
experiments (Mason, 2005). Alginate and cells were filled into the top of the glass 
tube above a PTFE piston on a threaded rod. As the rod was pulled downward using a 
pneumatic drive, the PTFE piston was lowered causing the viscous cell/alginate 
mixture to leave a thin coating on the wall of the glass tube. The resulting cavity 
above the PTFE piston and cell/alginate mixture was simultaneously filled with a 
CaCh solution at the top of the glass tube. (Diagram not shown.) These cell/alginate 
tubes were carefully removed and cut into disc sections for further analysis as 
described in section 2.4.3.1. This downward pneumatic, piston driven tube extrusion 
device was replaced by the upward syringe driven tube extrusion device shown in 
Figures 7 and 8 to make 4mm diameter tubes.
2.4.3.1. Evaluation of alginate discs
Cultures of rSMCs were trypsinized, centrifuged at lOOg for 10 minutes, resuspended 
in n-saline and homogeneously mixed into non-derivatized alginate (3% Fluka) in n- 
saline to a final concentration of 2.7% alginate and lxlO6 viable cells/mL. A tube
- 8 5 -
(9mm diameter x 14cm length x 0.25mm wall thickness) was extruded by the reverse 
coating technique using a glass tube and pneumatic piston device described in section
2.4.3. 0.5% CaCh in water was used to cross link the alginate molecules to form a 
hydrogel. The cell/alginate tube was removed from the glass tube and placed into a 
petri dish containing complete DMEM to dilute residual CaCh. Then using a device 
similar to a cookie cutter, 7mm diameter discs were stamped through both sides of the 
tube as it lay flat in the dish. The individual discs were cultured in 24 well (1.9cm ) 
microwell plates (Costar, Coming Life Sciences, Coming, New York) with lmL of 
complete DMEM. This process was detailed in Figure 6, section 2.4.1. The number 
of cells in a 7mm diameter alginate disc was estimated to be ca. 9.6x103 given the cell 
concentration of lx l06cells/mL and the volume of a disc (n  r2 h), where h was 
estimated to be 0.25mm (tube wall thickness) and mm3 was converted to mL by 
multiplying by 0.001 the standard units conversion. Control cells were also cultured 
in T25 flasks (25cm2) at 9.6x103cells/flask (4X102cells/cm2) and in microwell plates 
(1.9cm2) at 9.6x103cells/well (5x103cells/cm2). The amount of complete DMEM 
used in each microwell was lmL and 5mL in the T25 flask, which were 0.5mL/cm 
and 0.2mL/cm2 respectively. Cells were incubated in a 37°C humidified incubator 
containing 10% CO2 / 90% air.
Control cells in the T25 flasks were trypsinized daily. Cells in alginate discs were 
released from alginate hydrogel by addition of 0.1 M trisodium citrate solution 
(section 2.5.5). In all cases, total cell density was determined using a hemacytometer 
(section 2.5.2). Viability was assessed using trypan blue dye exclusion assay (section
2.5.3). Spent medium samples were removed from all culture vessels and analyzed 
for glucose using the YSI bioanalyzer (section 2.5.6). The results from this 
experiment are described in section 3.3.2.2.
2.4.3.2. Evaluation of matrix components and cross 
linking solution
An experiment was conduction in which rSMCs were mixed with non-derivatized 
alginate, extruded into 4mm tubes and cross linked using CaCL solution. After 
rinsing the tubes with complete DMEM or n-saline, the rSMCs were released from the 
alginate hydrogel using trisodium citrate solution. Then the cells were seeded into
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microwells and monitored for glucose consumption. This approach was used to 
determine any significant detrimental effect of scaffold components (e.g. cross linking 
solution) or process steps. In addition control cultures of rSMCs were prepared which 
examined the elimination of each component/step from the tube fabrication.
In detail, rSMCs were trypsinized, centrifuged, resuspended in complete DMEM as 
described in section 2.4.1. Equal volumes of resuspended cells and non-derivatized 
alginate (2% Fluka, in n-saline, pH7.2) were mixed at a concentration of 
2xl06cells/mL. Four tubes (4 mm in diameter, 100-200pm in wall thickness and 
12cm in length) were extruded within glass tubes and cross linked in 1% CaCl2 in n- 
saline, pH 7.2, for 15 minutes. After exposure to CaCl2, the tubes were rinsed with 
either complete DMEM (1.5,12.5 or 125mL) or n-saline (1.5mL) to reduce residual 
CaCb. These volumes were delivered over a 1, 2 and 15 minute time period for the 
1.5,12.5 and 125mL volumes respectively using a syringe driver. Rinse volumes 
greater than 1.5mL were not possible using n-saline because the alginate tubes 
completely dissolved. After rinsing, 0.1M trisodium citrate solution was added to the 
glass tube to dissolve the alginate tubes. After the tube was visibly dissolved, a cell 
count and viability assessment using trypan blue dye exclusion was performed on the 
resulting cell suspensions. The cells were then mixed in complete DMEM and seeded 
at lmL/well into microwells and incubated in a 37°C humidified incubator containing 
10% C02 / 90% air.
Likewise, control cultures of rSMCs were set up to examine the serial elimination of 
each scaffold component or process step used in tube fabrication as shown in Table 3. 
Complete DMEM was substituted for each component eliminated so that the sample 
was manipulated in a similar manner, but without the effect of that component. The 
components/steps that were serially eliminated included exposure to CaCl2, addition 
to trisodium citrate, addition to alginate, and centrifugation of the cells. Trisodium 
citrate was not a scaffold component; however, in this study it was used to release the 
cells from the alginate hydrogel and therefore it was important to determine if its 
inclusion resulted in any detrimental effect to the cells.
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cells
centrifuged
added to 
alginate
added to 
trisodium 
citrate
exposed to 
CaCl2
Tubes fabricated, rinsed 
and released with sodium 
citrate
+ + + +
Control, No CaCl2 
exposure
+ + + -
Control, No CaCl2 & 
sodium citrate
+ + - -
Control, No CaCI2 , 
sodium citrate, alginate
+ - - -
Control, No CaCl2, 
sodium citrate, alginate, 
centrif.
Table 3. Conditions examined to evaluation the matrix components and cross linking 
solution on rSMC growth. Tubes were extruded and cross linked with CaC12, rinsed, 
then the rSMCs were released using trisodium citrate. Control conditions were 
created that serially eliminated each component or step of the tube fabrication. (The + 
symbol indicates step/component was utilized, the -  symbol indicates step/component 
was not utilized)
The rSMCs released from the tubes were seeded into the microwells between 
0.74x103 -  1.7xl03cells/cm2. The number of rSMCs released from the tubes rinsed 
with complete DMEM and n-saline was determined because the rinse using n-saline 
dissolved the alginate tubes. The control rSMCs were theoretically seeded at ca.
5.3x103cells/cm2 (see Table 4); however, a cell count was not performed following 
manipulation of the control cultures through their process steps so a lower density was 
likely due to losses. The volume of rSMCs added to each well was not adjusted for 
the actual cell count; therefore, there was as much as a 7.5 fold difference between the 
theoretical seeding densities for the control cells and the actual density of the rSMCs 
in each tube group. The seeding density difference did not appear to be significant as 
described in the results in section 3.3.2.3.
- 8 8 -
Alginate tube rinse 
condition
Viability
(%)
Seeding density 
(xlO3 cells/cm2)
1.5 mL complete 92 1.4
1.5 mL n-saline 85 0.74
12.5 mL complete 89 1.7
125 mL complete 87 1.3
control cells 96* 5.3 (theoretical)
* = after trypsinization
Table 4. Viability and seeding density for rSMCs released from alginate tubes. The 
viability for the conditions was similar; however, the control cell’s viability appeared 
to be highest as measured after trypsinization, not after manipulation through the 
process steps. The seeding densities were similar for the tube conditions, whereas the 
density for the control cells theoretically was greater. The actual cell density of the 
control cells was not determined after manipulation, but the actual seeding density 
was likely to be lower.
2.4.3.3. Evaluation of tubes in situ
Cells (rSMCs or hMSCs) were mixed into alginate-GRGDY and extruded into 4mm 
diameter alginate tubes as described in section 2.4.3. The tubes were cross linked 
using a 1% CaCl2 solution in n-saline. The cell/alginate tubes were washed with 
culture medium and incubated in the glass tubes filled with culture medium (e.g. 
complete DMEM or MSCCM). Fresh medium was added regularly (e.g. twice a day, 
daily or every two days) using a 5-10mL syringe (Becton Dickinson). Micrographs of 
these constructs were taken, and the spent medium was analyzed to see if glucose 
consumption and lactate production were similar to cells grown in tissue flasks.
Results are shown in section 3.3.5.2 for rSMCs and in section 3.4.2.4 for hMSCs.
2.4.4. Formation of alginate beads
Both rSMCs and hMSCs were immobilized in alginate (or alginate-GRGDY) beads. 
Beads were fabricated because it was an easier and more rapid method to produce 
high numbers of multiple individual units to evaluate at micro-scale level the cell 
growth and viability as compared to fabricating multiple tubes and/or cutting tubes 
into sections for evaluation. These processes were outlined in section 2.4.1, Figure 6.
Cells from tissue flask cultures were trypsinized, centrifuged and resuspended in 
culture medium as described in section 2.4.1, and homogeneously mixed with alginate
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or derivatized alginate to final concentrations ranging from 0.5-3% alginate and lxlO6 
-  2xl07viable cells/mL. After mixing the cell/alginate mixture was drawn into a lmL 
syringe; and beads were fabricated by very slowly syringing the mixture through a 
sterile 0.1mm diameter blunt needle and forming small droplets that dripped into a 
0.5-2% CaCh solution used to cross link the alginate molecules to form spherical 
shaped hydrogel beads (see section 2.4.1, Figure 6). The beads were left in the CaCh 
solution for 5-20 minutes, then the CaCL solution was decanted or the entire contents 
were poured into a metal strainer to collect the beads. The beads were transferred into 
a Petri dish and culture medium was added to rinse the beads to reduce the residual 
CaCh levels. The beads were transferred into microwells containing culture medium 
using a 25mL pipet and cultured in a humidified 37°C incubator containing 5-10% 
CO2 . The size of the beads produced by this manual method was estimated to be ca. 
2-2.5 mm in diameter.
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2.5. Methods of cell and matrix characterization
2.5.1. Visualization of cell growth using light 
microscopy
Cells grown in tissue flasks were observed using 100-400X magnification on an 
inverted light microscope. The cells were observed for degree of confluency (cell 
density), presence of mitotic cells which indicated cultures were in exponential 
growth phase, and amount of cellular debris in the spent medium which indicated cell 
death. As the age of the culture increased, the cells became more densely packed in 
the flask. For optimal detachment as single cells, the cultures were trypsinized when 
ca. 80-90% confluent. In addition the pH of the spent medium indicated a healthy 
culture if it was orange/red in color due to release of CO2 from respiring cells and 
buildup of metabolic waste products such as ammonia. Cultures that were red/purple 
indicated lower cell density or possibly poor cell growth. The medium from cultures 
that were contaminated with microorganisms was turbid or more yellow (acidic) in 
color.
Cells seeded onto the surface or within the alginate or collagen constructs were also 
observed in this same manner. In addition the morphology of the cells could be 
observed to determine whether the cells were rounded, or elongated and networked 
together.
2.5.2. Cell enumeration using hemacytometer
The density of the cell suspension was determined using a hemacytometer. After 
trypsinization and quenching with complete medium, a small sample ca. 0.5mL was 
removed to determine the cell density. lOOpL of cell suspension was typically added 
to lOOpL of trypan blue dye (Biowhittaker) and mixed homogeneously using a 
micropipet. Then ca. 20pL of sample was injected onto the hemacytometer under a 
cover slip. Cells were counted in the grid that was etched onto the surface of the 
hemacytometer. The cell count was repeated for a total of 3-4 replicates and 
averaged. The total number of cells/mL was determined by multiplying the total cells 
counted in 10 squares by 1000 times the trypan blue dilution factor (usually 2) as 
shown below. The multiplication factor of 1000 was obtained from the volume of
-91  -
lmm3 contained in the counting grid (10 squares x 1mm x 1mm x 0.1mm) and 
converted to mL (lmm3 = 0.00lmL) for the original sample.
Avg. no. of cells in 10 squares 1 1000 x Dilution factor (2) -  Number of cells/mL
(equation 2.1)
Accuracy of the cell count was dependent upon the homogeneity of the cell 
suspension. Suspensions that were aggregated produced lower results than actual 
numbers. Therefore this operation was dependent upon the age of the culture, 
effective trypsinization and the operator’s technique. If possible between 100-300 
cells were counted for each replicate so that the numbers were not prone to increased 
statistical error due to small sample size.
2.5.3. Cell viability using trypan blue dye exclusion
Viability was assessed using the trypan blue dye exclusion assay. Trypan blue is a 
small molecular weight dye that stains the cytoplasm of cells. Equal volumes of 
trypan blue stain and cell suspension were added together. Live cells had an intact 
cell membrane which excluded the dye. Dead cells had a permeable membrane that 
allowed the dye to enter the cell, thus dead cells appeared blue. The microscopic 
evaluation was completed within 15 minutes after dye addition because trypan blue 
dye will eventually permeate live cells. The viability of the cell suspension was 
determined by the equation:
^ ~ . . .  tl Number o f live cells (unstained) . . .
Percentage o f viable cells = -----------------------------------     x 100
Total number o f cells (unstained + stained)
(equation 2.2)
2.5.4. Calculation of cell growth rates
Adherent cells grown in tissue culture exhibit a characteristic growth cycle that 
includes a lag phase in which the cells adjust to the culture conditions, an exponential 
growth phase in which the cells proliferate rapidly, a stationary phase in which cell 
growth diminishes, and a death phase in which metabolic by-products build up and 
become toxic to the cells inhibiting further growth and/or essential nutrients are 
depleted in the culture medium. (Doran, 1995) Cells seeded below an optimal
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density (<10 cells/cm ) typically experienced a longer lag phase due to insufficient 
release of growth factors into the culture medium. Once the cells have assimilated to 
the culture conditions, growth commences. Mammalian cells have a relatively long 
growth cycle. A7r5 rSMCs have a population doubling time of ca. two days in tissue 
flasks. The growth of cells in the flasks (closed system) can be described as dX/dt = 
pX, which when integrated with initial conditions of X = Xo at t=0, becomes X = Xo 
exp (pt). For the time required for the cell population to double, Td, the cell 
population increases from Xo to 2Xo. Thus the equation becomes 2Xo= Xo exp (pTd) 
which when reduced after taking the natural logarithm of both sides becomes Td = In 
(2) / p (Doran, 1995; Butler, 2004).
The aim of this research was to characterize the growth rate of the A7r5 rSMCs, and 
later the hMSCs, in tissue culture vessels. Extensive growth kinetics studies were 
conducted for the rSMCs over 20 consecutive passages (more than 34 population 
doublings) to measure growth rates of these cells. The cells were cultured in T 150 
flasks as outlined in section 2.1.1.2. Studies were also repeated using hMSCs over 
10-12 consecutive passages as per section 2.2.2.2. The initial and final cell densities 
(Xo and X) were determined by trypsinization and cell count using a hemacytometer. 
Then the population doubling level (PDL) was calculated to be:
PDL = logio (X/Xo) / logio (2) (equation 2.3)
The doubling time (Td, hours) of the cells was calculated from the total length of 
culture (T, hours) and the equation:
Td = T / PDL (equation 2.4)
Then the growth rate (hours'1) was calculated directly from the equation (Doran, 
1995; Butler, 2004):
p = In (2) / Td (equation 2.5)
or combining with equation (1) and (2):
p = 2.3 * logio (X/Xo) / T (equation 2.6)
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Variations of the growth rate were calculated by multiplying p by 24 hours/day to 
obtain PD/day. Alternatively, the growth rate of the cells (cells/cm /hour) was 
estimated from the slope of the line plotted for the increase from initial seeding 
density to final density (cells/cm2) plotted versus time (hours).
Two detailed growth studies using rSMCs were performed in T25 flasks with daily 
cell count, viability assessment and measurement of glucose concentration in the 
spent medium. Cells were seeded in T25 flasks at two densities, 5.1xl03 and 
4.0x1 (^cells/cm2. Two seeding densities were selected for the T25 flasks to 
determine possible differences in growth rate and glucose consumption. Additionally, 
24 well microwell plates were seeded at 5.1x103 and 4.8x103cells/cm2. Cell counts 
were not performed for microwell cultures, since the rSMCs could not be effectively 
trypsinized and detached from the surface without the contents spilling out. The 
rSMCs adhered too strongly to the microwell surface. Only spent medium samples 
for glucose concentration were removed for analysis from the microwells.
T25 flasks have a surface area of 25cm2 and 24 well plates have a surface area of 
1.9cm2. The amount of growth medium was 5mL (0.2mL/cm2) and lmL (0. 
53mL/cm2) respectively. The microwell volume was significantly affected by 
evaporation during incubation at 37°C for the culture length; therefore, this larger 
medium volume was selected and the actual volume of the medium at each time point 
was used as a correction factor during glucose consumption analysis as described in 
section 3.3.2.2. The results obtained from the rSMCs growth studies are discussed in 
section 3.3.1.1 and from the hMSCs in section 3.4.1.1.
2.5.5. Release of cells from matrix using trisodium
citrate solution
Trisodium citrate was used to release the cells from the alginate hydrogel by reversing 
the cross linking of the alginate molecules (Read, 2001). Citrate is a chelator of 
calcium ions; therefore, the calcium ions dissociate from the alginate hydrogel. After 
release, the cells were assessed for viability using trypan blue dye. Control 
experiments using rSMCs were performed to determine the effect of trisodium citrate 
solution on cell viability over a time period typically required to perform analysis on a 
matrix. If the rSMCs exposed to the trisodium citrate solution do not exhibit an
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overall lower cell viability nor a decrease in cell viability over the time period 
examined as compared to the control cells; then this method could be used to access 
cell viability.
A 0.1M trisodium citrate solution was prepared in complete DMEM. In the first 
study, rSMCs were trypsinized, centrifuged at lOOg for 10 minutes, resuspended in 
PBS, and added to 4 fold volume of trisodium citrate solution to a final cell 
concentration of 7xl04cells/mL. Control rSMCs were treated identically except 
added to 4 fold volume of complete DMEM. This is the appropriate control since the 
trisodium citrate solution was prepared in complete DMEM. The second study was 
performed identically to the first, except rSMCs were added to a 9 fold volume of 
trisodium citrate solution and control cells were added to a 9 fold volume of complete 
medium to a final cell concentration of lx l0 5cells/mL. In both studies, the rSMCs 
were added to an equal volume of trypan blue dye and assessed for viability over a 
time course. These results are discussed in section 3.3.2.1.
2.5.6. Metabolite analysis of spent medium using
biochemical analyzer
The YSI 2700 Select Biochemistry Analyser (YSI (UK) Ltd., Analytical 
Technologies, Famborough, United Kingdom) utilized an immobilized enzyme 
reaction on a membrane to measure the amount of substrate in a sample. The 
substrate (e.g. glucose or lactate) was catalyzed using oxidase to produce hydrogen 
peroxide, H2 O2 , which was then oxidized at the platinum anode to produce electrons 
(Figure 9. A). The membrane consisted of three layers including an outer 
polycarbonate membrane which excluded large molecules, cells, and debris; a middle 
membrane containing the immobilized enzyme; and an inner cellulose acetate 
membrane that only permitted chemical compounds, such as H2 O2 , with molecular 
weights below 200 to pass through (Figure 9.B). When a sample was injected into the 
buffer-filled sample chamber, the substrate diffused through the polycarbonate 
membrane where it was catalyzed to H2 O2 (reaction 1). The H2 O2 then passed 
through the cellulose acetate membrane and was oxidized to yield electrons (reaction 
2).
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AReaction 1: 
Glucose + O2
L-Lactate + O2
Reaction 2:
G lucose oxid ase
L -lactate ox idase
H2 O2 + D-Glucono-8-Lactone
H2 O2 + Pyruvate
H202 Platinum anode 2H+ + 02 + 2e'
B
immobilized oxidase
silver 
platinum anode^plati
o-nng
cellulose acetate 
membrane
polycarbonate
membrane
1 plat
Current
(nA)
Time (seconds)
Figure 9. Operation of YSI bioanalyzer. (A) Enzymatic and electrochemical 
reactions. (B) Sensor probe and membranes. (C) Typical sensor response, where i * 
= initial baseline current, i piat= plateau (steady state) current, i a, = final baseline 
current, (adapted from YSI 2700 Select Biochemistry Analyzer User’s Manual)
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When the H2 O2  reaction reached a dynamic equilibrium, a steady state electrical 
current was produced that was proportional to the concentration of the substrate. The 
resultant current was used to calculate the actual concentration of the substrate in the 
sample. The sensors’ response or output current was measured against a calibration 
standard of known substrate concentration. In addition after every sample and 
calibration, a baseline current was measured. If a shift was detected, the pump 
continued to flush buffer through the sample chamber until the current stabilized 
(Figure 9.C).
Samples of the spent medium from both rSMC and hMSC cultures were removed and 
frozen in ca. lmL volumes. At the completion of a study, the samples were removed 
from storage, thawed and analyzed on the YSI bioanlayzer.
2.5.6.1. Using glucose consumption to monitor cell
growth
Glucose is utilized by cells as an energy source. The rate at which glucose is 
consumed in a culture can be used as an indication of cell proliferation (Ozturk,
1997). Culture conditions can affect the glucose consumption of a population of cells. 
If culture conditions are standardized by maintaining control over the composition 
and volume of medium, the gas exchange (O2 , CO2 ), the age and type of cells, the 
seeding density, and the culture length; then it is possible to use glucose consumption 
as an indication of cell proliferation.
The glucose consumption in tissue flasks was calculated by measuring the glucose 
concentration in the medium at initial seeding and then just prior to trypsinization. 
Then the rate was determined by dividing the amount of glucose consumed by the 
time integral of the change in cell density. The cell densities were determined by 
trypsinization and cell count using a hemacytometer. The final formula used was:
g c r - ^ L ~  G‘v g'v
‘ J [A exp (kt )  -  A ) ] t ! 2  ( X ,  - X 0) T / 2  (equation 2J)
f X’ds
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where GCR = glucose consumption rate (g/cell/hour), Gc = glucose consumed during 
culture period (g/L), V = volume of growth medium (L/cm2), and the time integral of 
the change in cell density, Xs, for the culture length (hr cells/cm2).
An exponential curve was fit to the cell growth data, and then the change in cell 
density between two time points (t=0 and t=t) was calculated using Xo = A and Xt = 
Aexp(kt), where A = the initial seeding density and k equals the growth rate constant. 
The time integral was further simplified to (Xt - Xo)T/2 for estimating when only two 
data points for a cell passage existed, where Xs = cell density (cells/cm2) and T = total 
culture time (hours). The cells were passaged during exponential growth phase so the 
estimates would be more reliable.
Ultimately, glucose consumption was used to monitor the cell growth of the cells 
when direct cell density measurements were not possible when cultures were grown in 
microwells or in alginate scaffolds. In these cases, glucose data in g/L were plotted 
over the desired culture period in hours; and then a linear curve was fit to the data.
The final glucose consumption rate (g/hr) was determined from the slope of the curve 
over the culture period (g/L/hr) multiplied by the volume of the growth medium (L) in 
the culture vessel.
2.5.6.2. Using lactate production to monitor cell 
growth
Lactate is a by-product of glutamine metabolism. The lactate levels in the spent 
medium were measured using the YSI bioanalyzer. Lactate data in g/L were plotted 
over the desired culture period in hours and then a linear curve was fit to the data.
The final lactate production rate (g/hr) was determined from the slope of the curve 
over the culture period (g/L/hr) multiplied by the volume of the growth medium (L) in 
the culture vessel.
In addition, the metabolic state of the cells was monitored using the ‘respiratory 
quotient’ which was the ratio of the amount of lactate produced over the amount of 
glucose consumed.
Respiratory quotient = Lp / Gc (equation 2.8)
- 9 8 -
Where Lp = lactate produced during culture period (g/L),and Gc = glucose consumed 
during culture period (g/L).
If the respiratory quotient was 1, the cells were metabolizing aerobically. A ratio of 2 
indicated anaerobic metabolism, and a value in between 1 and 2 indicated something 
intermediary (Carrier, 1999).
2.5.7. Live/dead assay using fluorescence microscopy
Another technique used to determine cell viability employed two fluorescent dyes -  
calcein AM and ethidium homodimer (EthD-1) which were supplied as a Live/Dead 
kit (Molecular Probes, Eugene, Oregon, USA). Calcein AM diffuses into the cell and 
was converted by intracellular esterase activity into a polyanionic, fluorescent 
molecule. Since live cells have an intact membrane, this fluorescent molecule was 
retained inside the cell cytoplasm. EthD-1 was a highly charged (polyionic) 
fluorescent molecule which diffused into dead cells which have a permeable 
membrane and then bonded to the nucleic acids. Upon binding EthD-1 undergoes a 
40-fold increase in fluorescence. The optimal concentration of calcein AM required 
for this assay was determined by simultaneously evaluating live cell samples which 
exhibited high green fluorescence, while exhibiting negligible green fluorescence in 
dead cell samples. The saturating concentration of EthD-1 required for this assay was 
determined by observing dead cell samples with increasing concentrations of EthD-1 
until maximum fluorescence was observed with minimal red background (excess dye) 
in the sample. Samples were prepared for evaluation by harvesting rSMCs from 
tissue flasks using trypsin/EDTA and then centrifuging at lOOg for 10 minutes. The 
supernatant was removed and discarded without disturbing the cell pellet. The cell 
pellet was resuspended in PBS or DPBS since the phenol red in DMEM interfered 
with the fluorescence signal. Approximately lx l06cells were resuspended in 333 pL 
of PBS, and then 333 pL each of 4pM EthD-1 and 2pM calcein AM was added. The 
sample was allowed to incubate at room temperature for 45 minutes to 1 hour prior to 
evaluation using rSMCs. For the hMSCs, 30 minutes at 37°C was sufficient for 
optimal viewing without the alginate bead/background becoming excessively stained. 
The samples were observed on a fluorescence microscope with optimal 
excitation/emission wavelengths of ca. 495/515nm for calcein AM and 495/635nm for 
EthD-1.
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2.5.8. Cytology and histology preparation
Cytology preparations were made from hMSCs that were grown in microwells. The 
hMSCs were scrapped from the microwell surface with a metal spatula and smeared 
onto a glass microscope slide (SuperFrost Plus, Menzel-Glaser, Germany). After the 
slide was allowed to air dry for 20 minutes, the cells were fixed in high grade acetone 
at room temperature for 10 minutes. Then the slide was allowed to air dry so the 
acetone evaporated, and the slide was stored frozen at -20°C until analysis. The slides 
were exposed to hematoxylin to stain the cells’ nuclei blue and to the specific 
monoclonal antibody for a -smooth muscle actin (ASMA, Dako UK Ltd., Ely, UK) 
using the biotin avidin complex method to assess the presence of these specific cell 
proteins in the cytoplasm. ASMA is an indicator for smooth muscle cells.
Histologic preparations were made of the hMSC/alginate beads by fixing in 10% 
formaldehyde saline solution (formal saline) at room temperature. Early preparations 
were performed by smearing/spreading the bead across the surface of a glass slide 
prior to perfecting the techniques needed to prepare microsections embedded in 
paraffin wax due to the fragile nature of bead and its translucent appearance within 
the paraffin block. In order to locate the beads, they were marked with histological 
marking ink, placed in biopsy capsules and cassettes (Surgipath Europe Ltd., 
Peterborough, UK) and underwent standard histopathologic processing in formalin, 
industrial methylated spirits, xylene and paraffin wax in a Leica ASP 300 processor 
(Leica Microsystems (UK) Ltd., Milton Keynes, UK). The beads were embedded in 
paraffin wax and sliced into 3 micron sections on a rotary microtome. Sections were 
dewaxed and stained with hematoxylin and eosin (H&E) for overall morphology 
immediately after cutting. Eosin stained the cells’ cytoplasm pink; and hematoxylin 
stained the nuclei blue. Slides that were prepared for immunohistochemistry were 
first pressure cooked for 4 hours. This procedure was performed as an antigen 
retrieval step for the cell proteins that became crosslinked during histological 
processing. Due to non-specific binding (see results section 3.6.1), a biotin blocker 
(Dako) was applied to the samples. Then the monoclonal antibody with the biotin 
avidin complex was left on the slide overnight. The next day the slide was washed, 
allowed to dry, covered with a glass coverslip and sealed. The immuno-slides were 
also counter stained with hematoxylin to clarify the cells’ nuclei. A positive result
- 100 -
using monoclonal antibodies specific for the cell cytoplasmic protein, ASMA, was 
indicated by brown cytoplasmic staining around the cell nucleus.
2.5.9. Fluorescence activated cell sorting (FACS)
During differentiation studies, ca. 5 hMSC/alginate beads were washed twice with 
lmL DPBS then the beads were dissociated into a single cell suspension by adding 
200|iL of 0.1 M trisodium citrate and 200pL of 0.25% trypsin/0.02% EDTA to the 
beads containing 200pL DPBS for ca. 30minutes and then gently micropipetting until 
the bead was completely dispersed. Then 400pL of complete medium was added to 
quench the trypsin activity. One bead was dissolved per antibody tested, including a 
bead for the ‘empty’ control (containing no antibody). The dissociated cell 
suspension was centrifuged at 1200rpm (160g) for 5 minutes, the supernatant was 
poured off, the pellet was resuspended with 500pL DPBS and lOOpL was aliquoted 
into individual tubes (1/antibody tested + empty control). A dilution of 1:100 was 
made of each antibody in DPBS and then lOOpL of antibody solution was added to 
the individual lOOpL of cell suspension for a final 1:200 dilution level (one antibody 
per tube). DPBS was added to the empty control sample. The samples were vortexed 
and incubated in the refrigerator for 1 hour. Then the tubes were centrifuged at 160g 
for 5 minutes, the supernatant was poured off and the pellets were resuspended with 
100-200pL of DPBS. If a secondary polyclonal with a fluorescent tag was needed for 
conjugation to the primary antibody, a second dilution series with IOOjaL of diluted 
antibody with fluorescent tag in DPBS (1:100) was added to the lOOpL of cell 
suspension sample resuspended in DPBS (final 1:200) which was already exposed to 
the primary antibody and incubated in the refrigerator for 1 hour. The primary 
monoclonal antibodies used were CBL555 anti-human CD34 type III (Cymbus 
Biotechnology Ltd., Chandlers Ford, UK) and anti-mouse smooth muscle cell actin 
(Ab-2) (Oncogene Research Products, Boston, Massachusetts, USA). These 
antibodies were conjugated to secondary anti-mouse immunoglobulins/Rhodophyta- 
phycoerythrin (RPE) Goat F(ab) (DAKO A/S, Copenhagen, Denmark). The SH2 
(endoglin) and SH4 monoclonals (gift from StemCell Technologies) were already 
conjugated to fluorescein isothiocyanate (FITC). After the cells were labeled with the 
fluorescent tag, the individual samples were immediately run through a FACS 
machine (Beckman Dickinson FACSCalibur, BD Biosciences, San Jose, California, 
USA) which produced graphical outputs showing the distribution of the cells.
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Each cell was designated by a dot on the graph. The gated region of the graph was 
selected using an empty sample from the distribution of the cells on the graph of side 
scatter (SSC-H) vs. forward scatter (FSC-H). The gate was selected for the desired 
cell population which excluded cellular debris and cell aggregates. Examples of the 
designated gated area are shown in the Appendices, section 6.2.4.
Cells within the gated region on the graph of RPE tag (FL2-H) versus FITC tag (FL1- 
H) were negative for the fluorescent tag and hence the surface marker. Cells that 
expressed the surface marker, and hence were positive for the antibody with 
fluorescent tag, fell outside the gated region (in R2). The FACS results were used to 
monitor the change in hMSC surface markers after being immobilized within the 
alginate-GRGDY beads and cultured in either DMEM (control medium) or in 
CDMEM with rSMC co-cultures. These studies are described in section 3.6.
2.5.10. pH measurements
PH measurements were made using a standard pH meter and electrode (Hanna 
Instruments Inc., Woonsocket, Rhode Island, USA). A two point calibration using pH 
7.0 and pH 4.0 standards was performed prior to analysis to ensure the probe was 
operating properly.
2.5.11. Viscosity measurements
The alginate solution viscosity had a strong dependence on alginate concentration. 
Only alginate concentrations around 0.5-3% were considered for matrix studies with 
cells. Viscosity measurements were taken using a cone and plate rheometer (LVDV- 
II+, Brookfield, Massachusetts, USA) with a lmL working volume which had been 
calibrated using a silicone oil standard (RT1000, Cannon Instrument Co., State 
College, Pennsylvania, USA). Water in a room temperature water bath was circulated 
through the device jacket in order to maintain a constant temperature during 
measurements since viscosity is temperature dependent. The viscosity was measured 
at several shear stress rates (altered by changing the number of revolutions per 
minute). For simplicity, the alginate solutions were assumed to behave as a 
Newtonian liquid so that the formula for viscosity was calculated as: 
r| = x / y (equation 2.9)
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where rj = Newtonian viscosity (Ns/m ), x = shear stress (N/m ) and y = shear rate 
(1/s)
(Coulson and Richardson, 1996).
The molecular weight of alginate can be determined from the viscosity of the alginate
using the Mark Houwink Equation:
r\ = K * Ma (equation 2.10)
where M = molecular weight, and constants a = 1 and K = 2x1 O'5 (Smidsrod, 1972).
The determination of molecular weight of the alginate is important for 
characterization of the matrix solution, since the length of the polymer chains has 
important implications for the hydrogel strength and structure -  such as porosity and 
dissolution characteristics as described in section 1.4.2.3 (Martinsen, 1989; Leo, 
1990). Alginate treatments such as heat sterilization and filtration greatly affect the 
molecular weight of the alginate (Leo, 1990, Vandenbossche and Remon, 1993).
2.5.12. Statistical analysis
Statistical analysis was performed using the single factor analysis of variance 
(ANOVA) program from Microsoft Excel 2002. The single factor ANOVA analysis 
tool performed a simple analysis of variance, testing the hypothesis that the means 
from two or more samples were equal (drawn from populations with the same mean). 
This technique expands on the tests for two means, such as the t-test. Analysis of the 
groups of data that produced a p-value >0.05 indicated that the means were not 
statistically different (to the 95% confidence level); whereas a p-value <0.05 indicated 
one or more of the samples did not have the same mean.
2.6. Cell proliferation assays 
Quantitation of cell growth of attachment dependent cells is usually performed by the 
cell count method that involves cell harvesting using trypsinization, staining and 
enumeration using a hemacytometer and microscope (section 2.3.2). This method is 
labor intensive, time consuming and results can be dependent upon the operator. In 
addition, cell cultures that are post-confluent tend to be densely packed and 
aggregated which tends to produce inaccurate results due to cell clumping (Lombarts,
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1992). Release of cells from matrices and quantification using the cell count method 
can be inaccurate for the same reasons, in addition, the cells can be lysed during their 
release from the matrix. Therefore, an intact cell component-based protocol was 
preferred to monitor cell proliferation. Two assays were investigated during this 
research: CyQuant assay for nucleic acid quantification and MTT (3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay for mitochondrial 
dehydrogenase activity. These assays were investigated during the research project. 
The CyQuant assay was tested with the earlier rSMC studies and the MTT assay was 
tested with subsequent research on hMSCs.
2.6.1. CyQuant assay
This assay uses a fluorescent dye, CyQuant® (Molecular Probes, Eugene, Oregon, 
USA; product no. C-7026), which binds to nucleic acids giving a signal that is 
proportional to the cell number (Jones, 2001). The assay was performed in 96 well 
microplates (Costar, Coming Life Sciences, Coming, New York, USA; product no. 
3603) and analyzed on a fluorometer (Fluorocount, Packard BioSciences, Perkin 
Elmer™ Life Sciences, Boston, Massachusetts, USA). The cell samples were frozen 
and stored at -20°C for up to four weeks before quantitation. Upon thawing, lysis 
buffer was added to the cell sample to make the nucleic acids accessible to the stain. 
The quantity and ratio of RNA and DNA in cell cultures can vary based upon cell 
type and culture conditions; therefore ribonuclease (RNAse) (Sigma) was also added 
to the cell samples to eliminate contributions of RNA to the results.
2.6.I.I. Preparation of cell number standard
A reference standard for A7r5 rat SMCs was required for converting sample 
fluorescence values into cell numbers by diluting a known quantity of cells to 
concentrations between 50 to lx l0 5cells/well. The cell number standard was prepared 
by trypsinizing flasks of rSMCs and performing a cell count using a hemacytometer. 
The cells were dispensed into aliquots (ca. l-2xl05cells/tube) for individual assays 
and then centrifuged at 200g for 5 minutes. The supernatant was removed without 
disturbing the cell pellet and discarded. The cell pellet was frozen and stored until 
needed for assays. On the day of analysis, one or more tubes were removed and 
thawed. IX cell lysis buffer (Molecular Probes, #3603, component B) was prepared
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and added to each cell pellet and mixed by pipetting and vortexing. RNAse was also 
added at this point to samples in which only nucleic acid contributions from DNA 
were desired. RNAse was added to the cell sample at a concentration of 
ca.l.35Kunitz units/mL. After ca. 1 hour, the individual tubes were combined and 2X 
CyQuant®GR dye (Molecular Probes, #3603, component A) in IX cell lysis buffer 
was added to the sample. This achieved a final concentration of IX CyQuant dye in 
IX cell lysis buffer. Then dilutions were made to achieve a standard curve between 
50 to lx l0 5cells/well. Similarly, twice the concentration of dye (2X) was used to 
prepare cell number standards with IX cell concentration to determine the robustness 
of the assay.
2.6.1.2. Preparation of DNA standard curve
A sample of bacteriophage X DNA (Molecular Probes, product no. C-7026) was used 
to prepare a standard curve for DNA content. This curve was used to calibrate the 
assay for samples analyzed on the Fluorocount on separate days due to variation in the 
fluorescent signal intensity which is instrument dependent. Dilutions were prepared 
in IX cell lysis buffer from lOOpg/mL DNA sample to cover the range between 0 -  
lOOOng/mL of DNA. Additional dilutions with twice the CyQuant dye concentration 
were prepared in IX cell lysis buffer to cover the range between 0 -  2000ng/mL of 
DNA.
2.6.1.3. Analysis on fluorometer
Microplates were loaded into the Fluorocount and 3-5 independent readings were 
taken of each plate using 405nm excitation and 530nm emission filters. The gain was 
set to the well with the highest DNA concentration (in the DNA standard curve). The 
gain was held constant at 1 and the PMT (voltage) was set to 800 and 900. The 
higher PMT setting results in a higher sensitivity of the fluorescence reading.
Samples were analyzed at two PMT (voltage) readings to ensure all wells could be 
read by the fluorometer so that readings at the same PMT setting from different 
experiments could be compared. All readings were subtracted from the background 
fluorescence (reading from the control well that did not contain any cells).
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2.6.1.4. Interference of assay components with 
fluorescence results
A set of typical rSMC standard curves is shown in the Appendices, section 6.1.2.1, 
Figure 69. The assay was linear up to 56,000cells/well when treated with RNAse. 
However, the standard curve slope increased ca. 47% when the CyQuant dye 
concentration was doubled. A set of typical DNA standard curves is shown in the 
Appendices, Figure 70. The assay was linear for both dye concentrations; however 
the standard curve slope increased ca. 38% when the CyQuant dye concentration was 
doubled. This was not expected and may have been due to additional binding of the 
dye to the DNA or higher background interference with the higher dye concentration. 
However a similar increase in fluorescence was observed in both the DNA and rSMC 
standard curves. Before this issue was resolved, the assay was tested to see if the 
alginate matrix components interfered with the fluorescence results. Tubes containing 
rSMC reference standard (as described in section 2.6.1.1) were thawed and treated 
with RNAse and added to CyQuant dye to a final lXCyQuant dye concentration in 
IX cell lysis buffer. Three cell concentrations (4.2 xlO3, 8.4 xlO3 and 
16.8x103cells/well) were transferred into a 96 well plate. Then either a dissolved 
alginate solution or control solution (n-saline and PBS) were added to each individual 
wells at 0, 5, 20 and 80pL per well. The wells were thoroughly mixed with a 
micropipette and measured on the fluorometer at 900 PMT. As shown in the 
Appendices, section 6.1.2.1, Figure 71, the fluorescence signal increased considerably 
as the volume of alginate solution increased indicating the alginate or other 
components of the solution significantly altered the binding affinity of fluorescence 
dye to the cellular DNA as compared to the control solution at the same cell 
concentrations. The cell standard consisted of OpL volume of solution and is shown 
in the Appendices, Figure 69. It conformed well to the previous standard using IX 
dye concentration. Due to the interference of the alginate solution with the 
fluoroprobe’s binding affinity to the cellular DNA, the CyQuant® assay was deemed 
unacceptable for use as a proliferation assay for this application.
2.6.2. MTT assay
A modified MTT assay (Mosmann, 1983) was performed in 96 well microplates 
(Sarstedt Inc., Newton, North Carolina, USA). Three methods of cell preparation
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were used based upon whether the hMSCs were in a cell suspension, if they were 
immobilized in alginate beads or if they were adherent cultures in microplates.
Details described below are the finalized assay method. The results used to construct 
these methods are described in detail in section 3.5.3. In addition the method used to 
determine whether alginate interfered with MTT absorbance is described section
2.6.2.8. Overviews for the steps of each assay are provided in the Appendices, 
section 6.1.1.
2.6.2.1. Preparation of cell number standard
Flasks of hMSCs were trypsinized as per usual protocol and a 0.4mL sample was 
removed for a cell count using a hemacytometer to determine the cell concentration as 
per section 2.5.2. The cells were centrifuged, supernatant removed and pellet 
resuspended to 2xl06viable cells/mL using Dulbecco’s phosphate buffered saline with 
lg/L D-glucose and 36mg/L sodium pyruvate (DPBSG, Biowhittaker, Cambrex, 
Verviers, Belgium). A 20pL aliquot of this cell suspension was added to 80pL of 
DPBSG to perform an additional cell count to confirm the actual cell concentration in 
the resuspended pellet. A serial dilution of the cell suspension was performed in a 96 
well microplate with volumes of DPBSG added to equalize the volume in all of the 
wells to IOOjiL total volume. The dilutions were performed in duplicate with cell 
concentrations per well shown in Table 5. This dilution series created a cell standard 
curve. MTT solution was added as described in section 2.6.2.4.
Volume of 
cells (pL)
Volume of 
DPBSG (pL)
Number of viable 
cells/well (xlO4)
100 0 20
75 25 15
50 50 10
25 75 5
12 88 2.4
In separate vial add 60pL of cells to 
continue dilutions be
OpL of DPBSG then 
ow
50 50 1.2
30 70 0.72
10 90 0.24
0 100 0
Table 5. Dilutions performed for MTT cell standard.
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2.6.2.2. Preparation of standard of hMSCs 
immobilized in alginate beads
At each time point, cell/alginate beads were removed from culture using a 25 mL 
pipet and placed in 10cm petri dish (Sterilin, Bibby Sterilin, Stone, UK) containing 
DPBSG. This wash step was used to remove residual culture medium containing 
phenol red that would interfere with the absorbance reading. Then the cell/alginate 
beads were transferred into a 96 well microplate using a 25mL pipet. Duplicate serial 
dilutions of beads were made to assess the linearity of each MTT assay, such that the 
wells contained 0 (for a background blank), 1, 2 and 3 beads as shown in Table 6.
This dilution series created a cell standard curve for the cells immobilized in the 
beads, since the number of cells/well would be a multiple of the number of beads.
The number of cells/well was determined from dissolving additional beads and 
performing a hemacytometer count as described in the next section. Then, as needed, 
the volume of DPBSG was adjusted to lOOpL/well using a micropipet MTT solution 
was added as described in section 2.6.2.4.
Number of beads 
per well
Volume of 
DPBSG (pL)
Total (average) number 
of cells/well
0 100 0
1 100 IX
2 100 2X
3 100 3X
Table 6. Dilutions performed for MTT assay with alginate beads. The total number 
of cells/well was determined for each experiment by dissolving additional beads and 
performing a hemacytometer count. The average number of cells/bead, denoted as 
IX, was multiplied by 2 (2X) and by 3 (3X) to calculate the remaining total number 
of cells/well.
2.6.2.3. Determination of cell concentration in 
alginate beads
The cell concentration of the beads was determined separately by dissolving of 1 -3 
beads in lOOpL of 0.3M trisodium citrate (Sigma) and lOOfiL of trypsin/EDTA or 
10pL of 10X trypsin/EDTA in saline (BioWhittaker) for at least 15 minutes. Then the 
beads were dispersed into a single cell suspension using a 200fiL micropipet. The 
total volume of the sample was measured using a 1-2 mL pipet, an aliquot was 
removed and a cell count was performed using a hemacytometer (section 2.5.2) and 
viability assessed using the trypan blue dye exclusion assay (section 2.5.3). The total
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cell concentration was calculated by multiplying the cell concentration per mL by the 
total volume. The average cell concentration per bead was calculated by dividing the 
total cell concentration by the number of beads dissolved which varied by experiment 
depending upon the size of the bead and the original concentration of cells 
immobilized in the bead.
2.6.2.4. Addition and incubation of MTT solution
A lOpL aliquot of 5 mg/mL MTT (Molecular Probes or Sigma) dissolved in DPBSG 
was added to each sample well and incubated for 3 hours (range of 1-3 hours used) at 
37°C in a humidified, 5% CO2 incubator (Galaxy S, RS Biotech, United Kingdom). 
Plastic film was used to cover the plate to minimize evaporation during incubation. 
The water soluble MTT salt diffused into the hMSCs (through the alginate hydrogel if 
present) and mitochondrial dehydrogenase activity converted the salt into an insoluble 
formazan product. After the 3 hours (range of 1-3 hours used), 40fiL of 0.3 M 
trisodium citrate in distilled water (BioWhittaker) was added to dissolve the alginate 
within the bead. No mixing of the cell suspension was performed in order to reduce 
loss of cells adhering to the pipet inner surface. After 1 additional hour at 37°C (total 
of 4 hours - range of 2-4 hours used), the microplate was centrifuged (5 81 OR, 
Eppendorf AG, Hamburg, Germany) at lOOg for 5 minutes, the supernatant was 
carefully removed with a micropipet without disturbing the pellet/cells until an ‘O’ 
appeared in the bottom of the well. This procedure eliminated any volume 
inconsistencies that may have arisen from the initial DPBSG or alginate beads. In 
addition, the removal of the supernatant eliminated the majority of the alginate 
solution from the well. Due to the pronounced color change of the yellow MTT 
solution to purple formazan product, the supernatant in the pipet tip could be easily 
observed not to contain sample when removing the supernatant.
For hMSC cell standards that did not contain alginate (so theoretically did not need 
the addition of trisodium citrate), this procedure was followed to mimic the contents 
of the residuals (except alginate) in the wells containing beads.
2.6.2.5. Dissolution of formazan product
After the supernatant was removed, the dissolution procedure continued immediately 
or the plate containing the cell pellets was wrapped in foil and frozen. Freezing and
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storage of the plates at -70°C allowed a time course study to be performed; then all 
plates could be completed (e.g. dissolved and read) on the same day. Plates from each 
time point, if frozen, were thawed and each well with cell pellet or bead(s) was 
reconstituted with 70pL DPBSG. The plate was tapped gently to distribute the pellet 
and DPBSG. For experiments with alginate-GRGDY beads, instead of 70|liL of 
DPBSG, 50pL of DPBSG and 20pL of 10X trypsin/EDTA in saline were added to 
dissolve cell-to-cell networking within the bead. Addition of 10X trypsin/EDTA was 
critical to achieve a homogeneous suspension. Plates containing 
DPBSG/trypsin/EDTA were incubated wrapped with film for ca. 30 minutes at room 
temperature; then the bead(s) was thoroughly resuspended into a single cell 
suspension using a micropipet. Plates not requiring trypsin/EDTA (e.g. those without 
alginate-GRGDY beads) were processed to the next step immediately and did not 
require incubation nor mixing to homogenize the sample. Finally lOOpL of a solution 
of isopropanol (Sigma) with 0.1N HC1 (Fluka) was added to all samples to 
permeablize the cells and dissolve the formazan product. The plate(s) was covered 
with film and incubated at room temperature for 20 minutes. Then each well was 
mixed thoroughly with a separate micropipet and incubated at room temperature for 
another 20 minutes. Then each sample was mixed again after a total of 40 minutes.
2.6.2.6. Analysis of data
Within a maximum of one hour from the time of isopropanol/HCl addition, the 96 
microwell plates were read on a spectrophotometer (Packard Bioscience 
Spectracount™, Packard-Becker BV, Groningen, Netherlands) at an absorbance 
reading of 600nm. In some cases these data were subtracted from the background 
absorbance at 670nm.
The majority of researchers using isopropanol to dissolve the formazan product 
measured absorbance at 570nm with background subtraction (reference wavelength) 
at 630nm (Mosmann, 1983; Wang, D., 2003; Yang, 2003). Carrier (1999) read the 
plates at 620nm. Zund (1999) used 550nm blanked with isopropanol solution (MTT 
solution was removed prior to dissolution with isopropanol and 10% formic acid).
The closest filter available on the Packard Bioscience microplate spectrophotometer 
to 570nm was 600nm; therefore, this wavelength was used. As demonstrated in 
section 3.5.1, this difference did not affect the results of the assay.
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The complete assay protocols are summarized in the Appendices, section 6.1.1.1 for 
the cell number standard and section 6.1.1.2 for the cell number using alginate beads. 
For experiments with simultaneous MTT absorbance measurement and cell count 
with hemacytometer using trypan blue, the absorbance could be plotted using the 
actual viable cell count.
2.6.2.7. Adherent cell assays
All of the adherent cell assays were performed in 24 well microplates (Coming) to 
evaluate cell growth of hMSCs over a time course. The spent medium was removed 
from the well, and 300pL of DPBSG was added to the well. Then 30|iL of 5mg/mL 
MTT solution was added. After the plate was incubated for 1-3 hours (3 hours 
required for high cell densities) at 37°C, 120pL of 0.3 M trisodium citrate was added 
to the well. Although there was no alginate in these samples, trisodium citrate was 
added to reflect the same procedure used for dissolution of alginate beads. After an 
additional hour of incubation (2-4 hours total), the entire MTT solution was removed 
from the microwell. Centrifugation was not necessary since the cells were adherent to 
the microwell. At this point the plate was frozen and stored at -70°C, or the assay was 
continued immediately to the dissolution step. For dissolution, the plates were 
thawed (if frozen) and 210pL of DPBSG and 300fiL of isopropanol/0. IN HC1 were 
added to each well. The plates were then incubated at room temperature covered with 
film. After 20 minutes, the contents of the well were mixed with separate micropipets 
to release the formazan, and returned for a further 20 minutes of incubation. After a 
total of 40 minutes dissolution and an additional mixing step, a lOOpL sample was 
removed and read on the spectrophotometer in a 96 well microplate. These results 
were correlated to data obtained using the 96 well format by multiplying the 
absorbance results by a factor of 3.0 (3 times the volume of DPBSG and 
isopropanol/HCl were added to the 24 well microplate compared to the 96 well 
microplate). Since the 24-well plates used three times the amount of isopropanol/HCl 
for dissolution than the 96 well plates, a much higher concentration of cells (e.g. 
formazan product) could be dissolved. The complete adherent cell assay protocol is 
summarized in the Appendices, section 6.1.1.3.
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2.6.2.8. Interference of alginate with MTT 
absorbance
In order to determine if residual alginate or assay residuals (e.g. trisodium citrate) 
interfered with the MTT assay, alginate beads without cells were made by mixing 
25% v/v MSCCM with 75% v/v of 1% alginate (Pronova SLG100) and adding drop- 
wise through a syringe with blunt needle (0.1mm diameter) into a solution of 1% 
CaCh in n-saline and letting cross link for 15 minutes. The alginate beads were 
collected by pouring through a sterile metal strainer, and then washed with DPBSG. 
Using this manual procedure, the alginate beads were approximately 2-2.5mm in 
diameter.
For this experiment, the wells of a 96 well microplate were loaded with 12pl of cell 
suspension (producing 2.05x104cells/well) and an increasing amount of alginate 
(number of alginate beads) per well. The alginate beads did not have cells 
immobilized within them, so the cell concentration of the well was constant for each 
well. The number of alginate beads, volume of DPBSG and cell suspension added to 
each well is shown in Table 7. The cell suspension of hMSCs was prepared as per 
section 2.6.2.1; however, the same volume of cells (12pL) was added to each well to 
produce the same number of cells/well. The MTT assay was carried out with 
dissolution of the beads using trisodium citrate (but no trypsin/EDTA) according to 
procedure detailed in section 2.6.2.4 and 2.6.2.5. This assay was performed without 
freezing the plate. Although the supernatant from each well was removed after 
centrifugation as detailed in section 2.6.2.4; the residual volume/well would still 
contain an increasing concentration of alginate as the number of beads/well increased.
Number of beads 
per well
Volume of 
DPBSG (pL)
Volume of cells 
(pL)
Total number of 
cells/well (xlO4)
0 100 0 0
0 88 12 2.05
1 88 12 2.05
2 88 12 2.05
3 88 12 2.05
4 88 12 2.05
Table 7. Concentration of cells and num >er of beads used for the alginate
interference test for the MTT assay. The same concentration of cells was used per 
well; whereas an increasing number of alginate beads (without cells) were added to 
each well.
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The absorbance readings varied between 0.2 and 0.3 for all the conditions 0,1, 2, 3, 
and 4 beads per well. A graph of these results is shown in the Appendices section
6.1.2.2, Figure 72. The absorbance values were not greatly effected by the increased 
level of alginate per well. Single factor ANOVA (analysis of variance) statistical 
comparison indicated that the results were statistically different (p=0.0000) among the 
5 samples; however, the statistical difference between the absorbance readings for 0 
and 4 beads was not significant (p=0.4023) and between the absorbance readings for 2 
and 3 beads (p=0.5021). The variability of the data seems to be due to well-to-well 
variability (Wan, 1994), rather than a true effect of the presence of alginate or an 
increasing concentration of alginate. More replicates would have been useful to help 
confirm this. Despite this shortcoming, the results were significantly better than the 
CyQuant assay; therefore, the MTT assay was deemed acceptable for further work.
2.7. Methods for differentiating hMSCs
HMSCs were immobilized in alginate-GRGDY beads for conducting differentiation 
studies as described in section 2.7.1. The preparation of the rSMCs cultures for the 
differentiation studies is described in section 2.7.2 and 2.7.3. In addition, a media 
differentiation study was conducted with hMSCs grown long term in microwell plates 
as described in section 2.7.4 to establish a base-line for a-smooth muscle actin 
(ASMA) protein expression for cultured hMSCs using the biotin avidin complex 
method as described in section 2.5.8. ASMA is a sensitive indicator for smooth 
muscle cells.
2.7.1. Preparation of hMSCs immobilized in alginate beads
Sodium alginate was derivatized to incorporate GRGDY peptides for cell attachment 
as described in section 2.3.3. The alginate was dialyzed for 2-6 days in water using 
dialysis cassettes, treated with activated charcoal, filtered through Celite and then 
concentrated either by PEG treatment or by lyophilization as described in section
2.3.3.5.
Cultures of hMSCs were trypsinized, centrifuged twice to remove residual trypsin and 
EDTA, and mixed homogeneously into the alginate-GRGDY solution at 5x106 to 
2xl07cells/mL as described in section 2.4.1. Hydrogel beads of 2-2.5mm diameter
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were produced as described in section 2.4.4. The beads were collected in 1% CaCh in 
n-saline solution for 10-15 minutes and rinsed with MSCCM. For differentiation 
studies, the beads were transferred into Millicell-CM culture plate inserts (Millipore 
Corp., Bedford, Massachusetts, USA) and cultured in 24-well microplates (Coming) 
containing ca. lmL of MSCCM and incubated at 37°C in a 5% CO2 humidified 
incubator.
2.7.2. Preparation of rSMC co-cultures and conditioned
medium
RSMCs were cultured in tissue flasks as previously described in section 2.1.1.2. Due 
to the presence of residual trypsin/EDTA in the medium during passaging, flasks used 
for differentiation studies were refed with 20mL (0.13 mL/cm2) of fresh DMEM after 
the cells had adhered to the flask surface, typically one day after passaging. The 
conditioned DMEM medium (CDMEM) from ca. 2-6 day old cultures of rSMCs was 
collected and centrifuged at 200g for 5 minutes to remove all cell debris and residual 
cells from the medium. The supernatant was removed and the CDMEM was stored in 
the refrigerator until needed. The CDMEM was not stored for longer than ca. 1 week 
prior to use in the differentiation studies since the stability of its components had not 
been determined. Co-cultures of rSMCs were prepared for differentiation studies 
from ongoing flask cultures. The rSMCs were trypsinized as described in section 
2.1.1.2 and seeded at 5x10 cells/cm into 24 or 12-well microplates containing lmL 
or 2-3mL of complete DMEM per well respectively, and incubated at 37°C in a 10% 
CO2 humidified incubator.
2.7.3. Differentiation of hMSCs using CDMEM and rSMC
co-cultures
After ca. 1-3 days, the Millicell inserts containing the hMSC/alginate beads (as 
described in section 2.7.1) were transferred into the 24 or 12-well microplates 
containing the rSMCs. First of all, the inserts were removed from their individual 
wells using sterile tweezers, and the MSCCM was carefully removed from inside the 
insert without disturbing the hMSC/alginate beads. Concurrently, the spent medium 
was removed from the microwells containing the rSMC co-cultures. Then the inserts 
containing the hMSC/alginate beads were placed into the microwells containing the
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rSMC co-cultures (1 insert per well). The Millicell insert and microwell were 
carefully filled with the supernatant from CDMEM as prepared in section 2.7.2. The 
culture plate inserts contained a 0.4pm membrane, which acted as a physical barrier to 
the rSMCs such that they could not come into direct contact with the hMSC/alginate 
beads. However, the membrane allowed molecules to diffuse through. Beads were 
removed from culture at approximately three day intervals and analyzed for changes 
in the cell characteristics using fluorescent activated cell sorting (FACS) as described 
in 2.5.9 and immunohistochemistry as described in section 2.5.8. Similarly, inserts 
containing hMSC/alginate beads were also transferred into microwells containing 
complete DMEM (not conditioned in rSMCs) for control cultures. These control 
beads were removed and analyzed at the same time intervals as the beads that were 
cultured in the CDMEM and rSMC co-cultures.
2.7.4. Media differentiation studies of hMSCs in
microwells
Since long term cultures of hMSCs have been characterized as ‘smooth muscle cell­
like’ (Charbord, 2000; Dennis and Charbord, 2002; Kadner, 2002) and because there 
are undefined components in the FBS used in the culture medium, a base-line study 
was performed to determine levels of ASMA staining in cultured hMSCs. Cultures of 
P5 hMSCs were trypsinized from the P4 JM cell bank, seeded into 12-well microplates 
(3.8cm2) at a density of 5xl03cells/cm2 with 2mL of MSCCM per well, and incubated 
at 37°C in a 5% CO2 humidified incubator. After five days when the cells were ca. 
90-100% confluent, the spent medium from each well was removed and replaced with 
MSCCM, complete DMEM or rSMC conditioned DMEM (CDMEM) as described in 
section 2.7.2. For this study the CDMEM was obtained from centrifuged supernatant 
from conditioned medium from P6-P8 rSMCs after 2-4 days in culture. The culture 
medium for each condition was replaced every 3 days, and the length of storage of the 
CDMEM at 6°C was between 1-5 days prior to use since the stability of the 
conditioned medium was not known. At time points on days 3, 6 and 9, the cell layer 
was scraped with a metal spatula, smeared onto a glass slide and fixed in acetone as 
described in section 2.5.8. The slide was allowed to air dry and then was stored at - 
20°C until analysis. The slides were exposed to hematoxylin to stain the cells’ nuclei 
and to the specific monoclonal antibody stain for ASMA to assess the presence of 
these specific cell proteins.
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3. Results
The results for sodium alginate formulation and incorporation of the pentapeptide 
Gly-Arg-Gly-Asp-Tyr onto alginate polymer (alginate-GRGDY) are discussed in 
sections 3.1 and 3.2 respectively. These sections are focused on the process results 
which are independent, although closely linked, to the results obtained using cells.
The incorporation and characterization of rat smooth muscle cells (rSMCs) with the 
alginate and collagen matrices are discussed in section 3.3. Results obtained using 
human mesenchymal stem cells (hMSCs) and alginate matrices are described in 
section 3.4. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) assay results for cell proliferation are discussed in section 3.5. Finally the 
results from differentiation studies using hMSCs in alginate-GRGDY beads are 
provided in section 3.6.
3.1. Alginate formulation
Alginate concentrations ranging from 0.5-6% w/v were examined. Initially, WFI for 
cell culture applications was used to mix with the alginate. However, low cell 
viability and cell lysis were observed upon mixing due to the non-physiological 
conditions (e.g. low pH and osmolarity) especially in the high viscosity alginates.
Then the alginate was reconstituted in buffered saline solutions (e.g. DPBS and PBS) 
since they were buffered and isotonic. However when 1% CaCh solution (ca. 90mM) 
was added to cross link the alginate, the PBS caused insoluble calcium phosphate (i.e. 
CaHP0 4 ) precipitates to form which were undesirable as explained in the next section 
on cross linking solution. Finally normal saline (n-saline, 0.9% NaCl in WFI, pH 7- 
7.4) was selected because it was the best alternative, although the pH was unstable 
because it was not buffered. When the alginate in n-saline was mixed with an equal 
volume of cells resuspended in complete DMEM medium, the pH was stable at ca.
7.6.
The alginate solutions were mixed overnight or autoclaved (121°C for ca. 22 minutes) 
to aid dissolution. Higher alginate concentrations (2-6% w/v) had to be autoclaved to 
ensure a homogeneous mixture. Viscosity studies showed that heat treatment 
significantly reduced the high molecular weight components of the alginate (Leo,
1990; Vandenbossche and Remon, 1993; Zoro, 2005) resulting in lower equilibrium 
modulus (Wong, M., 2001). Zoro showed the effect of autoclaving on the viscosity of
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Fluka alginate in n-saline solution for concentrations between 0 and 2% (Table 8).
The 1% solution viscosity was reduced from 109 to 13mPa s after autoclaving, which 
was calculated to be a molecular weight change of 151 to 66kDa (Zoro, 2005). 
Similarly, this research showed that the viscosity of 1% w/v Manugel was reduced 
from 200 to 5mPa s after autoclaving. Because the sterilization cycle length 
(including warm up, sterilization, and cool down) would vary considerably depending 
upon the size of autoclave and load, this process step would require careful 
standardization for a marketed product. Considerable validation of this process would 
need to be performed to understand the impact on the final matrix’s strength, porosity, 
and decomposition. This heat treatment was also intended to sterilize the alginate 
solution. In actuality thermophilic bacillus spores were found to be prevalent, as 
discussed in section 3.1.2., which were resistant to these autoclaving conditions. This 
problem led to the sourcing of sterile alginate, Pronova SLG100, from NovaMatrix to 
avoid diversion from the main target.
Fluka in n-saline Not autoclaved Autoclaved
0% alginate viscosity (mPa sec) 1.2 1.2
0.5% alginate viscosity (mPa sec) 20 3.5
1.0% alginate viscosity (mPa sec) 109 13
1.5% alginate viscosity (mPa sec) 472 44
2.0% alginate viscosity (mPa sec) 1360 154
Molecular weight (kDa) 151 66
Table 8. Comparison of the viscosity and molecular weight of Fluka alginate in n- 
saline that was autoclaved (Zoro, 2005).
Filtration through a step-down series of Cuno Inc. filters as described in section 2.3.1 
ending a 0.2 or 0.1 pm membrane was an alternative method for sterilization; however 
this method was not desirable. Due to the high viscosity of the 1% w/v alginate 
solution, a 0.1% w/v alginate solution was required to effectively filter the solution.
In addition, a low flow rate (3mL/min) using a large filtration surface area (27cm2) 
was required to process only ca. 250mL of 0.1% alginate solution through the 0.2pm 
filter step prior to fouling of the filter which was associated with an increased pressure 
differential of 2.3bar across the membrane because the high molecular weight 
polysaccharide chains were retained by the filter. The filter rating was 77 psig (5.3
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bar). Only the low molecular weight components and water passed through the 
membrane. The resulting alginate filtrate had to be lyophilized to dryness to return to 
the desired 1% concentration. In addition, the solution was still found to have 
thermophilic spores even after passing through the 0.1 pm filter. This was most likely 
due to the high pressure causing the pores of the filter to deform and thereby allowing 
the small bacillus spores to pass through. Bacillus subtilis endospores range in size 
down to ca. 0.38 microns in diameter (Katz, 2005).
3.1.1.1. Cross linking solution
Several formulations were examined for the calcium chloride cross linking solution. 
Initially the calcium chloride was just dissolved in WFI for cell culture applications. 
Calcium chloride could not be added to a buffered phosphate saline solution, such as 
PBS, because when combined a calcium phosphate precipitate formed. Therefore the 
final cross linking formulation selected was calcium chloride in n-saline for the 
reasons described above for the alginate solution. The pH of the CaCh in n-saline 
solution was adjusted between 7 to 7.4 using 0.1N NaOH. All of the CaCh 
formulations were sterile filtered through a 0.2pm cellulose acetate membrane 
(Nalgene) or autoclaved for 22 minutes at 121 °C. Barium chloride was also 
investigated as a potential cross linking solution. This experiment is described in 
section 3.3.4.
Cells are known to be sensitive to calcium levels, particularly muscle cells which 
contract and dilate during stimulus. In addition, calcium levels could adversely affect 
cell receptors, such as cadherins, which are transmembrane, calcium dependent 
glycoproteins that mediate cell-cell interaction by binding homophilically (by 
adhering to the same cell surface adhesion protein) with adjacent cells (Kukreti,
1998). Calcium ions are essential in stabilizing the active conformation of the 
cadherins. Another family of cell adhesion receptors, selectin, is completely 
dependent on the conformational changes associated with filling of two Ca2+ binding 
sites. Binding is also sensitive to pH which must be maintained near physiological 
levels (Kukreti, 1998).
The physiological CaC^ concentration for cells, which is present in DMEM medium, 
is 1.8mM. The concentrations used to cross link the alginate are considerably higher
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and may be toxic to cells such as rSMCs. The molar concentrations of CaCL were 
calculated to be 180, 90,45, and 9mM for 2%, 1%, 0.5%, and 0.1% solutions 
respectively. Due to the high molarity of the CaCL solutions needed to cross link the 
alginate molecules, the lowest concentration that was found to reproducibly work was 
0.5%. 1-2 % CaCh was found to work as well as a 0.5% solution, typically a 1% 
concentration was used. These results corresponded well with Martinsen (1989) who 
showed gel strength and volume reduction were independent of CaCL concentration 
above 20mM. Section 3.3.2.3 describes an experiment conducted to determine if the 
transient exposure to CaCh was toxic to rSMCs.
3.1.2. Sterility issues with alginate
During culturing in MSCCM, the alginate-GRGDY beads with entrapped hMSCs 
were observed turning white (or black, microscopically due to loss of light 
transmission) when the alginate was autoclaved beginning with the ‘intermediate’ 
alginate-GRGDY process (section 2.3.3, Figure 4). The potential source of the 
contamination was investigated by sterility testing of all components of the 
derivatization process (as described in section 2.3.3.7) and the cell cultures (section 
2.2.2.3). From the sterility tests performed, microorganisms were observed in the 
alginate samples despite having undergone autoclaving. Therefore, all of the 
conditions for autoclaving were monitored. The autoclaves were serviced and 
calibrated routinely. Correct temperature, pressure and sterilization length were 
verified using the 3M Electronic Test System device (3M Health Care Ltd., 
Loughborough, UK); and indicator ampoules containing Bacillus stearothermophilus 
spores (Sterikon plus Bioindicator, Merck KGaA, Darmstadt, Germany) were used to 
verify kill of heat resistant microorganisms. The autoclaves were found to be 
functioning properly. It was hypothesized that the high viscosity of the alginate could 
be protecting the microorganisms from thermal inactivation. Therefore 1%, 0.1% and 
0.01% alginate solutions in water were prepared and autoclaved with a control (water, 
no alginate). All samples were placed in terrific broth or in DMEM and incubated 
overnight at 37°C. All samples except the control were positive for microbes (under 
microscope 60X magnification). A sample from the 1% autoclaved alginate was re­
combined with terrific broth to make a 0.1% alginate solution and was autoclaved 
again. This sample was then added to new DMEM or terrific broth and incubated at
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37°C. The re-autoclaved samples contained a few microorganisms (observed 
microscopically under 60X magnification).
Samples of the autoclaved 1% (Manugel DMB) alginate in water were submitted to 
Dr. Michael Wren at University College London Hospital for identification. The 
actively growing microbes were recovered from the alginate solution by plating on 
agar media plates using standard microbiological techniques. Then the microbes were 
dehydrated by graded series of ethanol to cause sporulation. Then the new solution of 
spores (not in the presence of alginate) was autoclaved again to see if the spores were 
truly thermophilic and not due to inadequate sterilization caused by the alginate’s high 
viscosity or other protective effects. Tubes of the autoclaved spores were incubated 
in a 37°C incubator and 60°C water bath with control ampoules of thermophilic spores 
(Sterikon). Live bacillus cultures were microscopically observed from the autoclaved 
spores the second time through the autoclaving process. Finally, the microbes from 
the original alginate sample were identified by the Central Public Health Laboratory 
(Colindale, London, UK) as Bacillus licheniformis. Other commercial alginate 
sources in the lab were autoclaved from Pronova test kit (MVG, LVG, LVM, MVM); 
and were also observed to contain microbes after autoclaving; although the microbes 
were not specifically identified as was done for the Manugel DMB alginate.
Interestingly, other groups have studied immobilized spores (Bacillus subtilis and 
Bacillus stearothermophilus) in alginate beads as bioindicators in the validation of 
thermal sterilization processes (Serp, 2002). Therefore the protective effect of 
alginate from thermal inactivation of thermophiles has been studied. Bacillus 
licheniformis has been isolated from marine alga (Yan, 2003), but no previous reports 
were found from isolation in alginate. Bacillus licheniformis was isolated from milk 
powder from 18 different countries (Ruckert, 2004). Although believed to be non- 
pathogenic, Bacillus licheniformis has been shown to be cytotoxic to McCoy mouse 
cells (Lindsay, 2000), and harmful when injected into pregnant cows (Agerholm,
1999) and immunodepressed mice (Agerholm, 1997). There have been five cases 
reported of Bacillus licheniformis infection in patients with cancer and central venous 
catheters (Blue, 1995). Given these reports, clearance of this microorganism from 
alginate is absolutely essential to its future use as an implantable tissue engineering 
matrix. The variability of its removal using different purification processes may be
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one of the reasons why alginate implants have elicited varied immune responses in 
animal studies (Klock, 1994; Zimmerman, 2000; Orive, 2002).
3.2. Derivatization of alginate-GRGDY
This section summarizes the general physical results for derivatization of alginate 
with GRGDY peptides. Results from studies conducted with rSMCs and hMSCs for 
bioactivity (cell association) and characterization are provided in sections 3.3 and 3.4. 
A description of the three derivatization methods used to prepare alginate-GRGDY 
during the course of this research was provided in the Materials and Methods section 
2.3.3 and summarized in Figure 4. A synopsis of these processes is provided in Table 
9. The range of reactant’s concentration used in the alginate-GRGDY derivatization 
were increments (e.g. IX, 10X and 50X) of Rowley’s (1999) reactant concentrations, 
where IX was lmg of alginate containing 38pg of sulfo-NHS, 67pg of EDC and lpg 
of peptide; 10X was ten times the reactants and 50X was fifty times the reactants 
(section 2.3.3.2).
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Table 9. Summary of the three methods used to produce alginate-GRGDY. The 
‘initial process’ was tested using IX, 10X and 50X reactants (e.g. sulfo-NHS, EDC 
and peptide) and after dialysis was treated with activated charcoal and filtered through 
Celite. The ‘intermediate process’ used autoclaved alginate which was tested using 
1X-35X reactants and the post-dialysis alginate was concentrated using polyethylene 
glycol (PEG). The ‘sterile process’ utilized sterile Pronova SLG100 alginate using 
1X-27X reagents that were filtered prior to use. Aseptic operations were conducted in 
a laminar floor hood (LFH) using sterilized equipment, 0.2pm filtered water for 
dialysis, and the post-dialyzed alginate was lyophilized.
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3.2.1. Effect of alginate source/treatment on reactant
concentration
As described in the methods section 2.3.3, the ‘initial process’ used 1% alginate in 
MES/NaCl buffer which was made by reconstituting the alginate overnight without 
autoclaving. These solutions were the most viscous and required the highest reactant 
concentrations (50X) to achieve cellular interaction. This cellular interaction was 
evident by the elongation of the cells from the initial spherical shape obtained after 
trypsinization and immobilization in the alginate hydrogel. The IX and 10X 
concentrations had little or no cellular interaction. These results are discussed for 
rSMCs in section 3.3 and for hMCSs in section 3.4. The 50X concentration was 
needed for high guluronic acid containing alginates (Fluka, Manugel, Pronova). 
During the ‘intermediate process’, the 1% alginate in MES/NaCl buffer was 
autoclaved and immediately the effective concentration of reactants decreased to 27- 
35X because the 50X beads did not maintain shape and completely dissociated within 
1 day after immobilization. This was most likely due to the lower gel strength after 
sterilization due to the decrease in the high molecular weight components (Leo, 1990; 
Vandenbossche and Remon, 1993; Wong, M., 2001). In addition, the 50X reactants 
incorporated many more GRGDY peptides onto the guluronic acid subunits, thereby 
not permitting enough calcium binding sites to hold the polysaccharide chains 
together. Thus the hydrogel dissociated very rapidly. Figure 10 shows the calcium 
binding sites between adjacent G subunit blocks which would be blocked by the 
presence of a GRGDY peptide within the binding domain. Finally, the ‘sterile 
process’ used highly purified, sterile alginate (Pronova SLG100) which was higher in 
viscosity (ca. 148mPa s) than autoclaved Manugel (ca. 5mPa s). For this process, the 
27X reactants were too high, possibly due to its higher purity, and hydrogel beads 
dissociated within 1 day of formation. Therefore 9-12X reactants were determined to 
be optimal.
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Figure 10. Schematic showing the calcium (Ca ) binding site with the carboxylic 
acid groups (COO-) on adjacent guluronic acid molecules. This is the same site on 
which the GRGDY peptide was attached, (adapted from Llanes, 2000)
3.2.2. Other factors influencing reactant amounts
As described in the previous section, the alginate source and treatment affected the 
concentration of the reactants. However, large batch variability of EDC was also 
detected when the EDC batch was changed from Sigma lot number S08123-262 to 
SI 4736-023. As a result, the effective concentration of reactants decreased from 27- 
35X to 9X. In addition, the temperature used for the carbodiimide reaction was found 
to affect the reaction, as would be expected due to changes in reaction rates and 
molecular mixing. Temperature control of the steps would be beneficial since the 
room temperature ranged between 20-26°C. In addition the temperature during 
dialysis varied from cold (6-10°C) during the initial process to very warm (26-31°C) 
in the hood during the sterile process. The diffusion of molecules across the dialysis 
membrane would certainly be affected by temperature.
3.2.3. Dialysis length
During this research the length of dialysis in water varied from 2 to 6 days. Initially a 
2 day dialysis length was frequently used for speed of operation. In addition the 
dialysis cassette membrane expanded considerably within the first 48 hours, and there 
was concern that the cassette would burst if dialysis continued for a longer length. A 
2 day dialysis length for the ‘initial process’ was probably sufficient because of the 
subsequent charcoal absorption step. However, later in the ‘intermediate process’ it 
became evident that 2 days of dialysis was insufficient. It was observed that the
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hydrogels (i.e. beads) would swell within 24 hours after formation. The outer shell of 
the bead was still intact however the inner contents of the beads appeared to spill out 
due to the influx of water into the bead. Therefore dialysis was returned to a 
minimum of 5 days during the ‘sterile process’.
3.2.4. Charcoal absorption and diamentacous earth 
(Celite) filtration
Activated charcoal absorption provided an advantageous step to remove heavy metals 
and polyphenols from commercial alginate (Skj&k-Braek, 1989) and other cell-toxic 
residuals, such as EDC, leftover from the carbodiimide reaction. However, this 
absorption process was not suited for sterile operations that are mandatory for cell 
culture applications. In addition, the Celite filtration times were very long (5-8 hours) 
due to the high viscosity and the high molecular weight components (long chain 
polysaccharides) that were retained in the Celite film layer. As a result the alginate- 
GRGDY filtrate, although biologically active, had a very low alginate concentration 
(i.e. water-like consistency) and evidently consisted of primarily small chain 
polysaccharides (i.e. low molecular weight) causing the cell/alginate beads to be 
amorphous, often pancake or donut shaped, after cross linking in CaCh.
3.2.5. PEG concentration
As discussed earlier, dialysis caused the alginate to have an increase in water content 
due to influx of water into the dialysis cassette. During the ‘intermediate process’, 
solid PEG crystals (8K and 35K MW) were used to concentrate the alginate-GRGDY 
after dialysis while still inside the dialysis cassettes. This method was non-sterile, 
messy, and cumbersome because the PEG had to be carefully scraped off the 
membrane surface in order to monitor the volume/weight change of the alginate- 
GRGDY. In addition, the water diffusion across the membrane did not decrease 
consistently at the same rate (mL/hr) possibly due to the variable change in membrane 
pore size due to stretching of membrane from influx of water. Thus the concentration 
step required hourly monitoring. Using the liquid Pierce concentrating solution was 
slightly easier than the solid PEG; however it still had the problem associated with 
monitoring the decrease in volume. Although the concentrating solution was 
provided sterile, it was impossible to handle the dialysis cassettes in a sterile manner 
for multiple weighing.
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3.2.6. Lyophilization
During the ‘initial process’, lyophilization was associated with decreased biological 
activity such that the cells did not elongate within the alginate-GRGDY hydrogel 
post-lyophilized to the same extent as within the hydrogel prior to lyophilization.
This was most likely because the alginate-GRGDY did not freeze-dry properly.
Phase change alters the pH and moisture that can damage peptides (Wu, 2000; Bafifi 
and Gamick, 1992; Volkin and Klibanov, 1992). The lyophilization unit was shared 
with multiple users which frequently resulted in the removal of the alginate-GRGDY 
from the unit prior to completion of the drying process. If material was removed 
during the cycle or prior to complete drying; any remaining frozen water crystals 
would melt due to the loss of vacuum and/or increase in temperature above the glass 
transition temperature. Even if reffozen, the water becomes bound to the dried 
material resulting in higher final moisture content and decreased stability of the 
peptide in the alginate cake. Therefore during the ‘intermediate process’, the use of 
PEG was investigated to concentrate the alginate-GRGDY as described in previous 
section 3.2.5. However, due to the disadvantages with using PEG, lyophilization was 
revisited for aseptic improvements during the final ‘sterile process’. Once a dedicated 
lyophilizer was used and a strict 2 day minimum cycle length was followed, the 
biological activity of the lyophilized alginate-GRGDY seemed to improve. In 
addition, a more reliable alginate concentration could be achieved upon reconstitution, 
and aseptic operations such as transfer of alginate after dialysis into sterilized vials for 
freeze drying were possible to maintain sterility.
3.2.7. Reconstitution of alginate-GRGDY
Lyophilized alginate-GRGDY was typically reconstituted with n-saline (0.9% NaCl) 
to achieve a final 1% alginate concentration so that it was isotonic for subsequent 
addition to the cell suspension. Reconstitution of lyophilized alginate-GRGDY using 
n-saline was not a problem for alginate that was only dialyzed for 2 days. However 
after 5 days of dialysis, the sterile (Pronova SLG100) alginate-GRGDY would not 
reconstitute using n-saline. Apparently the extensive dialysis with water removed the 
majority of the sodium ions resulting in protonation of the carboxyl groups on the 
non-GRGDY-derivatized alginate polysaccharides turning it into alginic acid which is
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insoluble in water (Doumeche, 2004). However, alginic acid can be solubilized by 
adding sodium carbonate (Na2 CC>3), sodium hydroxide (NaOH) or trisodium 
phosphate Na3P(>4 1 2 H2 O) (www.fao.org/docrep/W6355E/w6355e04.htm). In this 
system, phosphate and carbonate were not desirable. Therefore the sterile (Pronova 
SLG100) alginate-GRGDY dialyzed for 5 days was solubilized by adding ca. 22.5- 
35pL of IN NaOH (Sigma) to 0.75-lmL of n-saline (not pH adjusted) in each vial. 
Less NaOH, if any, was needed to reconstitute the alginate-GRGDY that underwent a 
shorter dialysis length. The pH was measured to be 8.5 for 2-day dialyzed alginate- 
GRGDY reconstituted with 13pL IN NaOH per mL of n-saline. However the pH was 
4.0 for 5-day dialyzed alginate-GRGDY reconstituted with 22.5pL IN NaOH per mL 
of n-saline. These results were extremely variable due to the difference in dialysis 
length. However, the readings were taken using minimal sample volume to cover the 
electrode; therefore future readings will be performed with a micro-electrode. In 
addition the viscosity of the reconstituted 1% alginate-GRGDY was measured using a 
cone and plate rheometer and found to range between 29 to 56mPa s. In addition a 
sample containing 0.75% w/v alginate-GRGDY containing 9xl06hMSCs/mL was 
measured to be 33mPa s. The original (underivatized) Pronova SLG100 was 
measured to be 60mPa s when reconstituted to 0.75% w/v in culture medium with no 
cells.
3.2.8. Sterility of alginate-GRGDY
Reactants used in the carbodiimide chemistry were tested for sterility using terrific 
broth as described in section 2.3.3.7. Prior to the introduction of 0.2pm filtration it 
was found that the GRGDY peptide contained low levels of microbes. In addition the 
pharmaceutical grade alginates were found to contain the thermophilic bacillus spore, 
B Jicheniformis (section 3.1.2). All of the other components including the sulfo-NHS, 
EDC and the Pronova SLG100 alginate appeared to be free from microbial 
contamination. However 0.2pm filtration was still performed on the sulfo-NHS and 
EDC because it was possible that there were still microbes present, but unable to grow 
under the conditions of the sterility test. The EDC caused precipitates to form in the 
terrific broth, but did not affect the testing and observations. After ensuring sterile 
components and equipment throughout the process, samples from the various process 
steps were found free from microbial contamination including: post 20 hour reaction,
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post dialysis using 0.2pm filtered water and gamma-irradiated dialysis cassettes, and 
post lyophilization and reconstitution. Samples were maintained and observed out to 
2 weeks to confirm sterility.
3.2.9. Summary
Sodium alginate was selected as the matrix for this research project based upon the 
success of alginate hydrogels in the cell therapy field and the initial success reported 
growing anchorage dependent cells on the surface of hydrogels by incorporating RGD 
containing peptides onto the polymer backbones. In addition, a variety of hydrogel 
shapes (e.g. sheets, tubes and beads) could be easily fabricated using solutions of 
divalent cations such as CaCb. Sodium alginate solutions were prepared using a 
variety of commercial sources with different properties including composition of 
mannuronic and guluronic subunits and molecular weights (viscosities). Autoclaving 
was used as a method of sterilization; however it was associated with a severe 
decrease in viscosity (i.e. 1% solution - 200mPa s reduced to 5mPa s). Sterile 
filtration was performed using a 0.1% alginate solution through a series of Cuno Inc. 
filters down to 0.1pm pore size with low volume throughput. Both sterilization 
methods were found to be unacceptable for elimination of microbes. The 
thermophilic bacillus spore, B.licheniformis, was found to be contained in several of 
the commercial alginate suppliers. Sterile Pronova SLG100 alginate was procured 
and found to be free from these microbes. The cross linking solution used for the 
majority of the experiments was 1% CaCL in n-saline pH 7-7.4, despite its high 
molarity (90mM) compared to physiological conditions (ca. 2mM). Carbodiimide 
chemistry was used to incorporate GRGDY peptide onto the alginate polysaccharide 
polymer. A progression of three derivatization processes was used during the course 
of the project culminating in a final sterile preparation. The amount of reactants (e.g. 
sulfo-NHS, EDC and peptide) added to the alginate was varied between IX and 50X, 
where IX was lmg of alginate containing 38pg of sulfo-NHS, 67pg of EDC and lpg 
of peptide; and 50X was fifty times the reactants per lmg of alginate. The 
concentration of reactants was determined to be dependent upon the alginate type and 
treatment. Lower viscosity (molecular weight) and higher purity alginates needed 
lower concentrations of reactants probably due to better mixing and less impurities. 
Other factors such as EDC batch heterogeneity, reaction and dialysis temperature, and 
mixing could be attributed to further variability of the process. Hydrogels produced
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with too many peptides incorporated into the guluronic polysaccharide chains 
dissociated within 1 day of formation most likely due to decreased gel strength, 
interference with calcium ion binding sites, or influx of water into the hydrogel due to 
residual levels of reactants remaining after a short (e.g. 2 days) dialysis step. At least 
5 days of dialysis were deemed necessary to reduce the levels of residual reactants. 
However the excessive dialysis also rendered the sodium alginate into alginic acid; 
therefore NaOH was added upon reconstitution with n-saline to solubilize the 
alginate-GRGDY after lyophilization.
3.3. The characterization of rSMCs in tissue flasks and 3-D
matrices
In order to understand and characterize rSMC growth within alginate hydrogels, the 
growth characteristics of rSMCs in tissue flasks needed to be established. RSMCs 
were obtained from an immortalized rat cell line, A7r5, from American Type culture 
collection. These cells have been well characterized (Kimes and Brandt, 1976). A 
frozen working cell bank was established for experiments conducted in this research 
project as described in section 2.1.1.1. The viability of the rSMCs post-thaw was 79 
+/- 7% (n=l 1). The rSMCs were assessed according to its percent viability at each 
passage, the doubling time (hr), the population doubling per day (PD/day), and the 
glucose consumption rate (g/cell/hr). The cell concentration was measured using a 
hemacytometer, viability using trypan blue dye and the glucose and lactate 
concentrations in the culture medium using the YSI bioanalyzer. Following these 
measurements, the specific growth rate, glucose consumption rate (GCR) and 
respiratory quotient were calculated.
RSMCs were immobilized within alginate, collagen and alginate-GRGDY matrices, 
and the interaction of the rSMCs with the matrices was studied. These studies helped 
to concurrently establish the alginate-GRGDY derivatization process. The biological 
activity of the alginate and collagen matrices was assessed by observing the cells’ 
interaction with the matrices, such as the change in morphology. The cells remained 
rounded (spherical) indicating no interaction, or the cells elongated indicating 
association with the matrix.
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During preparation and culturing of 3-dimensional hydrogels, measurements such as 
viability of the cells post-immobilization into the alginate, cell density and glucose 
consumption were taken and compared to data for rSMC in 2-dimensional (tissue 
flasks) environments.
3.3.1. Growth of rSMC in tissue culture plastic
RSMCs were passaged according to section 2.1.1.2 and data such as the number of 
cells harvested per flask and viability were collected. These results were used to 
calculate the growth rate and doubling time of the rSMCs. In addition, samples of the 
spent medium were collected so that glucose and lactate measurements could be 
obtained using the YSI bioanalyzer as described later in this section. The average 
viability of the rSMCs during passaging was 97 +/- 2% (n=88). During 
trypsinization, the rSMCs adhered to the tissue culture plastic very strongly.
Therefore the flasks were tapped firmly against the palm of the hand to release the 
cells from the plastic after being exposed to the trypsin/EDTA for about 5-6 minutes. 
Trypsinization was not possible in micro well plates because the cells adhered too 
strongly; and the cells could not be released by tapping due to medium spillage out of 
the microwells.
3.3.1.1. Growth rate of rSMCs
A7r5 rSMCs had a population doubling time of ca. two days in tissue flasks. Figure 
11 shows graphs of three separate experiments examining the population doubling 
level (PDL) increase for rSMCs grown in T150 flasks over multiple passages (Pl- 
P23). The PDL level was calculated by taking the logarithm of the population 
increase (the total number of cells harvested/cm2 divided by the number of viable 
cells planted/cm2) and dividing by the logarithm of 2 as described in section 2.5.4, 
equation 2.3 (Doran, 1995; Butler, 2004). The slopes of the linear approximations 
averaged 0.019 ± 0.0008 PD/hr. These lines were fit through zero. The inverse of 
the slope of the line was the doubling time, td, which averaged 53 ± 2 hours. The 
growth rate, p, was calculated as the natural logarithm of 2 divided by the doubling 
time as described in section 2.5.4, equation 2.5 (Doran, 1995; Butler, 2004) and 
multiplied by 24 (to convert hours to days) which averaged 0.31 ± 0.01 day'1.
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The initial seeding density was not tightly controlled during the routine passaging of 
the T150 flasks due to the use of a standard 1:3 split ratio. A very slight difference in 
growth rate was observed for the A7r5 rSMCs related to passage number. Cells 
between passages 6 and 13 (P6-P13) had a slightly lower growth rate of 0.30 day*1 
than cells between passages 14 and 22 (P14-P22) which was 0.33 day*1. The 
individual data for the tissue flask passages are summarized in Table 10. The R 
values were negative for the graphs in which the linear estimate for the growth rate 
data for P13-P22 were fit through zero. This result indicated that there was 
considerable variability in the cell density measurement. As the passage level of the 
cells increased, the cells may have become more aggregated upon trypsinization 
which led to greater inaccuracy in the cell density at later time points in culture 
(Lombarts, 1992).
During the exponential growth phase, cells exhibit their highest growth rate. As they 
become densely packed, normal (non-transformed) cells become contact inhibited and 
growth declines or ceases (Batt and Roberts, 1998). The optimal culture processes are 
seeded at a cell density such that there is a minimal lag phase, ensuring a maximum 
growth rate to the final density permitted by the cells. Maintaining the cells beyond 
this time is difficult since at high cell densities, the culture has a high nutritional 
demand and starts to experience gas and mass transfer limitations. All in vitro 
mammalian cell cultures exhibit a decline in growth and eventual death. In order to 
design a tissue engineering application for the A7r5 cells, it was essential to 
understand the conditions which promote optimal growth in tissue flasks prior to 
commencing with growth in three dimensional matrices.
Therefore, experiments were conducted in tissue flasks to determine the effects of 
different seeding densities on growth rate and glucose consumption. Daily cell counts 
were performed for cells planted in T25 flasks at 4xl02 and 5xl03cell/cm2. The cells
7 “7planted at 4x10 cell/cm experienced a lag phase for the first two days of culture due 
to the very low seeding density. Although the cultures seeded at 4xl02 cells/cm2 
entered exponential growth phase, by day 9 (the last time point at which cells were 
harvested) the cells were only at ca. 6xl03cells/cm2. The cells seeded at 
5x10 cells/cm achieved a final cell density of ca. 2.7x10 cells/cm on day 5.
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The exponential growth phase of the cells in T25 flasks seeded at 4x102 and 
5xl03cell/cm2, days 2-9 and 0-5 respectively, was plotted to determine the growth rate 
as shown in Figure 12.
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Figure 12. Cell growth curves for rSMCs cultured in T25 flasks at 2x104 and 
5xl03cells/cm2. The data points for days 6-10 for cells seeded at 5xl03cells/cm2 and 
for days 0-1 for cells seeded at 4x l02cells/cm2 were excluded such that only the 
exponential growth phase of the culture was selected for analysis.
An exponential curve was fit to the cell growth data to determine the growth rate 
constant. The data points for days 6-10 for cells seeded at 5xl03cells/cm2 and for days 
0-1 for cells seeded at 4xl02cells/cm2 were excluded such that only the exponential 
growth phase of the culture was selected for analysis. The exponential of the cells
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seeded at 4x10 cells/cm was 0.019 hr' and for cells seeded at 5x10 cells/cm was 
0.014 hr'1, respectively. Thus the doubling time was 71 hours for the cells seeded at 
4xl02cells/cm2 versus 53 hours for the cells seeded at 5xl03cells/cm2. The growth 
rate, p, was calculated by dividing the natural log of 2 by the doubling time and 
multiplying by 24 to convert hours to days. The growth rates were 0.23 day'1 and 
0.31 day'1, respectively. The viability o f the cultures was also determined using 
trypan blue dye. Cells seeded at 4xl02cells/cm2 maintained a viability > 92% for the 
9 days observed; and cells seeded at 5xl03cells/cm2 maintained a viability > 92% out 
to day 6 in culture and then gradually decreased to 85% on day 10.
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3.3.1.2. Glucose consumption rate of rSMCs
Glucose measurements were taken from the spent medium from each T150 tissue 
flask passage and measured using the YSI bioanalyzer. The glucose consumption 
rate (GCR) was calculated from the formula as described in section 2.5.6.1. The GCR 
was found to be about 60% higher in the lower passage cells than for the higher 
passage cells; however given the standard error these differences were not significant. 
For passages P6-P13 the glucose consumption rate averaged 2.1xlO'10 +/- 1.3x10' 
10g/cell/hr (n=50) and for passages P14-P22, the GCR averaged 1.3x1 O'10 +/- 0.4x10' 
10g/cell/hr (n=33).
The glucose consumption rate (GCR) was also measured in the T25 tissue flasks. A 
linear curve was fit to the glucose data for the time period of each phase as show in 
Figure 13. The initial seeding and final cell densities were used to calculate an 
average cell density for the time period examined. For cells seeded at 5xl03cells/cm2 
during the exponential growth phase between days 0-5, the glucose consumption rate 
was calculated to be 7.7xl0'ng/cell/hr. For cells in stationary phase at a 
concentration of ca. 2.7x104cell/cm2 between days 5-10, the GCR was calculated to 
be 5.3x10'1‘g/cell/hr. Similarly for cells seeded at 4xl02cells/cm2, the GCR during 
exponential growth between days 2-9 was calculated to be 6.5x10’1 ^ cell/hr.
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Figure 13. Glucose data for determination of glucose consumption rates in T25 flasks 
seeded a t4 x l0 2cell/cm2 and microwells seeded at 5xl03cells/cm2.
Glucose consumption rates were also measured for cell growth in microwells. The 
average of 5 studies, all seeded at ca. 5xl03cells/cm2, produced a glucose 
consumption rate of 1.4x1 O'10 ± 4.2x10'1 ^ ce ll/h r. A summary table of the glucose 
consumption rates for all of these studies is shown in Table 10.
Overall, the glucose consumption rates were similar between flasks and microwells 
for SMC seeding densities between 4x102 and lx l0 4cells/cm2. Therefore, the A7r5 
rSMCs can be grown in either micro wells or flasks for experimental purposes.
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Table 10. Summary of doubling times, growth rates and glucose consumption rates 
for rSMCs grown in tissue vessels. The cells were grown in microwells, T25 and 
T150 flasks. The growth rate and GCR were similar for cells seeded at the same 
density. T150 flasks were used for cell passaging and T25 flasks were used for some 
growth curve studies. Microwell comparability to T-flasks was needed as an adequate 
control condition for the cell densities used with rSMCs immobilized in alginate 
beads.
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3.3.2. RSMCs and non-derivatized alginate matrices
Initially matrix studies were performed using rSMCs with non-derivatized alginate 
hydrogels formed into sheets, tubes and beads as described in section 2.4. This 
section describes the results from these early studies and the progression that was 
made toward alginate-GRGDY hydrogels with an interlude exploring collagen as a 
matrix.
3.3.2.1. Effect of trisodium citrate on rSMCs viability
Once the rSMCs were incorporated into the alginate matrix, the matrix needed to be 
evaluated for cell density and viability using hemacytometer and trypan blue. The 
cells first needed to be released from the alginate hydrogel using 0.1M trisodium 
citrate as per section 2.5.5. Initial studies were performed to determine the effect of 
exposing the rSMCs to 0.1 M trisodium citrate. Typical viability assessments took an 
average length of 10 minutes to complete three replicate counts and usually never 
exceeded 15 minutes. Therefore, a maximum time of 30 minutes was used to evaluate 
the effect of trisodium citrate.
As can be seen in Figure 14, the average overall viability of cells exposed to 0.1 M 
trisodium citrate solution was similar to that of the control cells which were 
resuspended in complete DMEM. In the first experiment, the average viability of 
cells exposed to trisodium citrate was 73 ± 7 % compared to the viability of control 
cells, which were not exposed to trisodium citrate, which was 79 ± 6% for the 20 
minute evaluation period. In the second experiment, the viability of the cells exposed 
to trisodium citrate was 88 ± 4% and the viability of the control cells was 91 ± 4% for 
the 30 minute evaluation period. In addition, the cells exposed to 0.1 M trisodium 
citrate did not appear to gradually decrease in viability during the evaluation periods.
Since the viability of cells exposed to trisodium citrate was similar to the viability of 
the control cells, 0.1M trisodium citrate solution can be used to release the cells from 
the alginate hydrogel in order to assess viability.
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Figure 14. Effect of trisodium citrate on cell viability. RSMCs were exposed to 0.1M 
trisodium citrate for up to 30 minutes to determine if there was any decrease in 
viability of the cells during assessment as compared to control cells that were not 
exposed.
3.3.2.2. RSMCs immobilized in non-derivatized 
alginate tubes and beads
Initially rSMCs were immobilized in various formulations of sodium alginate and 
cross linked using CaCh as per sections 2.3.1, 2.4.1, 2.4.3 and 2.4.4. In all 
experiments when n-saline or PBS was used to formulate the alginate, and the cells 
were centrifuged and resuspended in DPBS or complete DMEM, and the tube or 
beads were cross linked using 0.5 to 2% CaCb, the initial cell viability was high. The 
average cell viability immediately after cross linking for 42 different combinations of 
alginate, CaCh, and cell resuspension formulations was 89 +/- 9%. However for all 
these experiments, cell viability dropped significantly during the first 4 to 5 days in 
culture and the cells did not proliferate within the alginate matrix.
One experiment conducted in which cells were extruded in alginate tubes and discs 
were cut and placed into microwell plates as described in section 2.4.3.1, the average 
cell viability of the rSMCs immobilized in alginate disc was 87+/- 5% on day 0 and 
60 +/-10% on day 1. Thereafter, cell viability decreased significantly from 38 +/-
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10% on day 2 down to 3 +/-1% after 5 days of cultivation. The viability remained 
below 3% for the remaining time points on day 7 and 9. The cell density of the 
rSMCs immobilized in the alginate discs remained unchanged at 7.3x103 +/- 
2.9x103cells/disc during the nine days of cultivation which indicated that the cells 
were not proliferating within the alginate matrix. The cells were originally seeded in 
the alginate at a concentration of lx l0 6cells/mL which corresponded to ca.
9.6x103cells/disc. Figure 15 shows the decrease in viability and the unchanged cell 
growth of the rSMCs in the alginate discs (squares) for the time period evaluated.
In the same experiment, the control rSMCs that were seeded into T25 control flasks at 
9.6x10 cells/flask (4x10 cells/cm ) experienced a lag phase in which no growth 
occurred for the first two days due to the low seeding density. After day 2, the cells 
grew exponentially from the initial seeding of 9.6x103cells/flask to 1.4xl05cells/flask 
on day 9. This growth corresponded to a population doubling level (PDL) increase of
3.9. The average control cell viability for the T25 flasks was ^ 92% during the nine 
days of cultivation. The exponential increase in cell growth and high viability for the 
control cells are shown in Figure 15 (triangles).
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Figure 15. Total cells and viability for rSMCs in alginate discs and tissue flasks. The 
viability of the rSMCs in the alginate decreased from 87% to 3% over the 9 days; 
whereas the total cells remained the same at 7.3xl03 +/- 2.9x103cells/disc. The 
control rSMCs in the flasks were >92% viable for the 9 days, and the cells grew 
exponentially from 9.6xl03 to 1.4xl05cells/flask.
In addition to cell growth and viability assessment, glucose measurements were taken 
of the spent medium from the microwells containing the cells in alginate discs seeded 
at 9.6x103cells/disc/well and T25 flasks containing control cells seeded at 
9.6xl03cells/flask (4xl02cells/cm2). Due to the very low seeding density of the 
control cells in the T25 flasks, control cells were also seeded into micro wells at 
9.6x103cells/well (5xl03cells/cm2) which was a more optimal density per square cm. 
Controls cells were set up in both flasks and microwells because rSMCs seeded into 
microwells could not be adequately trypsinized and evaluated for density and 
viability. In order to detach the rSMCs from the growth surface, the culture vessels 
need to be tapped firmly against the palm of the hand; hence the liquid contents easily 
spilled out of the shallow, open-topped microwells during this step. Therefore, 
control rSMCs seeded into microwells were only evaluated for glucose consumption.
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Because the same total number of cells was seeded into the T25 flasks, microwells 
and alginate discs, relative comparisons could be made on their glucose consumption. 
Figure 16 shows the glucose consumption for 9.6xl03 cells seeded into alginate discs, 
microwells and T25 flasks. Later in the project, the MTT assay was used to 
determine cell concentrations using mitochondrial dehydrogenase activity; therefore 
the cell density in microwells could be determined as shown in section 3.5.5.
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Figure 16. Glucose consumption for rSMCs immobilized in alginate versus control 
cells in tissue flasks and microwells. The GCR for the rSMCs in the alginate was 
zero, which indicated the cells were not proliferating compared to rSMCs in the tissue 
culture plastic.
A linear curve was fit to the glucose data, and then the glucose consumption rate 
(GCR) was calculated for the different vessel volumes (lm L for microwells and 5mL 
for T25 flasks). The GCRs are summarized in Table 11. In addition, the degradation 
rate of glucose in the complete DMEM at 37°C was also measured to be 0.0002g/hr. 
The GCR for the cells in alginate discs was 0.0004g/hr, only 2 fold higher than 
glucose degradation rate. This increase was insignificant when compared to the 15.5 
fold increase in GCR for the cells in microwells and 37.5 fold increase in flasks. 
Overall the low GCR indicated that the rSMCs immobilized in alginate were not 
proliferating as compared to the control cells.
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G lucose  
consum ption  
or degradation  
rate (g/L/hr)
V olum e  
per vessel 
(L)
G lucose  
consum ption  
or degradation  
rate 
( x l0 ‘7g/hr)
Fold increase 
over the 
degradation o f  
g lu cose at 37°C
com plete DM EM * 0.0002 .001 2.0 -
rSM Cs in alginate disc 0 .0004 .001 4.0 2
rSM Cs in m icrowell 0.0031 .001 31 15.5
rSM Cs in T25 flask 0.0015 .005 75 37.5
* The degradation rate o f  g lu cose in com p ete DM EM  at37*C .
Table 11. Comparison of glucose consumption rates for rSMCs immobilized in 
alginate and in control microwells and flasks.
Initial microwell experiments exhibited a sinusoidal increase in the glucose 
concentration which was caused by individual sampling of different well locations in 
the plate (results not shown). Since the glucose was not being consumed by the cells 
and the complete DMEM was being concentrated due to evaporation, the glucose 
appeared to increase in concentration. Volume decrease due to evaporation was 
greater in microwells along perimeter of plate, than in the center of the plate. This 
effect was corrected in all experiments by measuring the volume of spent medium in 
each well or flask that was evaluated. The individual glucose concentrations were 
then corrected by multiplying the measured glucose concentrations by the ratio of 
original medium volume to the measured medium volume at each time point.
Another experiment was conducted to determine the effect of the type of complete 
medium and alginate on cell proliferation and viability. RSMCs were immobilized in 
1% Sigma and 1% Fluka alginate beads as per section 2.4.1 and 2.4.4. Two complete 
medium formulations, DMEM and aMEM, were used to resuspend the rSMCs and as 
the growth medium for cultivating the beads in microwells. In addition one tube was 
made with Sigma alginate and aMEM medium and cut into 7mm discs to compare to 
the same condition made into beads. Another condition included cells in Sigma 
alginate beads with aMEM which were refed daily with fresh aMEM out to day 7 to 
compare to static cultures.
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During the 16 days of assessment, the cell density for all conditions remained 
unchanged at ca. lx l0 4cells/well from two 2 mm beads (data not shown). The cell 
viability of all alginate and medium conditions immediately after immobilization of 
the cells was very high at 94 +/- 2%; however, thereafter all viabilities decreased. 
Both the Fluka and Sigma alginates using complete DMEM had the sharpest decrease 
in viability down to 3 +/- 1% by day 5 (Figure 17, dashed lines); whereas, all other 
conditions using aMEM medium had only decreased down to 42 +/- 7% (solid lines). 
However all of the conditions using aMEM  medium decreased down to 7 +/- 3% 
viable by day 16. It was apparent that the presence of additional nutrients (e.g. 
nonessential amino acids, antioxidants, deoxy- and ribonucleosides) in the aMEM 
medium maintained higher cell viability as compared to the complete DMEM.
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Figure 17. Viability of rSMCs immobilized in different types of alginate and 
complete media. The viability of the rSMCs cultured in aMEM medium was 
significantly greater than the viability of the rSMCs in the complete DMEM. The 
type of alginate (e.g. Fluka or Sigma) appeared to be less significant.
Glucose data were obtained from the spent medium samples collected from each 
condition. Linear approximations of these data, which are shown in Figure 18, were 
used to calculate the slope in order to estimate the glucose consumption rate (g/L/hr).
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The GCR was multiplied by the microwell volume (0.001L) to achieve a GCR in g/hr. 
As shown in Table 12, the GCR was greatest in the control cells (not in alginate) 
seeded at 9.6x103cells/well or 5xl03cells/cm2. The GCR for cells grown in the 
complete DMEM medium was 24.5 fold higher than the glucose degradation rate at 
37°C. Control cells in the aMEM medium were 14 fold higher than the background 
rate. The highest GCR for the alginate conditions was for the cells immobilized in the 
Sigma alginate tube and aMEM medium which was 7.5 fold higher than the 
background rate. All of the other alginate conditions had nominal GCRs only 1.5 to
3.5 fold higher. One possible reason for the higher GCR for the alginate tube 
condition than for the beads may be due to the wall thickness (mass transfer layer) of 
the alginate matrix. Cells in the 2mm beads had a maximum diffusion distance of 
1mm to the edge of the alginate whereas cells in a 0.25mm thick disc cut from a tube 
had only a maximum of 0.125mm distance. The GCR data combined with the 
decrease in cell viability over time further substantiated that the rSMCs were not 
proliferating in the alginate matrix.
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Figure 18. Glucose consumption of rSMCs immobilized in different types of alginate 
and complete media. The GCR of rSMCs in alginate, regardless of type and media, 
was significantly lower than the GCR of the control cells (no alginate) in microwells.
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Alginate
type
Complete
medium
type
Glucose 
consumption or 
degradation rate 
(xl0'7g/hr)
Fold increase 
over the 
degradation of 
glucose at 37°C
Complete 
medium only *
NA DMEM 2 -
Control cells NA aMEM 28 14
NA DMEM 49 24.5
Cells in beads Sigma aMEM 7 3.5
Fluka aMEM 7 3.5
Sigma DMEM 3 1.5
Fluka DMEM 5 2.5
Cells in tube Sigma aMEM 15 7.5
Cells in beads 
with refeeds
Sigma aMEM 4 2
* The degradation rate of glucose in complete DMEM at 37°C.
Table 12. Comparison of glucose consumption rates for rSMCs immobilized in 
alginate beads and tube with different complete media.
3.3.2.3. Effect of matrix components and cross 
linking solution on rSMC growth
Because the rSMCs were not proliferating in the alginate matrices, an experiment was 
conducted to determine if the process conditions used to immobilize the cells (e.g. 
transient exposure to CaCh) were irreversibly damaging the cells. The cells were 
centrifuged, resuspended in complete DMEM, mixed with alginate, and cross linked 
into alginate tubes as described in section 2.4.3.2. Different volumes of rinses (1.5,
12.5 or 125mL) using either n-saline or complete DMEM were used to rinse the 
alginate tubes after cross linking. After completing rinses, the cells were released 
from the alginate using trisodium citrate in DMEM. Control cultures of rSMCs were 
set up to examine the serial elimination of each scaffold component or process step as 
shown in Table 3, section 2.4.3.2. Complete DMEM was substituted for each 
component eliminated so that the sample was manipulated in a similar manner, but 
without the effect of that component.
For each alginate tube rinse condition, different initial seeding densities were obtained 
(see Table 4, section 2.4.3.2) due to the loss of alginate and hence cells during the
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washes especially when n-saline was used. The concentration of CaCh was expected 
to be close to 1% (90mM) after completion of the cross linking step. The 
concentration of CaCh was 0.018% (1.6mM) in complete DMEM and 0% in n-saline. 
Therefore, the diffusion of CaCh molecules and exchange of Na+ ions for Ca2+ ions 
that originally cross linked the alginate molecules occurred more rapidly during the n- 
saline wash. In fact, the 12.5 and 125mL rinse conditions using n-saline completely 
dissolved the alginate tube and could not be evaluated in this experiment. Despite 
these differences in seeded densities, general comparisons could still be made.
Overall, the scaffold components and process steps (1% CaCh, 0.1M trisodium citrate 
solution, alginate and centrifugation) did not have a detrimental effect on rSMC 
growth when rSMCs were released from hydrogel following extrusion and 
subsequently seeded into microwell plates. Cells from the tube that were rinsed with 
1.5mL n-saline exhibited the lowest glucose consumption. This lower glucose 
consumption is most likely due to the initial lower seeding density than the other 
conditions. The glucose data are show in Figure 19. The average GCR for all of the 
alginate tubes and control cells conditions was 3.6xl0'6 ± 4.7xl0'7g/hr. These results 
were comparable to the other microwell studies done with a similar seeding density
X j ;(5x10 cells/cm ) for which the average GCR over the culture period was 3.9x10 ±
*71.3x10' g/hr. Therefore the matrix components/process conditions did not 
significantly effect cell growth as measured by GCR.
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Figure 19. Glucose consumption of cells extruded into alginate tubes, released from 
the hydrogel using trisodium citrate and then cultured in microwells. The tubes 
(solid lines) were rinsed with 1 5mL of n-saline or 1.5, 12.5 or 125mL of complete 
DMEM prior to dissolution with trisodium citrate. The control cells (dashed lines) 
were processed with the serial elimination of one step of the matrix component or 
process step (e.g. exposure to CaCE, dissolution with trisodium citrate, combining 
with alginate and centrifuging). The GCR was similar for all the conditions.
3.3.3. RSMCs immobilized in collagen
This section describes the interlude during which collagen matrices were explored to 
provide cell adhesion sites for the rSMCs and to further understand the effects of the 
matrix components and cross linking solutions on the rSMCs.
Collagen solutions were prepared as described in section 2.3.2 and sheets were 
prepared as per section 2.4.2.2. Briefly, the rSMCs were trypsinized, centrifuged and 
resuspended in 50pL of complete aMEM medium and added to 450pL of collagen 
and 10X EMEM and various concentrations of IN NaOH ranging from 37.5 to 
50pL/well in a 24 well microplate. The NaOH was used to adjust the original acidic 
pH of the collagen solution to a basic pH to permit the collagen matrix to set. The 
cells within the collagen matrix were seeded at 5xl05cells/well. Control cells were
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seeded directly into microwells without the collagen matrix at 9.6xl03cells/well or 
5x103cells/cm2. The spent medium was collected to measure the glucose 
consumption data and the results are shown in Figure 20.
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Figure 20. Glucose consumption of cells immobilized in collagen and then cultured 
in microwells. The collagen matrix was set with IN NaOH, ranging from 37.5 to 
50pL/well.
All of the different volumes of NaOH investigated allowed the collagen matrix to set. 
However, the integrity and strength of the matrix varied for the different NaOH 
volumes and hence pH of the final collagen and SMC matrix composition. On day 1 
for all of the NaOH concentrations, the rSMCs appeared to be associated with the 
collagen matrix and exhibited elongation in a 3-D star-burst form. By day 3, the 
collagen and SMC matrices containing 37.5pL/well NaOH were significantly 
shrunken to a pellet size clump which primarily contained rounded cells throughout 
due to the collapse of the matrix. In the matrices containing 42.5 and 45pL/well 
NaOH, the cells were observed to still have well-formed star-burst shaped clusters 
throughout the matrix. The 40, 47.5 and 50pL/well NaOH contained primarily 
rounded cells, and the 40pL/well NaOH condition had slight shrinkage of the matrix
y= -0 .0 0 3 2 x  + 3.1287  
R2 = 0.661
y =  -0.0061 x + 2.9729  
0.6472
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around the perimeter of the well. By day 5, the 40 and 42.5pL/well NaOH exhibited 
a slight to medium amount of shrinkage.
Due to the lower seeding density of the control cells, all of the collagen matrix 
conditions except the 37.5 pL/well NaOH which had completely shrunken, had a 
higher glucose consumption rate than the control cells. The highest GCR, as shown in 
Table 13, was observed in the cells that were seeded into the matrix containing 45 pL 
of NaOH. These cells had a GCR 6 fold higher than the control cells; however, these 
cells were seeded at a significantly higher concentration (35 fold higher per mL of 
medium) than the control cells. Additional studies were performed with higher 
control cell seeding densities in microwells and were found to have a GCR of 7.4x10' 
6g/hr when seeded at 1.26xl05cells/well or 6.63x104cells/cm2. This rate was more 
comparable to the GCR of 9.2x1 O'6g/hr for the collagen matrix condition containing 
45 pL NaOH.
GCR
(xlO^g/L/hr)
Volume 
per vessel 
(x 10'3L)
GCR
(xlO^g/hr)
Fold increase 
over the 
control cells
Control, no collagen 15 1 1.5 —
Collagen, 37.5pL NaOH 7 1.5 1.1 0.7
Collagen, 40pL NaOH 35 1.5 5.3 3.5
Collagen 42.5pL NaOH 32 1.5 4.8 3.2
Collagen, 45 pL NaOH 61 1.5 9.2 6.1
Collagen, 47.5pL NaOH 47 1.5 7.1 4.7
Collagen, 50pL NaOH 47 1.5 7.1 4.7
Table 13. Comparison of glucose consumption rates for rSMCs immobilized in 
collagen matrix.
The pH of the mixture containing collagen, 10X EMEM and NaOH matrix was 
measured subsequently to the experiment. RSMCs were not added to the matrix for 
these measurements. The pH of each matrix was 6.8, 6.5, 9.0,10.5, 11.5 and 12.0 for 
each of the conditions respectively between 37.5 and 50pL/well NaOH. After 
measuring the pH, it was difficult to understand why cells immobilized in collagen 
matrices under very alkaline conditions (the highest amount of NaOH) resulted in cell 
growth with the highest glucose consumption rate. However, in actuality, the rSMCs 
were exposed to this alkaline pH for only ca. 15-20 minutes, during the formation and
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setting of the collagen matrix (from the time the cells were added to the mixture until 
the matrix was allowed to set). Thereafter, lmL of complete aMEM was added to 
each microwell containing the collagen matrix. The addition of the aMEM complete 
medium would have buffered any difference in pH in the individual matrix 
formulations. The growth of the cells in the collagen matrix was most likely affected 
by the amount that the collagen matrix shrunk/collapsed or was able to support the 
outgrowth of the rSMCs. As the cells proliferated, the edges of the collagen matrix 
around the perimeter of the microwell separated slightly and pulled away from the 
well. The matrices containing 37.5 and 40pL/well NaOH which appeared to have a 
pH closest to physiological 7.0 were significantly collapsed. These matrices would 
not have supported cell proliferation and therefore would have had lower GCRs. In 
fact, cells lying at the bottom of the collagen matrix were observed to have attached to 
the bottom of the microwell and formed a bridge between the collagen and 
polystyrene, thus preventing the collapse. Although the matrices containing greater 
than 42.5pL/well NaOH had initially a very alkaline pH, the matrices maintained their 
rigidity to support the attachment and proliferation of the rSMCs.
3.3.4. RSMCs immobilized in collagen and alginate
The A7r5 rSMCs were shown to proliferate in collagen and not to be detrimentally 
affected by the matrix components/process conditions used to immobilize the cells 
within an alginate matrix. The next experimental goal was to determine if alginate 
could be combined with the collagen and cell matrix and then cross linked to 
determine if the cells would proliferate in presence of the alginate and any residuals 
from the cross linking solutions.
Collagen and alginate matrices were made as per section 2.4.2.3 by adding 4% w/v 
Fluka alginate in a n-saline solution to the collagen formulation in order to achieve a 
final 1% alginate concentration that comprised ca. 24% v/v of the matrix composition. 
Because alginate was added into the matrix formulation the final concentration of the 
collagen in the scaffold was reduced from 1.6g/mL (ca. 74% v/v) down to 1.25g/mL 
(ca. 58% v/v). In addition, the amount of complete DMEM that was used to 
resuspend the cells after centrifugation was also reduced to maintain a high collagen 
concentration. The addition of alginate and the lower collagen concentration in the
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matrix still permitted the collagen to set after formulation, however, the ingredients 
had to be added in a particular order and mixed homogeneously to prevent premature 
setting of the collagen or cross linking of the alginate (see section 2.4.2.3). After 
formulation, the collagen was allowed to set in individual microwells, then the cross 
linking agent (CaCh or BaCb) was added to cross link the alginate. Three 
concentrations (1%, 0.5% and 0.1%) of CaCb or BaCh were examined. These cross 
linking solutions were all made in n-saline; therefore, one of the control solutions 
used to compare against the cross linking solutions was just n-saline. The other 
control solution was complete DMEM.
Approximately 18 hours after the cells were incubated, the microwells were first 
observed. The rSMCs in the control matrices that were exposed to complete DMEM 
and n-saline were associated with the scaffold. The cells were spreading out within 
the scaffold in 3-D star-burst, spindly structures as shown in Figure 21.A. The rSMCs 
in the matrices treated with 0.5% and 1% CaCk or BaCb were rounded with no 
association with the surrounding matrix nor elongation as shown in Figure 21.B. 
However, a few rSMCs in the 0.1% CaCh or BaCh treated matrices were slightly 
elongated within the matrix especially around the perimeter of the microwell where 
the matrix was thicker due to meniscus effect. Throughout the remaining time points, 
these condition remained the same: the cells remained rounded and had a grainy 
appearance in the matrices exposed to 1% and 0.5% CaCk or BaCb cross linking 
solutions; the cells exhibited slight elongation, but no proliferation in the 0.1% CaCk 
or BaCb cross linking solutions; and continued proliferation in the control matrices 
which used complete DMEM and n-saline as cross linking solutions.
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Figure 21. RSMCs immobilized in collagen/alginate matrix on day 1. (A) Control 
matrix that had complete DMEM as the cross linking solution. Cells were elongated 
within matrix. (B) Matrix that had 1% CaCE used as cross linking solution. Cells 
remained round within the matrix. Photos 200X and 100X magnification.
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The glucose concentration in the spent medium for each cross linking condition was 
corrected for evaporation. Figure 22 shows the glucose data for each condition over 
the 13 day experiment. The control cultures with cells seeded at 1.26xl05cells/well 
(6.63x104cells/cm2) directly into the microwell with no matrix (pink line). All o f the 
matrix conditions were also seeded at 1.26xl05cell s/well in order to help compare 
GCR based upon similar starting conditions. The GCR are summarized in Table 14.
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Figure 22. Glucose consumption of rSMCs in collagen/alginate matrices exposed to 
different crosslinking agents. The cells with no matrix had a significantly higher 
GCR than the cells within the matrices crosslinked with CaCh. BaCl2 results were 
similar to the CaCl2 (data not shown).
During glucose testing, the spent medium samples from the complete DMEM and n- 
saline cross linking conditions were observed to have become slightly gelatinous after 
thawing. The samples were dissolved upon addition of collagenase, so it was 
assumed that the freezing step realigned the residual collagen molecules such that 
they reset after thawing. This phenomenon was not observed in any of the other 
conditions using CaCl2 or BaCl2 as the cross linking solution.
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Matrix condition with 
cross linking solution
slope of 
linear fit 
(xlO^g/L/hr)
Glucose 
consumption rate 
(GCR) 
(xl0'7g/hr)*
Fraction of GCR 
compared to 
control cells with 
no matrix
Matrix with no cells -5 6.5 0.09
Cells with no matrix -57 74 —
Control solution, 
complete DMEM
-37 48 0.6
Control solution, 
N-saline
-29 38 0.5
1% CaCl2 -12 16 0.2
0.5% CaCl2 -20 26 0.4
0.1% CaCl2 -22 29 0.4
1% BaCl2 -15 20 0.3
0.5% BaCl2 -19 25 0.3
0.1% BaCl2 -22 29 0.4
* Total volume per well was 1.3mL
Table 14. Comparison of glucose consumption for rSMCs in collagen/alginate 
matrices.
The control cells seeded with no matrix (directly into microwell) had the highest GCR 
of 7.4x1 O^g/hr. The control matrices, which were exposed to n-saline and complete 
DMEM instead of CaCl2 or BaCl2, had the next highest GCR of 4.8x1 O^g/hr for 
complete DMEM medium and 3.8x1 O^g/hr for n-saline. The GCR for matrices 
exposed to 0.1% CaCl2  and BaCl2 cross linking solutions was 2.9x1 O'6g/hr. The 1% 
and 0.5% CaCl2 and BaCl2 solutions were both lower. Thus it appeared that the cross 
linking solutions had a negative impact on SMC attachment and proliferation, even in 
the presence of collagen. These GCR can be easily compared in Figure 23.
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Figure 23. Comparison of rSMC GCR (g/hr) for collagen/alginate matrices with 
different cross linking solutions.
By day 10 in culture, only the control matrices, which were exposed to n-saline and 
complete DMEM instead of CaCh or BaCh, had shrunken slightly around the 
perimeter of the microwell. The amount of shrinkage may have been less in these 
matrices than the previous collagen matrices due to the presence of alginate, the lower 
concentration of collagen, or the lower seeding density. All the other matrices that 
were exposed to cross linking solutions had no shrinkage. Figure 24 shows cell 
growth in the day 14 culture of the control matrix in which n-saline was used as the 
substitute for CaCb or BaCh cross linking solutions. The rSMCs were bridged 
between the polystyrene of the microwell surface and the collagen/alginate matrix.
The cells held the matrix in place to prevent it from shrinking significantly around the 
perimeter of the microwell.
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Figure 24. RSMCs immobilized in collagen/alginate matrix on day 14. Control 
condition which used n-saline as the cross linking solution. The arrows indicate the 
rSMCs bridging between the collagen/alginate matrix and the polystyrene surface of 
the microwell. 100X magnification
3.3.5. RSMCs immobilized in alginate-GRGDY
Experimental findings had progressed from observing no growth in alginate matrix to 
achieving some growth in alginate/collagen matrices in which very low 
concentrations of CaCh or BaCb cross linking solution had been used. The ultimate 
research goal was to incorporate a cell adhesion site onto the alginate molecules so 
that alginate can be used to encourage cell attachment and proliferation. Research 
performed in Mooney’s lab (Rowley, 1999) had indicated that the pentapeptide 
glycine-arginine-glycine-aspartic acid-tyrosine (GRGDY) can be incorporated. The 
results from experiments performed to incorporate this bioactive molecule are
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discussed below. References to alginate incorporated with this pentapeptide have 
been shortened for convenience to alginate-GRGDY.
3.3.5.1. RSMCs seeded onto alginate-GRGDY sheets
Results from cross linking experiments containing alginate/collagen matrices 
indicated that CaCh and BaCk cross linking solutions resulted in lower cell 
attachment and glucose consumption rates. Since the cross linking solutions appeared 
to be detrimental to rSMCs, initial experiments with alginate-GRGDY were 
conducted by pre-forming the alginate-GRGDY matrices as sheets in the bottom of a 
microwell and then seeding the cells separately onto the surface of the alginate. 
Alginate-GRGDY sheets were constructed as described in section 2.4.2.1. After 
formation, the alginate sheets were rinsed thoroughly of excess CaC^ prior to the 
addition of rSMCs. Initial experiments were performed using OX, IX, 10X, and 50X 
alginate-GRGDY (Fluka), as described in section 2.3.3.2 from Rowley’s (1999) 
reactant concentrations, where IX was lmg of alginate containing 38pg of sulfo- 
NHS, 67pg of EDC and lpg of peptide; 10X was ten times the reactants and 50X was 
fifty times the reactants. The OX alginate was not taken through the peptide 
incorporation chemistry so it could be was used as the control.
RSMCs were added at a high concentration of 3xl05cells/well (8xl04cells/cm2) in 
2mL of complete DMEM to the microwells containing alginate sheets. After 
incubation of these cultures, no cell attachment was observed in the OX, IX, and 10X 
alginate-GRGDY sheets. However, the rSMCs did attach to the 50X alginate- 
GRGDY. Figures 25. A and 25.B show images of rSMCs attached to the alginate 
surface which were slightly elongated and bridged small spaces between adjacent 
cells between day 2 and 3 in culture. However, on day 5 of the culture no further 
outgrowth of these cells was observed. These alginates had been lyophilized in order 
to prepare known concentrations of the alginate after dialysis.
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Figure 25. RSMCs seeded onto surface of 50X Fluka alginate-GRGDY sheet. (A) 
Day 2 of culture. Arrows indicate spaces between adjacent cells. (B) RSMCs bridged 
the gap between spaces of adjacent cells on the surface of sheet on day 3. 200X 
magnification.
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Significant improvement in cell attachment was observed when the alginate-GRGDY 
was treated with activated charcoal, filtered through Celite, and not lyophilized.
When rSMCs were seeded at 4xl04cells/cm2 into the microwells containing the 
alginate-GRGDY sheets; the rSMCs attached to both Manugel and Fluka (high G) 
alginate sheets containing 50X pentapeptide. The rSMCs did not attach to the IX and 
10X alginate-GRGDY sheets. Micrographs were taken over the time course of the 
experiment and day 2 results are shown in Figure 26.A. The 50X alginate-GRGDY 
(Manugel) sheets exhibited the best cell attachment and highest percent confluency 
(cell density) which were similar to the control cells seeded directly into microwells 
without an alginate matrix (Figure 26.C). RSMCs seeded into the microwells 
containing 10X alginate-GRGDY sheets exhibited almost no elongation and remained 
rounded throughout the culture period (Figure 26.B).
Due to the very low concentration of alginate (-0.5%) after the dialysis step, the 
alginate solutions needed to be lyophilized to prepare higher concentrations of 
alginate solutions (~l-3%) to permit addition of cells to the solution. During the 
lyophilization cycle, the bottles were inadvertently removed part-way through the 
cycle by other users. Although drying was eventually completed at a later time, the 
50X Manugel bottle was inadvertently broken. The remaining alginate-GRGDY was 
reconstituted to -2% concentration and alginate sheets were made. However, very 
few rSMCs were associated with the 50X Fluka alginate-GRGDY (data not shown).
It was assumed that improper lyophilization or being removed part way through the 
cycle was detrimental to the cell binding sites on the alginate-GRGDY since the cells 
had attached prior to lyophilization. However, it was also possible that the biological 
stability of the alginate-GRGDY also decreased with age of the alginate.
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Figure 26. RSMCs seeded 
on Manugel (High G) 
alginate-GRGDY sheets on 
day 2 of culture. (A) Cells 
on 5OX alginate-GRGDY 
sheet were elongated and 
networked. (B) Cells on 
10X alginate-GRGDY sheet 
were rounded and were not 
attached to the surface. (C) 
Control cells seeded onto 
microwell surface were 
attached and nearly 100% 
confluent.
Cells are designated as: (e) 
elongated or (r) rounded. 
Areas are designated as: (d) 
densely packed cells or (n) 
no cells.
All photos at 100X
magnification.
In another experiment IX, 10X, and 50X alginate-GRGDY were synthesized using 
Pronova MVG alginate, a high grade commercial material. Alginate sheets were 
constructed and seeded with rSMCs as previously described. On day 1 the rSMCs 
had associated with the 50X alginate-GRGDY, only a few (<1%) associated with the 
10X concentration, and none to the IX. The rSMCs seeded onto the 50X alginate- 
GRGDY did not grow and expand beyond the point that was observed on day 1 
(Figure 27).
1
HI
Figure 27. RSMCs seeded on Pronova MVG alginate containing 50X GRGDY on 
day 1. Cells were attached and just starting to elongate. Arrows indicate cells 
attached to surface of sheet. 100X magnification.
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3.3.5.2. RSMCs immobilized within alginate-GRGDY 
hydrogels
Although the alginate was very dilute after dialysis, several attempts were made to 
immobilize rSMCs within the alginate-GRGDY. Cells were added to Fluka alginate- 
GRGDY as per section 2.4.1 and made into beads using 0.5% and 1% CaCE solution 
for between 5 to 15 minute exposure times as per section 2.4.4. The beads were very 
fragile (not rigid hydrogel spheres) after rinsing in complete DMEM. The 50X 
alginate-GRGDY beads completely dissolved by day 2. However, prior to the beads 
dissolving, on day 1 several cells were observed to have elongated within the bead 
(Figure 28). The OX, IX, 10X beads showed no cell outgrowth and remained intact 
out to day 10.
< y
Figure 28. RSMCs elongated within 50X Fluka alginate-GRGDY hydrogel. Day 1 
after immobilization in hydrogel, the beads were very fragile (not rigid spheres) and 
then completely dissolved by day 2 of culture.
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In another experiment, rSMCs were resuspended in a very small volume of complete 
DMEM in order to combine with the IX, 10X and 50X Pronova MVG alginate- 
GRGDY solution to make into alginate sheets. Some of these rSMCs elongated 
within the 50X alginate-GRGDY hydrogel, but not to the same extent as the rSMCs 
that were seeded onto the surface of pre-formed alginate sheets.
RSMCs were also mixed homogeneously with 50X Pronova MVG alginate-GRGDY 
and extruded into tubes at 8xl06cells/mL using a 3.8mm diameter bullet as the float. 
These tubes were cross linked using 1% CaCh in n-saline. The alginate tubes were 
incubated in situ within the glass tubes in complete DMEM as described in section
2.4.3.3. Fresh medium was added each day from days 0 to 9 and every two days 
thereafter. Photographs of these constructs were slightly distorted and out of focus 
due to the reflection of the light and the curvature of the glass tube. Figure 29 shows 
the growth of the rSMCs over the culture period on day 3, 11, and 17. The cells 
appeared to attach, elongate and proliferate within the tube. However, it was not 
known if the cells grew within the alginate or grew along the glass tube surface. As 
the rSMC culture aged, the cells began to form larger aggregates which could be 
visualized in the day 11 and 17 photos.
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Figure 29. RSMCs 
immobilized in 50X 
Pronova MVG alginate- 
GRGDY tubes at 
8xl06cell/mL.
Micrographs show the 
growth of cultures on (A) 
day 3, (B) day 11 and (C) 
day 17. Due to the 
curvature of glass tube, the 
images were slightly 
distorted.
Cells are designated as (e) 
elongated within alginate 
along wall of glass tube. 
Areas are designated as (d) 
densely packed cell 
aggregates.
All photos at 100X
magnification.
The spent medium from the tubes was analyzed to see if glucose consumption and 
lactate production were similar to cells grown in tissue flasks. Figure 30 shows the 
cumulative glucose consumption of the rSMCs from a representative tube. The 
glucose consumption rate (GCR) of 0.0187 g/L/hr was determined from the linear 
approximation for the cumulative amount of glucose consumed. Using the vessel 
volume of the tube as 1 5mL, the cells consumed 2.8xl0’5g/hr. The final number of 
cells per tube was not determined, but they were originally seeded with 8xl06cells/mL 
and ca. 147gL was used to make the tube with 100pm wall thickness with outside 
diameter of 4mm (Volume = Pi * (r22-ri2)* h = 3.14 * ((4/2)2 -  (3.8/2)2)mm2 * 120mm 
/ lOOOmL/mm3) which equaled 1.18xl06cells, or a GCR of 2.4x10'1 ^ ce ll/h r. This 
estimate was about 9 fold lower than the average GCR of 2.1xlO"10 +/- 1.3x10’ 
10g/cell/hr (n=50) which was obtained from tissue flasks for the same cells (P I2) from 
section 3.3.1.2. It was likely that the actual number of cells in the tube was 
significantly lower than 1.68xl06cells due to the daily refeeds with fresh medium. 
Some fragments of alginate and cells were dissociated from the tube and washed 
away during the addition o f new medium.
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Figure 30. Glucose consumed by rSMCs immobilized in 50X Pronova MVG 
alginate-GRGDY tube seeded with ca. 1.18xl06cells. The tube was refed daily with 
fresh complete DMEM. The GCR was estimated from the slope of the linear 
approximation for the cumulative amount of glucose consumed.
-164-
Since the tubes were batch fed daily, there was concern about oxygen deprivation 
between refeeds. The respiratory quotient was calculated to be the ratio of the amount 
of lactate produced versus the amount of glucose consumed as per section 2.5.6.2.
This number was used to determine if the culture’s metabolism was anaerobic and 
aerobic. A respiratory quotient o f 1 indicated aerobic metabolism, a ratio o f 2 
indicated anaerobic metabolism, and a value in between indicated something 
intermediary (Carrier, 1999). Figure 31 shows that the tube had a respiratory quotient 
ranging from 0.9 to 1.5, which was maintained even after the daily refeeds were 
extended to two days.
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Figure 31. Determination of rSMC respiratory quotient in alginate-GRGDY tubes. 
The ratio of the amount of lactate produced versus the amount glucose consumed was
1.1 +/- 0.1 (n=14) which indicated aerobic respiration.
These ratios were compared to cells grown in vented tissue flasks which were 
equilibrated with 90%air and 10%CC>2, so they were not oxygen deprived. These 
culture conditions had an identical respiratory quotient of 1.1 +/- 0.1 (n=19).
Alternatively to batch feeding, flow circuits were set up using the glass tubes as the 
bioreactor containing the rSMCs immobilized in the alginate-GRGDY. The 
bioreactor volume was ca. 1 5mL (4mm diameter tube, 12cm in length). The flow of 
the complete DMEM through the tube was originally set very low ca. 5mL in 24
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hours (0.2mL/hr). Thus the complete DMEM in the reactor volume was replenished 
ca. three times within the 24 hour period. In the future, the flow of the medium 
through the tube should be programmed throughout the cultivation period based upon 
pre-set parameters such as glucose consumption, lactate production or oxygen levels. 
Initially the flow may need to be low to allow the cells to elongate and network within 
the hydrogel. Then the flow can be gradually increased since the cell-to-cell binding 
will make the cell/alginate construct stronger and less susceptible to dissociation of 
the alginate due to calcium ion exchange into the culture medium. The flow circuit 
will need to be constructed with tubing that does not contain any leachable toxic 
substances that will inhibit cell growth.
3.3.6. Summary
The average growth rate of A7r5 rSMCs grown in T150 tissue flasks seeded between
f   ^ 1
5-9x10 cells/cm was determined to be 0.31 ± 0.01 day' which was a doubling time 
of 53 ± 2 hours (Figure 11). RSMCs seeded at a lower density (e.g. 4x1 O^ells/cm2) 
experienced a two day lag phase during which no growth occurred; however 
thereafter the growth rate was 0.23 day'1 (Figure 12) which was a doubling time of 71 
hours. The glucose consumption rate (GCR) for rSMCs was similar between 
passages P6-P22, although large standard errors existed. However, within any given 
experiment, the same passage level cells were used for all test and control conditions; 
therefore, rates could be compared directly. Overall, the GCRs were similar 1.4x1 O'10 
± 4.2x10'1 ^ cell/hr between flasks and microwells for rSMC seeding densities 
between 4x102 and lx l04cells/cm2 (Table 10).
High cell viability was achieved following extrusion of rSMCs in alginate and cross 
linking with CaCb. The average cell survival measured was 87 ± 7% (n= 42) using 
trypan blue dye exclusion assay. However, cell viability dropped rapidly from 87% 
down to 3% in just 9 days; and there was no increase in the number of cells within the 
alginate hydrogel discs (Figure 15) as compared to the rSMCs in control flasks. An 
alternative culture medium, aMEM, which was richer in supplements than complete 
DMEM was tested. The rSMCs’ viabilities were higher in the aMEM as compared to 
complete DMEM, but they still decreased to 20% by day 10 (Figure 17). Glucose 
measurements were taken from the spent medium from the microwells of the 
rSMC/alginate beads and discs and confirmed that the cells in the hydrogels were not
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surviving (Figures 16 and 18). A separate experiment was conducted to determine the 
effect of matrix components and cross linking solution on rSMC growth. Alginate 
tubes of rSMCs were extruded, rinsed with medium and then dissolved using 
trisodium citrate. Control cells were set up which serially eliminated each step of the 
process or component. The rSMCs from all of the conditions were plated into 
microwells and similar GCRs were obtained (Figure 19). Therefore the 
immobilization process (and dissolution process) was not detrimental to the rSMCs. 
Therefore, because the rSMCs were strongly anchorage dependent cells and the 
alginate matrix did not provide cell adhesion sites, the rSMCs could not attach and 
died.
Collagen matrices were used to confirm that the rSMCs proliferated in matrices in 
which cell adhesion sites were provided. Glucose consumption was used to measure 
cell proliferation (Figure 20). In further studies performed with rSMCs in 
alginate/collagen matrices, rSMCs were sensitive to increased concentrations of 
divalent cations in the cross linking solution (Figures 21-23). Control conditions in 
which complete DMEM and n-saline were used as mock cross linking solutions had 
the highest GCR and the 1% cross linking solutions had the lowest GCR. It was 
concluded that the higher concentration of cross linking solution caused more alginate 
hydrogel to be formed, thereby obstructing the rSMCs interaction with the collagen. 
Studies performed with rSMCs in collagen/alginate matrices also demonstrated the 
importance of the physical strength of the matrix because cell elongation and 
proliferation caused the matrix to shrink/collapse. RSMCs were observed bridging 
the space between the polystyrene microwell surface and the collagen matrix to 
prevent the matrix from collapsing (Figure 24).
Carbodiimide chemistry was used to incorporate GRGDY peptides onto the alginate 
polysaccharide chains, thus providing cell adhesion sites. RSMCs attached and 
elongated on the surface of 50X alginate-GRGDY sheets (Figure 25, 26A, 27). Very 
few observations were made of rSMCs elongation when immobilized within alginate- 
GRGDY hydrogel beads (Figure 28) and appeared to occur only when the hydrogel 
was rapidly dissociating. RSMCs within rigid alginate-GRGDY hydrogel beads 
never showed elongation. When rSMCs were extruded within 50X alginate-GRGDY 
tubes, cell elongation was observed (Figure 29); however the cells’ association with
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the wall of the glass tube cannot be discounted. Alginate preparations containing only 
IX and 10X reagent concentrations (as per section 2.3.3.2) did not allow rSMC 
attachment nor elongation on the surface of sheets (Figure 26B) and within beads and 
tubes. The GCR was measured for rSMCs cultured in an alginate-GRGDY tube 
(Figure 30) and found to be 2.4x1 O'1 Vcell/hr which was 9 fold lower than the GCR 
of rSMCs in tissue flasks. The respiratory quotient for rSMCs cultured in alginate- 
GRGDY tubes within the glass tube reactor was measured (Figure 31) and found to be
1.1 indicating aerobic metabolism. RSMCs grown in tissue flasks had the same 
respiratory quotient as rSMCs in the alginate-GRGDY tube.
The next section describes the work conducted using adult human mesenchymal stem 
cells (hMSCs). Similar methods and measurements were used to characterize the 
hMSCs as described in this section for rSMCs cultured in tissue flasks and alginate 
hydrogel constructs.
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3.4. The characterization of hMSCs in tissue flasks and alginate
matrices
In order to understand and characterize hMSC growth within alginate hydrogels, the 
growth characteristics of hMSCs in tissue flasks needed to be established. Each cell 
source used for this research was assessed according to its percent viability post-thaw 
(if frozen), percent viability at each passage, the doubling time (hr), the population 
doubling per day (PD/day), the specific growth rate (cells/cm2/hr) and the glucose 
consumption rate (g/cell/hr). The cell concentration was measured using a 
hemacytometer, viability using trypan blue dye and the glucose and lactate 
concentrations in the culture medium using the YSI bioanalyzer. Following these 
measurements, the specific growth rate, glucose consumption rate (GCR) and 
respiratory quotient were calculated.
HMSCs were immobilized within alginate and alginate-GRGDY matrices, and the 
interactions of the hMSCs with the matrices were studied. Cell studies were used to 
concurrently establish the alginate-GRGDY derivatization process. The biological 
activity of the alginate matrices was assessed by observing the cells’ interaction with 
the matrices, such as the change in morphology. The cells remained rounded 
(spherical) indicating no interaction, or the cells elongated indicating association with 
the peptide incorporated onto the alginate. These interactions were observed with the 
hMSCs either seeded on the surface of hydrogel sheets or within beads or tubes.
During preparation and culturing of 3-dimensional hydrogels, measurements such as 
viability of the cells post-immobilization into the alginate, cell density and glucose 
consumption were taken and compared to data for hMSC in 2-dimensional (tissue 
flasks) environments. In addition the metabolic activity of the cells was measured 
using the MTT assay. All of the MTT data and results are discussed in section 3.5.
3.4.1. Growth of hMSCs in tissue culture plastic
Due to the limited supply of hMSCs from bone marrow transplant donations, it was 
necessary to produce frozen stocks of cells for this research. Fresh and frozen sources 
of hMSCs were obtained from the Wolfson Institute, UCL and were used for these 
studies. One isolation of hMSCs directly from bone marrow cells (BMCs) was
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performed, but cell growth was slow. The reason for poor growth was not known, but 
the Wolfson Institute had similar experience with a separate sample from the same 
BMCs. A frozen vial from these cells at P2 was also expanded and growth was lower 
compared to other banks previously used.
Fresh hMSCs were passaged and used to produce frozen working cell banks of 
hMSCs. Vials of hMSCs were removed from liquid nitrogen storage and thawed in a 
37°C water bath and planted into tissue flasks to expand the number of cells to 
conduct the experiments described in this section. The cell banking and passaging 
methods are described in detail in section 2.2.2.
One primary cell bank of hMSCs was produced at passage 4 (P4); however several 
additional sources were obtained which were frozen at P2, P3 and P4 levels from the 
Wolfson Institute. In addition a higher passage cell bank was established at P8; 
however this bank had limited use due to its higher passage level. For the primary P4 
cell bank established, the cells maintained a consistent and high viability over the 
length of storage (ca. 5 months) as determined by trypan blue dye exclusion assay 
(section 2.5.3). Table 15 shows a summary of each cell source’s characteristics in 
chronological order that the cell sources were used. These data were generated from 
5 different hMSC sources (2 fresh and 5 frozen banks) for a total of 24 individual cell 
expansions.
The first data column ‘Fresh hMSC’ was derived from freshly isolated cells (never 
frozen). The remaining data columns represent cell sources that were all derived from 
frozen hMSCs stocks which were cryopreserved as per section 2.2.2.1. Since the 
initial cell concentration of hMSCs isolated from BMCs cannot be determined due to 
the presence of other mononuclear cells, the earliest cell growth data was obtained 
from passage 2 after the density was determined from the harvest of the PI cells.
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% V ia b ility  - 
p o st th aw
8 8 .4  ± 5 . 4  
(n = 6 )
8 7 .6  ± 3 . 9  
(n = 7 )
8 9 .7  ±  0 .6  
(n = 2 )
N A
%  V ia b ility  
P a ssa g e  <  7
9 8 .6  ± 1 . 3  
( n = l l )
9 9 .0  ±  0 .8  
(n = 2 5 )
9 8 .0  ±  0 .9  
(n = 8 )
9 7 .7  ±  0 .8  
(n = 1 2 )
% V ia b ility  
P a ssa g e  >  8
9 8 .7  ± 1 . 0  
(n = 1 3 )
9 8 .1  ±  1 .6  
(n = 1 3 )
9 8 .7  ± 0 . 5  
(n = 2 5 )
9 7 .9  ± 0 . 8  
(n = 2 )
9 4 .7  ± 1 . 6  
(n = 3 )
D o u b lin g  t im e  
< P 7  (h rs .)
6 4  ± 1 6  
(n = 9 )
7 6  ± 1 8  
(n = 2 4 )
5 0  ± 9  
(n = 8 )
7 2  ± 3 6  
( n = l l )
D o u b lin g  t im e  
>  P 8  (h rs .)
7 6  ± 1 5  
(n = 1 2 )
1 4 6  ± 8 4  
(n = 1 2 )
1 6 8 ± 108  
(n = 2 0 )
9 8  ± 3 6  
(n = 2 )
1 0 2  ± 1 1  
(n = 2 )
P D /d a y
< P 7
0 .2 8  ±  0 .0 7  
(n = 9 )
0 .2 3  ±  0 .0 5  
(n = 2 4 )
0 .3 4  ±  0 .0 7  
(n = 8 )
0 .2 6  ±  0 .0 7  
( n = l l )
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0 .2 3  ±  0 .0 5  
(n = 1 2 )
0 .1 5  ± 0 . 0 9  
(n = 1 2 )
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(n = 2 0 )
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(n = 2 )
0 .1 6  ± 0 . 0 2  
(n = 2 )
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P 7  (x lO 2 
c e lls /c m 2/h r)
2 .3 0  ± 0 .9 1  
(n = 6 )
1 .2 9  ± 0 . 5 6  
(n = 1 4 )
3 .4 0  ± 0 .7 5  
(n = 6 )
1 .31 ± 0 . 5 6  
(n = 5 )
G row th  rate >  
P 8  (x lO 2 
c e lls /c m 2/h r)
1 .8 9  ± 1 . 2 7  
(n = 3 )
0 .9 0  ±  0 .6 5  
(n = 9 )
0 .6 3  ±  0 .2 0  
(n = 6 ) s 
r
 
II 
o
w 
° 0 .5 8  ±  0 .5 7  
(n = 2 )
G C R  <  P 7
(xlO *10
g /c e ll/h r )
0 .7 3  ±  0 .3 2  
(n = 7 )
N D 1 .7 2  ± 0 .4 5  
(n = 8 )
1 .9 8  ± 1 .3 3  
(n = 6 )
G C R  >  P 8
(x lO '10
g /c e ll/h r )
1 .02  ± 0 . 4 8  
(n = 1 2 )
2 .1 3  ±  2 .1 7  
( n = l l )
N D 4 .1 0  ±  2 .1 6  
(n = 2 )
N D
Table 15. Summary of hMSC growth in tissue flasks including percent viability of 
cells post-thaw, passaging viability, doubling time, growth rate and glucose 
consumption rate (GCR). The data were grouped and summarized for cells at passage 
levels less than or equal to P7 and for cells above P7. (P = passage level; PD = 
population doubling; GCR = glucose consumption rate; ND = not determined)
The data for Table 15 were grouped and divided into two groups -  cells below or at 
P7 or cells above P7 (at P8 or greater). This distinction was made due to the gradual 
decrease in growth rate of the hMSCs over increasing passage level. This observation 
will be discussed further below.
Overall the average viability of the thawed hMSCs was similar for all the cell banks 
produced averaging 87.6 +/- 4.2% (n=19). The viability of the cells at each passage
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after trypsinization was uniformly high >98% at all passage levels, except the cells 
above P7 from the P2/P3 MC banks (last data column of Table 15). This decreased 
viability may have been due to a higher bacterial contamination level in those cells 
(discussed further in section 3.4.3) because penicillin/streptomycin was not utilized in 
these cultures. The viability of the cells at each passage did not appear to be affected 
by increasing passage level, at least to passage 12 which was the highest level that 
these hMSCs were grown for this research.
The doubling time and growth rate of the hMSCs were calculated according to section 
2.5.4 and found to be 69 +/- 23 hours (n=52) for hMSCs <P7 and 134 hours +/- 88 
hours (n=48) for hMSCs >P8. The growth rate from these doubling time calculations 
at every passage was also calculated to be 0.26 +/- 0.07 hr'1 for <P7 and 0.17 +/- 0.09 
hr'1 for >P8.
3.4.1.1. Specific growth rate of hMSCs
The hMSCs’ growth kinetics appeared to be greatly influenced by the passage level 
with the lowest passage cells having the highest growth rate and the higher passage 
cells having a significantly lower rate. Due to this observation, cells were not used 
for experiments above PI 2. Figure 32 shows the graph of the hMSCs’ specific 
growth rate versus passage number for the cells used from 5 independent BMC 
sources (n=59). The specific growth rates were determined by the linear 
approximation of the increase of cell density over the culture length. These rates were 
generated at each cell passage and contained between 1 to 3 data points from the 
number of total cells harvested/cm2. The majority of the specific growth rate data was 
collected from frozen P4 JM cell bank (n=27) which ranged from 2.2 +/- 
0.74x102cells/cm2/hr at P5 down to 0.70 +/- 0.30x102cells/cm2/hr at P10. However 
data from fresh stocks (n=9) and other frozen cell stocks at P2/P3 MC (n=7), P4 SE 
(n=7) and P8 JM (n=9) were also used in these analyses.
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Figure 32. HMSC specific growth rate versus passage level for fresh cells and frozen 
cells grown in tissue flasks. Frozen cells were derived from frozen cell banks. The 
fresh hMSCs (not previously frozen) appeared to have a higher growth rate than 
frozen cells. The growth rate of both fresh and frozen hMSCs significantly decreased 
between passages 2 and 12. The majority of hMSC growth data was collected from 
cells expanded from a frozen P4 cell bank. For the frozen cells, the specific growth 
rate ranged from 2.2 +/- 0.74 x l0 2cells/cm2/hr at passage 5 down to 0.70 +/-^ A ___
0.30x10 cells/cm /hr at passage 10. These data were generated from a total of 59 
observations (9 for fresh cells, 50 for cells from frozen source).
Although these results suggested that the frozen hMSCs have ca. 50% lower growth 
rate than fresh cells; these data were from 5 different donor sources, a factor which 
can contribute to the greatest variability in growth rate (Phinney, 1999). When the 
growth rates from the same donor(s) were compared directly between freshly 
passaged hMSCs and the same cells after freezing; a different result was obtained as 
shown in Figure 33. Growth rates were calculated according to section 2.5.4, and 
were compared for one donor between P5 and P7, for another donor between P9 and 
P10.
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Figure 33. Growth rate comparison between freshly passaged hMSCs and the same 
cells after cryopreservation. Two donors were compared, one between P5 and P7 and 
another between P9 and P10. (A) Individual data points obtained from donor 1 
designated as ‘1’ and donor 2 as ‘2’. (B) The mean and standard error of the growth 
rates determined from each donor for each passage.
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The linear approximation was determined from the pooled data from the two donors 
for the cells passaged fresh and the cells passage after freezing. Despite being two 
different donors, the linear approximation for the decrease in growth rate versus
r\_____________ __
passage level fit the frozen data well (R =0.91). The fresh data were similar; however 
the growth rates were significantly higher at P10 which skewed the linear 
approximation slightly.
The spread of the individual data points is shown in Figure 33 . A; however the mean 
and standard errors were similar for the two data sets as shown in Figure 33.B.
Bruder (1997) also observed that growth rates were similar for fresh and 
cryopreserved hMSCs.
Alternatively, the population doubling increase per day (PD/day) of the hMSCs can 
be calculated and used as a way to interpret the cell growth data as per section 2.5.4. 
These data are shown in Figure 34 and represent all o f the growth data from all 
hMSCs used in this research. These data also show that there was a substantial 
decrease in cell growth between passages 2 and 12 . A table of the mean and standard 
error (SEM) of each data point is provided in the Appendices section 6.2.1.1, Table 
18.
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Figure 34. Population doublings per day (PD/day) of hMSCs in tissue flasks from 
passage 3 to 12. Early passage cells (P3-P5) were 0.3-0.4 PD/day; however, this 
decreased considerably at later passages (P9-P12) which were 0.05-0.15 PD/day. 
These growth data were generated from the mean and standard error from all hMSCs 
used (n=101).
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These growth rate data were compared against data published by Kinner (2002) who 
found that after three passages the hMSCs underwent 9-11 population doublings. The 
growth kinetics used in their study varied among 10 patients from 0.24 to 0.45 PD/day 
or an average of 0.4 +/- 0.05doublings/day (Kinner, 2002). After converting their 
PD/day calculation from In to log, the rates became 0.1 to 0.2 PD/day or an average of 
0.17 +/- 0.02 PD/day and were similar to these results.
The growth data for hMSCs were also compared to the growth data obtained from the 
rSMCs used initially in this project. As can be seen in Figure 35, the hMSCs have 
very different growth characteristics as would be expected between primary cells 
versus immortalized cells. As previously shown, there was a considerable decrease in 
PD/day for the hMSCs between passages 3 and 12. In contrast, due to their 
immortalization, the rSMCs maintained a relatively constant growth rate (0.32 +/- 
0.06 PD/day) between passages 2 to 22.
♦ hMSCs
0.6  - ■ rSMCs
0.5
0.4 -
y= 0.0008x +0.3213 
R* = 0.0106
0 .2  -I
y=-0.0344x + 0.4681 
R2 = 0.8996
0 5 10 15 20 25
Passage level
Figure 35. Population doubling per day (PD/day) of rat smooth muscle cells versus 
human mesenchymal stem cells. There was a considerable decrease in PD/day for the 
hMSCs between passages 3 and 12, ranging from 0.29 PD/day at P5 down to 0.05 
PD/day at PI 1. In contrast, due to their immortalization, the rSMCs maintained a 
relatively constant growth rate (0.32 +/- 0.06 PD/day) between passages 2 to 22.
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Binder (1997) and Phinney (1999) have also noted the decreased growth rate of 
hMSCs cultures in vitro as the number of population doublings (e.g. passage level) 
increased.
3.4.1.2. Glucose consumption rate of hMSCs
At each passage, a sample of the spent medium from the tissue flask cultures was 
tested for glucose concentrations using the YSI bioanalyzer. In addition, the initial 
concentration of glucose was measured from the MSCCM. From these data and the 
average number of cells during the culture period, the GCR was calculated as 
described in section 2.5.6.1. The average GCR for each cell source was summarized 
previously in Table 15. The GCR appeared to be slightly higher at passages >P8 for 
several of the cell sources used; although the data were highly variable with large 
standard errors. These data were plotted against passage level in Figure 36.A to see if 
this observation was significant.
If all data (P3-P12) were used in the linear approximation, there seemed to be an 
increase in GCR as passage number increased (Figure 36.B -  solid line). However, 
due to the decrease in growth rate of higher passage cells, these cells were also 
maintained in culture longer. Therefore, the GCR data were also plotted against time 
in culture as shown in Figure 37. There appeared to be a slight decrease in GCR for 
cells that were in culture longer. Therefore, the increase in GCR for higher passage 
cells was not due to the increased length in culture. If the few data points at P3, PI 1 
and PI 2 were excluded, since most of the data were collected from P5-P10, then GCR 
did not increase with passage level (Figure 36.B - dashed line). When all the data 
were combined, the average GCR for all hMSCs < P7 was 1.46+/-0.92xl0'10g/cell/hr, 
and for hMSCs >P8 was 1.75+/-1.75xlO‘10g/cell/hr.
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Figure 37. Glucose consumption rate (GCR) versus length o f time in culture. There 
appeared to be a slight decrease in GCR for length in culture; therefore, the increase 
in GCR for higher passage cells does not appear to be due to the increased length in 
culture.
In summary, the hMSCs had a high post thaw viability and high viability during 
passaging in tissue flask cultures. The doubling time, growth rate characteristics and 
GCR were established for hMSCs grown in tissue flasks. These data and additional 
information obtained from metabolic activity (MTT assay) as described in section 3.5 
were used to compare data generated from hMSCs immobilized in alginate. The next 
section provides the results for immobilization of hMSCs in 3-D alginate hydrogels.
3.4.2. HMSCs and alginate matrices
Preliminary results using rSMCs showed that alginate-GRGDY had a different degree 
of biological activity (e.g. cell association) based upon the concentration of the 
reactants (e.g. 10X versus 50X) that were used to derivatize the Fluka, Manugel or 
Pronova MVG alginate as described in section 3.3.5. In addition, the reaction 
parameters (e.g. time and temperature), length of dialysis, treatment with activated 
charcoal, filtration using Celite and concentration using lyophilization also were very
- 1 7 9 -
likely to effect the strength of the alginate hydrogel, the porosity, amount of 
impurities and concentration of alginate in the final product.
Therefore initial studies with hMSCs were performed using two alginate sources: 
Fluka and Manugel DMB both which contained high G-subunits to see whether the 
two alginates performed differently in terms of cell interaction (biological activity), 
and maintained good shape/strength which did not dissociate during culture. First 
hMSCs were seeded onto preformed alginate-GRGDY sheets to decouple the cross 
linking and cell seeding steps. Then the hMSCs were immobilized directly into 
beads.
3.4.2.1. HMSCs seeded onto alginate-GRGDY sheets
Hydrogel sheets were constructed with alginate-GRGDY (Manugel) using the 
methods described in section 2.4.2.1. The alginate sheets were washed three times 
with WFI and then once with MSCCM to remove excess CaCh from the sheet 
fabrication step. HMSCs at P10 were seeded at 6xl04cells/mL onto the surface of 
10X and 50X alginate-GRGDY sheets with 2mL of MSCCM per well using a 12 well 
microplate (Coming). At this concentration the cells would have been seeded at 
3x104 cells/cm2, if the 12 well surface area of 3.9cm2 was used as the estimated 
surface area of the alginate sheet. After four days of culture at 37°C, the hMSCs 
seeded onto the surface of 10X alginate-GRGDY sheets remained rounded and did 
not attach to the surface of the sheet (Figure 3 8. A). Whereas the hMSCs seeded onto 
the surface of the 50X alginate-GRGDY sheets elongated and formed a monolayer of 
cells (Figure 38.B). The hMSCs elongation on the surface of the 50X alginate- 
GRGDY was comparable to the control hMSCs seeded on the surface of a microwell 
(Figure 38.C); although the cells on the hydrogel appeared to be at a lower density 
and more spindle-shaped than in the microwell. This apparent difference in cell 
density was attributed to the cells sliding or settling off the surface of the alginate 
hydrogel onto the microwell surface below, as a large number of cells were observed 
growing under the hydrogel on the surface of the microwell. Due to the thickness of 
the alginate hydrogel, the microscope field of focus could easily be distinguished 
from cells positioned on the surface of the hydrogel as opposed to the surface of the 
microwell.
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Figure 38. 1 OX and 5OX 
alginate-GRGDY 
(Manugel) sheets seeded 
with hMSCs after 4 days 
of culture. (A) 1 OX - All 
cells remained round and 
did not attach to surface of 
alginate. (B) 50X - The 
cells attached to the 
surface of the alginate and 
elongated forming a 
network of spindle-shaped 
cells. (C) Control cells 
seeded onto the microwell 
surface after 4 days of 
culture. All cells are 
attached to surface, 
elongated and densely 
packed. All photos 100X 
magnification.
-181  -
3.4.2.2. Comparison of hMSCs immobilized in non- 
derivatized versus derivatized alginate beads
Fluka alginate was derivatized using 50X reactants and GRGDY peptide, dialyzed for 
2Vi days, treated with activated charcoal and filtered through Celite as described in 
section 2.3.3. Then it was lyophilized and reconstituted with WFI. Non-derivatized 
Fluka alginate was prepared using 2% w/v of Fluka alginate in n-saline (0.9% NaCl) 
solution, pH7.3, and autoclaved for 22min at 121 °C. The alginate was mixed with lg 
activated charcoal per 15mL of alginate and then filtered through a 1.2pm Supor® 
membrane filter (Pall, Gelman Laboratory, Acrodisc® syringe filter, Portsmouth, 
UK). Alginate beads were made with 50% v/v hMSCs at P8 resuspended in MSCCM 
to a final concentration of 2xl06cell/mL in the two alginate solutions using the 
method described in section 2.4.4. A time course of photos were taken of the hMSCs 
interaction with the alginate matrices. Immediately after immobilization, the hMSCs 
were all rounded within both hydrogel matrices. The hMSCs in the non-derivatized 
alginate matrix remained rounded and did not elongate within the hydrogel during the 
7 day study (Figures 39.A-C). In contrast, the hMSCs in the alginate-GRGDY 
elongated within 24 hours (Figure 39.D) and even more extensively by day 3 and 7 
(Figures 39.E-F). Day 1 and 3 photos were taken with a phase contrast microscope. 
Whereas photos C and F were taken with a fluorescence microscope showing hMSCs 
that were stained with calcein AM, for cytoplasm of live cells after 7 days in culture.
These results indicated for the first time that hMSCs were able to elongate within a 
alginate-GRGDY hydrogel. Previous findings using rSMCs demonstrated that these 
cells were not able to elongate within the alginate-GRGDY hydrogels, but only when 
seeded freely on the surface of the hydrogel. These results also confirmed that 
hMSCs do not interact with non-derivatized alginate as was found with rSMCs. Later 
studies also continued to support this finding; and furthermore, it was found that any 
amount of non-derivatized alginate (within the range examined) mixed into alginate- 
GRGDY immediately rendered the hydrogel biologically inactive. These results 
confirmed earlier collagen and alginate studies with rSMCs which showed that 
alginate rendered the collagen biologically inactive after cross linking the alginate.
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Figure 39. Time course of hMSC seeded at 2xl06cells/mL within non-derivatized 
(OX) alginate beads and 50X alginate-GRGDY beads (Fluka). (A) HMSCs on day 1, 
(B) day 3 and (C) day 7 in non-derivatized alginate beads. (D) HMSCs on day 1, (E) 
day 3 and (F) day 7 in 50X alginate-GRGDY beads. Photos A, B, D and E are taken 
with phase contrast microscope. Photos C and F are taken with fluorescence 
microscope using calcein AM, which stains the cytoplasm of live cells. All photos 
100X magnification.
-183 -
3.4.2.3. Effect of reactant and cell concentrations on 
immobilized hMSCs in alginate-GRGDY 
beads
Additional studies were performed with beads constructed with hMSCs using 1 OX 
and 50X alginate-GRGDY (Manugel) as described in section 2.4.4. The cell pellet 
was resuspended in MSCCM at a concentration 5xl06cells/mL and added at 25% v/v 
to the alginate-GRGDY. Immediately after cross linking with 1% CaCh in n-saline, 
the beads were rinsed twice with MSCCM and transferred into 24 well microplates 
containing lmL of MSCCM and incubated at 37°C. Initially the hMSCs are all 
rounded within the alginate hydrogel after immobilization. However after 4 days of 
culture some of the hMSCs within the 1 OX alginate-GRGDY had elongated slightly 
within the matrix (Figure 40.A). However the hMSCs within the 50X alginate- 
GRGDY were all elongated and extensively networked within the matrix (Figure 
40.B).
Figure 40. HMSCs seeded at 5xl06cells/mL in 10X and 50X alginate-GRGDY beads 
(Manugel) after 4 days o f culture. (A) 10X alginate-GRGDY - A few cells around the 
perimeter of the bead have elongated. The majority of remaining cells remained 
rounded and did not elongate. (B) 50X alginate-GRGDY - All of the cells elongated 
and were extensively networked throughout the entire bead. All photos 100X 
magnification.
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In this study the hydrogels with higher cell density (5xl06cell/mL) had notably better 
networking of cells than the previous study which had only 2xl06cells/mL (Figure 
39.E versus Figure 40.B). Throughout the course of research the concentrations of 
hMSCs varied from lx l 06 up to 2xl07cells/mL of alginate. It was found that the 
highest concentration, 2xl07cells/mL, produced the best consistency of cell 
elongation throughout the bead and the most cell-to-cell networking as assessed 
microscopically. At lower concentrations (<107cell/mL), the hMSCs were spaced 
further apart and physically could not bridge the gaps between adjacent cells. In some 
cases the cells elongated inconsistently throughout the bead, and some cells remained 
rounded or took longer to eventually elongate. This result could be a growth factor- 
release event or triggered by a product of metabolism, as it is well documented that 
cells at low density in tissue culture flasks (such as for cell cloning) have much slower 
growth rates than cells seeded at high densities (Freshney, 1994). During cell growth 
the medium is conditioned by release of small molecular metabolites and 
macromolecules (Takahashi and Okada, 1970). Therefore cells at low density or 
immobilized in a substrate such as a hydrogel with mass transfer restrictions, may be 
adversely influenced by these factors.
Because the GRGDY peptide was an expensive reagent, the amount of peptide added 
to the carbodiimide reaction was examined to see if the concentration required for 
biological activity (e.g. cell elongation) could be reduced. Alginate was derivatized 
according the protocol described in section 2.3.3 using 12.5mL of 1% Manugel DMB 
alginate (125 mg) with three peptide concentrations including IX (0.125mg)
GRGDY, 10X (1.25mg) and 50X (6.25mg). A 50X concentration of reactants 
(237.5mg of sulfo-NHS and 418.75mg of EDC) was used in each formulation.
HMSCs at P6 were combined at 20% v/v to the alginate at 5xl06cells/mL. After 1 
day of incubation in MSCCM, the hMSC beads were observed and all three 
conditions had the same high degree of cell elongation and networking throughout the 
beads. This was a significant finding since previous studies with both Manugel and 
Fluka alginate showed that 10X reactants produced considerably lower biological 
activity than the 50X reactants; therefore the amount of reactants, EDC and sulfo- 
NHS, were limiting the extent of derivatization of peptide onto the alginate and not
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the concentration of peptide. Therefore a lower peptide concentration could be used 
in the derivatization process.
3.4.2.4. Culturing hMSCs in alginate-GRGDY tubes
In addition to the observations made with sheets and beads, hMSCs were combined 
with alginate-GRGDY and immobilized into tubes as described in section 2.4.3, 
Figure 7 and 2.4.3.3. The cell-alginate solution was composed of 25%  v/v cell 
suspension and 75% v/v 50X alginate-GRGDY (Manugel DMB). Two tubes with P4 
hMSCs at 5xl06cells/mL were extruded in glass tubes using a large diameter ball (ca. 
3.71mm) as the float. After cross linking was completed using l%CaCl2 in n-saline, 
the tubes were rinsed and filled with MSCCM. The tubes were incubated at 37°C as a 
static culture and refed with ca. 5mL fresh MSCCM every 10-14 hours. The glass 
tubes held a total volume o f 1.5mL MSCCM. Samples of the spent medium were 
taken and frozen at each time point and analyzed on the YSI bioanalyzer for glucose 
and lactate. In addition a time course o f photos was taken. On day 3, the hMSCs 
were elongated, but the cell-cell networking was low (Figure 41.A). By 12 days in 
culture, the cells were densely networked (Figure 41 .B).
Figure 41. Time course o f hMSC growth in 50X alginate-GRGDY (Manugel) 
extruded into tubes seeded at 5x10 cells/mL. (A) HMSCs after 3 days o f culture and 
(B) after 12 days of culture. Due to the curvature o f glass rod, the field o f view was 
blurred slightly at edges at 100X magnification.
As shown in Figure 42, analysis o f the glucose consumed showed that both tubes had 
similar rates. The glucose consumption increased slowly between 0-100 hours and 
then reached a steady-state thereafter. A linear approximation was made for the
cumulative glucose consumed for tube 2 between 100 and 200 hours in culture. The 
slope o f this line was 0.0219 g/L/hr. Therefore using the vessel volume o f 1,5mL, the 
cells consumed 3.3xlO'5g/hr. The final number of cells per tube was not determined, 
but they were originally seeded with 5xl06cells/mL and ca. 210pL was used to make 
the tube 145pm thick with outside diameter of 4mm (Volume = Pi * (r2 2-ri2)* h = 3.14 
* ((4/2)2 -  (3.71/2)2)mm2 * 120mm / lOOOmL/mm3) which equaled 1.05xl06cells, or a 
glucose consumption rate o f 3. lx l0 '1 ^ ce ll/h r. This estimate was lower than the 
GCR data obtained from hMSCs grown in tissue flasks for the same cells (JM2-37) 
below P7 which from Table 15 was 7 .3xl0 'n +/- 3.2x10 '1 ^ c e ll/h r  (n=7).
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Figure 42. Glucose consumption of hMSCs in 50X alginate-GRGDY (Manugel) 
tubes seeded with 1.05xl06cells. The daily measurements o f glucose consumed are 
shown by the closed symbols. The cumulative glucose consumed is shown by the 
open symbols. Four data points (black) were estimated from actual glucose consumed 
from four data points surrounding these time points as the tubes were refed but 
samples were not taken. The linear approximation was estimated from the cumulative 
glucose consumed in tube 2 between 100-200 hours in culture.
The respiratory quotient (ratio o f lactate produced versus glucose consumed) was 
calculated for this experiment and found to be 2.4+/-1.2 in the first five days o f 
cultures and then decreased to 1.14+/-0.17 for the remaining culture period. This 
indicated that the cultures were primarily anaerobic during the initial culture and more 
oxygen was required by the hMSCs. Therefore, in future experiments constant flow
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should be supplied to the bioreactor containing hMSCs. The respiratory quotient of 
representative tissue flask cultures of hMSCs was measured to be 0.90+/-0.18 (n=46) 
which, as expected, indicated aerobic metabolism.
In addition to providing continuous medium flow through the glass bioreactor, further 
refinement to the glass bioreactor also requires surface treatment to ensure that the 
hMSCs do not adhere to the glass tube surface, since it would be undesirable to have 
the cells attach and grow outside the hydrogel construct. Low binding microwell 
plates were used for bead studies to ensure cells that dissociated from the alginate did 
not grow and attribute to the glucose consumption rate in the microwell studies.
3.4.2.5. Viability and proliferation of hMSCs in 
alginate beads
The viability of hMSCs immediately after immobilization in alginate and alginate- 
GRGDY beads was assessed using the trypan blue dye exclusion assay as per section 
2.3.2.6. The viability averaged 95 +/- 3% for 10 independent experiments ranging 
from lxlO6 up to 2xl07cells/mL. This value was slightly lower than the ca  98% 
viability observed when passaging the cells in tissue flasks as shown previously in 
Table 15.
A 5 day time course was performed to assess the viability and total cell concentration 
of hMSCs immobilized in non-derivatized alginate (Manugel) at 0.5% and 0.75% w/v 
composition (Figure 43). The viability and total cell concentration were determined 
by releasing the cells from the alginate using trisodium citrate and counting the cells 
on a hemacytometer using trypan blue. The 0.5% w/v alginate composition was 
formulated using 1% Manugel in WFI and combining with 50% v/v of cell suspension 
in MSCCM, and the 0.75% w/v formulation was made by combining the 1% Manugel 
in WFI with 25% v/v of cell suspension. The cells were prepared at a concentration 
of lx l06cell/mL with an average of 2-3 beads counted at each time point. The initial 
viability was 98% for both conditions. The viability in the 50% v/v alginate beads 
(final 0.5% w/v alginate) decreased to 70% after 4 days; whereas the viability of the 
75% v/v alginate beads (final 0.75% w/v alginate) maintained 85% viability after 5 
days in culture. The reason for the decrease in viability was not known, other than the 
cells were immobilized in non-derivatized alginate without any attachment sites for
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the cells. Additional time course experiments that assessed hMSC percent viability 
and total number of cells per bead were performed during experiments conducted with 
the MTT assay. These results are discussed in section 3.5.
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Figure 43. Viability and total number o f hMSCs in non-derivatized alginate beads 
(Manugel) at 50% v/v and 75% v/v composition. The initial viability was 85% for 
both conditions. The 50% v/v alginate beads decreased to 70% viable after 4 days, 
whereas the 75% v/v beads maintained 85% viability after 5 days in culture.
An additional time course study was performed using the live/dead fluorescence assay 
as described in section 2.5.7. The two probes were calcein AM (green) indicating 
cytoplasm o f live cells and ethidium homodimer (red) staining nucleic acids o f dead 
cells. These studies only provided a qualitative as opposed to a quantitative result for 
cell viability. The study was conducted using hMSCs immobilized in 9X Pronova 
SLG100 alginate-GRGDY beads at 9xl06cells/mL using 1% CaCb in n-saline. 
Immediately after immobilization the beads were rinsed with complete DMEM; then 
cultured in either complete DMEM or in MSCCM for 17 days. Figure 44 shows the 
sequence o f the three images o f hydrogel beads cultured in complete DMEM on day 3 
(A-C) and day 17 (G-I); and in MSCCM on day 3 (D-F) and day 17 (J-L). Each 
sequence was taken without moving the field o f view.
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Figure 44. (On previous page) Live/dead fluorescence assay for time course of 
hMSCs immobilized in 9X alginate-GRGDY beads (Pronova SLG100). Sequence of 
light and fluorescence microscopy with calcein AM (green) indicating cytoplasm of 
live cells and ethidium homodimer (red) staining nucleic acid of dead cells. Beads 
cultured in complete DMEM on day 3 (A-C) and day 17 (G-I); and in MSCCM on 
day 3 (D-F) and day 17 (J-L). 100X magnification.
Interestingly the hMSCs did not elongate within the hydrogels cultured with complete 
DMEM; whereas the hMSCs within the hydrogels cultured with MSCCM elongated 
and networked within 1 day. The complete DMEM was most likely deficient in the 
necessary growth factors for this to occur (e.g. bFGF is added to the MSCCM).
3.4.3. Sterility issues with hMSCs cultures
During the course of this research project the sterility of the alginate derivatization 
process was continually improved until a sterile process was achieved as described in 
sections 2.3.3.7 and 3.2.8. However it became apparent that the alginate was not the 
only possible contributing factor to microbes within the system. So the fresh 
MSCCM and spent medium from cultures of hMSCs were visually examined in 
microwells to detect the presence of microbes as per section 2.2.2.3. Terrific broth 
was not used because precipitates formed when MSCCM was added. The formulated 
MSCCM was also sterile filtered for added sterility assurance. Once filtered, the 
MSCCM was rarely contaminated. Despite the presence of lOOUpenicillin/mL and 
lOOfiL streptomycin/mL (P/S) in the MSCCM, microbes were observed in the 
cultures of hMSCs that did not appear to be sensitive to P/S nor to other antibiotics 
tested in MSCCM including 50mg/L gentamycin, lOOmg/L kanamycin and lOOmg/L 
erythromycin. The microbes had no adverse macroscopic effect on the culture (e.g. 
pH or turbidity change) and the cells continued to grow. However after the spent 
medium in the microwells settled overnight, cellular debris, dead cells and microbes 
were observed at 400X magnification or greater. The microbes were not 
homogeneously dispersed throughout the microwell, but outgrowth appeared in 
discrete foci throughout the well (Figure 45). Samples were provided to the 
microbiology lab at UCLH to try to identify the organism(s), but they could not 
isolate any microbes from the spent medium.
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The presence o f microbes was exacerbated when the hMSCs were immobilized in 
alginate-GRGDY due to the high cell concentrations used (e.g. 2x l07cells/mL) in the 
beads. The microbes were observed microscopically as tiny dots within the bead, but 
they also dissociated from the bead and dropped onto the microwell surface below the 
beads. Occasionally these beads were observed to undergo discoloration as discussed 
in the next section.
Cell debris
Microbes
Figure 45. Microscopic image of spent medium from hMSCs cultures which 
contained small microbes, cell debris and dead cells. The microbes moved slightly 
and appeared in discrete foci through the microwell. 200X magnification.
3.4.4. Discoloration of alginate beads
A further challenge to the hMSC-alginate system was the discoloration o f beads that 
occasionally occurred during culture. This problem was first experienced when the 
alginate (Manugel) was autoclaved to sterilize prior to the derivatization process 
which caused the activation o f thermophilic bacillus spores, B.licheniformis, as was 
described in section 3.1.2. The beads appeared to be contaminated when they started 
turning an opaque whitish-gray color, while appearing black under the microscope. 
After completing the sterile derivatization process, this problem still persisted so the
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culture medium and hMSCs were scrutinized as described in the previous section. 
Microbes were observed in the spent medium.
Communication with the alginate manufacturers (NovaMatrix) also shed some 
understanding into the possible cause(s) of the discoloration that may or may not have 
also been attributed to contaminants present in the hMSCs cultures. The alginate 
beads actually turned white, but appeared black under the microscope light. This loss 
of light transmission through bead was caused by calcification within the gel network 
as a result of the presence of phosphate in the culture medium. Hydrogels made from 
Pronova SLG100 alginate contained high amounts of calcium due to their high 
content of guluronic (G) subunits; therefore they were susceptible to calcification.
Low G alginates were less susceptible to calcification (Email correspondence with Jan 
Egil Melvik, NovaMatrix/FMC Biopolymer, March 2004). Also other calcium 
chelating compounds such as phosphate, lactate and citrate in the medium should be 
avoided or minimized. Likewise large amounts of sodium will weaken the beads due 
to the exchange of calcium ions from the hydrogel.
An experiment was conducted using Pronova SLG100 alginate in which beads 
without cells were made by the standard protocol and then incubated in MSCCM or 
complete DMEM medium. The beads cultured in the MSCCM where initially clear 
but gradually turned a yellow/brown tint after about 7-13 days in culture, whereas the 
beads in complete DMEM medium were not discolored. Based upon this information, 
it was likely that phosphate present in the MSCCM had caused some calcification 
within the hydrogel network. Another experiment was conducted in which hMSCs
i % *7and rSMCs were immobilized at 5x10 and 2x10 cells/mL in the non-derivatized 
Pronova SLG100 alginate. The beads containing the high cell concentration of 
hMSCs rapidly turned brown within a few days; and the beads with the low cell 
concentration gradually turned yellow then brown over a couple weeks. In contrast, 
the beads containing the rSMCs at both concentrations never discolored during the 
study. These results showed that increased levels of lactate produced by cells at high 
concentration within the beads also created a microenvironment which would cause 
further calcification. Finally the presence of microbes (both in the alginate and in the 
hMSC cultures) could further exacerbate the system and cause further calcification. 
Separate studies also showed the derivatization of the alginate and the size of the bead
-  193 -
were not a contributing factor, as small beads (<lm m) were just as likely to calcify as 
large beads (>2mm). Figure 46 shows micrographs taken of calcified 12X alginate- 
GRGDY beads (Pronova SLG100) seeded at lx l0 7cells/mL and cultured in MSCCM 
for 6 days. The beads were smaller than those typically produced manually due to 
disruption of the stream (spray) during bead formation which produced smaller beads, 
but without control of sphere size.
Necrotic cells
Figure 46. Micrographs o f calcified 12X alginate-GRGDY beads (Pronova SLG100) 
with hMSCs seeded at lx l0 7cells/mL. All beads were cultured for 6 days in 
MSCCM. (A) Normal bead with cells completely networked. A few black necrotic 
cells are present. (B) Bead with small section starting to calcify. (C) Small, 
iridescent normal bead adjacent to large, black calcified bead. (D) Several linked 
beads which are completely calcified. All photos 100X magnification.
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3.4.5. Summary
Frozen stocks o f hMSCs were prepared from isolation o f BMCs from a Ficoll 
gradient and tissue culture plate adherence. The hMSCs had viability post thaw of 88 
+/- 4% (n=19), and during passaging a viability of >98% (n=109). The growth 
kinetics o f hMSCs appeared to be greatly influenced by the passage level. The 
doubling time was 69 +/- 23 hours (n=52) for hMSCs <P7 and 134 hours +/- 88 hours 
(n=48) for hMSCs >P8. The growth rate as calculated from the doubling time was 
0.26 +/- 0.07 hr'1 for hMSCs <P7 and 0.17 +/- 0.09 h r'1 for >P8. The specific growth 
rate (on a per cell basis) for frozen hMSCs ranged from 2.2 +/- 0.74 x l0 2cells/cm2/hr 
at P5 down to 0.70 +/- 0.30x102cells/cm2/hr at P10 (Figure 32). The growth rate of 
fresh and cryopreserved hMSCs was determined to be similar for the same donor 
(Figure 33.B). Alternatively population doublings were also used to calculate growth 
rates. Early passage cells between P3 and P5 had 0.3-0.4 PD/day, which decreased 
between P9 and P I2 to 0.05-0.15 PD/day (Figure 34). In contrast, due to their 
immortalization, the rSMCs maintained a relatively constant growth rate (0.32 +/- 
0.06 PD/day) between P2 to P22 (Figure 35). Glucose measurements were taken 
from the spent medium for the cultured hMSCs. The GCR for all hMSCs < P7 was 
1.46+/-0.92xl0'10g/cell/hr, and for hMSCs >P8 was 1.75+/-1.75xlO'10g/cell/hr (Figure 
36). The GCR was found to be independent o f passage level and culture length 
(Figure 37), given the large standard error associated with the data.
HMSCs were immobilized into alginate and alginate-GRGDY hydrogels and the 
biological activity (e.g. cell elongation) was studied in sheets, tubes and beads. 
Following immobilization, viability averaged 95 +/- 3% for 10 independent hMSC 
experiments ranging from lxlO6 up to 2x l07cells/mL. No elongation was observed in 
the non-derivatized alginate hydrogels (Figure 39. A). The extent o f hMSC elongation 
within the derivatized alginate-GRGDY was dependent upon the concentration o f 
reagents used during the carbodiimide chemistry (e.g. EDC, sulfo-NHS and peptide). 
Initially 50X reagents were necessary for Manugel and Fluka alginates (Figures 38, 
39.B and 40); then a significant experiment demonstrated that only IX level of 
peptide was required for equivalent cell elongation and networking using 50X levels 
of EDC and sulfo-NHS. The cell concentration required for uniform cell elongation
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and complete networking was 2xl07cell/mL. In addition, elongation o f hMSCs 
within alginate-GRGDY beads was sensitive to the culture medium. HMSCs within 
hydrogels incubated with complete DMEM did not elongate during a 17 day time 
course whereas they did using MSCCM. The live/dead assay was used to 
qualitatively assess the viability and the extent of elongation of the cells within the 
hydrogel (Figure 44). Cell elongation and networking was observed in hMSCs 
immobilized in alginate-GRGDY tubes (Figure 41). The GCR was measured to be 
3.1xl0‘n g/cell/hr (Figure 42). This estimate was lower than the GCR (7.3 xlO '11 +/- 
3.2x1 O'1 ^ /cell/hr) obtained from the same hMSCs grown in tissue flasks. The 
respiratory quotient o f the cells in the tubes was calculated to be 2.4+/-1.2 in the first 
five days of cultures indicating the cells were under anaerobic metabolism.
Two challenges unfolded for the hMSC-alginate hydrogel system. First, microbes 
were observed in the spent medium from the hMSCs cultures (Figure 45). The 
microbes were not sensitive to the antibiotics tested, and could not be isolated and 
identified when sent to UCLH microbiology testing laboratory. This problem was 
independent o f the B. licheniformis contaminants found in the alginate (as described 
in section 3.1.2). Furthermore during culture some of the alginate-GRGDY beads 
turned white, but appeared black under the microscope (Figure 46). Hydrogels made 
from high guluronic (high G) alginate, such as Manugel and Pronova, contained high 
amounts o f calcium within the gel network. Therefore they were susceptible to 
calcification from the presence o f chelating compounds such as phosphate in the 
MSCCM and increased levels o f lactate produced at high cell concentration and in the 
presence o f microbes.
Preliminary data was collected on the viability and cell concentration of hMSCs 
immobilized in alginate beads during a 5 day time course (Figure 43). These 
quantitative analyses o f the hMSC-alginate hydrogels formed the basis on which cell 
proliferation (metabolic activity) studies were conducted on hMSCs immobilized in 
alginate-GRGDY beads using the MTT assay. These studies are described in the next 
section.
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3.5. MTT assay for cell proliferation (metabolic activity)
Every aspect of enhancing the expansion of human cells and of preparing engineered 
tissue rests upon the ability to measure the number of cells at every stage and their 
metabolic status. (Later measurement o f phenotype status will be important.) As the 
present research developed it became clear that progress was conditional on 
advancing this aspect. The previous section (3.4) demonstrated that hMSCs would 
associate within alginate-GRGDY hydrogels and preliminary results showed viability 
was high (Figure 43). Due to the potential loss o f cells or decrease in viability during 
release of the cells from the alginate matrix using trisodium citrate and trypsin/ETDA, 
it was desirable to estimate the cell number in the beads using an alternative method. 
One common technique that has been used to quantitate cell number includes 
determination of DNA content (Papadimitriou and Lelkes, 1993; Carrier 1999). Early 
efforts in this research project developing a DNA fluorescence assay (CyQuant) 
proved unreliable in the presence o f alginate and other residual components (see 
sections 2.6.1.4 and 6.1.2.1, Figure 71). Instead, the MTT assay was used to monitor 
cell proliferation and metabolic activity within alginate beads.
The MTT assay was first developed by Mosmann (1983) as a quantitative 
colorimetric assay for mammalian cell survival and proliferation. It was modified 
and further developed for uses in quantitation of lymphokines (Green, 1984), drug 
cytotoxicity (Huveneers-Oorsprong, 1997), cell-mediated cytotoxicity (Ferrari, 1990), 
cell chemosensitivity to antitumor agents (Heo, 1990), evaluation of cell/biomaterials 
interactions (Ciapetti, 1993) and assessment of cell viability (Ferrera, 1993; He,
1996). More recently it has been used to assess cell viability and proliferation in 
tissue engineering scaffolds (Carrier, 1999; Chung, 2002; Dar, 2002; Wang, L., 2003; 
Wang, D., 2003; Yang, 2003; Zund, 1999).
Heo (1990) found the MTT assay to be more sensitive than the 51Cr-release assay in 
measuring the antitumor activity of effector cells. As a result it required significantly 
lower number of cells to perform the assay. Ciapetti (1993) confirmed results 
obtained from materials’ cytotoxic effect by MTT assay correlated to data from 3H- 
thymidine uptake. Ferrera (1993) found MTT reduction activity correlated to oxygen 
consumption and adenine nucleotide levels in heart biopsy samples.
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The assay involves the mitochondrial dehydrogenase conversion of water soluble 
yellow MTT salt (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) into 
an insoluble, intracellular purple formazan product which only occurs in 
metabolically active (live) cells (Mosmann, 1983). After the formazan is dissolved 
using an organic solvent, the concentration is measured using a spectrophotometer 
and the result quantitated to the number of cells present in the sample. Mosmann 
found that isopropanol was the most suitable solvent, since ethanol sometimes 
precipitated the serum proteins in the mixture. In order to minimize the interference 
of the phenol red component in the tissue culture medium when read at the wave 
length used to measure the purple dye of the dissolved formazan, acid was added to 
the isopropanol. This ensured the cell/culture media mixture was fully acidic so that 
the phenol red color indication was yellow.
A variety of reagents other than isopropanol have been used to dissolve the formazan 
crystals. Ferrera (1993) and Ciapetti (1993) found dimethyl sulfoxide (DMSO) 
worked adequately to dissolve formazan. Dar (2002) used a mixture of 20% aqueous 
sodium dodecyl (lauryl) sulfate (SDS) and formamide (1:1 volume ratio) to dissolve 
the formazan crystals off alginate scaffolds. Other researchers using polymer 
scaffolds for tissue engineering applications have utilized primarily DMSO (Wang, 
L., 2003; Chung, 2002) or isopropanol combined with HC1 or formic acid (Carrier, 
1999; Wang, D., 2003; Zund, 1999; Yang, 2003) to dissolve the formazan and to 
minimize interference with the phenol red component in the tissue culture medium.
Initially, the MTT assay was tested on hMSCs and found not to be adversely affected 
by alginate or residual components as summarized in section 2.6.2.8. However, the 
assay needed to be conducted on live cells to metabolize the MTT. Therefore, it was 
important to incorporate a hold/storage step such that multiple time points could be 
dissolved and analyzed at the same time to reduce day-to-day variability. In addition, 
the hold step was convenient to incorporate due to the considerable incubation length 
required to run through the entire assay protocol. Freeze steps had not been reported 
in the literature and so the affect of the freeze step needed to be compared to samples 
that had not been frozen. The MTT assay was found to be especially appropriate for 
this kind of time course study because the cells were assayed in situ, stored frozen,
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then dissolved and analyzed on the same day. The assay method described in section 
2.6.2 was created from experienced gained from the experiments and results described 
in this section.
3.5.1. MTT assay parameters
For all MTT assays the culture medium was completely removed or rinsed from the 
bead/cell constructs to eliminate contributions to the phenol red component in the 
culture medium. Then the MTT stock solution was added to wells containing DPBSG 
to ensure the cells were not depleted of glucose during the 2 hours incubation with 
MTT reagent. He (1996) found that 5mM glucose produced maximal color 
development of MTT reduction by mitochondria, although incubation lengths were 24 
hours for their analyses.
The detergent SDS was originally tested as the formazan dissolution agent as per Dar 
(2002) who used the MTT assay for cardiomyocytes seeded onto alginate scaffolds. 
However, under the conditions of this protocol, SDS was deemed unsuitable since the 
solution solidified into a thick paste after adding the SDS to the trisodium citrate 
dissolved alginate-cell solution. Most likely this was due to the ionic interaction of 
alginate with the SDS or divalent cations such as calcium in the dissolved alginate 
solution. Each SDS molecule has two negative charges. It is possible that Dar (2002) 
did not experience this problem because they used porous (freeze-dried) alginate 
scaffolds that were not dissolved during the assay. Subsequent to SDS, isopropanol 
with 0.1N HC1 was determined to be a suitable solvent to dissolve the formazan 
crystals in the presence of dissolved alginate.
A full wavelength scan was performed on a representative sample of dissolved 
formazan with alginate/cells (Figure 47) using the Uvikon 922 Spectrophotometer 
(Kontron Instruments, Milan, Italy). In addition, a scan was performed on a 
MTT/isopropanol/HCl blank (sample without alginate/cells) and a sample of 
isopropanol/HCl. The peak of the MTT/isopropanol/HCl blank (unreacted -  no 
conversion of MTT into formazan) was below 450nm. The peak of the dissolved 
formazan with alginate/cells sample (reacted) was below 600nm. These peaks clearly 
do not overlap at wavelengths greater than 450nm.
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Figure 47. Full wavelength scan o f a sample of dissolved formazan with alginate and 
cells. Arrows indicate the peak wavelength o f 560nm and the wavelength o f 600nm 
used to measure the absorbance on the microplate spectrophotometer. The 
absorbance reading at 600nm was 92% of the reading at 560nm.
The spectrograph also showed that the actual formazan peak occurred at 
approximately 560nm. However, the absorbance at 600nm was not significantly 
different from the absorbance at 570nm. For the three replicates performed, the 
average absorbance at 600nm was 1.65 +/- 0.17 and at 570nm was 1.79 +/- 0.18. 
Hence, the absorbance readings at 600nm were 92 +/- 0.2% of the readings at 570nm. 
Because the absorbance readings at 570nm were surrounded by a shallow fall off and 
the readings at 600nm were on the shoulder o f the peak; readings at 600nm be more 
susceptible to optical error. Future work will be performed with a new spectrometer 
specified to read at 560-570nm; however since this was the wavelength reading 
available on the current instrument, the Packard Bioscience Spectracount™ 
microplate reader was acceptable for reading these samples at 600nm.
The spectrophotometer was also able to perform dual wavelength reading. In the 
future a reference wavelength set at 670nm could be utilized to also measure each 
sample so that turbidity o f the sample which causes light scatter to improve the data 
set. The subtracted data would then be a more representative value (Harris, 1996).
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Next the MTT assay was tested for reliability and robustness. A number of 
parameters such as operator and cell source variability were examined, in addition to, 
MTT incubation length, formazan dissolution time and stability at different 
temperatures.
3.5.I.I. MTT operator and cell source variability
Samples of hMSCs were tested by two different operators (myself -  JM -  and a 
student being supervised - LP) using similar or different cell sources. Since this assay 
was being developed for use in alginate beads, it was essential to determine whether 
HMSCs harvested directly from tissue flasks produced similar absorbance cell 
standard curves to cells immobilized in alginate.
As shown in Figure 48, similar absorbance results for two different operators (JM and 
LP) were produced for alginate beads after 1 day of incubation (red and black lines). 
In addition, similar results were obtained using two different cell sources - frozen 
working hMSC banks at similar passage level (P7 and P8) - when tested 
simultaneously using two different operators (JM and LP). Figure 48 (green and light 
blue lines) shows that the two different hMSC banks produced very similar 
absorbance standard curves, despite the high standard deviations on some of the 
individual data points. Similar results were also obtained for day 1 cells immobilized 
in either alginate-GRGDY or alginate beads (Figure 48, pink and dark blue lines), 
these were tested by same operator (JM). However, overall there seemed to be a large 
amount of variability among the 3 different assay/cell treatments.
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Figure 48. MTT variability using hMSCs from different cell sources and using 
different operators. HMSCs at PI 1 in alginate beads after 1 day incubation (red, 
black lines), hMSCs from P7 or P8 tissue flask cultures (green, light blue lines), 
hMSCs from P7 cultures in alginate or alginate-GRGDY beads after 1 day incubation 
(pink, dark blue lines). Absorbance read at 600nm.
The MTT assay has been shown to be sensitive to cell culture methods (Carrier,
1999). The first set o f alginate beads (red and black lines) was produced from 0.1% 
alginate (Manugel DMB) in water (pH 5.6) which was filtered through a series of 
filters (CUNO) including a carbon zeta plus, a zeta plus and then a 0.2 pm filter as 
described in section 2.3.1. The filtrate was lyophilized and then reconstituted to 1/10th 
o f its original volume to obtain 1% alginate in n-saline. The hMSCs were derived 
from the P8 cell bank at passage 11 (PI 1), were densely packed on day 11 of culture 
(refed on days 4 and 9). The hMSCs were immobilized into the alginate at 
5.6xl06cells/mL and analyzed on dayl. The second set of beads (pink and dark blue 
lines) was produced using 1% sterile alginate (Pronova SLG100) reconstituted in 
MES/NaCl buffer and 1% 27X alginate-GRGDY derivatized from Pronova SLG100. 
The hMSCs were derived from the P4 cell bank from S. Elliman at passage 7 (P7), 
were 90% confluent on day 3 o f culture. The hMSCs were immobilized into the 
alginate or alginate-GRGDY at 9.6xl06cells/mL and analyzed on day 1. These key 
differences in conditions are summarized in Table 16. Finally, the cells immobilized
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in alginate or alginate-GRGDY (pink and dark blue lines) were derived from the same 
cells as the P7 standard curve (green line). The only difference that produced this 
significant decrease in slope was due to the cells being immobilized in beads (alginate 
or alginate-GRGDY) for one day whereas the cells continued growing in tissue flasks 
for 1 further day before they were assayed on the same day.
Operator Cell source Alginate source HMSC culture 
condition
Alginate 
beads day 1
LP P8  cell bank at 
P l l ,  were 
densely packed 
on day 1 1  of 
culture (refed on 
days 4, 9).
From serial 
filtered (0 . 2  
pm) Manugel 
alginate
Immobilized into 
alginate at 
5.6x106 cells/mL 
and analyzed on 
dayl of 
incubation
Alginate 
beads day 1
JM
Alginate- 
GRGDY 
beads day 1
JM From P4 (S.E.) 
cell bank at P7 
on day 3 of 
culture
From sterile
Pronova
alginate
derivatized with 
27X GRGDY
Immobilized into 
alginate at 
9.6x106  cells/mL 
and analyzed on 
dayl of 
incubationAlginate- 
GRGDY 
beads day 1
JM From sterile
Pronova
alginate
P7 standard JM From P4 (S.E.) 
cell bank at P7 
on day 4 of 
culture
No alginate Cells trypsinized 
and tested 
immediately in 
MTT assay
P8  standard LP From P7 cell 
bank at P8
Table 16. Key differences among cell sources and culture differences in initial MTT 
experiments.
The variability from these different culture and alginate immobilization conditions 
was clearly evident from this early analysis. Several factors still needed to be 
investigated such as the MTT incubation length and formazan dissolution time. In 
addition, each set of these assays was conducted and analyzed on different days. This 
also will contribute to variability. Implementing a frozen storage step may help to 
improve consistency since time course samples would be analyzed at the same time.
3.5.1.2. Cell passage number
Initial data for different cell banks at similar passage level (P7 & P8 ) and culture 
conditions produced similar absorbance curves (Figure 48, green and light blue lines);
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however, different passage levels and/or culture conditions seemed to show a 
difference (Figure 48). It was also shown that hMSCs cultured in tissue flasks at 
different passage levels have significantly different growth rates (section 3.4.1, Table 
15); therefore, cells at different passage levels may have different mitochondrial 
dehydrogenase activity and produce different MTT results. Experiments performed to 
date have not been able to directly compared, especially using rigid control of assay 
parameters which will be discussed in the rest of this section. Therefore, the cell 
passage level should be studied as future work.
3.5.1.3. Length of incubation for MTT conversion
Ferrera (1993) found that tetrazolium reductase (TR) activity plateaued after 90 
minutes of incubation with MTT solution. However, Huveneers-Oorsprong (1997) 
found that TR activity did not have a maximum after 3 hours incubation in rat and pig 
hepatocytes. As part of assay development, it was necessary to determine whether a 
difference in MTT incubation length effected absorbance results for hMSCs. For this 
study, three plates were loaded with duplicate samples of a hMSC cell standard that 
was prepared as described in sections 2.6.2.1 and 2.6.2.4 and Table 5. The initial 
incubation time at 37°C with MTT solution was varied between 1, 2 and 3 hours in 
length. The final hour of incubation after addition of trisodium citrate was performed 
for each plate such that the total incubation length at 37°C was 2, 3 and 4 hours. The 
remaining steps including centrifugation, removal of supernatant, freezing of plates, 
and dissolution of formazan was performed according to sections 2.6.2.4 and 2.6.2.5 
without the addition of 10X trypsin/EDTA. In studies without alginate-GRGDY 
beads, addition of trypsin/EDTA tended to make the cells more aggregated and sticky 
due to the trypsin; therefore it was excluded from this study. Each plate was read on 
the spectrophotometer within 1 hour from isopropanol/HCl addition and again after 
ca. 20-25 minutes. The absorbance results for the subtracted data (read at 600nm and 
reference at 670nm) are shown in Figure 49. The assay appeared to be linear for cell 
densities per well less than 1 0 x l 0 4 cells/well.
-204-
MTT incubation length I formazan dissolution time
— ♦— 2 hr / 40  min 
-•-O' - 2  h r /66 min
— A—  4 hr / 59 min 
A- 4 h r /7 9 min
—• — 3 h r /49 min 
3 h r /7 2 min
3.0
2.5
2.0 .o
1.5
1.0
0.5
0.0
0 5 10 15 20 25 30 35
Cell density per well (x104)
Figure 49. Effect o f MTT incubation length (2, 3, 4 hours) and formazan dissolution 
time (minutes at 37°C) on absorbance readings for cell standard curves. The first 
reading was performed for formazan dissolution time <1 hour (closed symbols). The 
second reading was performed for formazan dissolution times >1 hour (open 
symbols). Incubation and dissolution occurred at 37°C. Absorbance readings 
appeared to become non-linear for cell densities greater than 10xl04cells/well. 
Absorbances read at 600nm and subtracted against reference at 670nm.
In order to determine whether the incubation length or formazan dissolution time 
produced different results, linear approximations were performed on the cell standard 
curves produced below 10xl04cells/well. The linear approximations for each data set 
are shown in Figure 50. The 4 hour MTT incubation length produced greater 
absorbance readings than both the 2 and 3 hour incubation lengths at the first 
formazan dissolution times (<1 hour). However, the second readings obtained at the 
second formazan dissolution time (>1 hour) were all significantly lower than the 
initial readings at all three incubation lengths (e.g. 2, 3, 4 hours). During this study, 
formazan dissolution occurred at room temperature (ca. 24°C).
A single factor ANOVA (analysis o f variance) was used to determine whether the 
differences in absorbances for the first reading were statistically different from the 
second reading. First o f all, the mean and variance o f the 2, 3 and 4 hour results for 
the first reading were analyzed (for absorbances at 8.6x104cells/well) and found to be 
statistically similar (p>0.05), see Appendices section 6.2.2.1, Table 20. The mean and
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variance of the second readings at the same cell density were also similar. Since the 
data at each reading were not statistically different, the data for each reading were 
pooled and the ANOVA was repeated to compare the pooled data obtained from first 
reading and the pooled data obtained from second reading. The difference of the 
pooled data at each reading was statistically significant (p<0.05). All statistics were 
performed at the 95% level o f significance. Therefore at this cell density, it appeared 
that the formazan dissolution time was a more critical parameter than the length of 
MTT incubation since the means o f the two readings were statistically different.
MTT incubation length / formazan dissolution time
♦  2hr/40min ■ 3hr/49min A4hr/59min
02 hr/66 min □ 3 hr/72 min A4 hr/79 min1.2
1.0 y = 0.1251x  
R2 ■ 0.9986 
y = 0.1102x  
R2 = 0.9974  
y = 0.109x
R2 = 0.9838
0.8
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€
I  0.4-Q<
y = 0.0935x 
R2 = 0.9804  
y = 0.0875x  
R2 = 0.9941 
y = 0.0863x 
R2 = 0.984
0.2
0.0
- 0.2
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Figure 50. Linear approximations o f the cell standard curves for different MTT 
incubation times (2, 3, 4 hours) and for different formazan dissolution lengths 
(minutes). Absorbances obtained from the first readings after 2, 3 and 4 hour 
incubation lengths (solid lines) were overall greater than second readings after 2, 3 
and 4 hour incubation lengths (dashed lines). Analysis o f the data at 8.6x104cells/well 
demonstrated that the mean o f the pooled first readings were statistically different 
from the pooled second readings (p<0.05). Absorbances read at 600nm and 
subtracted against reference at 670nm.
The single factor ANOVA was repeated for the data set at 4. lx l0 4cells/well. At this 
cell density, there was a statistical difference (p<0.05) between the mean and variance 
o f individual time points at both the first and second reading, so the data for each time 
point could not be pooled. This result meant that MTT incubation length did have an 
affect on the absorbance, with 2 hour incubation length showing significant
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differences between both the 3 and 4 hour incubation lengths for both the first or 
second dissolution reading. At this cell density only the 2 hour sample showed a 
difference between the first and second dissolution reading; the 3 and 4 hour samples 
did not have a statistical difference. The mean, variance and summary of p-values for 
these analyses are summarized in the Appendices section 6.2.2.1, Table 19 and 20. 
Further analyses for data at 2.1x104 and 1.2xl04  cells/well showed no statistical 
difference (p>0.05) among MTT incubation lengths and between pooled data between 
first and second dissolution times.
In summary, these statistical analyses demonstrated that for low cell densities (e.g. 
2.1xl04  and 1.2xl04 cells/well) the MTT incubation length and formazan dissolution 
time do not significantly affect the absorbance readings for the periods examined. 
However, at the higher cell densities (e.g. 8.6xl04  and 4.1xl04 cells/well); these 
parameters become more significant. Higher cell concentrations required more MTT 
to be reduced into formazan which may become diffusion or rate limited within the 2  
hour incubation length. This limitation was demonstrated by the statistically 
significant differences at 4.1xl04 cells/well between the 2 hour data and the 3 and 4 
hour data. At 8.6x104 cells/well, the data variance increased so similar comparison 
could not be made. However, the overall decrease in absorbance readings for all three 
incubation lengths at the second formazan dissolution time ( > 1  hour) was found to be 
more statistically significant. This may have been due to the increased cell 
concentration or the increased formazan concentration. Further analysis on the 
stability of dissolved formazan needed to be performed.
3.5.I.4. The effect of temperature on stability of 
formazan absorbance
Previous work indicated that absorbance readings decreased significantly between 
first readings (taken after <1 hour after addition of the isopropanol/HCl solution) and 
second readings (taken after >1 hour). A temperature controlled study was performed 
at three dissolution temperatures (6,19 and 37°C). HMSCs at P9 were trypsinized, 
centrifuged and resuspended at 7.8x105cells/mL in DPBSG. Six wells in each of 
three 96-well microplates were loaded with lOOpL of cell suspension. MTT solution 
was added and incubated at 37°C according to section 2.6.2.4. Following
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centrifugation and removal o f supernatant, the three plates were frozen at -70°C.
Upon thaw and addition o f DPBSG and isopropanol/HCl to each well according to 
section 2.6.2.5, one plate was incubated at each temperature (6, 19 and 37°C). The 
DPBSG and isopropanol/HCl added to the microplate incubated at 6°C were also 
chilled before addition to that plate. After 15-20 minutes, the wells were mixed with 
a micropipet to aid in the formazan dissolution and read on the spectrophotometer. 
After reading each plate was returned to its designated incubation temperature. After 
30 minutes, the wells were mixed again by micropipet, read and incubated.
Additional readings (with no mixing) were taken at 30 minute intervals out to ca. Vh 
hours. The plates were wrapped in film during incubation to reduce evaporation 
effects. The results are shown in Figure 51.
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Figure 51. Stability o f formazan absorbance at 6, 19 and 37°C. Each data point 
represents the mean and standard error o f 6 wells for each temperature. The cell 
concentration was 7.8xl04cells/well. Absorbance read at 600nm.
The formazan product did not appear to be dissolved completely at the initial reading 
(ca. 20 min.) at 6 and 19°C, hence a second mixing step was performed as indicated, 
and both absorbance levels increased at the second reading. Thereafter the 
absorbance readings at 6°C and 19°C appeared to be stable during the 2V* hours of 
incubation. A single factor ANOVA comparison o f the readings at 6°C showed there 
was a statistical difference in the absorbance readings out to 2 V2 hours when the first 
reading was excluded from the analysis (p=0.0263). In contrast, there was not a
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statistical difference in the 19°C absorbance readings, excluding the first reading since 
dissolution was not complete (p=0.4262). Overall there was a 23% decrease in 
absorbance reading after 2/4 hours at 37°C. ANOVA comparison confirmed a 
statistically significant difference among those absorbance readings at 37°C 
(p=0.0000). Overall the absorbances at 6 °C were ca. 22% lower than both 19 and 
37°C. This difference in absorbance may be due to a difference in formazan 
dissolution at the lower temperature or may be attributed to the temperature 
dependance on absorbance (Adams and Berman, 1981).
At the conclusion of the study, the final volume remaining in each well of the three 
treatment groups was measured. The average volume remaining per well was similar 
for all three conditions, therefore evaporation did not play a role in this study. 
Additionally all three plates were stored at 6 °C for ca. 27 hours and the plates were 
read to see if storage at 6 °C was feasible. All absorbances readings (Figure 52) 
obtained after this storage period including the plate originally tested at 6 °C were 
lower than previous values (6 °C plate, p=0.0005). Therefore longer term storage of 
plates even at 6 °C is not possible without having a decrease in absorbance readings.
In a separate study, dissolved formazan samples were frozen at -70°C immediately 
after reading, and later thawed and read. These samples also showed a decrease of 31 
+/- 5% in absorbance readings after freezing (data not shown).
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Figure 52. Temperature stability o f  formazan absorbance after temperature study at 6, 
19 and 37°C. All plates held for 27 hours at 6°C then read. ANOVA comparison 
showed that all samples had a statistically significant decrease in absorbance levels 
during this storage. Therefore long term storage at 6°C was associated with decreased 
absorbance readings. Absorbance read at 600nm.
Wan (1994) reported on the stability o f dissolved formazan solution in isopropanol at 
room temperature (temperature not specified) and at 4°C. They found the absorbance 
decreased by approximately 10% of the original reading during the one hour time 
period that the samples were held at room temperature. Whereas the samples held at 
4°C did not vary significantly during the one hour period. Their results also showed 
the initial absorbance reading at 4°C was 21% lower than the absorbance reading at 
room temperature. Previous findings during this research project did show that 
formazan absorbance levels decreased at 24°C between the first and second reading 
(section 3.5.1.3, Figure 50). However, the results o f this temperature controlled 
study, showed the absorbance readings at 19°C and 37°C at the second time point (ca. 
45 minutes) and the 19°C at the third time point (ca. 70 minutes) were very 
comparable (p=0.4492). Therefore the recommended protocol (as outlined in section 
2.6.2.5) was to perform the isopropanol/HCl dissolution at room temperature, mix the 
samples after 20 and 40 minutes, and then read the plate immediately after the second
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mixing (within 1 hour of start of dissolution). Additional stability studies of 
absorbance readings were conducted with hMSCs in alginate-GRGDY beads, these 
results are discussed in section 3.5.3 and presented in Figure 56.
3.5.I.5. Fresh versus frozen MTT assay
Formazan absorbance readings were compared for fresh versus frozen sample 
preparations of hMSCs in alginate-GRGDY beads over a 6  day time course. HMSCs 
at P7 were trypsinized, centrifuged and resuspended at lx l0 7cells/mL in 27X 
alginate-GRGDY (Pronova SLG100) and cultured in MSCCM. At each time point, 
2, 4 and 6  days, a duplicate cell standard of beads was prepared for the MTT assay as 
described in sections 2.6.2.2, 2.6.2.4 and 2.6.2.5. One set of samples was processed 
fresh through all the steps of the MTT assay. The other set was frozen after 
centrifugation and removal of supernatant, and then thawed on a subsequent day for 
dissolution using isopropanol/HCl. Due to these conditions, the fresh samples were 
processed and read on three separate days and the frozen samples were started (MTT 
conversion to formazan) on the same days as the fresh, but completed and read on a 
separate day as a group.
Absorbance values were very similar between the fresh and frozen samples for 1 
bead/well for all three time points (Figure 53). A single factor ANOVA comparison 
indicated that only the day 6  fresh sample was statistically different from the other 
five samples for 1 bead/well (*, p<0.05). The variability of the absorbance readings 
was much greater for 2 beads/well; however no general trend was noted. The data for 
3 beads/well corresponded to a cell density greater than 10xl04 cells/well and was 
disregarded as it was outside the linear range of the assay. A summary of the mean, 
standard error (SEM), variance and statistical comparison (p-value) for the study is 
provided in the Appendices, section 6.2.2.2, Table 21.
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Figure 53. Comparison of MTT assay results using fresh versus frozen samples 
containing hMSCs in 27X alginate-GRGDY beads (Pronova SLG100) at 
lx l0 7cells/mL. The bar graph shows the variability of absorbance corresponding to 
the number of beads per well for the fresh versus frozen protocol performed on day 2 , 
4 and 6 . The data from 1 bead/well showed no differences in absorbance, except for 
the day 6  fresh sample (*, p<0.05). The data for 2 beads/well was significantly more 
variable; however no trend could be observed. The data for 3 beads (>10xl04  
cells/well) was discounted because it was above the linear range for the assay. 
Absorbance read at 600nm.
These preliminary data also showed that the absorbance readings did not increase 
during the six day study, thus this would suggest that the cell number per bead 
remained constant over the 6  days. This conclusion was substantiated by concurrent 
analysis performed by dissolving a representative bead at each time point and 
performing a cell count using a hemacytometer. Using this method, the cell density 
was found to remain constant (5.05 +/- 0.11 xl0 4cells/bead) during the 6  days. The 
cell viability was 85% and 8 6 % on day 2 and day 4, respectively; but dropped to 73% 
on day 6  (data not shown).
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3.5.2. Using MTT assay to monitor hMSC proliferation in
alginate and alginate-GRGDY beads
For this experiment, the MTT assay was used to determine whether there was cell 
growth in alginate-GRGDY beads over a time course. In addition, simultaneous 
measurements were made for glucose consumption and cell number and viability 
using hemacytometer and trypan blue dye exclusion assay.
Two sets of hMSC/alginate beads were made using the methods described in section 
2.4.4 from hMSCs at P7 which were resuspended at lx l0 7 cells/mL in MSCCM. 
Alginate beads were made with 40% v/v cells in MSCCM and 60% v/v sterile 
alginate (Pronova SLG100) reconstituted in 0.1 M MES, 0.3M NaCl buffer pH 6.5. 
Alginate-GRGDY was made using derivatized 27X Pronova SLG100 alginate 
according to the ‘sterile process’ method outlined in section 2.3.3, but prior to 
implementation of every sterilization step. Three beads were placed into each well of 
a low-binding 24 well microplate (Coming) containing lmL of MSCCM. These 
plates were used so that any cells detached from the alginate beads would not attach 
and grow on the bottom of the microplate; thereby increasing the glucose 
consumption or lactate production. Time points were performed on day 1, 3, 5, 7.
The spent medium volume was measured from each well to measure any loss due to 
evaporation. An aliquot was frozen for subsequent metabolite analysis using the YSI 
2700 Select Biochemistry Analyser as described in section 2.5.6. Beads were 
removed for the MTT assay and assayed as fresh samples as described in section 
2.6.2.2, 2.6.2.4 and 2.6.2.5, except trypsin/EDTA was not yet being utilized to 
dissociate the beads during the MTT assay. The cell concentration and viability of the 
beads were determined using a hemacytometer and trypan blue dye as described in 
section 2.6.2.3. Figure 54 shows the MTT absorbances for the time course performed 
on the alginate and alginate-GRGDY beads as measured for 1 bead/well and 2 
beads/well. Data for 3 beads/well was discounted because the results were highly 
variable and above the linear range of the assay.
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B e c a u s e  r e p l ic a te  w e l l s  w e r e  n o t  p r e p a r e d  f o r  e a c h  c o n d it io n  ( d u e  t o  r e s t r ic t io n  in  
b e a d  n u m b e r s ) ,  t h e  d a ta  w e r e  n o t  s t a t i s t ic a l ly  a n a ly z e d . F o r  t h e  a lg in a te  b e a d  
c o n d it io n ,  t h e  c e l l s  d i s s o c ia t e d  h o m o g e n e o u s ly  f r o m  th e  a lg in a t e  b e c a u s e  th e r e  w a s  
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in t e r a c t io n  ( e lo n g a t io n  a n d  n e t w o r k in g )  w ith in  t h e  a lg in a t e - G R G D Y  b e a d . O n  d a y  7  
th e  a lg in a t e - G R G D Y  b e a d s  d i s s o lv e d  m o r e  c o n s i s t e n t ly  th a n  d a y  3 a n d  5 . T h is  
c h a n g e  m a y  h a v e  b e e n  th e  r e s u lt  o f  a n  in c r e a s e  in  c o n ta m in a t io n  le v e l  d u r in g  th e  
c o u r s e  o f  in c u b a t io n . S o m e  o f  t h e  a lg in a t e - G R G D Y  b e a d s  w e r e  d is c o lo r e d  a t th e
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later time points; although discolored beads were not used in the assay. This 
discoloration issue is discussed further in section 3 .4 .4 .
Overall, although the data were variable, there was no significant change or possibly a 
slight decrease in absorbance over the 7 days (using the 1 bead/well data) which 
indicated that no cell proliferation occurred in the beads. However, the absorbance 
readings were similar whether the hMSCs were seeded in alginate or in alginate- 
GRGDY beads which indicates the hMSCs have similar metabolic (tetrazolium 
reductase) activity whether immobilized in alginate-GRGDY or in underivatized 
alginate beads. Variability in absorbance readings could also be attributed to bead 
heterogeneity.
Concurrently the total number of cells/bead was determined using a hemacytometer as 
per section 2.6.2.3. The total number of cells/bead decreased by ca. 25% over the 7 
day period in both bead conditions (Figure 55.a), this may have been due to cell lysis 
and the loss of cells during the dissolution of the beads with trisodium citrate and 
trypsin/EDTA using a micropipet. Disrupting the beads into a single cell suspension 
subjected the cells to high shear stresses during multiple, vigorous pipetting. 
Additionally the contamination causing discoloration of the beads may have also 
contributed to cell death. The fraction of cells viable was similar in both conditions 
and was ca. 85-90% on day 1 and ca. 79-85% on day 7.
The glucose consumption was plotted (Figure 55.b) and determined to be the similar 
in both the alginate and alginate-GRGDY beads. The slope of the lines used for the 
linear approximation of the glucose consumption was used along with the number of 
cells obtained from hemacytometer counts and the culture volume to obtain the 
specific GCR on a per cell basis. If a constant cell concentration was assumed 
(6 .2 x 1 0 4 cells/bead) over the culture period and each well contained three beads and 
2mL of MSCCM, the GCR was calculated to be 4.33x1 O’ 1 ^ cell/hr. The volume of 
each well was measured during the 7 days to adjust losses due to evaporation.
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Figure 55. HMSCs in alginate or 27X alginate-GRGDY beads (Pronova SLG100), 
corresponding results for (a) total number of cells and fraction viable, and (b) glucose 
consumption. The cell number and viability decreased during the experiment, 
possibly due to cell lysis during evaluation. The GCR was similar for both 
conditions.
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The main conclusion from this experiment was that a step for dissolution of the 
alginate-GRGDY beads using trypsin/EDTA needed to be introduced to improve 
resuspension of the cells into a homogeneous suspension. A concentrated trypsin 
solution was needed due to the micro-scale volumes needed for a 96 well microplate 
assay. In addition, the buffer solution could not contain phenol red due to interference 
with absorption values. This eliminated the 0.25% trypsin/0.2% EDTA that was 
already being used for cell trypsinization and counting of cells in beads. Therefore, 
10X trypsin/EDTA in saline solution (5g trypsin, 2g EDTA 4Na/L in 0.9% NaCl, 
Sigma T4174) was selected and tested for these reasons.
3.5.3. Addition of 10X trypsin/EDTA in saline to improve
bead dissolution
This section describes the experiments implementing the use of 10X trypsin/EDTA in 
saline to aid in complete resuspension of the cells from alginate-GRGDY beads. For 
further clarification, the MTT assay steps referenced in this section are those listed in 
the Appendices, section 6 .1.1.2.
In the first set of experiments, 20pL of 10X trypsin/EDTA in saline was added to 
each microwell at the same time (e.g. step 5) as the trisodium citrate after 1 hour 
incubation with MTT solution. Then after a total of 2 hours of MTT incubation, the 
beads were resuspended with a micropipet to break up the cell aggregates. However, 
the cells were very sticky after addition of 10X trypsin/EDTA in saline and many 
adhered to the inside of the pipet tip. In addition, the cells would not pellet after 
centrifugation at lOOg, nor at a higher force (160g). As a result it was concluded that 
trypsin/EDTA did not help resuspend the cells into a single cell suspension when 
introduced at this step in the MTT assay protocol. The results of this experiment are 
discussed further in section 3.5.4.
In the next experiment, 0-20pL of 10X trypsin/EDTA in saline was added to the 12X 
alginate-GRGDY (Pronova SLG100) beads after the beads had been frozen, thawed 
and DPBSG had been added (e.g. step 10). The absorbance results are presented in 
Figure 56. The dashed line represents the control condition in which no 10X 
trypsin/EDTA in saline was added. As observed during the dissolution of these beads
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and as shown by the lower overall absorbance readings, this condition was not 
adequate to homogenize the cell suspension. The remaining solid lines represent the 
conditions containing 10-20pL o f 10X trypsin/EDTA in saline. All o f these 
conditions greatly improved the homogeneity o f the suspension such that the 
formazan crystals were completely dissolved. This study also incorporated additional 
absorbance readings to confirm previous results on the stability o f the formazan 
absorbance. This study confirmed that the addition o f 10X trypsin/EDTA in saline 
did not adversely affect the stability o f the absorbance readings over a 2 hour time 
course with the plates stored at 19°C. A single factor ANOVA comparison indicated 
that there was no statistical change in each individual sample over the 2 hour 
dissolution time. There was a statistically significant difference between the 
absorbance readings for the sample with no trypsin/EDTA treatment and the samples 
containing trypsin/EDTA for each time point. A summary o f the comparison is 
provided in the Appendices, section 6.2.23.  In addition this plate was held at 6°C for 
27 hours after the study and then read on the spectrophotometer. All absorbance 
readings dropped significantly during the storage at 6°C (data not shown). Storage of 
the dissolved formazan samples for greater than 2 hours is not recommended.
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Figure 56. Addition o f 10X trypsin/EDTA in saline to 12X alginate-GRGDY 
(Pronova SLG100) beads to aid in dissolution o f beads during MTT assay. The blue 
line was the control condition in which no trypsin/EDTA was added. These 
absorbances were overall lower than the conditions using trypsin/EDTA. Additional 
readings were taken during the dissolution to examine the stability o f the absorbance 
readings at 19°C. All samples were found to be stable during the 2 hours. 
Absorbance read at 600nm.
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In summary, a reliable dissolution step for alginate-GRGDY beads was incorporated 
into the MTT assay using 10X trypsin/EDTA in saline. These cells had been in 
culture in the alginate-GRGDY beads for 17 days prior to the experiment. In 
addition, the trypsin/EDTA was determined to have no affect on the stability of the 
formazan absorbance readings during a 2 hour dissolution study at 19°C.
3.5.4. Comparison of MTT absorbances for cell standards
produced from tissue flasks and alginate beads
This experiment was conducted to determine whether cells immobilized in alginate- 
GRGDY beads (on day 0) at two different concentrations produced the same 
absorbance readings as a cell standard dilution performed from the same cells 
harvested from tissue flasks but never immobilized in alginate. It had already been 
seen that beads from a time course can produce different cell standard curves (section 
3.5.1.1). Due to the differences in metabolic activity between cells in tissue flasks 
and cells immobilized in alginate beads, it may be more suitable to determine a cell 
standard from cells immobilized in alginate beads rather than trypsinized cells from 
tissue flasks at later time points. However their equivalence must first be 
demonstrated on the day of immobilization.
HMSCs were harvested from tissue flasks and centrifuged twice to remove residual 
trypsin/EDTA. The pellet was resuspended with MSCCM to supply an aliquot of 
cells to make beads at lx l0 7cell/mL; then the remaining cell suspension was 
resuspended further with MSCCM to supply an aliquot of cells to make beads at 
5xl06cell/mL. Finally the remaining cell suspension was further diluted with DPBSG 
to 2xl06 cell/mL to provide a cell suspension for a cell standard dilution as shown in 
section 2.6.2.1, Table 5. The beads at lx l0 7 and 5xl06  were made according to the 
standard procedure (section 2.4.4) and then tested immediately in the MTT assay 
(section 2.6.2.2 and 2.6.2.4) alongside the cell standard dilutions made from the cell 
suspension at 2xl06 cells/mL. After MTT incubation, 20}iL of 10X trypsin/EDTA in 
saline was added to each microwell at the same time (at step 5, Appendices, section 
6 .1.1.1 and section 6 .1.1.2) as the trisodium citrate after 1 hour incubation with MTT 
solution to aid in homogenating the cells. Then after a total of 2 hours of MTT
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incubation, the beads were resuspended with a micropipet to break up the cell 
aggregates. However, the cells were very sticky after addition o f 10X trypsin/EDTA 
in saline and many adhered to the inside o f the pipet tip. In addition, the cells would 
not pellet after centrifugation at lOOg, nor at a higher force (160g). Therefore the 
addition o f trypsin/EDTA did not aid in resuspension of the cells when introduced at 
this step.
Despite these difficulties, the assay was continued and the plates were frozen. 
Thereafter the plates were thawed, the formazan was dissolved and then the plates 
were read (section 2.6.2.5). Again these data were highly variable at cell densities 
greater than 7.5xl04cells/well, probably due to the stickiness o f the cells. If data 
above this concentration were eliminated from analyses, then the linear 
approximations produced very similar results. As can be seen in Figure 57, cells 
immobilized into 9X alginate-GRGDY (Pronova SLG100) beads at two densities, 
lx l0 7 and 5xl06cells/mL, produced the same standard curve when plotted against the 
number of cells/well; however these data were only generated from 1 data point and 2 
data points respectfully. The cell standard curve was generated from 4 data points.
2.000 ♦ Day 0, 5 e6  b ead s -  Day 0, 1e7 beads * Day 0, Cell Std.
1.800
1.600
1.400
y = 0.0978X  +  0 .0473  
R2 = 0 .9976
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1.000
0.800
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y = 0.0918 x + 0.0367
R2 = 1
y = 0.0879X + 0.0394
R2 = 0.9998
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0.200
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Figure 57. MTT absorbance for freshly harvested cells compared to same cells 
immediately after immobilization into 9X alginate-GRGDY (Pronova SLG100) 
beads. Linear curves were estimated from absorbance data below 7.5xl04cells/well, 
since the data above these points were non-linear. The cells immobilized at 
5xl06cells/mL (blue line) and lx l0 7cells/mL (pink line) in alginate-GRGDY 
produced the same cell standard curve as the original cells (green line). Absorbance 
read at 600nm.
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These results confirmed that similar MTT absorbance standard curves are produced 
using a dilution series of hMSCs immediately after immobilization into alginate- 
GRGDY beads at two different concentrations and a standard curve produced from a 
cell dilution series from the original cell suspension.
3.5.5. Use of the MTT assay to monitor proliferation of
hMSCs in alginate-GRGDY beads, microwells and 
tissue flasks
A final experiment was performed to evaluate cell proliferation in various tissue 
culture plastic (TCP) as compared to alginate-GRGDY beads. HMSCs at P7 were 
trypsinized, centrifuged and immobilized into alginate-GRGDY beads at 
2x10 cells/mL according to the standard manual protocol. The exact number of cells 
per bead and viability was determined after dissolution of the bead with trisodium 
citrate and trypsin/EDTA using a hemacytometer and trypan blue dye as described in 
section 2.6.2.3. This same number of cells (9.8x104) was also seeded into the 
following TCP (all from Coming), each with 2mL of MSCCM:
1) 24-well microplate, cell culture-treated (1.8cm2 growth area, 5.4x104 cells/cm2);
2) 24-well microplate, low binding (1.8cm2 growth area, 5.4x104 cells/cm2);
3) T25 tissue culture flask (25cm2 growth area, 3.9x103cells/cm2).
The hMSC beads containing 2xl0 7cells/mL in 12X alginate-GRGDY (Pronova 
SLG100) were transferred into a 24-well low binding microplate (1 bead/well) with 2 
mL of MSCCM. The low binding plates were used so that any cells detached from 
the alginate-GRGDY beads would not attach and grow on the bottom of the 
microplate; thereby increasing the glucose consumption. The spent medium volume 
was measured from each vessel to measure any loss due to evaporation. An aliquot 
was frozen for subsequent metabolite analysis using the YSI 2700 Select 
Biochemistry Analyser as described in section 2.5.6. Beads were removed for the 
MTT assay as described in section 2.6.2.2, 2.6.2.4 and 2.6.2.5; 10X trypsin/EDTA in 
saline was utilized to help dissolve the beads after the plates were thawed at step 1 0 , 
Appendices, section 6 .1.1.2. HMSCs from one T25 flask were trypsinized, 
centrifuged and resuspended in ca. 325pL DPBSG. HMSCs from the low binding 
plates were removed with the spent medium, centrifuged and resuspended in ca.
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325pL DPBSG. Then lOOpL of each cell suspension was added to a 96 well plate 
then lOpL of MTT solution was added and the normal protocol was performed.
These results were multiplied by a factor of 3.25 (lOOpL of 325pL cells used in MTT 
assay) and compared to the absorbance results obtained from one alginate-GRGDY 
bead. The hMSCs from the cell culture treated microwell plates were tested by the 
cell adherent MTT assay method outlined in section 2.62.1. These results were 
multiplied by a factor of 3.0 (3 times volume of DPBSG and isopropanol/HCl are 
added to a 24 well microplate compared to the 96 well microplate) to compare to the 
absorbance results obtained from one alginate-GRGDY bead.
Figure 58 shows the MTT absorbances for the 10 day time course performed on 
hMSCs under the 4 conditions (T25 flask, alginate-GRGDY bead, microwell-low 
binding plate and microwell-cell culture treated) which all were seeded on day 0  at 
9.8x104cells/vessel. Only the hMSCs cultured in the T25 flask exhibited cell growth 
as indicated by the 230% increase in absorbance readings. The other culture 
conditions resulted in either no significant change in absorbance readings (microwell- 
treated) or a decrease in absorbance (microwell-low and alginate-GRGDY beads) 
over the 10 day period. The absorbance reading of the hMSCs in the alginate- 
GRGDY beads decreased by ca. 33% over the 10 days. An additional absorbance 
data point was collected at day 15 for the alginate-GRGDY beads which continued 
this downward trend (Abs6 oonm = 0.47±0.01).
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Figure 58. Use of MTT assay to monitor cell proliferation in T25 tissue flasks, 12X 
alginate-GRGDY (Pronova SLG100) beads, low binding microwells and cell culture 
treated microwells. All four conditions were seeded at 9.8xl04 cells/vessel. Only the 
cells in the T25 flasks exhibited an increase in absorbance readings over the 10 days. 
The cells in the alginate-GRGDY beads showed a 33% decrease in absorbance. 
Absorbance read at 600nm.
These results can be explained by the characteristics of the four different culture 
vessels/types. The T25 flasks were the only condition in which the cells were not 
space-constrained when seeded at 3.9xl03cells/cm2. Therefore the cells were able to 
grow during the 10 day incubation. In contrast, the cells in the 24-well cell culture 
treated microplate were seeded at 5.4x104cells/cm2, which resulted in densely packed 
conditions after the cells attached to the growth surface. Thus, the hMSCs would 
have minimal space for growth, would become contact-inhibited and growth arrested 
(Batt and Roberts, 1998). The cells in the 24-well low binding microplate were 
seeded at a high density o f 5.4x104cells/cm2, but the plate treatment inhibited the 
attachment o f the cells to the surface. Therefore, most o f the cells aggregated into 
large clusters. These conclusions were all confirmed by phase contrast microscopy. 
Finally the cells seeded in the alginate-GRGDY beads at 2x10 cells/mL were also 
very tightly packed. After the cells elongated within the alginate forming a dense
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network, nutrient mass transfer would become restricted which may have resulted in 
the steady reduction in absorbance readings. However, the lack of proliferation in 
alginate-GRGDY beads was also observed at lower seeding densities, such as 
lx l0 7cells/mL (Figures 53 and 54) and 2x l06cells/mL (data not shown).
Concurrently the cell concentration and viability were confirmed by hemacytometer 
and trypan blue dye as described in section 2.6.2.3. The total number o f cells in the 
T25 flasks increased from lxlO 5 to 2 .7xl05cells/flask in the first 4 days o f the 
experiment as shown in Figure 59. Conversely there was no increase in number of 
cells in the alginate-GRGDY beads from the original concentration of 
lx l0 5cells/bead. The actual cell number in the micro wells was not measured by 
hemacytometer. Cell viability in the alginate-GRGDY beads was found to be greater 
than 80% for the 15 day period versus the >90% viability o f the cells in the T25 
flasks.
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Figure 59. Total number o f  cells and fraction viable in T25 flask and 12X alginate- 
GRGDY (Pronova SLG100) beads over a 15 day time course. Cultures were seeded 
at ca. 9.8xl04 cells per flask and per bead which is equivalent to seeding density 
achieved for 2x l07cell/mL in the beads. The total number of hMSCs in the T25 flasks 
increased, whereas the total number in the alginate-GRGDY beads remained 
relatively constant during the experiment.
- 2 2 4 -
The GCR was highest for the hMSCs in the T25 flasks due to the increase in cell 
number per flask (Figure 60). The GCR for hMSCs in alginate-GRGDY beads was 
lower than both the cells grown in T25 flasks and microwell cultures. The cells in the 
microwells with no adhesion surface had the lowest rate. The baseline degradation 
rate o f glucose in the culture medium with no cells was also measured.
The slope o f the linear approximations o f the glucose consumption, the
hemacytometer count and the culture volume were used to obtain the specific GCR on
a per cell basis. The GCR of hMSCs seeded at 2x l07cells/mL in the alginate-
GRGDY beads with 1 bead/well was 7 .1x l0 'n g/cell/hr as compared to 9.5x10'
1 ^ c e ll/h r  in the T25 flasks during exponential growth (first four days) and 6.5x10'
llg/cell/hr in the T25 flasks during stationary growth (days 4-10). These rates were
also comparable to the GCR of 4.3x10'* ^ c e ll /h r  from hMSCs seeded at
lx l0 7cells/mL in the alginate and alginate-GRGDY beads (section 3.5.2).
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Figure 60. GCR of hMSCs seeded at 9.8xl04cells in TCP (T25 flasks, microwells 
treated for cell culture and microwells with low binding surface) and 12X alginate- 
GRGDY (Pronova SLG100) beads over a 15 day time course. The T25 flasks had the 
highest GCR due to the increase in number o f cells/flask. The hMSCs in alginate- 
GRGDY appeared to have a lower GCR; however, when calculated on a per cell basis 
the GCR o f7 .1 x l0 'n g/cell/hr was similar to 6.5xl0‘n g/cell/hr for stationary growth 
in T25 flasks.
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3.5.6. Comparison of cell number derived from MTT
absorbance readings and from hemacytometer
In addition to the results previously described in section 3.5.5, the linearity o f the 
MTT assay was confirmed by using a series o f cell standard curves created from the 
individual cell suspensions from the 10 day time course experiment using T25 flasks. 
The absorbance readings were plotted according to the volume o f cells/well used for 
the MTT assay (e.g. 0, 25, 50, 75 and lOOpL). Figure 61 shows the data for the 10 
day time course that the cells were trypsinized and assayed.
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Figure 61. A series o f cell standard curves created from a time course o f T25 flasks 
seeded at 3.9xl03cells/cm2 and plotted according to the volume of cells/well used in 
the MTT assay. The resulting cell standard curves showed that the absorbance 
readings were linear with increase in volume of cell suspension per well. In addition, 
the absorbance readings increased between day 0 and day 10 indicating cell 
proliferation. Absorbance read at 600nm, background o f media blank subtracted.
The same cell standard curves for the T25 flasks were plotted by their corresponding 
cell number/well as was measured simultaneously by hemacytometer count (Figure 
62). All o f the cell standard curves, except from day 10, align very closely to the day 
0 standard curve and each other, indicating that the absorbance readings correlated 
very closely to cell number. The day 10 cell count obtained by hemacytometer was
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lower than expected (see Figure 59). This was due to cell aggregation which 
commonly occurs when flasks are trypsinized after a long time in culture or after the 
cells reach a high density (Lombarts, 1992). Aggregation would have most likely 
caused the actual cell density to be underestimated. This would result in a cell 
standard curve with a greater slope (higher corresponding absorbance readings). If  a 
higher cell density was substituted for the day 10 absorbance readings (e.g. those 
obtained for day 4 or day 7), the data line would shift closer to the other standard 
curves. This decrease in hemacytometer count was also observed for long term 
cultures with rat smooth muscle cells when comparing the CyQuant fluorescence 
results to the actual hemacytometer counts (see section 2.6, data not shown).
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Figure 62. T25 flask absorbance readings corrected for actual cell count obtained by 
hemacytometer. The actual cell density obtained by hemacytometer on day 10 was 
much lower than expected due to cell aggregation (see Figure 59). Therefore, higher 
corresponding absorbance readings were produced (T25 Day 10). The remaining cell 
standard curves from days 2, 4 and 7 all closely align to the day 0 data. Absorbance 
read at 600nm, background o f media blank subtracted.
The MTT absorbance readings obtained for hMSCs immobilized in 12X alginate- 
GRGDY (Pronova SLG100) beads were also plotted against the actual cell number 
obtained by hemacytometer (Figure 63). The cell standard curves generated from day
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0, 2, 4 and 7 bead samples conformed well to the initial (day 0) cell standard curve 
which did not contain alginate. The actual cell concentration of the day 10 bead was 
slightly higher than expected (Figure 59); therefore the corresponding absorbances 
caused the standard curve from day 10 to shift considerably below the other standard 
curves. Due to the large size o f the beads made by the manual method (ca. 2mm 
diameter) and the high cell concentration used (2x l07cells/mL), all o f the bead 
standard curves (day 0, 2, 4, 6, and 10) were based upon absorbance readings from 
only 1 bead. Data above 10xl04cells/well was excluded from analysis because these 
data were above the linear range o f the assay.
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Figure 63. MTT absorbance for 12X alginate-GRGDY (Pronova SLG100) beads 
plotted versus actual number o f cells/well. All data above 10xl04cells/well were 
excluded from analysis due to the non-linearity o f the assay above this concentration. 
Most o f the data, except the day 10 sample, conformed well to the day 0 cell standard 
curve which did not contain alginate. Absorbance read at 600nm, background of 
media blank subtracted.
Overall, the consistency o f the results would be improved if more data points could be 
generated. This would be possible using smaller diameter beads or a lower cell 
concentration per bead to obtain more data points within the linear range o f the assay. 
Previous cell standard data obtained from alginate-GRGDY beads made at
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6 75x10 cells/mL and 1x10 cells/mL showed good conformity to the cell standard curve 
on day 0 (Figure 57). However this previous experiment used 10X trypsin/EDTA in 
saline to improve the dissolution of the beads at the trisodium citrate addition step, so 
good linearity could not be achieved above 7.5x104 cells/well.
3.5.7. Summary
A modified MTT assay was produced to analyze a time course of hMSCs 
immobilized in alginate and alginate-GRGDY beads. A frozen storage step was 
introduced mid-way through the assay after the MTT was converted into the formazan 
product by mitochondrial dehydrogenase. The frozen storage step was deemed 
necessary to include due to the lengthy assay protocol and to reduce assay variability 
that may be associated with analyzing and reading samples on separate days. Samples 
prepared using the frozen assay were proven to be equivalent to the fresh assay using 
absorbance data from 1 bead/well (section 3.5.1.5, Figure 53). The length of MTT 
incubation at 37°C to allow complete conversion at high cell concentrations was 
determined to be 4 hours (Figure 50). The stability of the formazan absorbance 
readings was measured at 6 , 19 and 37°C (Figure 51). The dissolved formazan 
product was shown to be stable at 19°C for 2 Vi hours; compared to a 23% decrease in 
absorbance readings at 37°C. The stability of the formazan absorbance readings were 
also re-confirmed out to 2 hours at 19°C after using 10X trypsin/EDTA in saline to 
help dissociate the alginate-GRGDY beads (Figure 56). Dissolved formazan samples 
that were stored at 6 °C for 27 hours, or frozen and re-thawed showed a decrease in 
absorbance readings. All of the absorbance data were read at 600nm on a microwell 
plate spectrophotometer. A full wavelength spectrograph was found to produce 
similar readings at 600nm as compared to the peak absorbance at 560nm (Figure 47). 
Additional improvement in the data may be possible using the dual wavelength 
measurements by subtracting the absorbance at the reference wavelength of 670nm. 
Dual readings account for increased light scattering cause by turbidity in the sample 
which may slightly skew absorbance readings obtained from just the single 
wavelength (e.g. 600nm) (Harris, 1996).
-229-
A number of factors were determined to potentially affect the results of the MTT 
assay. These factors are listed below with the method or condition used to minimize 
the variability:
1. Length of incubation to permit MTT conversion to formazan -  optimized to 4 
hours for high cell concentrations.
2. Dissolution of the formazan product, including release from cells -  used a 
freeze step to lyse cell membrane, and isopropyl alcohol was added to dissolve the 
formazan product for ca. 40 minutes - 1 hour
3. Dissolution of alginate -  trisodium citrate was added to reverse cross linking 
of the alginate hydrogel
4. Dispersion of formazan/hMSCs in alginate-GRGDY beads -  1 OX 
trypsin/EDTA in saline was added and multiple pipetting steps were used to 
disperse the cells
5. Stability of the formazan absorbance readings -  performed dissolution at room 
temperature and read plate within 1 hour after isopropanol/HCl added.
6 . Residual excipients (e.g. alginate) -  the supernatant was removed prior to 
freezing
7. Volume variability per well -  the supernatant was removed until an ‘o ring’ 
appeared on bottom of well.
8 . Loss of material in pipet tips clinging to inside wall -  no pipetting was 
performed prior to freezing, mixing was performed after isopropanol addition.
9. Phenol red (pH indicator) contained in the culture medium -  samples were 
dissolved with isopropanol containing 0.1N HC1, the HC1 ensured an acidic pH 
causing the phenol red indicator to be yellow versus orange/red in neutral or basic 
pH which would interfere with absorbance readings.
Wan (1994) investigated the reproducibility of the MTT assay within the same plate, 
between plates and between different culture vessels. They found that the 
reproducibility of the assay was not satisfactory for any of these conditions. That is, 
the data obtained for these conditions were statistically different, when the results 
were expected to be the same. They determined that the cell number variability was 
the most significant factor influencing the reproducibility of the MTT assay. So it 
was essential that the cell suspension was homogeneously mixed before seeding the 
microplate to minimize the variation in cell number. In addition they also looked at
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non-random and random sampling across the microplate. Statistically significant 
differences were measured when a sample was measured by order, left to right across 
the plate. However, random sampling eliminated this difference. For the purpose of 
this MTT assay application (e.g. use as a cell number titration which requires using a 
serial dilution scheme) random sampling was not possible. However if the assay was 
used as a screening or toxicity test; random sampling could be utilized for evaluation 
of a biomaterial or the effect of a drug.
Randomized sampling was used to improve the reliability of these MTT results by 
randomizing the bead selection for analysis. In addition more replicates could be 
performed at each time point, depending upon availability of material. However the 
most important factor for generating reproducible results was the complete dissolution 
of formazan product which required 30 minutes of exposure to 10X trypsin/EDTA 
addition for cells in alginate-GRGDY beads and multiple pipetting during the 
isopropanol/HCl dissolution. Ferrara (1993) also found that one hour was sufficient 
to dissolve the formazan using DMSO; however some formazan was trapped in the 
compact tissue section that did not dissolve properly unless the sample was shaken 
vigorously to release the formazan during dissolution. If complete, homogeneous 
release of formazan was not achieved a linear relationship between tetrazolium 
reductase (TR) activity and cell viability could not be ascertained. Huveners- 
Oorspong (1997) found that the formazan crystals dissolved completely using both 
DMSO and isopropanol. DMSO gave higher absorbance readings; however, the 
coefficient of variation (CV) was higher using DMSO than isopropanol, and 
sometimes there was a color shift in some of the wells. In addition, the evaporation 
rate of isopropanol was overcome by chilling the plates to 4°C after removal of 
medium and adding ice-cold isopropanol to the wells. In these studies plastic film 
was used to reduce evaporation, however when the plates were dissolved at room 
temperature and read immediately (within 1 hour), minimal evaporation was noted. 
When the formazan was dissolved at 6 °C, the absorbance readings were lower than 
expected, most likely due to incomplete dissolution; therefore 19°C (room 
temperature) was the chosen temperature. Finally, an alternative tetrazolium salt that 
produces a more water-soluble formazan could be utilized to improve dissolution 
(Ishiyama, 1997).
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In addition to the factors described above, a number of experimental conditions also 
affected the reproducibility of the results. These factors would not affect the 
performance of the assay; however, they would affect the reliability of the data.
1. Homogeneity of cells mixed within alginate prior to bead formation
2 . Homogeneity of bead size/shape
3. Sterility of alginate/cells/medium
4. Purity of alginate (toxins causing cell death or decreased metabolism)
After tight assay parameters were established (e.g. for MTT incubation length, 
formazan dissolution time and temperature control) and a homogeneous cell 
suspension was achieved (i.e. by addition of 10X trypsin/EDTA at the appropriate 
step to dissociate the cells within the alginate-GRGDY matrix), a linear relationship 
was established between formazan absorbance readings and concentration of hMSCs. 
This relationship was established for a cell suspension of hMSCs from tissue flask 
cultures over a series of 7 days (Figure 62) and from a dilution series of cells 
immobilized in GRGDY-alginate beads over a 7 day time course (Figure 63). 
However, the day 10 data for both cell standard preparations were outliers in the study 
(refer to section 3.5.6). Combining these data with some additional studies generated 
using tight assay controls (Table 17), there appeared to be close agreement to a linear 
relationship between absorbance and cell concentration that was estimated to be y = 
0.085x ; where y was the absorbance measured at 600nm and x was the cell density 
per well (xlO4).
Since it has been shown that the growth rate of hMSCs varies with passage level and 
with donor source (section 3.4.1, Table 15; Bruder, 1997; Phinney, 1999); it is also 
likely that these parameters will also affect the linear relationship of the formazan 
absorbance readings and cell concentration. These two parameters were not 
investigated during this research.
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Study Corresponding 
figure number
Range of slope 
estimates
Level of assay 
control
Initial -  Alginate 
beads
48 0.89 to 0.92 Parameters not 
established
Initial -  cell 
standards
48 0.055 to 0.058 Parameters not 
established
Initial -  Alg. vs. 
alg.-GRGDY beads
48 0.038 to 0.040 Parameters not 
established
MTT incubation 
length and formazan 
dissolution time
50 0.086 (2hr MTT 
inc.)*
0.125 (4hr MTT inc.)
Tight control
Fresh vs. frozen 
samples
53 (all data 
not shown)
0.037 to 0.047 Trypsin/EDTA 
not used
Alg. vs. alg.- 
GRGDY beads
54 (all data 
not shown)
0.059 to 0.157 
0.043 to 0.092
Trypsin/EDTA 
not used
Equivalence of 
beads and flasks on 
day 0
57 0.088 to 0.98 * Tight control
T25 cell standard 62 0.085 * 
day 10-0.104
Tight control -  
Day 10 outlier
Bead cell standard 63 0.085 * 
day 10-0.057
Tight control -  
Day 10 outlier
Table 17. Linear relationship between formazan absorbance readings and cell 
concentration established for MTT experiments with tight assay parameters. The 
slope of the standard curves were highly variable in initial experiments in which 
parameters had not been established or when 10X trypsin/EDTA was not used to 
dissociate the alginate-GRGDY beads. The remaining data (*) produced similar 
slopes (using 2 hour MTT incubation length) which were estimated to be y = 0.085x; 
where y was the absorbance measured at 600nm and x was the cell density per cell 
(xlO4).
Under these conditions, the MTT was linear up to lx l0 5cells/well and sensitive down 
to 3xl03cells/well. Heo (1990) also showed that the MTT assay started becoming 
non-linear at cell densities above lx l0 5 cells/well. Alginate beads made by the 
manual method were ca. 2 -2 .5mm in diameter, which was too large for the study, 
especially when cell densities needed to approach 2xl0 7 cells/mL for the complete 
networking of cells within the alginate-GRGDY bead. For most assays, only 1 
bead/well could be used to estimate the slope of the linear approximations because the 
number of cells/well exceeded lx l0 5cells/well when 2 or 3 beads/well were tested. A 
new bead fabrication device is under development that will produce small diameter 
beads (<lmm) which will therefore have a lower number of cells/bead. This will
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allow the MTT assay to be run using multiple beads, without exceeding the non-linear 
range of the assay.
The MTT assay’s absorbance results showed that hMSCs do not proliferate within the 
alginate-GRGDY or unmodified alginate matrix (Figure 54) cultured for 7 days. In 
fact, there was a gradual decrease in absorbance readings (ca. 3 3 %) within the 
alginate-GRGDY beads cultured for 15 days (Figure 58). This decrease may be due 
to diffusion limitations in these large diameter (2mm) beads. Similarly, there was no 
increase in absorbance levels for hMSCs that were seeded at a high density
(5.4xl04 cells/cm2) in microwell plates. Only the cells seeded at a low density
   _
(3.9x10 cells/cm ) in T25 flasks showed an increase in MTT absorbance over the 15
day study (Figure 58). These results were due to availability of space in the T25
flasks since primary cells become contact-inhibited at high density as shown in the
microwell plates. Concurrently the cell numbers and viabilities of the beads were
confirmed by hemacytometer and trypan blue dye. The viability of the hMSCs seeded
at 2xl07 cells/mL in alginate-GRGDY beads was greater than 80% for the 15 days
evaluated in culture (Figure 59). Comparable results were also found in the 7 day
studies with hMSCs seeded at lx l0 7cells/mL in alginate and alginate-GRGDY beads
(Figure 55.a).
The experiments conducted in this research project showed no proliferation of rSMCs 
or hMSCs in alginate or in alginate-GRGDY matrices out to 2 weeks in culture. 
Similarly, Dar (2002) reported no proliferation of rat neonatal cardiac cells in alginate 
scaffolds despite retaining some spontaneous contraction for 2 weeks. More recently, 
Ma (2003) showed that alginate encapsulated MSCs become growth arrested. In 
addition, this research showed that the presence of cell-adhesion sites in the alginate- 
GRGDY does not encourage proliferation. Bone marrow cells have only been 
reported to proliferate on the surface of unmodified alginate as well as express 
osteoblast associated markers when exposed to differentiation medium (Wang, L., 
2003).
If the hMSCs do not proliferate within this system, it may not be a concern provided 
the cells are healthy and can be seeded at a high enough density to form an integral 
network throughout the alginate-GRGDY construct. In fact, these studies showed
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hMSCs had similar GCRs whether grown on 2-D TCP or immobilized 3-D alginate 
and alginate-GRGDY matrices. The GCR of hMSCs seeded at 2xl07cells/mL in the 
alginate-GRGDY beads with 1 bead/well was 7.1xl0'n g/cell/hr as compared to 
9.5x1 O' 1 ^ /cell/hr in the T25 flasks during exponential growth (first four days) and 
6 .5x1 O' 1 ^ ce ll/h r in the T25 flasks during stationary growth (days 4-10) (section 
3.5.5, Figure 60). These rates were also comparable to the GCR of 4.3x1 O' 1 ^ cell/hr 
from hMSCs seeded at lx l0 7cells/mL in the alginate and alginate-GRGDY beads 
(section 3.5.2, Figure 55).
3.6. Differentiation studies using hMSCs
HMSCs derived from bone marrow cells (BMCs) have been shown to differentiate in 
vitro into adipocytes, chondrocytes and osteoblasts (Bruder 1997; Phinney, 1999; 
Pittenger, 1999; Kinner, 2002), as well as myoblasts and myotubes (Wakitani, 1995). 
At the time of this research, the exact components of a specialized differentiation 
medium for smooth muscle cells had not been published; therefore, the idea of using 
conditioned medium from rSMC co-cultures (CDMEM) was tested. The preparation 
of rSMCs co-cultures for differentiation studies of hMSCs immobilized in alginate- 
GRGDY beads is described in sections 2.7.2 and 2.7.3.
Charbord (2000) proposed a sequential model of differentiation from hMSCs to 
vascular-smooth muscle-like stromal cells from cytoskeletal and extracellular matrix 
protein expression analyses in both humans and murine using principal component 
analysis. The human protein markers are summarized in section 1.7.3, Table 1, and 
include fibronectin and a-smooth muscle actin (ASMA) as early indicators of 
differentiation along the smooth muscle cell (SMC) pathway (Charbord, 2000). They 
determined that the default differentiation pathway for hMSCs was toward vascular 
SMCs if they received no other definitive biological factors or cues to an alternative 
differentiation pathway (Galmiche, 1993).
The presence of undefined biochemical components including proteins, growth 
factors and/or hormones in the fetal bovine serum (FBS) in the culture medium 
imparted further ambiguities that may have influenced the differentiation pathway of
-235-
these hMSCs. For these reasons, a media differentiation study was conducted with 
hMSCs grown long term in MSCCM (control), complete DMEM, and in conditioned 
DMEM from rSMC cultures (CDMEM) in microwell plates as described in section 
2.7.4 to establish a base-line of ASMA expression for cultured hMSCs. The results 
from these 2-D media differentiation studies conducted with hMSCs in long term 
culture in microwells are discussed in section 3.6.1.
The results from the 3-D differentiation studies carried out using hMSCs immobilized 
in alginate-GRGDY beads and cultured in CDMEM with rSMC co-cultures are 
described in section 3.6.2. Samples were taken over a time course; and histology 
preparations were made from the cross sections of the hMSC/alginate beads and 
immunostained for ASMA as described in 2.5.8. Some of these studies were 
compared directly to cultures of hMSCs/alginate beads in control medium (DMEM). 
The extent of differentiation of the hMSCs was also monitored using fluorescence 
activated cell sorting (FACS) to observe the change in cell surface markers as 
described in section 2.5.9.
3.6.1. Media differentiation studies in microwells (2-D)
Because hMSCs have been shown to express ASMA in culture (Charbord, 2000), it 
was important to determine the baseline expression of ASMA in long term hMSC 
cultures that were not associated with alginate-GRGDY hydrogel matrix and not 
exposed to the growth factors and intermediate biochemical products of metabolism 
produced by the rSMC co-cultures. HMSCs were seeded into microwells at 
5xl03cells/cm2 as described in section 2.7.4. The cultures were confluent after 5 
days, when the spent MSCCM was removed and the wells were refed with MSCCM 
(control medium), complete DMEM (control medium) or CDMEM. Over a 9 day 
time course, the hMSCs were scrapped from the microwell surface, smeared onto a 
microscope slide, fixed with acetone and exposed to hematoxylin which stains the 
cells’ nuclei blue and to cell-specific antibodies against ASMA which stain the cells’ 
cytoplasm brown. Figure 64 shows the time course results. The cytology smears of 
the hMSCs showed distinct blue nuclei and some non-specific ASMA staining, as 
indicated by the brown fiber-like strands (photos A-C), on the initial time point on 
day 3 of the study which was post-seeding day 8 . The staining was non-specific
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because it was not confined to the cytoplasm of the cell which would be the expected 
location of these cell-specific proteins. The cytology smears of the hMSCs cultured 
in MSCCM continued to show a small level of non-specific ASMA staining, whereas 
the cells cultured in DMEM and CDMEM had an increased level of non-specific 
ASMA staining after day 6  in culture (photos D-F). By day 9, both DMEM and 
CDMEM cultures had a high degree of non-specific ASMA staining; however the 
staining was still not confined to the cytoplasm of the cell (photos G-I). Higher 
magnification (400X) micrographs are shown in the Appendices, section 6.2.3, for 
these same preparations for day 6  (Figure 73) and for day 9 (Figure 74). These photos 
further help show the individual cell structure.
In conclusion the brown non-specific staining from the 2-D hMSC cultures grown in 
MSCCM, DMEM and CDMEM was determined to be an artifact of the method of 
preparation and not an indication that the cells were expressing ASMA. Due to this 
result, a biotin blocker (Dako) was used in future preparations to minimize the non­
specific binding of endogenous biotin in the samples.
Figure 64. (On next page) Time course of hMSCs in confluent microplate cultures 
grown in MSCCM, DMEM and CDMEM. All preparations were fixed with acetone 
and exposed to hematoxylin (blue nuclear stain) and ASMA (brown cytoplasmic 
stain). Small amounts of non-specific ASMA staining were observed in day 3 
preparations as indicated by brown fiber-like strands (A-C). No cytoplasm-specific 
staining was observed in the MSCCM cultures (A,D,G). However an increased level 
of non-specific ASMA staining was evident on day 6  and day 9 in the DMEM (E,H) 
and CDMEM (F,I) cultures; however, it was not confined to the cytoplasm of the 
cells.
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3.6.2. Differentiation studies in alginate-GRGDY beads
In previous bead studies described in section 3.4.2.2, it was shown that hMSCs 
readily attached and elongated within alginate-GRGDY hydrogel beads within 1 day 
of immobilization. And when seeded at high densities (e.g. 107cells/mL), hMSCs 
formed dense networks within the bead (section 3.4.2.3). In these differentiation 
studies, hMSC/alginate-GRGDY beads were removed from co-cultures of rSMCs and 
conditioned DMEM (CDMEM) over a time course and placed into formal saline 
( 1 0 % formaldehyde in buffered saline) for characterization using immunohistology.
In addition, fluorescence activated cell sorting (FACS) was used to analyze the 
hMSCs immobilized within the alginate-GRGDY beads to monitor the change in 
hMSC surface markers during co-culture with rSMCs. For these studies the 
hMSC/alginate-GRGDY beads were physically separated from the rSMC co-cultures 
by using cell culture inserts.
3.6.2.1. Immunohistological analysis of beads
During initial histology preparations, it was nearly impossible to locate the clear 
alginate beads within the paraffin block. Therefore preparations were made by 
smearing the 1 0 % formaldehyde-fixed bead across a glass slide and then staining with 
hematoxylin and eosin (H&E) for overall morphology as described in section 2.5.8. 
Hematoxylin stains the cell nucleus blue, and eosin stains the cell cytoplasm pink. 
Figure 65 shows the results from a differentiation study.
The hMSCs were immobilized in 50X alginate-GRGDY (Manugel DMB) beads at 
5xl06 cells/mL and placed into cell culture inserts as described in section 2.7.1 and
2.7.3. On day 1 the inserts were transferred into microwells containing rSMC co­
cultures and CDMEM. Phase contrast micrographs showed the hMSCs were 
elongated within the bead on day 1 (photo A) and on day 7 (photo C) of the time 
course study. The beads were noted to be more compact on day 7 of the study. The 
corresponding H&E preparations of the hMSCs are shown from day 1 (photo B) of 
culture which was day 0 of the differentiation study, and from day 7 (photo D) of 
culture which was day 6  of the differentiation study. The pink/purple color in the 
micrographs was due to background staining of the alginate from the eosin. The
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grainy, brown sections were caused by formalin pigmentation due to the smear 
preparation of the samples. Upon examination under higher magnification (400X), 
these H&E preparations showed a distinct difference in morphology of the hMSCs 
between day 1 and day 7. The day 1 beads contained a majority of hMSCs with 
narrow, pointy nuclei (photo E) which were indicative of primitive stem cells. 
Whereas the day 7 beads contained a greater number of hMSCs with larger, oval­
shaped nuclei (photo F) which were indicative of terminally differentiated cells 
(Bruder, 1997; Phinney, 1999).
Figure 65. (On next page) Differentiation studies of hMSCs at 5x106cells/mL in 5 OX 
alginate-GRGDY (Manugel) beads cultured in CDMEM with rSMC co-cultures. 
Phase contrast micrographs of the hMSCs elongated within the bead are shown from 
day 1 (photo A) and day 7 (C). Initial histology preparations were performed by 
smearing the hMSCs/alginate bead across glass slide. The corresponding H&E 
staining is shown on day 1 (B) and day 7 (D). The majority of hMSCs within the 
bead on day 1 contained narrow, pointy nuclei (E); whereas the day 7 beads contained 
a greater number of hMSCs with larger, oval-shaped nuclei (F), also circled in (D). 
The pink/purple background in photos B, D and E was due to eosin staining of the 
alginate. Some brown formalin pigmentation was present (arrows) due to the smear 
preparation. (A-D: 100X magnification, E-F: 400X magnification)
-240-
Phase contrast - Day 1 B H&E - Day 1
- 1  T O M
C Phase contrast - Day 7 H&E - Day 7
-241 -
In later differentiation studies, microsectioning of the hMSC/alginate bead was 
possible after the edge of the formaldehyde-fixed bead was marked with histological 
marking ink. Then the beads were placed in biopsy capsules and cassettes and 
underwent standard overnight histopathologic processing as described in section
2.5.8. The microsections were dewaxed and stained with H&E for overall 
morphology. The results from a differentiation study in which hMSCs were 
immobilized in 50X alginate-GRGDY (Manugel DMB) beads at 5xl06 cells/mL and 
cultured in CDMEM with rSMC co-cultures are shown in Figure 6 6 . Control hMSCs 
in 50X alginate-GRGDY beads were cultured in DMEM medium. Figure 6 6  shows 
H&E preparations of the hMSCs after immobilization on day 0 within the alginate- 
GRGDY bead (photos A&B). The cells were rounded after cross linking. 
Immunohistological preparations using a specific antibody stain for ASMA were used 
to assess the presence of ASMA, one of the specific cell proteins for SMCs. The day 
0 beads showed that some of the hMSCs initially stained positively for ASMA as was 
evident by the brown cytoplasmic staining of the cells in the sectioned bead (photo 
C). However, under higher magnification (400X) many of the cells also had a dark 
membrane (photo D) with no cytoplasmic staining which indicated the hMSCs may 
have taken up the stain due to the delicate condition of the cells immediately after 
immobilization in the alginate-GRGDY bead and exposure to the ‘harsh’ conditions 
(e.g. pressure cooking for 4 hours) of antigen recovery during histological 
preparation. This observation was further supported by the micrographs from day 3 & 
4, which showed that the cells had elongated within the alginate (H&E -  photo E); but 
the level of ASMA staining was very low (photos F&G) with only a couple positive 
cells, if any. It was also observed that the surface of the bead was uneven in 
appearance due to contraction of the cells/alginate (photo G). By day 11 of culture in 
the CDMEM with rSMC co-cultures there was a 40pm layer of positive ASMA cells 
around the rim of the bead (photo H).
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Figure 66. Histology sections of hMSCs in 50X alginate-GRGDY (Manugel) beads at 5xl06cells/mL 
prepared during a time course differentiation study. Day 0 hematoxylin and eosin (H&E) staining of 
hMSCs (photos A&B) initially rounded within alginate bead. Some hMSCs stained positively for ASMA 
(C&D). However some appear to have membrane stained instead of cytoplasm which indicated the cells 
may be sensitive to histology treatment on day 0 resulting in false positives. Day 3&4 H&E of hMSCs 
which have elongated (photo E) but only showed a small amount of ASMA staining in the cytoplasm, if 
any (F&G). The surface of bead became uneven due to alginate contraction (G). By day 11 there was a 
40pm layer of positive AMS A cells when cultured in CDMEM with rSMC co-cultures (H). Beads cultured 
in the control medium, DMEM (I), also had a thin edge of positive ASMA cells and several within the 
center of the bead as indicated by the arrow. (Scales: Photo A: 100X, B: 400X, C: 200X, D-I: 400X)
Part of the bead edge was detached during microsectioning which indicated the 
sections may have been sliced too thinly. In addition, the beads cultured in the 
control medium, complete DMEM, also had some hMSCs which stained positively 
within the bead as well as on the edge (photo I). A comparison of these samples is 
provided in the Appendices, section 6.2.3, Figure 75 between the negative control 
slides (unstained) and the ASMA-stained slides. When possible the same bead cross 
section was compared directly to show the difference between these two media 
conditions on day 4 versus day 11.
These early differentiation studies used 50X alginate-GRGDY (Manugel DMB) that 
was filtered through Celite after treatment with activated charcoal as described in 
section 2.3.3, Figure 4 by the ‘initial process’. Additional differentiation studies 
were conducted using alginate-GRGDY (Manugel DMB) that was autoclaved and 
was not treated with activated charcoal and filtered through Celite as described in 
section 2.3.3 by the ‘intermediate process’. In order to increase the cell networking 
within the alginate bead, these studies used a higher cell concentration 2xl0 7cells/mL 
in 9X alginate-GRGDY beads.
Immunohistological preparations showed the cell density was higher at the edge (rim) 
of the beads. After 9 days in culture in CDMEM with rSMC co-cultures there was a 
40-60|im rim of positive ASMA cells around the bead (Figure 67, photo A&B). On 
day 16, the extent of ASMA staining seemed to be significantly lower than previously 
observed on day 9 (photo C). On day 23 of culture, positive ASMA staining was 
again apparent (photo D); however, the hMSCs within the center of the bead were not 
networked completely (photo E), and gradually the bead fell apart during the micro 
sectioning by day 37 when only the rim of the bead survived histological preparation 
(photo F). A comparison of some of these slides is also provided in the Appendices, 
section 6.2.3, Figure 76. The negative control slides (unstained) and the ASMA- 
stained slides from the same bead cross section were compared directly to 
demonstrate the difference between time points on day 9 versus day 23.
The bead instability may have been due to decreased cross linking of the alginate 
hydrogel as calcium ions diffused out of the bead during the time course or during
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storage in the formal saline. Therefore in future studies lOmM CaCfe should be added 
to the formal saline to help maintain bead integrity during storage. These beads were 
ca. 2-2.5mm in diameter since they were made manually. This bead size was much 
greater than desired; therefore a bead device that will produce beads of smaller 
diameter (400-600pm) is being fabricated for future work. The large bead diameter 
was likely to have caused diffusion limitations of nutrients and oxygen into the center 
of the bead. In addition, during cross linking it was also possible that the outer shell 
of the alginate bead was well formed and very tightly cross-linked; whereas the center 
of the bead was less strongly cross-linked due to a diffusion limitation or gradient 
during exposure to the CaCL solution. Other researchers have observed a 
nonuniform distribution of biomass with a tendency toward growth at the surface 
(Leo, 1990; Constantinidis, 1999; Goosen, 1999).
The most likely cause for the bead instability would have been due to use of the 
autoclaved Manugel alginate during the ‘intermediate process’ (see Figure 4, 
section2.3.3). Autoclaving lowered the alginate viscosity to 5mPas, and thus the 
molecular weight and gel strength. In addition it was discovered that the autoclaved 
alginate contained activated thermophilic bacillus spores that may have contributed to 
the degeneration of the alginate within the center of the beads. The earlier 
differentiation studies by the ‘initial process’ used Manugel alginate that was not 
autoclaved, which was treated with activated charcoal and filtered through Celite. 
These steps, although not sterile processes, would have reduced the amount of 
bacillus spores and alginate impurities that may otherwise have resulted in 
degradation of the alginate or cell death during incubation. Further instability of the 
bead may have been caused by microbial contamination from the hMSC cultures. 
These contamination issues were discussed in detail in sections 3.1.2 and 3.4.3.
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7igure 67. Immunohistology preparations of 9X alginate-GRGDY beads at 2xl07cells/mL prepared using autoclaved Manugel DMB 
prepared by the ‘intermediate process’. All beads were cultured in CDMEM with rSMC co-cultures. On day 9 there was a 40-60 pm rim 
of hMSCs that stained positively for ASMA (Photo A: 100X, B: 400X). On day 16 the rim o f the bead seemed to have no positive 
ASMA staining (Photo C: 400X). On day 23 some positive ASMA staining (Photo D: 400X, E: 100X) was evident along rim of bead 
and through a center channel through the bead. However, the center of the bead was more detached from the rim and by day 37 
microsections revealed just the rim of the bead and no cells in the center section (F: 100X).
As previously observed, the hMSC/alginate-GRGDY beads seemed to become more 
compact with increased length in culture. This was most likely due to the contraction 
of the cells/alginate within the rim of the bead. However, future work will need to be 
performed using smaller sized beads to determine whether 1 ) the rim of these tightly 
networked cells formed initially due to better cross linking/hydrogel formation at the 
rim rather than in the center of the bead, 2 ) the rim of cells caused diffusion 
limitations of oxygen and/or nutrients to the bead center, 3 ) the presence of microbes 
caused instability in the center of the bead, or 4) the alginate slowly diffused out of 
the rim of the bead leaving the cells tightly networked within the rim. Reagents 
specific for staining polysaccharides such as alginate include periodic acid-Schiff 
reagent, Toluidine blue and Alcian blue (Lee, 1997).
3.6.2.2. FACS analysis of beads
During differentiation studies, hMSC/alginate-GRGDY beads were dissociated into a 
single cell suspension by exposing the beads to 0.1 M trisodium citrate and 0.25% 
trypsin/0.02% EDTA and gently micropipetting until the bead was completely 
dispersed. After the cells were centrifuged and washed with DPBS, the hMSCs were 
labeled with monoclonal antibodies with a fluorescent tag as described in section
2.5.9. Briefly the primary monoclonal antibodies used were against CD34 and 
ASMA which were conjugated to secondary mouse immunoglobulins/RPE Goat 
F(ab), as well as, SH2 and SH4 monoclonals which were conjugated to FITC. After 
the cells were exposed to the monoclonal antibodies labeled with the fluorescent 
marker, the cells were washed with DPBS to remove unbound antibodies. Then the 
samples were run through a FACS machine which produced graphical outputs 
showing the distribution of the cells and those labeled with the fluorescent tag. The 
actual outputs are provided in the Appendices, section 6.2.4.
Figure 6 8  shows the summary of the FACS results which were used to monitor the 
change in hMSC surface markers after being immobilized within the 50X alginate- 
GRGDY (Manugel) beads at 5xl0 6 cells/mL and cultured in either DMEM (control 
medium) or in CDMEM with rSMC co-cultures for 6  days. Each cell was designated 
by a dot on the graph. The gated region of the graph was selected using an ‘empty’ 
sample (one prepared without any antibodies) from the distribution of the cells on the
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graph of side scatter (SSC-H) vs. forward scatter (FSC-H) as described in methods in 
section 2.5.9. Cells within the gated region on the graph of RPE tag (FL2-H) versus 
FITC tag (FL1-H) were negative for the surface marker. Cells that expressed the 
surface marker, and hence were positive for the antibody with fluorescent tag, fell 
outside the gated region (in R2). Both bead culture conditions were negative for 
CD34 surface marker as shown by the cell distribution falling within the gated region 
(Figure 65, graph A&B). This result was expected since ex vivo cultures of hMSCs 
are typically CD34-; although some groups have identified precursors as CD34+ 
(Deans and Moseley, 2000). HMSCs are positive for SH2 and SH4 surface markers; 
whereas marrow-derived hemopoietic cells are negative for SH2 and SH4 surface 
markers (Haynesworth, 1992). In this differentiation study, the control bead cultures 
of hMSCs in DMEM retained their expression of SH2 and SH4, as indicated by the 
dots lying outside of the gated region (Figure 65, graph C&E). In sharp contrast, the 
bead cultures in CDMEM with rSMC co-cultures lost most of their expression for 
SH2 (Figure 65, graph D) and all of their expression for SH4 (Figure 65, graph F). 
Although ASMA is a cytoplasmic protein rather than a surface marker, this 
monoclonal antibody was also tested and the hMSC beads cultured in CDMEM with 
rSMC co-cultures had a slightly higher level of positive ASMA expression (Figure 
65, graph H) than the cells culture in the DMEM (Figure 65, graph G).
The complete FACS reports are provided in the Appendices, section 6.2.4. They 
show the histograms of the cell distribution and the percentage of cells within and 
outside the gated regions. The loss of expression of SH2 and SH4 surface markers in 
the hMSC/alginate beads cultured in CDMEM with rSMC co-cultures demonstrated 
that these hMSCs were differentiating by day 6  in culture.
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Figure 6 8 . FACS results for cell surface markers CD34, SH2 and SH4 and for 
cytoplasmic protein ASMA on day 6  of culture. Cells that were negative (non- 
fluorescent) for the surface marker were contained within the gated region. First 
column: Control hMSC/50X alginate-GRGDY (Manugel) beads cultured for 6  days in 
DMEM medium remained CD34- (A), SH2+ (C), SH4+ (E), and ASMA- (G).
Second column: hMSC/50X alginate-GRGDY (Manugel) beads cultured for 6  days in 
CDMEM with rSMC co-cultures were CD34- (B), SH2- (D), SH4- (F) and slightly 
more ASMA+ (H). Axes represent RPE tag (FL2-H) versus FITC tag (FL1-H).
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The FACS results coupled with the changes observed in cell morphology by day 7 of 
culture and the immunohistology data that showed positive ASMA staining by day 9- 
11 in culture provided preliminary evidence that the hMSC differentiation may be 
along the SMC pathway. In addition these results show, the biochemical components 
and/or intermediate products within the CDMEM/rSMC co-cultures provided at least 
some of the factors necessary to differentiate the hMSCs as compared to the control 
DMEM medium.
3.6.3. Summary
Differentiation studies were conducted on the hMSC/alginate-GRGDY beads using 
conditioned medium with rSMC co-cultures. Since long term cultures of hMSCs 
have been shown to differentiate along the vascular SMC pathway (Charbord, 2000), 
a time course media study was first conducted growing hMSCs in microwell (2-D) 
plates using three media conditions - MSCCM, DMEM and CDMEM - to determine 
the level of ASMA in hMSCs grown to confluency (high density) with these media. 
Cytology preparations were made; hematoxylin and ASMA were used to stain the 
cells. The hMSCs cultured in MSCCM showed no specific ASMA staining. The 
samples prepared from hMSCs cultured in DMEM and CDMEM exhibited a higher 
level of non-specific staining after 6  days in culture, and especially after 9 days 
(Figure 64). The staining was not defined to the cytoplasm of the cells; therefore, the 
staining was determined to be an artefact of the sample preparation.
When hMSCs were immobilized into 50X alginate-GRGDY beads and cultured in 
CDMEM with rSMC co-cultures, there appeared to be a change in the cell 
morphology within the beads. Initial H&E smears of the alginate beads, showed that 
the hMSCs within the bead on day 1 contained cells with narrow, pointy nuclei 
(Figure 65.E); whereas the day 7 beads contained a greater number of hMSCs with 
larger, oval-shaped nuclei (Figure 65.F) which was indicative of terminally 
differentiated cells. After satisfactory sample preparation for immunohistology was 
achieved on the hMSC/50X alginate-GRGDY beads, cross sections were prepared 
and stained with hematoxylin and the cell-specific protein, ASMA. Day 0 results of 
hMSCs immobilized in the beads showed that initially some cells were positive for 
ASMA (Figure 6 6 .D); however, these results may have been false positives due to the 
‘harsh’ conditions used to reverse cross linking of the cell antigens in the sample
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during histological preparation. Day 3-4 samples expressed little, if any, ASMA 
(Figure 6 6 .F). As the culture time increased the perimeter of the beads was found to 
have nicely networked cell layers (ca. 20-60 pm thick) that were positive for ASMA 
by ca. day 9-11 in culture (Figures 6 6 .H and 67.B). The center of the beads seemed to 
have significantly lower cell densities and lower levels of staining or no staining. 9X 
alginate-GRGDY beads prepared from autoclaved Manugel by the ‘intermediate 
process’ appeared to fall apart at later time points in culture (e.g. day 23-37 in Figure 
67.F). This may have been due to decreased stability of the alginate in the large 
diameter beads during culture due to the lower alginate molecular weight, diffusion of 
calcium ions out of the hydrogel, the presence of microbes, or poor hydrogel 
formation in the center of the bead at the cross linking step.
Differentiation studies combined with FACS analysis were performed and showed 
that within 6  days of culture hMSCs/50X alginate-GRGDY beads cultured in 
CDMEM with rSMC co-cultures lost expression of the hMSC surface markers SH2 
and SH4; whereas hMSCs cultured in DMEM remained positive for SH2 and SH4 
(Figure 6 8 ). Concurrent immunohistological preparations of these cells showed low 
levels of ASMA staining on day 4 and significantly increased levels of ASMA for 
both cultures grown in both DMEM and CDMEM with rSMC co-cultures on day 11 
(Figure 6 6 , photos F-I). Other cell-specific proteins for SMCs such as calponin, 
heavy chain myosin and h-caldesmon were not tested in these early studies, but will 
be incorporated in future studies.
Finally cell culture inserts with a 0.4pm membrane were used to physically separate 
the beads from the rSMCs co-cultures. In addition the supernatant collected from the 
CDMEM was centrifuged at 200g to ensure rSMCs and cell debris were not 
introduced into the hMSC cultures. Therefore differentiation of the hMSCs into SMCs 
by cell fusion would not have been possible. Although this possibility was not proven 
by analytical techniques such as PCR of known rSMC DNA sequences (not found in 
hMSCs); these analyses can be performed in future studies.
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4. Discussion and conclusions
4.1. Alginate as a tissue engineering matrix
Alginate is a natural, biodegradable polymer that sets rapidly within a solution of 
divalent ions. Alginate hydrogels have been used successfully to entrap secretory 
(e.g. pancreatic islet) cells (Mullen, 2000) and transformed producer-cell lines 
(Constantinidis, 1999; Joki, 2001; Tobias, 2001; Zheng, 2003) and have been used in 
some tissue engineering applications for soft tissue (Halberstadt, 2002), myocardium 
(Leor, 2000; Zimmerman, 2003), cartilage (Atala, 1994; Hauselmann, 1994; Wong, 
M., 2001; Lee, 2003; Kamil, 2004) and bone (Alsberg, 2001; Simmons, 2004). 
Human clinical studies have shown alginate to be well-tolerated (Hasse, 1997;
Laham, 1999; Caldamone and Diamond, 2001) and it has been used extensively in 
bandage dressings in surgery and wound management (Thomas, 2000). The 3-D 
configuration of a hydrogel provides structural support, preserves phenotypic 
expression and function of the cells that may not be achieved in 2-D cultures (Jen, 
1996). For these aforementioned reasons, sodium alginate was utilized as the matrix 
for conducting cell studies toward investigation of a tissue engineered blood vessel 
(TEBV). University College London has developed and patented a novel method of 
extruding alginate into a hydrogel tube using an automated device (Mason and Town, 
2002).
In this research immortalized rat smooth muscle cells (rSMCs) were initially used to 
study cell-alginate interactions. Immortalized rSMC were used due to the limited 
proliferation of adult SMCs in vitro (McKee, 2003). For all studies conducted, 
despite high initial cell viability, the rSMCs rapidly died after immobilization within 
the alginate hydrogels. In contrast, rSMCs proliferated within collagen matrices and 
within collagen/alginate matrices in which cross linking solutions were not used. The 
rSMCs’ remained spherical within the alginate (since no adhesion sites were present); 
whereas the rSMCs elongated within the collagen. In collagen/alginate matrices in 
which cross linking solutions were used, the rSMCs remained spherical. This change 
in morphology was thought to be one of the key indications of viability and 
proliferation, and demonstrated the need to incorporate cell adhesion sites, such as 
RGD, onto the alginate using carbodiimide chemistry.
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The pentapeptide GRGDY (Gly-Arg-Gly-Asp-Tyr) was chosen to incorporate onto 
the alginate polymer matrix based upon success reported by Rowley using myocytes 
(Rowley, 1999). This research found that the concentrations of reagents (i.e. EDC, 
sulfo-NHS and peptide) used in the carbodiimide chemistry were critical in order to 
obtain sufficient cell association while simultaneously maintaining the hydrogel 
strength because the peptide was incorporated into the same moiety as the calcium 
binding site during cross linking. Too much peptide incorporated onto the alginate 
polymer resulted in rapid dissociation of the hydrogel. The alginate source and 
preparation, including method of sterilization, were also critical to the peptide 
derivatization process as summarized in section 3.2.9. Using cultured rSMCs and the 
‘initial process’ of alginate-GRGDY derivatization which included 2 days of dialysis 
followed by adsorption with activated charcoal and filtration through Celite, it was 
found that all alginates (e.g. Fluka, Manugel, and Pronova MVG) worked best with 
50X reactants. RSMCs were shown to attach and elongate on the surface of 50X 
alginate-GRGDY sheets (Figure 26A and 27); whereas no association occurred for the 
lower concentrations tested (Figure 26B). These results confirmed the results 
originally reported by Rowley (1999, 2002) using myocytes.
When entrapped within 50X alginate-GRGDY hydrogels, the rSMCs were observed, 
for the most-part, to remain spherical in morphology. Only in a few instances the 
rSMCs elongated within the 50X alginate-GRGDY hydrogel (Figure 28) and this 
appeared to occur only when the hydrogel was rapidly dissociating (due to too many 
peptides incorporated into the polymer) as summarized in section 3.3.6. RSMCs 
were shown to attach and elongate within tubes (Figure 29). However, the possibility 
that the rSMCs associated with the glass tube surface cannot be discounted. This 
conclusion was reached because elongation was observed only a few times for rSMCs 
immobilized within alginate-GRGDY beads, and even when repeated at later stages of 
the project when rSMCs were immobilized in 27X alginate-GRGDY beads using the 
final ‘sterile process’.
The expectation would have been that the rSMCs would have elongated along the 
pores of the alginate hydrogel containing the GRGDY peptides. It is possible that the 
pore size of the alginate-GRGDY matrix may have been too small or restrictive.
Eiselt (2000) suggests that alginate used in the physical form of a hydrogel contains
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small pore size (nm size scale) that does not allow cell movement. Zmora (2002) 
created macroporous scaffolds from 1% (high G) alginate scaffolds by freeze-drying 
methods and found both interconnecting round pores 110+/-30pm in diameter and 
non-connecting elongated pores 210+/-80pm depending upon the freezing regime. 
They also found that the seeded rat hepatocytes’ morphology was either elongated or 
spherical based upon the two pore microstructures (Zmora, 2002). Chandy (2003) 
also measured the pore size of an alginate/elastin/PEG matrix and found them to be 
35-75pm. These different pore microstructures were created by freezing the alginate 
matrix and examining the structure using a scanning electron microscope (SEM). 
Freezing is likely to alter the pore size; however this issue warrants future work to 
evaluate the pore size and microstructure.
The stiffness of the alginate hydrogel may have been another factor. Recently Genes 
(2004) found that chondrocytes would adhere at a level 10-20 times higher on 
alginate-G4 RGDY than on unmodified alginate. The alginate stiffness regulated the 
morphology of the chondrocytes -  rounded on weak surfaces with little actin 
expression and flattened on stiff surfaces with actin stress fibers (Genes, 2004). 
Therefore it was possible that these alginate-GRGDY hydrogels were not stiff enough 
to support the rSMCs’ cytoskeleton because they are composed largely of actin stress 
fibers. Activation of the cell cytoskeleton via cell adhesion is essential for 
maintaining proper cell function, proliferation, and differentiation (Saltzman, 2000). 
The cells would die without activation of the SMCs’ cytoskeleton as was observed in 
these studies. This hypothesis is in agreement with other reports for chondrocyte 
culture systems which showed cells maintained in a rounded morphology prevented 
the formation of stress fibers that were believed to mediate dedifferentiation when 
chondrocytes were grown on adherent surfaces (Takigawa, 1984). In contrast, 
primary rSMCs have been shown to proliferate within photopolymerized acryloyl- 
PEG-KQAGDV (Lys, Gin, Ala, Gly, Asp, Val) hydrogels (Mann, 2001). The 
KQAGDV peptide was identified as the most adhesive peptide for vascular smooth 
muscle cells (Mann and West, 2001). However, the differences between results with 
this peptide/polymer system and the current GRGDY/alginate system could not be 
addressed within the context of this research.
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4.2. Adult hMSCs for tissue engineering
A collaboration to investigate cell-alginate interactions using adult human 
mesenchymal stem cells (hMSCs) was established with the UCL Wolfson Institute of 
Biomedical Research which permitted more relevant studies using material (i.e. bone 
marrow cells or whole blood) that was more appropriate for adult autologous cell 
therapy. Not unexpectedly, the hMSCs showed significantly different growth kinetics 
compared to the immortalized rSMCs in tissue flask cultures. The growth rate of the 
hMSCs slowed considerably by passage 12; therefore all experimentation needed to 
be conducted prior to that level.
In contrast to the rSMCs, the entrapped hMSCs within 50X alginate-GRGDY 
hydrogels showed a dramatic change in morphology from spherical immediately after 
immobilization to more elongated within 1 day. These bead constructs were assessed 
using phase contrast microscopy and standard histological preparations. During this 
hMSC work the ‘initial process’ of alginate-GRGDY derivatization (Figure 4) 
required the highest concentration of reactants (e.g. 50X); whereas if the alginate was 
autoclaved which reduced its viscosity in the ‘intermediate method’, 27-35X reactants 
were sufficient. After changing to a new lot of EDC, 9X was the best concentration. 
Finally for the purest alginate (Pronova SLG100) used in the ‘sterile process’, 9X- 
12X reactants were sufficient for biological activity and maintenance of hydrogel 
integrity. An initial seeding density of 2xl0 7cells/mL showed that the hMSCs formed 
dense network of cells within the hydrogel. All of these results are summarized in 
section 3.4.5. The hMSCs may have been more amenable to elongation within the 
alginate-GRGDY hydrogel due to their more primitive state (i.e. adult stem cell) or 
differences in cytoskeleton (i.e. less actin is expressed in undifferentiated stem cells) 
(Wang, D., 2004).
A modified MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
assay was used to examine cell metabolism and proliferation by first exposing the 
hMSC/alginate beads to MTT and then dissociating the cell/alginate constructs using 
trisodium citrate and trypsin/EDTA. In addition a frozen storage step was 
incorporated into the assay so that a time course study could be meaningfully 
evaluated. Using the MTT assay it was found that hMSCs did not proliferate within
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either the unmodified alginate or alginate-GRGDY matrix within the 2 weeks 
examined. These results were further substantiated by concurrent cell density 
measurements using a hemacytometer. Cell viability >80% was maintained in the 
beads during the study. In addition, the glucose consumption rate (GCR) was 
measured and found to be comparable to hMSCs grown in two-dimensional culture 
vessels. The MTT assay was found to be a sensitive means for a time course 
evaluation of the metabolic activity of hMSCs entrapped in the alginate hydrogels. 
Overall there was ca. 33% decrease in metabolism during the 2 weeks examined as 
summarized in section 3.5.7.
It was anticipated that conversion of hMSCs to smooth muscle cells could be 
enhanced in a three-dimensional gel as was found with differentiation of MSCs to 
chondrocytes (Ma, 2003; Steinert, 2003). Chondrocytes have been shown to 
proliferate and maintain a stable differentiated phenotype when cultured in alginate as 
compared to 2-D cultures (Hauselmann, 1994; Lee, 2003). In the studies reported 
here, alginate-GRGDY hydrogel beads were examined as a surrogate for tubes of the 
same material which were placed into conditioned medium from rSMC co-cultures 
(CDMEM). The cultures were physically segregated using a plastic insert with a
0.4pm membrane. Three different analytical techniques were used to determine if the 
hMSCs were differentiating as was summarized in section 3.6.3. First, cytology 
slides were prepared from the hMSCs within the alginate-GRGDY beads in CDMEM 
with rSMC co-cultures and were identified as initially having cells exhibiting a 
primitive morphology with narrow, pointy nuclei. After further incubation of the 
hMSCs within the alginate-GRGDY beads in CDMEM with rSMC co-cultures a 
number of cells contained larger, oval-shaped nuclei. This morphology change was 
an indication of terminal differentiation (Bruder, 1997; Phinney, 1999).
Next, fluorescence activated cell sorting (FACS) was used to monitor the cell surface 
markers. In these studies, the hMSCs were initially confirmed to be CD34-, SH2+ 
and SH4+. The SH2 and SH4 antibodies recognize epitopes present on the surface of 
hMSCs and not on hematopoietic cells, and the surface antigens disappeared upon 
differentiation (Haynesworth, 1992). Furthermore, the SH2 antigen was identified to 
be endoglin, the transforming growth factor-P receptor III, which mediates TGF-P
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signaling during differentiation of MSCs into chondrocytes (Barry, 1999; Pittenger, 
1999). In the studies performed here, hMSCs/alginate-GRGDY beads cultured in 
CDMEM with rSMC co-cultures lost expression of the hMSC surface markers SH2 
and SH4; whereas control cultures of hMSCs/alginate-GRGDY beads cultured in 
DMEM retained expression. Therefore the loss of the SH2 and SH4 surface markers 
was an indication that the hMSCs exposed to CDMEM with rSMC co-cultures had 
differentiated.
Finally, immunohistochemistry was used to stain the hMSCs/alginate-GRGDY beads 
for presence of the smooth muscle cell-specific cytoplasmic protein, ASMA, using 
avidin-biotin complexed to a monoclonal antibody specific for ASMA. Microsections 
of the beads showed a dense cell layer was formed around the perimeter of the 
alginate-GRGDY beads. These cells stained positively for ASMA after the beads had 
been cultured in CDMEM with rSMC co-cultures. Although these three results do 
not unequivocaly demonstrate differentiation of the hMSCs into smooth muscle cells; 
they do show the potential for differentiation studies to be pursued using this 
cell/polymer system. Others have shown the potential for MSCs to differentiate into 
chondrocytes (Ma, 2003; Steinert, 2003) osteoblasts (Wang, L., 2003) and 
cardiomyocytes (Xu, 2004) using unmodified alginate. Additional analyses would 
need to be performed to determine if the hMSCs examined in this study differentiated 
into functional smooth muscle cells. These would include determining if the cells 
were sensitive to calcium channel antagonists and positive for additional cell-specific 
proteins such as caldesmon, calponin and heavy chain myosin during 
immunohistological preparations.
Three factors may have caused differentiation of the hMSCs within the alginate- 
GRGDY beads cultured in CDMEM with rSMC co-cultures.
1. The presence of intermediate products of cell metabolism or growth factors 
from conditioned medium and/or microfiltrate from rSMC cultures (those 
molecules that diffused through the 0.4pm membrane) triggered 
differentiation.
Some growth factors have been identified, but the results have been conflicting until 
recently. For example, Simper demonstrated adult stem cells derived from human 
whole blood differentiated into SMCs and endothelial cells (ECs) using specific
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growth factors. Endothelial outgrowth cells were selected by growing human 
mononuclear cells (MNCs) in endothelial growth medium (EGM-2). Smooth muscle 
outgrowth cells were selected by growing the MNCs in EGM-2 with 50ng/mL 
platelet-derived growth factor-BB (PDGF-BB) (Simper, 2002). On the other hand, 
Kinner reported that Ing/mL of transforming growth factor-pi (TGF-pi) significantly 
increased ASMA expression and the contractility of MSCs; whereas, lOng/mL of 
PDGF-BB decreased expression and contraction (Kinner, 2002). More recently, 
Seruya (2004) and Wang, D. (2004) have successfully demonstrated MSC 
differentiation into SMC using TGF-pi.
2. The second factor potentially causing differentiation relates to the density of 
hMSCs seeded within the 3-D alginate-GRGDY hydrogel bead.
Pittenger showed a high cell density (i.e. pelleted micromass) was necessary for 
chondrogenic differentiation (Pittenger, 1999). Reyes reported that differentiation of 
MSCs to all mesodermal lineages required that cells be seeded at high density (greater 
than 2xl04 cell/cm2). Whether the high cell density caused the cells to exit from cell 
cycle or whether cell-cell contact itself or factors secreted following cell-cell contact 
were required was not known (Reyes, 2001).
3. The third factor may have been the presence of GRGDY peptide in the 
alginate hydrogel.
Cultured SMCs produce ECM components including collagen, elastin, laminin, 
fibronectin, and glycosaminoglycans (Owens, 1995). RGD is the cell adhesion 
peptide for fibronectin. Attachment of MSCs to this peptide may signal the cells to 
differentiate. Several researchers have determined that the default differentiation 
pathway for hMSCs grown in vitro was toward vascular SMCs if they received no 
other definitive biological factors or cues to an alternative differentiation pathway -  
e.g. to adipocytes, chondrocytes or osteoblasts (Galmiche, 1993; Remy-Martin, 1999; 
Charbord, 2000). There have been several recent reports of in-vitro differentiation of 
MSCs on 3-D matrices as becoming “smooth muscle cell-like” through analyses of 
the proteins expressed during culture on 3-D matrices. MSCs grown on polyglycolic- 
acid (PGA) mesh coated with poly-4-hydroxybutyrate (P4HB) using non-specialized 
growth medium demonstrated myofibroblast-like characteristics by positive staining
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for ASMA and vimentin. Protein analysis showed production of collagen type I and 
III. No staining was noted for desmin (muscle cell marker), collagen II (osteoblast 
marker), collagen IV, and elastin (Kadner, 2002). In another study, early passage 
ovine MSCs grown in non-specialized growth medium stained positively for SH2, 
ASMA, and desmin, and a subset for calponin. These cells were also grown on a 
PGA-P4HB matrix and were shown to have biomechanical properties similar to 
native heart valve leaflets (Perry, 2003). The specific markers of differentiated 
smooth muscle cells include ASMA, smooth muscle myosin heavy chain, myosin 
light chains, calponin, SM-22a, h-caldesmon, vinculin, metavinculin, tropomyosin 
and intermediate filament proteins (desmin and vimentin) which are specific for 
vascular smooth muscle (Owens, 1995).
4.3. HMSCs/alginate-GRGDY hydrogel as a TEBV
In order to grow ex vivo a sufficient number of hMSCs to seed autologous tissue 
engineered blood vessels (TEBV) with 2xlO?cells/mL, 10.6mL of cell/alginate 
solution would be required to fabricate 5 tubes (4mm inner diameter x 20cm length x 
0.4mm wall thickness). This would require over 2x108 cells, not including cells 
required for release testing. Growth rate data were collected from fresh and frozen 
cell bank stocks derived from 5 different donors as measured by the population 
doubling time (PD/day). A minimum of 5 passages must be performed to achieve 
these numbers. However, it was noted that there was a substantial decrease in cell 
growth rate between passages 2 and 12 (section 6 , Table 18). This decrease was also 
reported by Bruder and Phinney; however, in their case the decrease in MSC growth 
rate was not associated with a loss in differentiation potential when extended 
subcultivation was used to differentiate cells through an osteogenic lineage (Bruder, 
1997; Phinney, 1999). Similar MSC growth rates have also been reported by Kinner 
(Kinner, 2002).
There is growing in vivo evidence that bone marrow cells (BMCs) will differentiate 
down the SMC pathway and can be used successfully as a cell source for a TEBV. In 
vivo canine studies have shown that bone marrow cells contributed to the construction 
of tissue engineered vascular autographs (Matsumura, 2003a); and there is now
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successful human clinical experience with these grafts in over 22 patients has been 
reported (Matsumura, 2003b).
Although alginate has not been reported as a potential matrix for TEBV; it has been 
used successfully for other structural tissues and has been found to be safe in humans. 
Part of this research focused on the formation of tubular constructs. Both rSMCs and 
hMSCs were shown to elongate inside alginate-GRGDY hydrogel tubes (Figures 29 
and 41). Interactions of the cells with the glass wall could not be discounted; 
although tubes made of cells with unmodified alginate did not produce any cell 
elongation. This interaction should be examined and discounted in future studies. All 
evidence from this research indicated no proliferation of the hMSCs within the 
unmodified alginate and alginate-GRGDY hydrogels. These results are further 
substantiated by results from Ma (2003) and Dar (2002). If no cell proliferation 
occurs in the matrix, then the constructs need to be initially seeded with the final 
number of cells to achieve 100% confluency. In fact, proliferation may be 
undesirable in a TEBV because proliferation of SMCs is associated with the 
pathology of cardiovascular disease (Ross, 1986; Schwartz, 1986).
The strength of the cell/alginate constructs was not addressed in this research. The 
evaluation of the strength of a TEBV derived from hMSCs/alginate-GRGDY 
constructs will be critical to determine if this approach is feasible. L’Heureux (1998) 
showed that fully confluent, overgrown sheets of cells when rolled together and 
further matured were strong enough (e.g. had burst strength over 2000mmHg) 
provided that the cells were producing extracellular matrix (ECM). If the alginate- 
GRGDY hydrogel tubes are seeded at very high density >2xl07cells/mL, then the 
construct would become densely networked within one day as was observed in beads. 
The strength of the MSCs can be increased by adding ascorbate to increase ECM (e.g. 
collagen) deposition or by using mechanical stimulation or pulsatile flow (L’Heureux, 
1998; Niklason, 1999; L’Heureux 2001; Thompson, 2002; Solan, 2003). Histological 
preparations of the large diameter (>2mm) hydrogel beads showed more cells located 
on or near the outer surface of the alginate construct which has been reported by 
others using alginate beads (Leo, 1990; Constantinidis, 1999; Goosen, 1999; Stabler, 
2002) and in media equivalents for skin (Girton, 2000; Michel, 1993) possibly due to 
air/liquid interface. This inhomogeneity in the large diameter beads may have been
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due to an oxygen or nutrient gradient; and therefore, avoidable using smaller diameter 
beads and thin walled tubes. Cell to cell contact must be achieved in these constructs 
in order to obtain the strength needed for a TEBV.
Growth factors could be incorporated into the cell/alginate hydrogel to stimulate 
growth or differentiation. Others have shown success releasing growth hormones 
(such as bFGF, VEGF, PDGF, hGH) from PLGA microspheres within alginate 
scaffolds (Perets, 2003), without alginate (Johnson, 1996) or a combination 
(Richardson, 2001). The alginate polysaccharide backbone is extremely versatile. 
Different peptides can be used to study attachment, proliferation and/or 
differentiation. Degradable peptide sequences could be incorporated onto the alginate 
backbone such as GGLGPAGGK (collagenase-sensitive) or AAAAAAAAAK 
(elastase-sensitive) as was shown by Mann using photopolymerized PEG hydrogels 
(Mann, 2001). It is possible that the lack of cell proliferation in the alginate and 
alginate-GRGDY beads in this research was due to lack of degradation of the alginate 
polymer. Degradation of the alginate polymer can be manipulated by altering the 
molecular weight by gamma irradiation (Alsberg, 2003; Kong, 2003). A lower 
molecular weight (<48kDa) is also desirable to clear the kidneys (Al-Shamkhani and 
Duncan, 1995).
Finally several challenges were overcome using this hMSC/alginate system as a tissue 
engineered construct during this research. Thermophilic bacillus spores were 
identified in the commercial alginate suppliers which became activated during 
autoclaving. Reliable and consistent preparation of sterile alginate was not a trivial 
issue; therefore a sterile supplier (NovaMatrix) was obtained to maintain the progress 
of this research. As a result, derivatized alginate-GRGDY material was produced by 
consistent and sterile methods. The purification of alginate remains a topic of much 
investigation (Klock, 1994; Zimmermann, 2000 and 2001; Orive, 2002).
In addition, a dramatic discoloration of the hMSC/alginate-GRGDY beads was 
observed and determined to be caused by calcification within the hydrogel network. 
The calcification was due to the high concentration of calcium ions within the cross 
linked alginate due to its high guluronic content and the presence of divalent ion 
chelators. The possible sources of these chelators were identified as high
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concentration of phosphate in the MSCCM growth medium, elevated levels of lactate 
produced locally by the high seeding density of the hMSCs within the alginate, and 
the presence of microbial contaminants within the system. Differentiation studies 
were usually not affected by calcification due to the switch to conditioned DMEM 
during these studies.
4.4. Conclusions
This research indicated that adult hMSCs can be encapsulated in alginate beads with 
retained viability and that the GRGDY peptide derivative encouraged attachment and 
elongation to form a dense network of cells which is required for a tissue substitute. 
Because the availability of autologous human cells is severely limited, beads were 
examined as a proxy for tubular constructs. Despite providing cell adhesion sites 
using a GRGDY peptide motif, the hMSCs did not proliferate within the alginate 
hydrogel. The MTT assay can be used to evaluate the metabolic activity of the cells; 
and the results using the MTT assay were consistent with measurements by 
hemacytometer and GCR. A frozen storage stage was incorporated to allow 
consistent examination of a time course. The lack of cell proliferation in the alginate 
beads may have been associated with the small pore size, degree of stiffness or lack of 
degradation after cell elongation and networking; however similar reports of no cell 
proliferation in unmodified alginate have been made by Dar (2002) using entrapped 
neonatal cardiac cells. In addition Ma (2003) showed MSC growth cycle arrest within 
1 day of encapsulation of MSCs in alginate.
The research described has identified a number of critical issues in the expansion of 
adult stem cells and their association with alginate scaffold for tissue engineering.
The issue of sterility with alginate emphasized the challenge this presents with natural 
polymers. However, the success in obtaining encapsulated cells which developed and 
associated once an RGD peptide was incorporated into the polymer indicates that the 
alginate scaffold has real potential. The action of the microfiltrate from the 
conditioned rSMC co-cultures probably has not caused more than partial 
differentiation of the hMSCs but indicates the potential of an equivalent human 
smooth muscle immortalized line and therefore necessitates further characterization of 
the active agents. Further progress rests on being able to measure the degree of cell 
proliferation and metabolism over extended times so that the ability to use the MTT
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assay with frozen material, which was established, is valuable. The issue of whether 
sufficient cell doublings during in vitro expansion of the adult hMSCs can be 
achieved remains as do many others but some of the key issues that will underpin 
future studies at UCL and elsewhere have been defined.
4.5. Recommendations for future work
4.5.1. Cell-alginate hydrogel construction
Cell/alginate beads of 2-2.5mm diameter were produced manually as described in 
section 2.4.3. This size was well above the 80-100pm limit of oxygen diffusion in 
human tissue (Schumacker and Samsel, 1989; Carmeliet and Jain, 2000). The 
maximum cell density used in these studies was ca. 2xl0 7cells/mL alginate. This 
density was limited by the minimum volume required for homogeneous resuspension 
of the pelleted cells and the concentration of the reconstituted alginate-GRGDY (see 
sections 2.4.1 and 2.4.4). Other reports have indicated that 5xl07 cells/mL matrix was 
required to produce homogeneous cartilage (Xia, 2001). Therefore it would be 
desirable to make beads of higher cell concentration with smaller diameter size (ca. 
400-600pm). Producing a smaller diameter bead would also be essential in order to 
achieve an effective comparison of similar dimensions of tube wall thickness. 
Alginate bead devices were commercially available (Innotec AG, Dottikon, 
Switzerland); however they operated at very large input volumes (ca. lOO-lOOOmL). 
For this project, microliter to milliliter volumes of cells/alginate (ca. lOO-lOOOpL) 
needed to be processed due to the limited supplies and expense of mammalian stem 
cell culture and reagents used to produce derivatized alginate. Therefore an in-house 
fabricated bead device capable of operating with microliter quantities for producing 
smaller diameter beads would be important.
Future studies should be performed to verify and adjust the pH and osmolality of the 
reconstituted alginate-GRGDY so that it is physiological to the cells. Initial pH 
measurements were inconclusive due to the large volume of alginate-GRGDY 
material needed to test with the current electrode system. A sterilizable, micron-sized 
pH probe would be ideal. Alternatively, a buffer exchange step could be incorporated 
during the last stage of dialysis with water that contained enough NaOH for 
reconstitution after lyophilization. However, this base addition during the dialysis
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step would still need to compensate for the final concentration of the alginate- 
GRGDY product after lyophilization and reconstitution due to the influx of water into 
the cassette during dialysis. The dependence of the carbodiimide reaction upon 
temperature and mixing conditions should also be further examined. The temperature 
used in this research was not well controlled and ranged between 20-26°C for the 
reaction chemistry. In addition, the dialysis temperature varied from cold (6-10°C) 
during the ‘initial process’ to very warm (26-31°C) in the laminar flow hood during 
the ‘sterile process’.
Several items were not well understood regarding the derivatization of alginate- 
GRGDY. The amount of uronic acid units in the alginate was estimated since this 
information was not provided by the manufacturers. Therefore the amount of 
reactants (eg. sulfo-NHS, EDC and peptide) added to the alginate was varied between 
IX and 50X, where IX was lmg of alginate containing 38pg of sulfo-NHS, 67pg of 
EDC and lpg of peptide; and 5OX was fifty times the reactants per lmg of alginate. 
More analytical chemistry needs to be completed such as determining the amount 
(number) of uronic acid units in the alginate and determining the amount of 
pentapeptide incorporated into the alginate. Then the efficiency or possibly rate at 
which the peptide is incorporated into the alginate can be determined from the 
concentration of reactants used. Mooney’s lab used a radioactive label to measure the 
amount of peptide incorporated into the alginate (Rowley, 1999), which was not 
feasible for this research. Levels of peptide incorporated into the alginate may be able 
to be determined from the tyrosine residue (due to its aromatic ring) which may be 
measurable using nuclear magnetic resonance (NMR).
Primarily high guluronic-containing alginates, such as Manugel DMB and Pronova 
SLG100, were used for this research. High guluronic-containing alginates produced 
strong hydrogels because they were highly cross linked. Because they contained high 
levels of calcium; they were susceptible to calcification. Low guluronic-containing 
alginates, such as Pronova SLM and Sigma alginates, are less likely to experience 
calcification and should be investigated further. The GRGDY-derivatization process 
of low guluronic-containing alginates will also need to be investigated because the 
mannuronic subunits may be less susceptible to reaction using carbodiiamide 
chemistry due to its different moiety. The use of barium chloride as a cross linking
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solution should be explored to see if this eliminates calcification. However the 
rSMCs seemed to be more sensitive to barium when studied initially in 
collagen/alginate matrices.
Finally the pore size and microstructure of the alginate-GRGDY hydrogels should be 
examined. The hydrogel pore size may be increased by adding surfactants such as 
BSA or Pluronic (F6 8  or F I08) to increase pore size (Eiselt, 2000).
4.5.2. MSCs as the cell substrate
It would be advantageous to create a hMSC cell bank that had a longer life-span in 
vitro on which to conduct studies since the cells used in these studies could only be 
grown to passage 12. This could be accomplished by two methods: isolating and 
generating a multipotent adult progenitor cell (MAPC) bank which would have 
unlimited passaging potential without obvious senescence or loss of differentiation 
potential (Reyes, 2001; Jiang, 2002); or incorporating human telomerase reverse 
transcriptase (hTERT) gene into a population of isolated hMSCs. HTERT has been 
successfully incorporated into human SMCs and resulted in cells that proliferated far 
beyond their normal lifespan but retained characteristics of normal control SMCs 
(McKee, 2003).
Due to the hMSC/alginate-GRGD Y beads dissociating at later time points and to 
improve the stability of the alginate beads during storage prior to 
immunohistochemistry preparation, lOmM CaCb should be added to the 
formaldehyde solution. The presence of calcium ions will help maintain the hydrogel 
structure during storage of the beads until histological preparations are made. 
Additional antibodies for identification of smooth muscle cell-specific proteins, such 
as h-caldesmon (now commercially available), desmin, calponin and heavy chain 
myosin, should be used in immunohistological preparations for verification of smooth 
muscle cell phenotype. H-caldesmon staining has been reported as being able to 
differentiate between smooth muscle cells and other cell varieties such as fibroblasts 
and myofibroblasts that sometimes express ASMA and desmin (D’Addario, 2002). In 
addition, a protein assay should be used to quantitate the amount of these proteins 
expressed by the hMSCs in the differentiation studies. A detailed protein analysis
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would also confirm whether hMSCs expressed ASMA at the beginning of a 
differentiation study or after long term culture in growth medium since 
immunohistology results showed non-specific binding of the biotin in the day 0  
hMSCs immobilized in alginate-GRGDY beads, as well as in long term cultures of 
hMSCs grown in DMEM and CDMEM. Finally, alginate degradation during 
culturing should be monitored using staining reagents specific for polysaccharides 
such as alginate including periodic acid-Schiff reagent, Toluidine blue and Alcian 
blue (Lee, 1997). Alginate may be lost during standard histological preparation (e.g. 
dewaxing step) so the hydrogels may need to be stained for presence of alginate prior 
to processing.
Differentiation studies were conducted with conditioned medium containing fetal 
bovine serum which could have affected growth and differentiation due to presence of 
undefined components. In the future, studies should be performed in defined 
medium. Gronthos and Simmons have shown the conditions and factors required for 
growth of stromal cells under serum deprived conditions in vitro. The exogenous 
factors determined to be essential included their SDM (serum-deprived medium, 
defined in glossary) containing L-ascorbate, glucocorticoid dexamethasone, PDGF- 
BB and EGF on fibronectin coated plates (Gronthos and Simmons, 1995). In 
addition, Seruya (2004) reported serum-free conditions that led to high-efficiency 
smooth muscle differentiation using rat MSCs isolated from muscle tissue plated on 
collagen IV-coated surfaces and exposed to transforming growth factor-pi (TGF-pl). 
These rat MSCs differentiated into a homogeneous population expressing ASMA and 
calponin (Seruya, 2004). Wang, D. (2004) also reported that TGF-pl affected the 
differentiation of rMSCs into SMCs. Initial research has also indicated that some 
minimal culture time is needed in MSCCM before transfer of the beads into CDMEM 
with rSMC cultures due to one study in which no elongation was observed in hMSCs 
grown in complete DMEM only (Figure 44). Finally further differentiation studies 
could be conducted to determine if hMSCs immobilized in unmodified alginate (no 
GRGDY peptide) differentiate when cultured in CDMEM with rSMC co-cultures. 
Alternatively differentiation studies could be performed using human SMC 
conditioned medium and co-cultures instead of rat SMC. A female source of hMSCs 
should be used with a male source of hSMCs such that DNA analysis using 
fluorescence in situ hybridization (FISH) testing could be performed after the study to
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determine if cross contamination of cells occurred. The presence of a Y chromosome 
in the female hMSCs would indicate contamination from the male hSMC co-cultures; 
and therefore, indicate differentiation potentially caused by cell fusion instead of by 
directed differentiation. It has been reported that BMCs can adopt the phenotype of 
the recipient cells in vivo by cell fusion rather than by directed differentiation (Terada, 
2002).
The issue of cell/alginate matrix contraction as observed in section 3.6.2.1 (Figure 
6 6 .G) will have to be studied further since it would be undesirable to have an uneven 
surface in the lumen of a mature blood vessel. An uneven surface could result in 
turbulent flow and thrombosis. Finally the possibility that the hMSCs are associating 
with the glass wall of the bioreactor needs to be examined and discounted by applying 
a non-binding surface onto the glass bioreactor.
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5. Glossary
Allogeneic - being genetically different although belonging to or obtained from the 
same species
Ammo acid abbreviations — A — alanine (Ala); C — cysteine (Cys); D — aspartic acid 
(Asp); E -  glutamic acid (Glu); F -  phenylalanine (Phe); G -  glycine (Gly); H- 
histidine (His); I -  isoleucine (lie); K -  lysine (Lys); L -  leucine (Leu); M -  
Methionine (Met); N- asparagine -  (Asn); P -  proline (Pro); Q -  glutamine (Gin); R - 
arginine (Arg); S — Serine (Ser); T — threonine (Thr); W — tryptophan (Trp); V-valine 
(Val); Y -  tyrosine (Tyr)
Aneurysm - a localized, pathological, blood-filled sac-like dilatation (widening) of a 
blood vessel caused by a disease or weakening of the vessel's wall
Arteriovenous fistula - abnormal channel between an artery and a vein, bypassing the 
capillaries, which may be congenital, in which smaller vessels are involved, or 
acquired due to acute local trauma or to erosion of an arterial aneurysm into an 
accompanying vein (from The Merck Manual — web version)
Autologous - Derived or transferred from the same individual's body (i.e. patient’s 
own)
CDMEM -  conditioned DMEM - the supernatant collected from centrifuged 
conditioned medium from rSMC cell cultures used for hMSC differentiation studies.
Complete DMEM -  culture medium consisting of the formulation of Dulbecco’s 
Modified Eagles Medium (DMEM) completed with 10% FBS, 2 mM 1-glutamine,
100 U penicillin/ml and 100 pi streptomycin/ml.
EDTA -  Ethylenediaminetetraacetic acid -  a divalent cation chelator used in 
combination with trypsin (porcine-derived proteolytic enzyme) to detach cells from 
the surface of polystyrene tissue flasks. It also sequesters calcium ions in an alginate 
hydrogel and causes the gel to dissolve.
FACS -  Fluorescence activated cell sorting.
Femoropopliteal bypass - a diseased (blocked) blood vessel located above or below 
the knee is bypassed by using either a transplanted healthy blood vessel or an artificial 
graft material (from my.webmd.com).
FITC - fluorescein isothiocyanate is the reactive form of fluorescein, a fluorescent dye 
for FACS analysis. FITC is a small organic molecule, and is typically conjugated to 
proteins via primary amines (i.e., lysines). Usually, 3-6 FITC molecules are 
conjugated to each antibody. Fluorescein is typically excited at 488nm using an argon 
laser, and emission is collected at 530nm.
Formal saline - 10% formaldehyde in buffered saline used to prepare histology 
samples
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Glucose consumption rate (GCR) — the amount of glucose consumed in the compete 
medium per hour in culture.
HLA -  Human leukocyte antigens are proteins on the surface of the body’s cells 
which identify an individual’s tissue type. The immune system uses HLA to 
recognize self vs. foreign. These proteins are encoded by genes comprising of the 
major histocompatibility complex (MHC) which in concert with T-cell receptors 
make possible the immune recognition of foreign antigens.
Homophilically -  refers to the type of cell adhesion where the cell surface adhesion 
proteins in the two cells are the same
Hypertonic -  having the higher osmotic pressure of two solutions
Integrins - family of cell surface proteins that are involved in binding to extracellular 
matrix components in some cases. The first examples described were fibronectin and 
vitronectin receptors of fibroblasts, which bind to an RGD (Arg Gly Asp) sequence in 
the ligand protein
Intima - The innermost membrane of an organ or part, especially the inner lining of a 
lymphatic vessel, an artery, or a vein.
Luminal - The inner open space or cavity of a tubular organ, as of a blood vessel or an 
intestine
Mitogen - agent that induces mitosis (cell division)
MSC, hMSC -  human mesenchymal stem cells derived from bone marrow
MSCCM -  mesenchymal stem cell culture medium consisting of the formulation of 
Mesencult basal medium, MSC growth stimulatory supplements (Stem Cell 
Technologies), rFGF, penicillin and streptomycin
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay
Normal saline (n-saline) -  0.9% w/v NaCl in distilled water, pH adjusted using IN 
NaOH to ca. 7-8.
Patency, Patent -  the state of being open, expanded or unblocked
RGD-modified alginate -  abbreviated term for alginate which has been modified by 
the addition of a poly-peptide containing arginine, glycine, and aspartic acid (RGD) 
onto the carboxylic acid moiety of the alginate polysaccharide chain.
RPE - Rhodophyta-phycoerythrin was originally isolated from red algae and is used 
as a fluorescent probe. Its primary absorbance peak occurs at 566nm with secondary 
peaks at 496 and 5 4 5 nm; the relative prominence of the secondary peaks varies 
significantly among RPEs from different species. Usually one RPE molecule is
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conjugated to each antibody for identification of cell-specific surface markers using 
FACS analysis. It emits at about 575nm.
rSMC -  rat smooth muscle cells derived from immortalized cell line ATCC A7r5
SDM -  serum-deprived medium as described by Gronthos and Simmons (1995) for 
hBMCs -  aMEM supplemented with lOpg/mL bovine pancreas-derived insulin, 2% 
BSA, 4pg/mL human low-density lipoprotein, 200pg/mL iron-saturated human 
transferrin, 2mmol/L L-glutamine, lOnmol/L dexamethasone sodium phosphate, 
lOOpmol/L L-ascorbic acid 2-phosphate, and 50pmol/L (3-mercaptoethanol.
SMC -  smooth muscle cells
Spent medium -  conditioned medium from confluent cultures of SMCs would contain 
complete medium, trypsin, EDTA, and by-products of cellular metabolism (eg. 
lactate, ammonia, LDH)
Systolic thickening - increase in apparent tracer activity during systolic contraction
WFI - Water for injection used for cell culture applications prepared by ultrafiltration, 
reverse osmosis, deionization, distillations and sterile filtration. Obtained from 
Biowhittaker, catalog 17-724G.
Xenogeneic - derived from a different animal species
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6. Appendices
6.1. Materials and methods appendices
6.1.1. Assay protocols
6.1.1.1. MTT assay for MSC cell number standard
S tep  1: T r y p s in iz e  M S C s  fr o m  t i s s u e  c u ltu r e  f la s k ( s )  u s in g  p ro ced u re  in  s e c t io n  2.2.22  and  
d e te r m in e  th e  c e l l  c o n c e n tr a t io n  a s  p e r  s e c t io n  2 .5 .2 .
S tep  2: C e n tr ifu g e  th e  c e l l s ,  r e m o v e  th e  su p ern a ta n t a n d  r e su sp e n d  th e  p e lle t  to  2 x l 0 6c e ll /m L  
in  D P B S G . R e p e a t  th e  c e l l  c o u n t  u s in g  2 0 p L  o f  c e l l  su s p e n s io n  an d  ad d  to  8 0 p L  o f  
D P B S G  to  c o n f ir m  th e  a c tu a l c e l l  c o n c e n tr a t io n  in  th e  re su sp e n d e d  p e lle t .
S tep  3: T ra n sfer  a liq u o ts  o f  c e l l  s u s p e n s io n  in to  a  9 6  w e l l  m ic r o p la te  a s in d ic a te d  in  T a b le  5 
( s e c t io n  2 .6 .2 .1 ) .  E q u a liz e  th e  v o lu m e  p e r  w e l l  b y  a d d ed  th e  v o lu m e  o f  D P B S G  
in d ic a te d  in  T a b le  5 .
S tep  4: A d d  lO p L  o f  5 m g /m L  M T T  s o lu t io n  to  e a c h  w e l l .  In cu b a te  at 3 7 °C , c o v e r e d  w ith  
f i lm .
S tep  5: A fte r  3 h o u rs , ad d  4 0 p L  0 .3 M  tr is o d iu m  c itra te  to  e a c h  w e ll .  In cu b a te  at 3 7 °C , 
c o v e r e d  w ith  f i lm  fo r  1 a d d it io n a l h o u r . (T r is o d iu m  c itra te  ad d ed  h ere  to  m im ic  
p r o to c o l to  d is s o lv e  a lg in a te  b e a d s .)
S tep  6: C e n tr ifu g e  p la te  at lO O g fo r  5 m in u te s
S tep  7: R e m o v e  su p ern a ta n t w ith o u t  d is tu r b in g  p e lle t /b e a d , u n til r in g  app ears o n  b o tto m  o f  
w e ll .
O p tio n a l S tep  8: F r e e z e /s to r e  p la te  a t -7 0 ° C , c o v e r e d  w ith  fo i l .  (F r e e z in g  r e c o m m e n d e d  for  
t im e  c o u r se  e x p e r im e n t .)
O p tio n a l S tep  8a: T h a w  p la te .
S tep  9: A d d  7 0 p L  o f  D P B S G  to  e a c h  w e l l  ( N o t e  ad d  5 0 p L  i f  p er fo r m in g  s te p lO ). G e n tly  tap  
p la te  to  lo o s e n  c e l l  p e l le t .  (N o t e  o p t io n a l s te p  10  an d  10 a  ca n  b e  p er fo rm ed , b u t th e  
tr y p s in /E D T A  te n d s  to  m a k e  th e  c e l l s  s t ic k y ) .
O p tio n a l S tep  10: A d d  2 0 p L  1 0 X  tr y p s in /E D T A  in  s a l in e  to  e a c h  w e ll .  In cu b a te  at R T  fo r  3 0  
m in u te s  c o v e r e d  w ith  f i lm . ( N o t e  th is  s te p  is  o n ly  req u ired  fo r  a lg in a te -G R G D Y  
b e a d s .)
O p tio n a l S tep  10a: U s in g  s e p a r a te  m ic r o p ip e ts , th o r o u g h ly  re su sp en d  c e l l s  u n til c o m p le te ly  
h o m o g e n e o u s  w ith in  s o lu t io n .
S tep  11: A d d  lO O pL  o f  i s o p r o p a n o l /0 .I N  HC1 s o lu t io n  to  e a c h  w e ll .  In cu b a te  at R T , co v e r e d  
w ith  f i lm  fo r  2 0  m in u te s .
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Step  12: U s in g  sep a ra te  m ic r o p ip e ts ,  m ix  e a c h  w e l l  th o r o u g h ly  (fo rm a za n  c r y sta ls  m a y  n o t  
y e t  b e  c o m p le te ly  d is s o lv e d ) .  In c u b a te  at R T , c o v e r e d  w ith  f i lm  fo r  2 0  a d d it io n a l 
m in u te s .
S tep  13: U s in g  sep a ra te  m ic r o p ip e ts ,  m ix  e a c h  w e l l  th o r o u g h ly  ( s o lu t io n  s h o u ld  b e  
c o m p le te ly  d is s o lv e d ) .
S tep  14: I m m e d ia te ly  read  p la te  o n  sp e c tr o p h o to m e te r  (read  s e t t in g  6 0 0 n m , r e fe r e n c e  se t t in g  
6 7 0 n m )  w ith in  1 h o u r  fr o m  t im e  o f  is o p r o p a n o l/H C l a d d it io n .
N o te : R T  =  r o o m  te m p era tu re  (1 9 ° C  id e a l , a b so r b a n c e  r e a d in g s  and  s ta b ility  o f  d is s o lv e d
form azan  w e r e  e f f e c te d  b y  te m p e r a tu r e .)
6.1.1.2. MTT assay for MSCs in alginate beads
S tep  1: T ra n sfer  b e a d s  fr o m  m ic r o w e l l  c u ltu r e  in to  p e tr i-d is h  c o n ta in in g  D P B S G . L et b ea d  
r in se  fo r  ca . 15  m in u te s .
S tep  2: T ra n sfer  b e a d s  in to  9 6  w e l l  m ic r o p la te ;  ad d  0 , 1 , 2 ,  3 b e a d s /w e l l  fo r  c e l l  stan dard .
S tep  3: E q u a liz e  D P B S G  v o lu m e  p e r  w e l l  t o  lO O p L /w e ll.
S tep  4: A d d  lO fiL  o f  5 m g /m L  M T T  s o lu t io n  to  e a c h  w e l l .  In cu b a te  at 3 7 °C , c o v e r e d  w ith  
f i lm .
S tep  5: A fte r  3 h o u rs , ad d  4 0 p L  0 .3 M  tr iso d iu m  c itra te  to  e a c h  w e ll .  In cu b a te  at 3 7 °C ,
c o v e r e d  w ith  f i lm  fo r  1 a d d it io n a l h o u r .
S tep  6: C e n tr ifu g e  p la te  at lO O g fo r  5 m in u te s
S tep  7: R e m o v e  su p ern a ta n t w ith o u t  d is tu r b in g  p e lle t /b e a d , u n til r in g  ap p ears o n  b o tto m  o f
w e ll .
O p tio n a l S tep  8: F r e e z e /s to r e  p la te  a t -7 0 ° C , c o v e r e d  w ith  fo i l .  (F r e e z in g  r e c o m m e n d e d  fo r  
t im e  c o u r se  e x p e r im e n t .)
O p tio n a l S tep  8a: T h a w  p la te .
S tep  9: A d d  7 0 p L  o f  D P B S G  to  e a c h  w e l l  (N o t e  ad d  5 0 p L  i f  p e r fo r m in g  s te p lO ) . G e n tly  tap  
p la te  to  lo o s e n  c e l l  p e l le t .
O p tio n a l S tep  10: A d d  2 0 p L  1 0 X  tr y p s in /E D T A  in  s a l in e  to  e a c h  w e ll .  In cu b a te  at R T  fo r  3 0  
m in u te s  c o v e r e d  w ith  f i lm . (N o t e  th is  s te p  is  req u ired  fo r  a lg in a te -G R G D Y  b e a d s .)
O p tio n a l S tep  10a: U s in g  se p a r a te  m ic r o p ip e ts , th o r o u g h ly  re su sp en d  b e a d (s )  u n til c e lls  
c o m p le te ly  h o m o g e n e o u s  w ith in  s o lu t io n .
S tep  11: A d d  lO O pL  o f  is o p r o p a n o l /0 .I N  HC1 s o lu t io n  to  e a c h  w e ll .  In cu b a te  at R T , c o v e r e d  
w ith  f i lm  fo r  2 0  m in u te s .
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S tep  12: U s in g  sep a ra te  m ic r o p ip e ts ,  m ix  e a c h  w e l l  th o r o u g h ly  (fo rm a za n  c r y sta ls  m a y  n o t  
y e t  b e  c o m p le te ly  d is s o lv e d ) .  I n c u b a te  at R T , c o v e r e d  w ith  f i lm  fo r  2 0  a d d itio n a l 
m in u te s .
S tep  13: U s in g  sep a ra te  m ic r o p ip e ts ,  m ix  e a c h  w e l l  th o r o u g h ly  ( s o lu t io n  s h o u ld  b e  
c o m p le te ly  d is s o lv e d ) .
S tep  14: I m m e d ia te ly  read  p la te  o n  s p e c tr o p h o to m e te r  (read  s e t t in g  6 0 0 n m , r e fe r e n c e  se tt in g  
6 7 0 n m )  w ith in  1 h o u r  fr o m  t im e  o f  is o p r o p a n o l/H C l a d d it io n .
N o te : R T  =  r o o m  te m p era tu re  (1 9 ° C  id e a l ,  a b so r b a n c e  r e a d in g s  an d  s ta b ility  o f  d is s o lv e d
form azan  w e r e  e f f e c t e d  b y  te m p e r a tu r e .)
6.1.1.3. MTT assay for adherent cells
S tep  1: R e m o v e  sp e n t m e d iu m  fr o m  ( 2 4  w e l l )  m ic r o w e l l  cu ltu res  an d  ad d  3 0 0 p L /w e ll  
D P B S G .
S tep  2: A d d  3 0 |iL  o f  5 m g /m L  M T T  s o lu t io n  to  e a c h  w e l l .  In cu b a te  at 3 7 °C , c o v e r e d  w ith  
f i lm .
S tep  3: A fte r  3 h o u rs , ad d  1 2 0 p L  0 .3 M  tr is o d iu m  c itra te  to  e a c h  w e l l .  In cu b ate  at 3 7 °C ,
c o v e r e d  w ith  f i lm  fo r  1 a d d it io n a l h o u r . (T h is  s te p  m im ic k e d  a d d it io n s  p er fo rm ed  to  
d is s o lv e  a lg in a te  b e a d s  b u t is  n o t  req u ir e d  i f  a lg in a te  n o t  u se d  in  s tu d y .)
S tep  4: R e m o v e  M T T  s o lu t io n  fr o m  w e l l s  (N o te :  fo r m a z a n  p r e c ip ita te s  trap p ed  w h e n  c e l ls  
a tta ch ed  to  p la te  su r fa c e ) .
O p tio n a l S tep  5: F r e e z e /s to r e  p la te  at -7 0 ° C , c o v e r e d  w ith  fo i l .  (F r e e z in g  r e c o m m e n d e d  fo r  
t im e  c o u r s e  e x p e r im e n t .)
O p tio n a l S tep  5a: T h a w  p la te .
S tep  6: A d d  2 1 0 p L  o f  D P B S G  to  e a c h  w e l l .
S tep  7: A d d  3 0 0 p L  o f  is o p r o p a n o l /0 .I N  H C 1 s o lu t io n  to  e a c h  w e ll .  In cu b a te  a t R T , c o v e r e d  
w ith  f i lm  fo r  2 0  m in u te s .
S tep  8: U s in g  sep a r a te  m ic r o p ip e ts , m ix  e a c h  w e l l  th o r o u g h ly  (fo rm a za n  c r y s ta ls  m a y  n o t y e t  
b e  c o m p le te ly  d is s o lv e d ) .  In c u b a te  at R T , c o v e r e d  w ith  f i lm  fo r  2 0  a d d it io n a l 
m in u te s .
S tep  9: U s in g  sep a ra te  m ic r o p ip e ts , m ix  e a c h  w e l l  th o r o u g h ly  ( s o lu t io n  sh o u ld  b e  c o m p le te ly  
d is s o lv e d ) .
S tep  10: Im m e d ia te ly  r e m o v e  lO O pL  fr o m  e a c h  w e ll ,  tra n sfer  in to  9 6  w e ll  p la te  and  read
p la te  o n  s p e c tr o p h o to m e te r  (rea d  s e t t in g  6 0 0 n m , r e fe r e n c e  s e t t in g  6 7 0 n m )  w ith in  1 
h o u r  fr o m  t im e  o f  is o p r o p a n o l/H C l a d d it io n .
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S tep  11: A c tu a l a b so r b a n c e  s h o u ld  b e  m u lt ip l ie d  b y  a  d i lu t io n  fa c to r  o f  3 (3  fo ld  v o lu m e  o f  
D P B S G /is o p r o p a n o l u s e d  c o m p a r e d  to  n o r m a l c e l l  stan d ard  p rep ared  in  9 6  w e ll)  to  
o b ta in  a c tu a l c e l l  c o n c e n tr a t io n  c o m p a r e d  to  th e  stan d ard .
N o te : R T  =  r o o m  te m p e r a tu r e  (1 9 ° C  id e a l ,  a b so r b a n c e  r e a d in g s  an d  s ta b ility  o f  d is s o lv e d  
form azan  w e r e  e f f e c te d  b y  te m p e r a tu r e .)
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6.1.2. Assay errors and standard curves
6 .I.2 .I. CyQuant assay
30000
25000
g 2 0 0 0 0
c 8 o
o□
♦
■
X
1X dy e/1 X cells 
2X dy e/1 X cells 
Control for alginate study 
Linear (1X dy e/1 X cells)
Linear (2X dye/1 X cells)
Linear (Control for alginate study)
y =  0 .5 0 1 6 x  
R? =  0 .9 3 6 5
15000
10000
y  = 0 .3 4 4 4 x  
R 2 =  0 .9 9 6 8
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y  =  0 . 3 3 3 9 x  
R 2 =  0 .9 3 4 3
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Number of cells/well
F ig u r e  6 9 .  T y p ic a l  C y Q u a n t  s ta n d a r d  c u r v e  u s i n g  r S M C s  a t  c o n c e n tr a t io n s  b e t w e e n  
5 0  a n d  5 6 ,0 0 0 c e l l s / w e l l .  W h e n  t h e  C y Q u a n t  d y e  c o n c e n t r a t io n  w a s  d o u b le d  ( 2 X )  fo r  
th e  s a m e  c o n c e n t r a t io n  o f  c e l l s  ( I X ) ,  t h e  s ta n d a r d  c u r v e  s lo p e  in c r e a s e d  f r o m  0 .3 4 x  t o  
0 .5 0 x .  T h e  ‘c o n tr o l  fo r  a lg i n a t e ’ s a m p le  i s  t h e  c e l l  s ta n d a r d  c u r v e  g e n e r a te d  fo r  th e  
d a ta  s h o w n  in  F ig u r e  7 1 .  T h e  a s s a y  w a s  f a ir ly  l in e a r  b e t w e e n  t h is  r a n g e  w h e n  t h e  c e l l  
s u s p e n s io n  w a s  tr e a t e d  w i t h  R N A s e  a s  d e s c r ib e d  in  s e c t io n  2 .6 .1 .1 .  R e a d in g s  w e r e  
ta k e n  a t 9 0 0  P M T .
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Figure 70. Typical CyQuant standard curve using bacteriophage DNA at 
concentrations between 5 and 2000ng/mL. When the CyQuant dye concentration was 
doubled (2X) for the same concentration o f DNA (IX), the standard curve slope 
increased from 24x to 33x. This corresponds to a similar increase observed when the 
CyQuant dye concentration was doubled in the cell standard curve shown in Figure 
69. Readings were taken at 900 PMT.
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Figure 71 Effect of alginate solution on fluorescence signal o f three cell 
concentrations using CyQuant assay. Three cell concentrations were tested with 0, 5, 
20 and 80pL of dissolved alginate solution. As the volume o f solution increased the 
fluorescence signal increased indicating the alginate or other components of the 
solution adversely affected binding o f fluorescence dye to the cellular DNA as 
compared to the control solution at the same cell concentrations. The cells were 
RNAse treated prior to addition of solutions and measured at a PMT setting o f 900. 
The cell standard curve is shown in Figure 69 for this experiment. From these data, 
an alternative proliferation assay was deemed necessary.
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6.1.2.2. MTT assay
Typical cell standard curves are provided in section 3.5.4, Figure 57 (cell standard 
from T-flask and alginate beads) and section 3.5.6, Figure 62 (cell standard from T25 
flasks) and Figure 63 (cell standard from alginate-GRGDY beads).
0.6 
0. 5 
„  0. 4
I
|  0. 3
JS
< 0.2 
0.1
1 2  3  4
No. of alginate beads/well
Figure 72. Determination o f alginate interference with the absorbance o f formazan. 
The same concentration (2.05x104cells/well) was tested with an increasing number of 
alginate beads/well. Absorbance readings were not affected by the increased level of 
alginate per well. Single factor ANOVA statistical comparison indicated that the 
results were statistically different (p=0.0000) among the 5 samples, however, the 
statistical difference between absorbance readings for 0 and 4 beads was not 
significant (p=0.4023) and between the absorbance readings for 2 and 3 beads 
(p=0.5021). The statistical difference was significant among the absorbance readings 
for 1 ,2  and 3 beads (p=0.0405). The variability o f  these results was likely due to 
well-to-well variability, and not due to alginate effect.
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6.2. Results appendices
6.2.1. Cell growth data
6.2.1.1. Cell population doubling levels per day for hMSCs
Passage number Population Doubling/day 
mean ± SEM
Number of observations 
(n)
P3 0.41 1
P4 0.27 1
P5 0.29 ± 0.06 13
P6 0.25 ± 0.06 18
P7 0.24 ± 0.08 19
P8 0 . 2 0  ± 0 . 1 1 15
P9 0.14 ±0.07 2 1
P10 0.18 ±0.05 1 0
P ll 0.05 ± 0.02 2
P12 0.06 1
Table 18. Mean and SEM of cell population doubling levels per day of hMSCs 
between passages 3 and 12. These data were generated from all hMSC growth from 
fresh and frozen sources for a total of 1 0 1  observations (n=1 0 1 ).
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6.2.2. Single factor ANOVA (analysis of variance) of MTT data
6.2.2.1. Length of incubation for MTT conversion and formazan
dissolution time
2 hr mean ± SEM 
(variance)
3 hr mean ± SEM 
(variance)
4 hr mean ± 
SEM 
(variance)
8 .6 x 1 0 4  cells/well
First reading (<lhr 
dissolution time)
0.989 ±0.119 
(0.014)
0.947 ±0.130 
(0.017)
1.066 ±0.117 
(0.014)
Second reading 
(>lhr dissolution 
time)
0.777 ± 0.068 
(0.005)
0.738 ±0.138 
(0.019)
0.763 ± 0.041 
(0 .0 0 2 )
4.1xl0 4 cells/well
First reading (<lhr 
dissolution time)
0.367 ± 0.027 
(.0 0 1 )
0.472 ±0.031 
(0 .0 0 1 )
0.539 ± 0.088 
(0.008)
Second reading 
(>lhr dissolution 
time)
0.293 ± 0.024 
(0 .0 0 1 )
0.381 ±0.063 
(0.004)
0.457 ± 0.075 
(0.006)
2 . 1 x l 0 4  cells/well
First reading (<lhr 
dissolution time)
0.189 ±0.046 
(0 .0 0 2 )
0.229 ± 0.039 
(0 .0 0 1 )
0.269 ±0.051 
(0.003)
Second reading 
(>lhr dissolution 
time)
0.186 ±0.029 
(0 .0 0 1 )
0.205 ± 0.068 
(0.005)
0.223 ±0.018 
(0 .0 0 0 )
1 .2 x l 0 4 cells/well
First reading (<lhr 
dissolution time)
0.137 ±0.028 
(0 .0 0 1 )
0.112 ±0.039 
(0 .0 0 2 )
0.158 ±0.023 
(0 .0 0 1 )
Second reading 
(>lhr dissolution 
time)
0.091 ± 0.024 
(0 .0 0 1 )
0.131 ±0.035 
(0 .0 0 1 )
0.139 ±0.019 
(0 .0 0 0 )
Table 19. The mean, standard error (SEM) and variances of absorbance readings for 
MTT incubation length and formazan dissolution time (from section 3.5.1.3, shown in 
Figure 50).
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Length of incubation for MTT conversion and formazan dissolution time 
(continued)
Comparison of p-values among designated time points (2, 3 or 4 hr) 
(for absorbances at 8 .6 x 1 0 4  cells/well)
p value ( 2 / 3 / 4  
hr time points)
1 st readings have same mean 
2 nd readings have same mean
First reading (<lhr 
dissolution time)
p=0.2613
Second reading (>lhr 
dissolution time)
p=0.7571
Comparison of p-values between pooled (2, 3 and 4 hr) time points at first
and second reading 
(for absorbances at 8 .6 x 1 0 4  cells/well)
p value of pooled 1 s‘ 
reading / pooled 2 nd 
second Therefore, 1st and 2nd readings have 
different meansPooled readings p=0 . 0 0 0 0
Comparison of p-values between designated ti 
(for absorbances at 4.1x104  ce
me points (2, 3 or 4 hr) 
ls/well)
p value 
( 2 / 3 / 4 )
p value
( 2 / 3 )
p value
(3/4)
p value 
(2/4)  _
First reading (<lhr 
dissolution time)
0.0003 0 . 0 0 0 1 0.1090 0 . 0 0 1 0
Second reading 
(>lhr dissolution 
time)
0.0008 
different means
0.0097 
different means
0.0848 
same mean
0.0004
different
means
Comparison of p-values between each time point (2,
and second reading 
(for absorbances at 4.1x104  cells/wel
3 or 4 hr) at first 
)
p value 
( 2  first / 2  second)
p value 
(3 first / 3 second)
p value 
(4 first / 4 second)
Both readings 0.0005 
different means
0.0095 
different means
0.1125 
same mean
Table 20. Single factor ANOVA statistical comparison of individual time points at 
first and second absorbance readings at 6.8xl04 and 4.1xl04 cells/well for MTT 
incubation length and formazan dissolution time (from section 3.5.1.3, shown in 
Figure 50). Analyses at 2.1x104 and 1.2xl04 cells/well were not statistically different 
(p>0.05) for any comparison.
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6.2.2.2. Fresh versus frozen MTT assay
Mean ± 
SEM 
(variance) 
for 1 bead
Compar­
ison of p- 
value 
for 1 bead
Compar­
ison of p- 
value 
for 1 bead
Mean ± 
SEM 
(variance) 
for 2  beads
Compar­
ison of p- 
value for 2  
beads
Compar­
ison of p- 
value for 2  
beads
Day 2 - 
fresh
0.189 ± 
0.026 
(0.0007)
0.6743 All 6  
samples 
(p=0.0005)
5 samples
(excluding
D6  fresh)
(p=0.3804)
*
0.549 ± 
0.034 
(0 .0 0 1 2 )
0.0209 All 6  
samples
(p=0 .0 0 0 0 )
5 samples 
(excluding 
D2 fresh) 
(p=0.0051)
4 samples 
(excl. D2 
&D4 
fresh) 
(p=0.0316)
Day 2 - 
frozen
0.198 ± 
0.042 
(0.0017)
0.449 ± 
0.083 
(0.0068)
Day 4 - 
fresh
0.174 ± 
0.025 
(0.0006)
0.0579 0.383 ± 
0.046 
(0 .0 0 2 1 )
0.0030
Day 4 - 
frozen
0.206 ± 
0.026 
(0.0007)
0.487 ± 
0.047 
(0 .0 0 2 2 )
Day 6  - 
firesh
0.251 ± 
0.017 
(0.0003)
0 . 0 0 0 0 0.475 ± 
0.045 
(0 .0 0 2 0 )
0.0042
Day 6  - 
frozen
0.184 ± 
0.019 
(0.0004)
0.391 ± 
0.033 
(0 .0 0 1 1 )
Table 21. Summary of the mean, standard error (SEM), variance and statistical 
comparison for fresh verses frozen MTT samples during 6  day time course. Only the 
day 6  fresh sample for 1 bead/well was statistically different from all the remaining 
samples (*, p>0.05). The frozen and fresh absorbance results were equally variable 
for 2 beads/well. Data from the 3 beads was discounted because the cell number was 
outside the MTT assay linear range. Therefore, the frozen storage step does not 
appear to adversely affect the MTT assay. Trypsin/EDTA was not used in this study.
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6.2.2.3. Addition of 10X trypsin/EDTA in saline to alginate-
GRGDY beads
Mean ± SEM (variance)
NoT/E lOpL T/E 20pL T/E 20pL T/E 
(replicate)
First reading 0.307 ± 0.007 
(0 .0 0 0 0 )
0.434 ±0.010 
(0 .0 0 0 1 )
0.416 ±0.010 
(0 .0 0 0 0 )
ND
Second
reading
0.343 ± 0.022 
(.0005)
0.420 ±0.013 
(0 .0 0 0 2 )
0.396 ± 0.022 
(0.0005)
0.428 ± 0.005 
(0 .0 0 0 0 )
Third reading 0.344 ± 0.023 
(0.0005)
0.429 ± 0.020 
(0.0004)
0.406 ±0.019 
(0.0004)
0.425 ± 0.008 
(0 .0 0 0 0 )
Fourth reading 0.335 ±0.018 
(0.0003)
0.431 ±0.019 
(0.0004)
0.386 ±0.021 
(0.0004)
0.431 ±0.014 
(0 .0 0 0 2 )
p-value among 
four readings
0.1249* 0.7181 * 0.2937 * 0.7884 *
Comparison of p-values among 
designated samples
All samples T/E containing 
samples
First
reading
0 . 0 0 0 0  # 0.0855 +
Second
reading
0.0013 # 0.0900 +
Third
reading
0.0017# 0.2726 +
Fourth
reading
0.0005 0.0346
Pooled
readings
0 . 0 0 0 0 0 . 0 0 0 2
Table 22. Summary of the mean, standard error (SEM), variance, and statistical 
comparison for hMSCs in alginate-GRGDY beads dissolved using 10X trypsin/EDTA 
(denoted as T/E). Each individual sample was not statistically different (*, p>0.05) 
for all four readings (out to 2 hour dissolution time). There was no statistical 
difference (+, p>0.05) between the samples containing trypsin/EDTA (T/E) for the 1st, 
2nd and 3rd readings. There was a significant difference between all the samples and 
the samples just containing trypsin/EDTA (#, p<0.05) for the 1st, 2nd and 3rd readings.
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6.2.3. Comparison of negative controls versus ASMA stained
i m m u n o h i s t o l o g i c a l  p r e p a r a t i o n s
A
Figure 73. Cytology preparations o f hMSCs stained with hematoxylin and ASMA on 
day 6 o f media differentiation study. High magnification (400X) o f cells grown with 
( A )  MSCCM, ( B )  DMEM and (C) CDMEM
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AFigure 74. Cytology preparations o f hMSCs stained with hematoxylin and ASMA on 
day 9 o f media differentiation study. High magnification (400X) o f cells grown with 
(A) MSCCM, (B) DMEM and (C) CDMEM
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Figure 75. Groupings o f immunohistology slides o f hMSC/alginate beads to compare 
ASMA staining to negative controls. When possible the photos were from the same 
position in the bead cross section. Beads were cultured in CDMEM and rSMC co- 
cultures for 4 days (Photos A&B) and for 11 days (C&D). Beads were also cultured in 
DMEM (control medium) for 4 days (E&F) and for 11 days (G&H). (All 400X 
magnification.)
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Figure 75. (Continued from previous page) Groupings o f immunohistology slides of 
hMSC/alginate beads to compare ASMA staining to negative controls. When possible 
the photos were from the same position in the bead cross section. Beads were cultured 
in CDMEM and rSMC co-cultures for 4 days (Photos A&B) and for 11 days (C&D). 
Beads were also cultured in DMEM (control medium) for 4 days (E&F) and for 11 days 
(G&H). (All 400X magnification.)
H Day 11 DMEM
—  wmr
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Negative control ASMA staining
Figure 76 Groupings of immunohistology slides to compare ASMA staining to 
negative controls in differentiation study using the ‘intermediate process’. The photos 
were obtained from the same position in the bead cross section. Photos A-D: day 9 o f 
culture; and photos E-F: day 23. (All 400X magnification)
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6.2.4. FACS reports for hMSC differentiation studies
Data. 045
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o
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Figure 77. FACS results from hMSCs/alginate beads cultured in DMEM (control)
and not labeled (empty).
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Figure 78 FACS results from hM SC s/alginate beads cultured in DMEM (control)
and labeled with CD34
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Figure 79. FACS results from hMSCs/alginate beads cultured in DMEM (control)
and labeled with SH2
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Figure 80. FACS results from hMSCs/alginate beads cultured in DMEM (control)
and labeled with SH4.
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Figure 81. FACS results from hMSCs/alginate beads cultured in DMEM (control)
and labeled with ASMA.
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Figure 82. FACS results from hMSCs/alginate beads cultured in CDMEM with
rSMC co-cultures not labeled (empty).
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Figure 83. FACS results from hMSCs/alginate beads cultured in CDMEM with
rSMC co-cultures and labeled with CD34.
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Figure 84. FACS results from hMSCs/alginate beads cultured in CDMEM with
rSMC co-cultures and labeled with SH2.
-296-
Data.059
CM R1
0 200 400 600 800 1000
FSC-H
Data.059
3  ° lU. 3
R2
10 10 '
FL1-H
Data.059
o -
10
FL1-H
Gate: G1 Gated Events: 485
Total Events: 1000 X Parameter. FL1-H (Log)
Y Parameter. FL2-H (Loq)
Region E vents % Gated % Total X Mean X Geo Mean Y Mean Y G eo Mean P x.P y  
R1 485 100 .00  4 8 .50  1.01 1.01 1 24 1 .16 1 .2
R2 485 100 00  48  50 1 01 1 01 1.24 1.16 3 .4
Gate: G1 Gated Events: 485
Total Events: 1000 X Parameter: FL1-H (Log)
Y Parameter: FL2-H (Log)
G ate E vents % Gated % Total
G1 485 100.00 48.50
G2 485 100.00 48 50
G3 0 0 00 0 00
X Parameter FL1-H (Log)
Marker Left. Right Events % Gated % Total Mean G eo Mean CV Median Peak Ch 
All 1. 9910 485 100.00 4 8 .5 0  1 01 1.01 6 .19  1 00 1
Figure 85. FACS results from hMSCs/alginate beads cultured in CDMEM with
rSMC co-cultures and labeled with SH4.
-297-
C
ou
nt
s
Data. 060
00
R1
200 4000 600 800 1000
FSC-H
Data.060
<n
R2
FL1-H
Data 060
iu i
10v 1 0 ' 10
FL2-H
10
Gate: G1
Total Events. 1000  
Y Parameter FL2-H (Log)
Gated Events. 584  
X Parameter: FL1 H (Log)
Region E vents % Gated % Total X Mean X G eo Mean Y Mean Y G eo Mean Px.Py
R1
R2
584
542
100 00 
92.81
58 40  
54 .20
3 47  
3 52
2 62  
2 73
9 48  
7 24
6 .76
6.10
1 . 2 
3. 4
Gate: G l
Total Events: 1000  
Y Parameter: FL2-H (Log)
Gated Events: 584  
X Parameter: FL1-H (Log)
Gate E vents % Gated % Total
G1 584 100 00 58 40
G2 542 92.81 54 .20
G3 42 7 19 4 .2 0
X Parameter FL2-H (Log)
Marker Lett, Right E vents % G ated % Total Mean Geo Mean CV Median Peak Ch 
All 1, 9910 584 100 0 0  5 8 .4 0  9 .4 8  6.76 157 21 6 67 9
Figure 86. FACS results from hMSCs/alginate beads cultured in CDMEM with
rSMC co-cultures and labeled with ASMA.
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